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General introduction

Clin i cal fea tures
The clinical approach to a child with a sus-
pected neuromuscular dis order starts with
a care ful his tory and phys i cal exam i na tion.
Com mon pre sent ing symp toms of mus cle
disorders in childhood include delay in
achieving motor milestones, abnor mal
gait, ten dency to fall, muscle weak ness,
and flop piness or hypotonia. The onset,
duration and evolution of symp toms and
signs usually lead to one or more diag nos-
tic pos sibilities. The age of onset is impor-
tant, as the dif fer en tial diag no sis of
weakness that is present dur ing the neo na-
tal period raises other diag nostic
11
Diagnostic evaluation of
neuromuscular dis or ders in
childhood
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Introduction
The term neuromuscular dis orders comprises a het erogeneous group of dis orders that
affect the peripheral motor or sensory neu ron (anterior horn cell, sensory gan glion, nerve
root, plexus or peripheral nerve), neuromuscular junction and skeletal mus cle (figure 1.1).
Over 600 dis orders have been identified to date. Most are rare, but all together they have a
prevalence in chil dren of approx imately 60 / 100,000 (table 1.1). This chapter describes
the current ini tial diag nostic approach in children with a sus pected neuromuscular dis order,
and dis cusses the pos sible future role of  skeletal mus cle ultrasound within the diagnostic
eval u a tion “path way” of these chil dren.
Fig ure 1.1
Structure of the
peripheral motor and 
sen sory neu ron,
neuromuscular junc -
tion and mus cle.
considerations than when the onset of
weakness is dur ing childhood (table 1.2
and 1.4).
Neuromuscular disorders in
infancy
In infancy the most prom inent sign of
neuromuscular dis orders is hypotonia
(figure 1.2). When supine, the child is in a
frog-like posi tion with sparse or no spon -
ta ne ous move ments. How ever, hypotonia
is a com mon sign in infancy that is not spe-
cific for neuromuscular disorders. It can
also be caused by a dysfunction of the brain 
or spi nal cord. Central hypotonia can
often be iden tified by history and physical
exam i na tion, show ing other signs of
abnormal brain func tion and pre cursors of
spasticity, such as fisting, scis soring or
rapid changes in mus cle tone (table 1.3).
In periph eral hypotonia pos tural reflexes
as well as ten don reflexes will be absent or
diminished. Mus cle atrophy can be a
prominent fea ture, but does not exclude
the possibility of central hypotonia. In
some chil dren the dif fer en ti a tion between
a cen tral or peripheral cause of the
hypotonia is not very obvious, especially
when disorders are pres ent that affect both 
central and peripheral ner vous system,
such as mito chondrial encephalo-
myopathies.
Neuromuscular disorders with
childhood onset
When neuromuscular dis orders become
apparent in childhood, delayed develop-
ment of motor skills or increased
12
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Congenital muscular dystrophy
Congenital myotonic dystrophy
Congenital myopathy (central core, nemaline rod)
Metabolic myopathies (acid maltase deficiency)
Muscle
Transient neonatal myasthenia gravis
Congenital myasthenic syndromes
Infantile botulism
Neuromuscular transmission
Hereditary motor sensory neuropathy type 3 (Dejerine Sottas
syndrome)
Peripheral nerve
Spinal muscular atrophy type 1Anterior horn cell disorder
Neuromuscular disorders in infancy
Table 1.2 Examples of neuromuscular dis orders com monly pre senting in infancy
0.1Myasthenia gravis
0.3Chronic inflammatory
demyelinating polyradiculopathy
0.8Limb girdle muscular dystrophy
1-2Myotonia congenita
3Guillain Barré syndrome
5Metabolic myopathy
5Fascioscapulohumeral dystrophy
3-5 (in boys)Becker muscular dystrophy
12Myotonic dystrophy
10-17Spinal muscular atrophy
17-40Hereditary motor sensory
neuropathy
30 (in boys)Duchenne muscular dystrophy
Prevalence /100,000Disorder
Table 1.1 Var ious neuromuscular dis orders and
their prevalence [Royden Jones 2003; Fenichel
1997]
stumbling and fall ing are often the par ents’
first com plaints. Older children are often
referred for neu ro logic exam i na tion
because they can’t keep up with their peers 
at school or sports.
Examination of the neuromuscular system
in young children is mainly done by
observing the child’s nat ural movements
such as sit ting, stand ing and walk ing. With
increasing age, muscle strength test ing can
be accomplished with more accuracy. In
case of prox imal mus cle weakness a
Gowers’ sign may be present: the child has
difficulties ris ing from the floor and uses
13
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Figure 1.2 Floppy infant. Note the head lag and frog-like posi tion.
Muscle atrophyFisting of the hands, scissoring on vertical
suspension, rapid changes in muscle tone
FasciculationsDysmorphic features
Normal consciousnessAbnormalities of other brain functions, such as 
decreased consciousness or convulsions
No malformation of other organsMalformation of other organs
Failure of movement on postural reflexesMovement through postural reflexes
Absent or depressed tendon reflexesNormal or brisk tendon reflexes
Peripheral hypotoniaCentral hypotonia
Clinical features in central and peripheral hypotonia
Table 1.3 Clin ical fea tures that are indic ative of a periph eral or cen tral cause of hypotonia [Fenichel
1997].
14
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Figure 1.3 Gowers’ sign. Pho tograph by Hein rich Curschmann (Klinische Abbildungen 1894, plate 8&9),
adapted with per mission from: http://www.artandmedicine.com
his or her hands to push off or climb up the
leg (fig ure 1.3). Toe-walking is commonly
encountered, but it is not specific and can
also be seen in upper motor neu ron dis or-
ders with spasticity or in chil dren with
idiopathic tight heel cords. Facial weak -
ness can result in a myopathic facies with a
tent-shaped mouth, ptosis and pau city of
spon ta ne ous move ment and facial expres-
sions (figure 1.4). 
Tendon reflexes are often decreased, but
can still be nor mal in early stages of
neuromuscular dis orders. A care ful eval u-
ation of the sen sory system is impor tant, as 
sensory problems can be pres ent in disor-
ders of the peripheral nerve, but are absent 
in dis orders of the ante rior horn cell,
neuromuscular trans mission and mus cle.
However, assess ing the presence of sen-
sory deficits poses some dif ficulties at a
young age.
It is impor tant to look for other diag nostic
clues, such as involvement of the skin or
other organs. Many mus cular dys trophies
and met abolic myopathies are accom pa-
nied by cardiac involvement, although
often later in the course of the dis ease. In
con trast, dis eases affect ing ante rior horn
cells, peripheral nerves or neuromuscular
junction spare the heart as a rule. 
Laboratory
investigations
Degen er a tion of mus cle tis sue leads to
leaking of creatine kinase (CK) and
transaminases into the serum. High CK
levels (up to 50 times the nor mal) can be
found in Duchenne and Becker mus cular
dystrophy and also in acute rhabdomyo-
lysis or malig nant hyperthermia. Other
15
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Figure 1.4 Myopathic facies in a child with myo -
tonic dys tro phy.
Duchenne muscular dystrophy
Limb girdle muscular dystrophy
Facioscapulohumeral dystrophy
Metabolic and mitochondrial myopathies
Muscle
Myasthenia gravisNeuromuscular transmission
Hereditary motor sensory neuropathy type 1 and 2
Guillain Barré syndrome
Peripheral nerve
Spinal muscular atrophy type 2 and 3Anterior horn cell disorder
Neuromuscular disorders in childhood
Table 1.4 Examples of neuromuscular dis orders com monly pre senting in child hood.
forms of mus cular dys trophy and inflam -
matory myopathies are asso ciated with
mild to moderate increased CK lev els,
whereas in con gen i tal and met a bolic
myopathies or myasthenic syn dromes the
CK is nor mal or only slightly increased
even when marked muscle weak ness is
present [Dubowitz 1995]. Other blood
and urine tests can pro vide valuable infor -
ma tion as screen ing pro ce dures. Lac tate
and pyruvate may be elevated in mito -
chondrial dis ease, whereas fatty acids and
carnitine (and its acylated pro file) may be
altered in defects of fatty acid oxi dation.
Immunologic tests may be infor mative,
such as ace tyl cho line recep tor anti bod ies
in sus pected myas the nia gra vis. 
Electromyography
Electromyography (EMG) is the cur rent
diagnostic instrument of choice in the
diagnosis of most neurogenic dis orders. In
this the sis the abbreviation “EMG” is used
for the combination of nerve con duction
studies (NCS) and nee dle electromyo-
graphy (needle EMG). 
Nerve con duc tion stud ies
Nerve con duction studies are rou tinely
performed with sur face electrodes and are
therefore non-invasive. They can be done
with rel a tively lit tle dis com fort in many
patients. In diseases affecting the periph-
eral nerve, the pathology may be located
primarily in the axon (axonal neuropa-
thies) or in the sur rounding myelin
(demyelinating neuropathies). Axonal
neuropathies show nor mal or only slightly
decreased nerve con duc tion veloc i ties. In
case of acute or severe axonal degenera-
tion less motor units will dis charge after
stim u la tion, result ing in a decreased
compound mus cle action potential ampli -
tude. Axonal dam age is often com pen-
sated by motor unit reinnervation through
residual func tional axons, which leads to a
normalization or only slightly decreased
compound mus cle action potential ampli -
tude. In demyelinating neuropathies
decreased motor nerve conduction veloc-
ity to 70% of the lower limit of nor mal or
less is the most prominent finding. Assess -
ment of sen sory nerve con duction velocity
and sen sory nerve action poten tial ampli -
tude is necessary to determine whether a
sen sory com po nent is pres ent.
In patients with myastenic syn dromes
repetitive 3 Hz nerve stim ulation is per-
formed to dem onstrate the typ ical
decremental response.
Needle EMG
Needle EMG is a valu able tool for diagnos-
ing neuromuscular dis orders, but can be
an uncom fort able and pain ful exam i na -
tion, especially in children. At rest, spon -
taneous muscle activ ity can be detected.
Fibrillations and positive sharp waves are
depolarisations of sin gle mus cle fibres and
indicate the loss of con tact between the
axon and the fibre. For this rea son spon ta-
neous activity is a prom inent symptom of
peripheral nerve dis orders, but it can also
occur in myopathies, when mus cle fibres
are split or when inflam mation is present
between the mus cle fibre and the axon.
Needle EMG at rest can also reveal myo -
tonic discharges, indicative of a form of
myotonia, and fasciculations, which are
spon ta ne ous con trac tions of one motor
unit and arise from irri tability of the motor 
neuron or its axon. As a nee dle electrode
can only detect elec trical activity arising
from a small mus cle area sur rounding the
needle tip, the needle has to be replaced
16
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repeatedly to evaluate the mus cle for pres-
ence of spon ta ne ous activ ity.
Voluntary contraction is required to eval -
uate the motor unit poten tials (MUPs) and 
their recruitment into force generation.
This can iden tify changes point ing to an
under ly ing myopathy or neu rop a thy. In
myopathies, the ampli tude of the MUPs
generally become smaller and their dura -
tion shorter, with a fast recruitment of
additional motor units because of loss of
muscle fibres within the motor units. In
neurogenic dis orders denervation causes
loss of MUPs, resulting in a less dense
interference or even single unit pat tern on
max i mal vol un tary con trac tion. Reinner-
vation of denervated mus cle fibres by
other axons results in MUPs with a larger
amplitude and lon ger dura tion.
A full eval uation of nee dle EMG requires
sev eral lev els of vol un tary mus cle acti va -
tion as well as moments with out vol untary
con trac tion to assess spon ta ne ous activ ity.
This requires cooperation of the patient
for at least part of the inves tigation. For
this reason per forming an EMG can be
chal leng ing, espe cially in chil dren
between the age of 1 and 6 years. A recent
retrospective study reported that lack of
cooperation because of fear or pain had
hampered the EMG inves tigations in 15 -
20% of the chil dren investigated
[Hellmann 2005].
The sen sitivity of EMG for detecting
neurogenic dis orders is high in every age
group (88% – 100%) [Buchthal 1982;
David 1994; Hellmann 2005]. In retro-
spective stud ies EMG shows lower sen si-
tivities for the  detec tion of myopathies,
especially in children. In floppy infants
with myopathies, the EMG results cor -
rectly pre dicted the final diagnostic
category in only 10%, whereas in chil dren
above the age of 5 years and in adults sen si-
tivities of approx imately 80% are reported
[Buchthal 1982; David 1994; Hellmann
2005; Rus sel 1992].
Muscle biopsy
In most myopathies a mus cle biopsy is
needed to estab lish the final diag nosis. Sev -
eral histological and histochemical staining
techniques can be applied to a mus cle
biopsy spec imen. Light microscopy can
reveal sev eral abnor mal i ties with rou tine
haematoxylin and eosin staining, for
example myopathic changes with internal
nuclei or dystrophic changes with replace-
ment of nor mal mus cle tissue by fat and
fibro sis (fig ure 1.5). Enzyme his to chem is-
try stain ing is rou tinely applied for fibre
typ ing, mito chon drial activ ity, and the
presence of inclusions such as rag ged red
bodies, minicores, or lysosomal accumula-
tions which could pro vide fur ther clues to
the diag no sis. Addi tion ally, immunohisto-
chemistry can be applied to visu alize spe -
cific pro teins, such as dystrophin which
absence con firms the diag nosis of
Duchenne mus cu lar dys tro phy. Cur rently
all kinds of other pro teins of the
sarcolemma, extracellular matrix, mem -
brane or inflam matory pro cesses can be
stained and tested to detect mus cular dys -
tro phies and inflam ma tory myopathies.
Electron microscopy is not rou tinely per -
formed, but can reveal ultrastructural
changes found in con genital myopathies
such as cen tral cores, minicores and
nemaline rods. Struc tural abnor mal i ties of
the mitochondria can also be visu alized
with this technique. Mitochondrial energy
production can be eval uated in mus cle
17
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Nor mal mus cle 
The mus cle fibres re approx imately equal in
size, with a reg ular pattern and hardly any
connective tis sue or fat in between. 
Neurogenic appearance
Grouped atro phic fibres and areas with rel a-
tively large mus cle fibres. Increased amounts
of con nective tis sue are seen around and
between the atro phic fibres. 
Mus cu lar dys tro phy
Increased vari ation in fibre type, fibre necro sis
and cen trally nucle ated fibres. The amount of 
fat and con nective tis sue is increased.
Figure 1.5 Examples of mus cle biop sies with HE stain ing (orig inal enlarge ment 200x): nor mal mus cle (upper 
panel), neurogenic changes (middle panel), and mus cular dys trophy (lower panel). With cour tesy of Prof.
M.M.Y. Lammens and Dr. H.J. ter Laak.
tis sue, by mea sur ing ATP pro duc tion and
enzyme complex activities.
A mus cle biopsy can be obtained percuta-
neously with a needle or sur gically by
means of a so-called open biopsy. An open
biopsy is done when more mus cle spec i-
men is needed, for exam ple for extensive
histochemical anal ysis or storage, or when
the selected muscle is severely atrophic
and dif ficult to local ize, but in most cir-
cumstances a needle biopsy can pro vide
suf fi cient mus cle tis sue. Nee dle biopsy is
pref er a ble when pos si ble. It can gen er ally
be per formed under local anaes thesia,
whereas an open biopsy requires gen eral
anaesthesia. Especially in patients with a
sus pected neuromuscular dis or der gen eral
anaesthesia can be haz ardous, as some
neuromuscular dis or ders are accom pa nied 
by weak ness of the respiratory muscles or
a risk of malig nant hyperthermia. There-
fore a careful selection of the patients in
which an open mus cle biopsy is indi cated is 
required.
Muscle biopsy will not lead to a final diag-
nosis in all patients. Some myopathies
result in only few structural abnor malities,
making it dif ficult to establish a def inite
diag no sis. More over, some myopathies
show selec tive mus cle involvement,
bringing the risk of sam pling errors. For
this rea son iden ti fi ca tion of mus cles that
19
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Figure 1.6 Elec tron micros copy of a sural nerve biopsy taken in a patient with a hered itary demyelinating
polyneuropathy (Charcot Marie Tooth type 4b). The nerve biopsy shows reduced myelinated fibre density
together with a very char acteristic find ing in this dis ease called focally folded myelin (right lower panel).
Enlargement 1200x and 1600x. With cour tesy of Prof. M.M.Y Lammens and Dr. H.J. ter Laak.
are affected by the disease process would
be preferable. It is important, how ever, to
avoid biopsies of too severely affected
muscles, as pro nounced atrophy or fibro sis
could also lead to dif ficulties in mak ing the
diagnosis. In these biop sies only fibrous
tissue and fat can be present with too little
muscle remaining to identify a specific dis-
ease. Imag ing techniques could aid in the
selection of the opti mal mus cle biopsy site
by visu alizing affected muscles and esti-
mating the sever ity of involvement.
Nerve biopsy
Nerve biopsy, routinely of the sural nerve, 
can be performed to help iden tify the
cause of an axonal or demyelinating neu -
ropathy. Light microscopy and electron
microscopy can reveal structural changes
of myelin or axonal degeneration, pro vid-
ing further direc tions to specific genetic
dis or ders (fig ure 1.6). More over, inflam-
matory processes can be detected,
pointing to vasculitis, or chronic inflam -
matory demyelinating polyradiculitis
(CIDP), which will have major therapeuti-
cal impli ca tions. 
Nowadays genetic test ing has replaced
nerve biopsy in many hered itary neuropa-
thies. How ever, many of the axonopathies
remain poorly understood and dif ficult to
cat e go rize. When clin i cal assess ment, lab-
o ra tory inves ti ga tions and electromyo-
graphy in these patients are unsuccessful in
identifying the cause, nerve biopsy has
been shown to aid in the diag nosis in about
38% [Royden Jones 2003]. 
Muscle imaging with MRI
and CT 
Mag netic res o nance imag ing (MRI) and
computed tomography (CT) are both well
capa ble of visu al iz ing mus cle tis sue (fig ure
1.7) [Alanen 1994; Mercuri 2007]. MRI
can show fatty infil tration on T1 weighted
sequences, whereas T2 and STIR images
20
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Figure 1.7  3T MRI of the forearm. Nerves, veins and arteries are eas ily rec ognizable. Tendons appear
as black struc tures within mus cle groups. Individual mus cles can par tially be dis tinguished.
APL = abduc tor pollicis longus; EDC = extensor digitorum communis; EPL = extensor pollicis longus;
FCR = flexor carpi radialis; FCU = flexor carpi ulnaris; FDP = flexor digitorum profundus; FDS =
flexor digitorum superficialis; FPL = flexor pollicis longus; PT = pronator teres. With cour tesy of Dr.
Giulio Gambarota.
can show oedema suggestive of inflam ma-
tion [Mercuri 2007; Reimers 1997]. MRI
is there fore capable of detect ing muscle
changes caused by neuromuscular dis or-
ders. In adults mus cle MRI is mainly used
in patients with inflam matory myopathies,
to determine the extent of mus cle pathol-
ogy and determine the opti mal site for
muscle biopsy [Fleckenstein 1996; Lovitt
2004; Reimers 1997]. In chil dren mus cle
MRI has been used to deter mine the distri-
bution of affected mus cles as this can help
to identify the presence of specific congen-
i tal myopathies and mus cu lar dys tro phies.
The diag nostic accuracy of these find ings
has not been investigated [Chan 2002;
Jungbluth 2004; Mercuri 2005]. 
CT has also shown to be capa ble of detect-
ing fatty infil tration caused by neuromus-
cular dis orders, but data on the diag nostic
accuracy of this technique are lacking too.
CT is supe rior to MRI in detecting
calcifications caused by inflammatory
myopathies (fig ure 1.8) [Gar cia 2000].
The major disadvantages of MRI are its
limited avail ability, and the necessity of
sedation or anaesthesia in young chil dren.
CT is widely available and requires seda-
tion less often because of its short scan
time but has the dis advantage of ion izing
radi a tion
Molecular genetic tests
When a neuromuscular dis order is sus-
pected of which the genetic abnor mality is
known, DNA anal ysis can be per formed in 
blood or skin biopsy sam ples. In some dis -
orders, such as Duchenne mus cular dys -
tro phy or spi nal mus cu lar atro phy, the
diagnosis is often already sus pected based
on clin i cal eval u a tion and mea sure ment of
CK levels. In these disorders molecular
genetic tests are often the next diagnostic
step. If genetic tests fail to con firm the sus -
pected diag no sis ancil lary inves ti ga tion are
needed. For exam ple, mus cle biopsy can
confirm the presence of Duchenne mus cu-
lar dys trophy and allows for fur ther
genetic test ing based on muscle RNA
extraction. In other neuromuscular dis or-
ders the clinical phe notype is not suf ficient
to direct genetic test ing and further eval u-
ation is necessary. For exam ple, in case of
a hered i tary motor sen sory neu rop a thy
(HMSN), an EMG is nec essary to deter-
mine whether the neu ropathy is axonal or
demyelinating, and in case of a myopathy a
muscle biopsy has to pro vide addi tional
clues for the pres ence of dystrophic
changes, fibre-type spe cific changes, inclu -
sions etc. Cur rently, in approx imately half
of all neuromuscular dis orders DNA
mutations have been detected, and this
21
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Figure 1.8 3D-CT scan of the lower leg show ing
multiple calcifications caused by juve nile
dermatomyositis.
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number is still expand ing. An updated list
of all avail able genetic tests can be found at
www.genetest.org and
www.dnadiagnostieknijmegen.nl.
Muscle ultrasound in the
diagnosis of
neuromuscular disorders
In the ini tial diag nos tic eval u a tion of chil-
dren with sus pected neuromuscular dis or-
ders, one would ide ally apply a tool that
can quickly and non-invasively determine
if fur ther invasive, uncom fortable or com -
plicated pro cedures, such as blood sam -
pling, EMG, and MRI with seda tion are
necessary. Mus cle ultrasound is a non-
invasive and pain less tool, that can easily
be used without sedation even in the very
young. We performed sev eral studies to
determine the value of mus cle ultrasound
in the diagnosis of neuromuscular dis or-
ders in chil dren. The first aim was to
determine the value of mus cle ultrasound
as a screening tool to eval uate if a neuro-
muscular dis order is present or if the
symptoms are caused by another con di-
tion. Such disorders are referred to as
“non-neuromuscular dis order” in this the-
sis, com prising all con ditions with symp -
toms mim icking a neuromuscular dis order
such as cen tral nervous sys tem dis orders,
but also benign vari ations of nor mal devel -
opment. We also assessed if muscle ultra-
sound can also be used in selecting mus cles
for mus cle biopsy, and the dif fer en ti a tion
between neurogenic or myopathic disor-
ders to direct fur ther inves tigations.
To offer a con text for the possible role of
muscle ultrasound, two flowcharts are
presented at the end of this chap ter (fig ure
1.9 and 1.10). These flow charts give an
impression of the ini tial steps that are cur-
rently taken to reach a diagnosis in chil-
dren with sus pected neuromuscular
disorders. In the general dis cussion of this
thesis (Chapter 15) we will revisit these
flow charts to determine where and how
muscle ultrasound has or might have addi -
tional value.
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Basis of ultrasound
imag ing
Reflections and acoustical
impedance
Sound waves and their echoes form the
basis of ultrasound images. A transducer
sends out pulses of high-fre quency sound
waves and receives their ech oes. Reflec-
tion of sound waves can occur when the
ultrasound beam encounters a dif ferent
tissue. Two fac tors influ ence the amount
of reflec tion: the acoustical imped ance of
the two tis sues and the angle between the
direction of the sound wave and the
reflect ing sur face (fig ure 2.1) [Fish 1990;
Shir ley 1978].
The acous ti cal imped ance com prises the
combination of the den sity of the tissue
and the sound velocity within the tis sue,
which is different for each tis sue type
(table  2.1).
The larg est dif fer ences in acous ti cal
impedance are found between bone and
air, in which sound has a velocity of
approximately 300 and 4000 m/s, respec-
tively, whereas in muscle the sound veloc -
ity is approx imately 1580 m/s [Shirley
1978]. The larger the dif ference in
27
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muscle ultrasound2
Introduction
Ultrasound has been used in medical prac tice since the early 1950s, when Wild and col-
leagues discovered the ability of high-frequency ultrasonic waves to visu alize liv ing tis sues
[Wild 1951]. Since then, the technique of ultra sound has rap idly evolved, lead ing to its
widespread use in almost all fields of med icine because of its non-inva sive nature and
real-time dis play. In 1980 it was first dis covered that dis eased muscles showed a dif ferent
ultrasound appear ance compared to healthy muscles [Heckmatt 1980]. Next to
neuromuscular dis orders, malig nancies, infec tions, hematomas and rup tures of the
musculoskeletal sys tem can also be detected with ultra sound [Camp bell 2005; Fornage
2000; Hashimoto 1999; Peetrons 2002]. Cur rently, ultra sound is widely avail able and
ultrasound techniques have fur ther improved, resulting in dis play of mus cle tissue with res -
olutions up to 0.1 mm [Cosgrove 1992], which is higher than the resolution that can be
achieved with for exam ple 3 T Mag netic Res onance Imag ing (MRI), which has a resolution
up to 0.2 x 0.2 x 1.0 mm [Saupe 2005]. 
This chapter pro vides insight in the technique of ultra sound imag ing and an intro duction of
its use in the dis play of healthy and dis eased muscle.
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Reflec tion:
Sound per pendicularly hits a struc ture with a differ-
ent acoustical imped ance. It returns to the
transducer, resulting in a white speckle on the ultra -
sound image.
Deflec tion:
Sound hits a struc ture obliquely. It gets deflected
and will not return to the ultrasound image. This
structure will there fore not be visualized on the
ultra sound image.
Scat ter ing:
The ultra sound beam encounters a structure smaller
than the wave length. The sound gets scattered and
only a small part of the sound returns to trans ducer.
This results in only a small increase of echo inten-
sity, while most of the ultrasound beam is
atten u ated.
Absorp tion:
The ultrasound beam is absorbed by the tis sue and
transformed into thermic energy. The amount of
absorption is depend ent on the type of the tissue and
the fre quency of the trans ducer.
Figure 2.1 Interactions between the ultrasound beam and tis sue.
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Figure 2.2 This fig ure shows the inter action between an ultra sound beam and nor mal or pathological tis -
sue (left panel) with exam ples of the cor responding ultra sound image (right panel). When the ultra sound
beam encoun ters tis sue with a dif ferent acous tical imped ance such as the tran sition from mus cle to fas cia,
part of the sound is reflected (left upper panel). As healthy mus cle con tains only lit tle fibrous tis sue only a
few reflec tions occur. This results in a rel atively black pic ture (right upper panel). The acous tical imped -
ance is very dif ferent between mus cle and bone, caus ing a strong reflection with hardly any sound pass ing
through. This results in a bright bone echo with a char acteristic bone shadow under neath (mid dle panel).
In neuromuscular dis orders such as Duchenne mus cular dys trophy mus cle tis sue is replaced by fat and fibro -
sis, result ing in many transitions with dif ferent acous tical imped ances and much reflec tion of the
ultrasound beam. This explains why the mus cle ultra sound image appears whiter. Attenuation of the ultra -
sound beam also occurs in Duchenne mus cular dys trophy, caus ing the super ficial part of the mus cle to be
whiter than the deeper part and mak ing the humerus nearly invis ible.
acoustical imped ance the larger the
amount of reflection of the ultra sound
beam. A small difference in acous tical
impedance will result in no reflection or
reflection of only a small part of the sound
wave, while most of the ultra sound beam
is trans mitted to deeper lay ers. This is also
the case within muscles: struc tures within
healthy muscles will mostly transmit the
sound (fig ure 2.2). Con versely, a transi-
tion with a very large dif ference in acous ti-
cal imped ance will result in reflec tion of
all sound. Behind such a tran sition, no
imaging is pos sible. For example, the dif -
ference in acous tical imped ance of air and
skin is very large, which makes it impossi-
ble to pro duce ultrasound images with out
gel or another con tact fluid between the
transducer and the skin (fig ure 2.3). In the
same way it is impossible to visualize
healthy (air-containing) lungs. A transition
from mus cle to bone or calcifications will
also cause a strong reflection. As the
amplitude of the sound wave cor responds
to the bright ness of the image, the strong
reflection of bone results in a bright spot
on the ultrasound image. Con sequently,
because hardly any sound gets through, no
structures beneath this tran sition can be
dis played, result ing in a char ac ter is tic
bone “shadow” (fig ure 2.2).
The amount of reflection is also deter-
mined by the angle at which the ultra sound
beam reaches a dif ferent tissue [Fish 1990;
Shirley 1978]. A large angle will result in
deflection instead of reflection of sound.
In this way the sound wave will not return
to the trans ducer and the structure will not 
be dis played (figure 2.1). Fas cia sur round-
ing muscle, nerves and bone will be espe -
cially echogenic when they are reached
per pen dic u lar by the ultra sound beam.
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4080Bone
1585Muscle
1570Blood
1540Connective tissue
1540Water
1450Fat
330Air
Sound velocity (m/s)Tissue
Table 2.1 Sound veloc ity in var ious tis sues [Shir -
ley 1978].
Figure 2.3 Ultra sound image of the quadriceps
muscle with artefacts caused by air between the
skin and the trans ducer. This results in a black
line beneath the skin where the air is located
(both arrows) most pro nounced on the right.
When the air bub ble is small (left arrow), the
changes are sub tle with only a slightly decreased
echo inten sity in the struc tures below. F = femur,
V = vastus intermedius mus cle, R = rectus
femoris mus cle.
Oblique scanning will dimin ish the
echogenicity of these struc tures (figure
2.4). Moreover, fascia between muscles
that are in line with the ultrasound beam
are dif ficult to visu alize; the fas cia either
remains  black or is dis played as an inter-
rupted line (fig ure 2.5).
When the ultra sound beam encounters
structures smaller then the wavelength of
the sound emit ted, such as indi vidual mus -
cles fibres, the sound waves are not
reflected but scat tered (figure 2.1) [Shir -
ley 1978]. Only a small part of this sound
will return to the transducer, and will
therefore result in only a small increase of
the grey level in the pic ture.
Attenuation and the choice of
transducer frequency
When the sound beam travels to deeper
layers, attenuation occurs. This is caused
by reflection and scattering, but also by
absorption and transformation of the beam 
into thermal energy. The amount of
absorption depends on the type of tissue
(for example: very high in bone) and
increases with higher frequencies of the
transducer (figure 2.6). For average soft
tissues, the loss amounts to approx imately
1 dB per 10 mm tissue depth for each MHz
[Cosgrove 1992]. Gen erally, the depth
penetration is lim ited to about 200 mm in
a 3 MHz probe, 100 mm for a 6 Mz probe
and 12 mm for 50 MHz probe [Cosgrove
1992]. The choice of a transducer will
therefore depend on the depth and type of
tissue that is under inves tigation (table
2.2).
Creation of an ultrasound image
The creation of an image from all return-
ing echoes is based on a computer anal ysis
31
C h a p t e r 2
Fig ure 2.4 Ultrasound image of the arm per pendicular (left panel) and after tilting the transducer 5
degrees (right panel). With angulation of the trans ducer sound reach ing struc tures within and sur round-
ing the mus cle and the bone gets partially deflected. As this deflected sound does not return to the
transducer, the image is rel atively black com pared to the image with a per pendicular posi tion of the
transducer. Bi = biceps brachii, Br = brachialis mus cle, H = humerus, dou ble arrow = sub cutaneous tis -
sue.
of the temporal and acous tic prop erties of
the ech oes. Sim plified, the time between
sending and receiving the ultra sound pulse
determines the loca tion of the cor respond-
ing speckle on the screen, whereas the
amplitude of the sound wave cor responds
to the bright ness of the image: white for a
strong echo, black for a weak echo, and
varying shades of grey in between [Fish
1990; Shirley 1978]. The grey value of a
certain tis sue is deter mined by the amount
and ampli tude of the reflection. This grey
value is called echogenicity, or “echo
intensity” in this the sis.
The returning ech oes gen erate small sig -
nals and must be ampli fied for fur ther pro-
cessing. This is done by a mech anism
called “gain”. Increas ing the gain will not
result in more sound being emit ted, but in
more ampli fication of the return ing echoes
[Cosgrove 1992]. Because of the attenua-
tion described ear lier the returning ech oes
occupy a wide dynamic range, from strong 
signals from superficial layers to very weak
signals from deep structures. To cor rect
for this attenuation a time gain con trol
amplifier (TGC) is applied, which pro -
gressively amplifies more distant ech oes
[Cosgrove 1992]. How ever, not only the
reflections of structures but also the back-
ground noise will be ampli fied (fig ure
2.6). There fore the com pen sa tion mech a -
nisms of TGC are limited: when overlying
tissues absorb too much sound and hardly
any sound waves reach or are reflected by
deeper layers, deeper structures can not be 
visu al ized.
The ampli tudes of the returning echoes
show a large vari ation, i.e. the dynamic
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Figure 2.5 This fig ure shows an ultra sound image of the peroneus longus mus cle (PL). Fascia per pendicu-
lar to the ultrasound beam appear as bright white lines, as does the bone (black lines in sche matic
drawing). Fascia with an oblique ori entation to the ultrasound beam, such as the fas cia between the
peroneus longus mus cle and the extensor digitorum longus (EDL) is less bright (grey line). The fas cia
between the peroneus longus and lateral gas trocnemius mus cle (GL) is in line with the ultra sound beam
and there fore not vis ible at all (dotted line). 
30-100Eye
7-17Superficial muscles
4-8Deep muscles
3-7Abdominal organs
2-3Transcranial
Transducer
frequency (MHz)
Tissue of 
examination
Table 2.2 Choice of trans ducer fre quency in the
exam i na tion of var i ous tis sues
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Fig ure 2.6 This fig ure shows ultra sound images of the calf mus cles made with two different trans ducer fre -
quencies. The top panel was made with a 17 - 5 MHz broad band lin ear trans ducer result ing in an image
with a rel atively high res olution but also strong attenuation of the ultra sound beam. The fib ula is hardly
visible because much of the sound is absorbed by the over lying soleus mus cle (S), gastrocnemius mus cle and
the sub cutaneous tis sue (dou ble arrow). Increas ing the TGC (right upper panel) ampli fies the sig nal com ing
from deeper layers. This makes it pos sible to visualize deeper struc tures, although these structures are still
difficult to dis criminate from sur rounding tis sue because the back ground noise was also amplified. The bot -
tom panel was made with a 8-4 MHz broad band lin ear trans ducer. Because of the lower frequencies less
attenuation of the ultrasound beam occurred, result ing in a better display of deeper struc tures but with a
lower res olution. Increasing TGC has also ampli fied sig nals from deeper struc tures in the right bot tom
image.
range of the returning sig nals is large,
often approaching 90 dB (i.e. the smallest
signal is a fac tor 109 smaller than the larg -
est sig nal) [Cosgrove 1992]. This range is
much more than can be displayed as differ-
ent grey lev els on the monitor; in most
ultrasound devices up to 256 grey levels
are shown. This is sufficient for visual
interpretation of the image, as the human
visual sys tem can identify even less dif fer-
ent grey lev els [Gonzales 2008]. Compres-
sion is applied to reduce the range of
returning sig nals to 256 grey lev els. Since
the most valu able clin i cal infor ma tion lies
in the lower and mid-range ech oes (rep re-
senting soft tis sue tex tures like muscle),
compression is preset to show most con -
trast in this range [Cosgrove 1992]. The
pre cise com pres sion pat tern cho sen is
rather arbi trary to result in an image suited
for its pur pose, i.e. easy visual interpreta-
tion of the tis sue of interest.
Image resolution and choice of
transducer frequency
The resolution of an ultra sound image
must be considered separately for the axial
(depth along the beam) and lat eral direc-
tion (transversely across the beam). The
axial res olution is directly related to the
frequency of the transducer; at best it
approaches the wavelength of the sound
emitted by the transducer [Fish 1990;
Shirley 1978]. As higher frequencies are
accompanied by smaller wavelengths, a
transducer with the high est fre quency will
achieve the best axial res olution, but also
the least amount of tissue pen etration.
Diag nos tic fre quen cies of ultra sound
probes for conventional tissue imag ing lie
in the range of 2 to 20 MHz, with cor re-
sponding wavelengths of 0.8 to 0.08 mm.
The lim iting fac tor for the lat eral res olu-
tion of ultra sound is the beam width, which
is pri marily determined by the ratio
between the wave length and the trans -
ducer aperture [Cosgrove 1992; Fish
1990]. For the background of beam width
determining fac tors and focal zone (the
depth on which the beamwidth is smallest)
we refer to basic ultra sound lit erature
[Fish 1990; Shirley 1990]. Generally
speaking the lateral res olution is best in the 
focal zone of the ultra sound beam and is
several times larger than the axial res olu-
tion [Cosgrove 1992]. This means that
when the focus of the ultrasound beam is
positioned at a depth that con tains the
structures of inter est, these struc tures will
be visu alized with the best lat eral
res o lu tion.
In clinical practice the transducer that can
reach the depth of the tissue of exam ina-
tion with the high est fre quency would be
pref er a ble. In mus cle ultra sound stud ies 5
or 7.5 MHz probes are generally used.
Nowadays it is also pos sible to use broad -
band trans ducers (for example a 5 to 17
MHz probe), com bining the advan tage of
high fre quencies to image super ficial struc -
tures with high resolution (up to 0.1 mm)
and lower fre quencies to reach deeper
struc tures (res o lu tion decreases to 0.3
mm).
Nor mal mus cle
Histology
To under stand what is visualized with
muscle ultrasound it is nec essary to know
the architecture of mus cles up to the max i-
mum ultra sound res o lu tion Mus cles are
composed of mus cle fibres that nor mally
have a diam eter of approx imately 40 to 80
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m [Engel 1986]. In clin ical prac tice the
res o lu tion of mus cle ultra sound is 100
micrometer at best, which means that
either one large or a group of small mus cle
fibres are the smallest struc tures within
mus cle that can be indi vid u ally visu al ized.
Each muscle fibre is sur rounded by thin
fibrous tissue called endomysium. A group 
of muscle fibres forms a muscle fas cicle,
surrounded by perimysium. This con nec-
tive tis sue also con tains small ves sels and
nerves. The outside of the mus cle is made
of fibrous tis sue called epimysium, which
is thicker and stronger than perimysium
(figure 2.7). The epimysium continues to
form ten dons and sheet-like tendons called
aponeuroses [Junqueira 1995]. 
Apart from a structural organi sation mus -
cles also have a func tional organi sation.
The func tional unit is called a motor unit,
consisting of a motor neu ron and the mus-
cle fibres it controls (fig ure 2.8). The
number of mus cle fibres in a motor unit
varies from less than ten to sev eral hun-
dred, according to the size and func tion of
the mus cle. Large motor units, where one
neu ron sup plies sev eral hun dred mus cle
fibres, are found in the trunk and thigh
muscles, whereas motor units of small eye
and hand mus cles, where pre cision move -
ments are required, con tain only a few
muscle fibres. The mus cle fibres of a
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Figure 2.7 Nor mal mus cle archi tecture. Reproduced with per mission from www.ivy-rose.co.uk.
Figure 2.8 The motor unit is the func tional unit
of a mus cle. It con sists of the motor neu ron and
the mus cle fibres it con trols. Repro duced with
per mis sion from https://ecampus.wsc.edu
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Fig ure 2.9 The macro archi tecture of a mus cle is formed by the way its mus cle fas cicles are orga nized.
This can be par allel such as the biceps brachii mus cle (A), pennate such as the tibialis ante rior mus cle
(B), or tri angular such as the latissimus dorsi mus cle (C). This archi tecture becomes vis ible on ultra sound
with lon gi tu di nal mea sure ments. The anat omy pic tures are adapted with per mis sion from
www.preventdisease.com.
motor unit are not grouped together but
spread throughout the mus cle fas cicles
[Junqueira 1995]. Therefore the diam eter
of a motor unit can range from less than a
millimetre to more than a centimetre
wide. As mus cle fibres can not ana tomi-
cally be attributed to one par ticular motor
unit, it is impos sible to tell with an imag ing
technique which mus cle fibre belongs to
which motor unit. Hypothetically, if
pathology were con fined to one motor
unit or a sin gle motor unit were activated
and would con tract, imag ing techniques
might be able to visu alize this par ticular
motor unit pro vided that the res olution
were good enough.
The orga ni za tion of mus cle fas ci cles
results in the macro architecture of a mus -
cle. In some muscles the fibres run parallel
to the long axis of the mus cle and a few of
them run through its whole length (fig ure
2.9a). In other muscles the fibres are
oblique to the long axis of the mus cle.
Because of their resemblance to feath ers
these are called pennate muscles (fig ure
2.9b). They can be divided in unipennate
muscles when the fibres have one linear
origin resem bling half a feather, bipennate
muscles when the fibres arise from a broad
surface resembling a whole feather, multi-
pennate muscles when septa extend into
the attachment of the muscles, dividing
them into sev eral featherlike por tions, and 
circumpennate muscles when the fibres
converge on a ten don extend ing into their
substance (like the feathers of a dart
flight). In other muscles the fibres con -
verge from a wide attachment to a fibrous
apex (figure 2.9c). This type of mus cle is
described as a fan-shaped or triangular
muscle [Moore 1992].
Ultrasound of normal muscle tissue
The sonographic appearance of mus cles is
fairly dis tinct and can eas ily be dis crimi-
nated from sur rounding structures such as
subcutaneous fat, bone, nerves, and blood
vessels (fig ure 2.10) [Lamminen 1988;
Peetron 2002]. Nor mal mus cle tissue is
relatively black, i.e. has a low echo inten -
sity. In the transverse plane (per pendicular
to the long axis of the mus cle) the mus cle
has a speckled appear ance because of
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Fig ure 2.10 Normal ultrasound image of the biceps brachii mus cle and sur rounding tis sues, mea sured at
two thirds of dis tance from the acromion to the antecubital crease of the left arm. The right panel sche -
mat i cally depicts the dif fer ent struc tures.
reflections of perimysial con nective tis sue,
which is moderately echogenic (fig ure
2.10). In the lon gitudinal plane (along the
long axis of the mus cle) the fascicular
architecture of the mus cle becomes visi-
ble. Reflections of the perimysial con nec-
tive tis sue result in a lin ear, pennate or
tri an gu lar struc ture in the ultra sound
image (figuur 2.9). The bound aries of the
muscle are clearly vis ible, as the epimy-
sium sur rounding the mus cle is a highly
reflective struc ture. In nor mal subjects the 
bone echo is strong and dis tinct with an
anechoic bone shadow under neath (figure
2.2b). Sub cutaneous fat has a low echo
intensity, but sev eral echogenic septa of
connective tis sue may be vis ible within this 
tissue layer (fig ure 2.11). Nerves and ten -
dons are relatively hyperechoic com pared
to healthy muscles, whereas blood ves sels
are hypo- or anechoic cir cles or lines
depending on the direc tion of the
ultrasound beam (figure 2.12). When one
is unsure about the nature of a round or
linear structure, dopp ler imag ing can con-
firm the pres ence of arteries or veins by
showing blood flow (figure 2.12).
All super ficial mus cles can eas ily be
imaged with ultra sound, although it can be 
dif fi cult to iden tify indi vid ual small mus-
cles when multiple muscle groups over lap.
Recent ultra sound tech nol ogy using
higher fre quen cies with cor re spond ing
higher res olutions has made it pos sible to
image indi vid ual super fi cial small mus cles
in for exam ple the hand (fig ure 2.13).
Deeper muscles espe cially in the pel vic
region or around the trunk are dif ficult to
visu al ize with suf fi cient res o lu tion because
of the reflection or absorption of sound by
superficial tis sue lay ers, such as skin, sub -
cu ta ne ous tis sue or other mus cles.
Muscle ultrasound in
neuromuscular
disorders: outline of this
thesis
Previous studies have shown that muscle
ultrasound can be of value in the diag nosis
of neuromuscular disorders by mak ing it
possible to reliably assess muscle thick ness
and objectify mus cle atrophy (or hypertro-
phy) [Heckmatt 1988b; Reeves 2004;
Reimers 1996b and 1998]. Changes in
muscle mor phology can also be visualized
with ultrasound. Neuromuscular disor-
ders can lead to increased muscle echo
intensity, i.e. a muscle becomes whiter in
ultrasound appear ance [Heckmatt 1980
and 1988c; Reimers 1996a]. It is thought
that the replacement of mus cle tis sue with
fat and fibro sis is the main cause of
increased mus cle echo intensity, as they
increase the number of reflec tions within
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Fig ure 2.11 Ultrasound image of the calf show -
ing sev eral lay ers of fas cia in the sub cutaneous
tis sue.
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Fig ure 2.12 Transverse (upper panel) and lon gitudinal (mid dle and lower panel) ultrasound image of
the prox imal fore arm. The median nerve is vis ible as a hyperechoic cir cle in the trans verse plane with a
honeycomb appear ance. In the lon gitudinal plane the fas cicle struc ture of the nerve becomes vis ible as
hyperechoic lines between the rel atively hypoechoic mus cles (flexor carpi radialis (FC) above and flexor
digitorum profundus (FD) below). The ulnar artery is vis ible as an anechoic line in the lon gitudinal
plane. In the trans verse image dopp ler imag ing is applied to confirm that this struc ture indeed is an
artery.  IM = interosseus membrane; dou ble arrow = sub cutaneous tis sue.
the mus cle and there fore the mean grey
value of the mus cle in the ultrasound
image (figure 2.2) [Reimers 1993a and
1993b]. The relation between mus cle echo
intensity and his tology will be dis cussed in
chap ter 3.
Markedly increased muscle echo inten sity
can eas ily be detected visu ally (figure
2.14). However, in the early stages of a
neuromuscular dis ease or in myopathies
that cause only lit tle structural abnor mal-
ity (such as metabolic myopathies), mus cle
echo intensity can be only slightly
increased and dif ficult to detect visually.
Visual eval u a tion of mus cle ultra sound
images has resulted in a sen sitivity of only
67 to 81% for the detection of neuromus-
cular dis orders in chil dren [Heckmatt
1988c; Zuberi 1999]. These sensitivities
are rel atively low when mus cle ultrasound
has to serve the purpose of a screen ing tool
for neuromuscular dis orders. Visual
assessment is also dependent on the expe-
ri ence of the inves ti ga tor [Krupinski
2004]. Other factors such as sys tem set -
tings and sub ject-related variables such as
age and sex influ ence muscle echo inten-
sity too [Maurits 2003; Reimers 1993a].
Addi tion ally, dif fer ences in the pro por tion 
of fibrous tis sue and the ori entation of
muscle fibres give each muscle a spe cific
appearance on ultrasound, and its own
normal range of echo intensities. A nor mal
tibialis ante rior mus cle for exam ple has a
whiter appear ance than the rectus femoris
muscle (fig ure 2.15). All these factors
(observer dependency, influence of sys -
tem and sub ject related vari ables, dif fer-
ences between muscles) can influence the
interrater reli abil ity and vari abil ity, and
reduce the specificity of the ultra sound
findings. The influence of sys tem set tings
can be elim i nated by stan dard iz ing the
mus cle ultra sound pro to col and keep ing
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Fig ure 2.13 Ultrasound image of small hand mus cles. The res olution of the 4-8 MHz trans ducer is not
sufficient to visu alize indi vidual hand mus cles, whereas in the pic ture of the 5-17 MHz trans ducer the
abductor pollicis brevis (Ab), flexor pollicis brevis F) and adductor pollicis (Ad) mus cle can be dis tin-
guished. The ten don of the flexor pollicis longus is vis ible as a bright spot (arrow). MC1 = first
metacarpal bone; MC2 = second meta carpal bone.
all sys tem set tings con stant. The other fac -
tors, how ever, can not be avoided when
the ultra sound images are assessed visu-
ally. Quan ti fi ca tion of mus cle echo inten-
sity is more objec tive and less observer
dependent [Krupinsky 2004], and is
therefore expected to increase the reliabil-
ity and possibly also the sen sitivity of mus-
cle ultrasound. For this rea son we chose to
develop a technique to quan tify mus cle
echo intensity and assess if quan titative
muscle echo intensity is a more reliable
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Fig ure 2.14 Transverse ultra sound image of a nor mal left quadriceps mus cle (A) and of a patient with
Duchenne muscular dystrophy (DMD) (B). Both are 3.5 years old.  The rectus femoris muscle is encir -
cled. Of this region the mean echo inten sity is mea sured, as shown in the his tograms below (scale black = 
0; white = 255). The rectus femoris of the DMD patient has an increased mus cle echo inten sity, with
the cor responding his togram being displaced to the right. Note the atten uation of the ultrasound beam,
i.e. the echo inten sity in deeper areas of the mus cle is decreased com pared to super ficial areas. VM =
vastus medialis; VL = vastus lateralis; VI = vastus intermedius; F = femur; dou ble arrow, sub cutaneous
tis sue.
Fig ure 2.15 The rectus femoris mus cle (left) gen erally has a lower mus cle echo inten sity than the tibialis
anterior mus cle (right). Both images are made in the same healthy 13-year-old. Dou ble arrow = sub cu-
taneous tis sue; R = rectus femoris mus cle; V = vastus intermedius mus cle; F = femur; TA = tibialis
anterior mus cle; T = tibia.
and sen sitive method to detect
neuromuscular dis orders. This work is
described in chapter 5.
To quantify muscle echo intensity we used
an eas ily appli cable method called quan ti-
tative grey scale analysis. This analysis can
be per formed with a stan dard his togram
function (fig ure 2.14), which is widely
available in for exam ple com mercial com -
puter software pro grams for image edit-
ing, such as Adobe Photoshop (Adobe
systems Inc., San Jose, California, USA).
After selecting a region of inter est within
the mus cle, the mean grey value of this
region can be cal cu lated (auto mat i cally)
from the histogram (Fig ure 2.14).  A prac -
tical approach to the use of quan titative
grey scale analysis is given in box 2.
With quan ti ta tive grey scale anal y sis the
entire image is in effect brought back to
one value, describing how black, grey or
white the muscle in the picture is on aver -
age. As sys tem set tings will strongly influ-
ence this value, it is very important to keep
all set tings that influence the grey value
such as the gain, com pression, focus and
TGC con stant throughout the mea sure-
ments.
One of the dif fi cul ties of quan ti ta tive mus-
cle ultrasound anal ysis is the appli cation of
normal val ues obtained with one ultra-
sound device to mea surements made with
another device. This is because each ultra -
sound device has its own hardware charac-
teristics that cannot be adjusted (for
example the fre quencies and beam shape
of the transducer, or sev eral post-process-
ing tech niques, which comprise the pro-
cessing of the sig nal between receiv ing the
sound by the transducer and the creation
of an image). Copy ing the user-adjustable
system set tings to another ultrasound
device will there fore not guar antee the
same range of muscle echo inten sities in a
given image. This gives rise to the ques tion
whether a new set of nor mal val ues would
have to be gathered for each different
ultrasound device used. If this would really
be necessary, it would almost cer tainly
decrease the chance that quan titative mus -
cle ultra sound will ever be widely applied
in daily clin ical prac tice but instead
remains a research tool in a research set -
ting only. In chap ter 6 we address this
prob lem. We inves ti gated the pos si bil ity
and sub se quently pro pose a con ver sion
algorithm to reli ably apply “old” nor mal
values to measurements made on a “new”
machine.
The main part of this thesis will focus on
the clin i cal diag nos tic value of quan ti ta tive
skel e tal mus cle ultra sound, inves ti gated in
sev eral pro spec tive and descrip tive stud-
ies. The diag nos tic accu racy of quan ti ta tive
muscle ultrasound as a screening tool in
the initial evaluation of children with a sus -
pected neuromuscular dis order is
described in part III. This is fol lowed by an
overview of the use of muscle ultra sound
in spe cific neuromuscular disorders in part
IV.
Muscle ultrasound is not only con fined to
static imag ing, but can also visualize mov -
ing muscles. This use of dynamic mus cle
ultrasound to visualize nor mal and patho -
log i cal mus cle move ments is intro duced in
part V. 
For read ers also seeking a prac tical
approach to mus cle ultrasound this the sis
con tains 4 “DIY” inter mez zos con tain ing a
sum mary of all prac ti cal infor ma tion
needed to per form mus cle ultrasound
mea sure ments your self.
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This is the first out of 4 text boxes providing practical information about the technique
of muscle ultrasound measurements. They will enable a reader to perform muscle
ultrasound measurements (box 1), quantify muscle thickness and echo intensity (box
2), convert normal values for application on different ultrasound devices (box 3) and
interpret muscle ultrasound results in a clinical setting (box 4).
1a. Transducer and system settings
After turn ing on the ultra sound device, select ing an appro priate trans ducer (7.5 MHz
in chil dren and super ficial mus cles in adults, 5 MHz in deeper mus cles of adults or a
broadband trans ducer com prising at least 7 to 12 MHz) and enter ing patient details, it is 
important to select the opti mal set tings for the visu alization of skel etal mus cles. Gain
and com pression set tings have to be cho sen so they will result in a pic ture in which a
normal mus cle is rel atively black (fig ure B 1.1). This ensures that dis eased mus cles will
appear whiter on the ultra sound screen. In other words, when the gain set tings are too
high at start of the exam ination nor mal mus cle will already appear white. If a diseased
muscle is then dis played, this mus cle will also be white and there fore less con trast
between nor mal and dis eased mus cle will be avail able for their dis crimination (fig ure B
1.2).  The focus has to be adjusted to a depth where the mus cle is expected. Nor mally 2
or 3 focal points at 1 to 3 cm will be suf ficient. It is impor tant to save these setting in a
default, often called “pre set”, mak ing
sure that every mea surement will be
performed with the same sys tem set -
tings (fig ure B1.3). This makes it pos -
sible to famil iarize one self with the
normal appear ance of mus cle and the
dif fer ence with dis eased mus cles, and
such a pre set is nec essary when one
wants to com pare mea surements
between dif ferent patients or sub jects.
If mus cle echo inten sity is quan tified
one needs to keep all sys tem set tings
con stant, oth er wise the mea sure ments 
are not com parable (see also box 2).
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How to perform muscle
ultra sound1
Figure B 1.1 Ultrasound image of the quadriceps mus cle
of a healthy 8-year old. The cho sen sys tem settings have
resulted in a rel atively black appear ance of this mus cle.
XOB
The TGC is auto matically applied to the
ultrasound image by the ultra sound sys tem
but can also be man ually adjusted by an
operator to obtain the desired image qual ity
on the screen (fig ure B1.3). Espe cially when
per form ing quan ti ta tive mus cle ultra sound
measurements one has to be sure that the
bars of the TGC are in the same (neu tral)
position, to be able to com pare mus cle echo
inten si ties between mea sure ments.
1b. Measurement errors
The patient has to be placed in a relaxed
position to avoid con traction of the mus cles
(figure B 1.4). Con traction of a mus cle
results in an increased muscle diam eter and a 
decreased echo inten sity (fig ure B 1.5), so it
is nec essary that patients can keep their mus -
cles com pletely relaxed dur ing the exam ina-
tion, espe cially at the time when the image is 
frozen and saved for stor age [Heckmatt
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Figure B 1.2 Ultrasound image of the quadriceps femoris mus cle in a patient with SMA (left picture)
showing increased mus cle echo inten sity in the rectus femoris mus cle. The right pic ture shows a healthy
muscle which appears as white as the mus cle of the SMA patient, because of adjust ments of the sys tem
settings: the over all gain and the TGC of the depth cor responding to the rectus femoris muscle have been 
increased. This figure emphasizes that sys tem settings have to be checked before inter preting the ultra-
sound image. Pref erably, sys tem settings should be kept con stant in a default or so-called preset, to
avoid this problem.
Figure B 1.3 Example of an ultra sound device
with spe cial atten tion to the sys tem set tings
showed on the dis play, focal zone, and TGC
bars.
1988a]. To com pare mus cle thick ness or mus cle
echo inten sity between sub jects and over time, all 
measurements have to be per formed at the same
anatomically defined loca tions with the sub ject in
a stan dardized posi tion. For exam ple, bend ing
the knee will cause an alteration of the direc tion
of the mus cle fibres in the quadriceps mus cle,
resulting in an increased mus cle echo inten sity
compared to a straight leg [Heckmatt 1980;
Zuberi 1999]. 
A gen erous amount of con tact gel should be used
to ensure opti mal acous tic cou pling and to pre -
vent pres sure on the under lying tis sues (fig ure
B1.5). Occa sionally, a water bath (i.e., immer -
sion of the limb) is nec essary when imag ing super -
ficial struc tures such as mus cles of the hand and
foot (fig ure B1.6). Espe cially when mea suring in a 
transverse plane it is impor tant to place the trans -
ducer per pen dic u lar to the under ly ing mus cle
tissue, as oblique scan ning will not only over esti-
mate mus cle thick ness [Heckmatt 1988a] but also result in a decrease of mus cle echo
intensity (fig ure B 1.7) [Heckmatt 1988c]. Plac ing the trans ducer in a way that results
in an opti mal bone echo and delin eation of the sur rounding fas cia will fur ther stan dard-
ize the mea surement, hereby avoid ing differences caused by angulation of the
transducer.
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Figure B 1.4 Mus cle ultra sound mea sure-
ment in a 9-month old child.
Figure B 1.5 Ultrasound image of the upper arm show ing the biceps brachii mus cle (Bi) and brachialis
muscle (Br). Compression (middle pic ture) decreases the mus cle thick ness, espe cially of the most super fi-
cial lay ers, i.e. the biceps brachii mus cle (arrow). Com pression can be avoided by pay ing attention to the
outline of the skin, which has to be slightly curved as shown in the left pic ture. Con traction of the biceps
brachii mus cle (right picture) increases its thick ness (arrow). H = humerus.
When an optimal muscle image has been created, the image has to be frozen without
movement artefacts. It is then stored on the ultrasound machine and preferably
transported to a local storage device for further off-line analysis.
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Figure B 1.6 Ultrasound image of the extensor digitorum brevis mus cle (EDB) mea sured sub merged in a
water bath, which avoids air artefacts and com pression of the tis sue, such as the sub cutaneous vein. LC = 
lateral cune iform bone; Cub = cuboid.
Figure B 1.7 Ultrasound image of the arm per pendicular (left panel) and after tilting the transducer 5
degrees (right panel). With angulation of the trans ducer sound reach ing struc tures within and sur round-
ing the mus cle and the bone gets partially deflected. As this deflected sound does not return to the
transducer, the image is rel atively black com pared to the image with a per pendicular posi tion of the
transducer. Bi = biceps brachii, Br = brachialis mus cle, H = humerus, dou ble arrow = sub cutaneous
tis sue.
Intro duc tion
The main mus cle ultrasound find ing in
many neuromuscular dis orders is
increased mus cle echo intensity, which is
said to be caused by the dis ruption of nor -
mal mus cle archi tec ture by infil tra tion of
fat and fibrous tissue [Heckmatt 1982;
Reimers 1996a; Walker 2004]. As mus cle
ultrasound is used for the diagnostic evalu-
ation of neuromuscular dis orders it is
important to know the influ ence of dif fer-
ent types of mus cle pathology on mus cle
echo intensity. This knowl edge can aid in
the inter pre ta tion of mus cle ultra sound
results when used for the detec tion of
neuromuscular dis or ders or deter mi na -
tion of mus cle biopsy loca tion. Until now
only two studies have exam ined the cor re-
lation between mus cle biopsy find ings and
muscle echo intensity [Reimers 1993a and
1993b]. A sig nif i cant cor re la tion was
found between the amount of interstitial
fat and mus cle echo intensity. It was not
possible to determine the influence of
fibrous tissue alone on muscle echo inten-
sity because the percentage fibrous tis sue
in the muscle spec imens of these stud ies
was either low [Reimers 1993b] or
strongly cor related to the amount of fat
[Reimers 1993a].
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ultrasound and muscle biopsy3
Abstract
Previous studies have shown that muscle echo intensity is sig nificantly correlated to the
amount of inter stitial fat. In this study we exam ined the influ ence of interstitial fibrous tis-
sue on mus cle echo intensity in 14 mus cles of golden retriever mus cular dys trophy dogs.
The cross-sectional mus cle specimens appeared to con tain only little fat (0% to 11%,
median 1.5%), whereas interstitial fibro sis varied from 5 to 38% (median 13%). This
allowed for separate investigation of the influ ence of mus cle fibro sis on mus cle echo inten-
sity. A sig nificant correlation between the amount of interstitial fibrous tissue and echo
intensity was found (r = 0.87; p < 0.001).
We con clude that in addi tion to interstitial fat, fibrous tissue too leads to increased mus cle
echo inten sity. This makes ultra sound a reli able method to determine the severity of struc-
tural mus cle changes.
Adapted from: Pillen S, Tak RO, Zwarts MJ, Lammens MMY, Verrijp KN, Arts IMP, van der Laak JA,
Hoogerbrugge PM, van Engelen BGM, Verrips A. Mus cle ultra sound: cor re la tion between echo inten sity
and fibrous tis sue. Ultrasound Med Biol. 2009;35:443-6
In the present study we aimed to deter -
mine the influ ence of fibro sis on mus cle
echo inten sity. The mus cles under inves ti-
gation had to con tain a vari able amount of
fibrosis and only a small amount of inter-
stitial fat to be able to sep arately assess the
influence of fibrosis. We there fore chose
to per form this study in golden retriever
dogs suf fer ing from mus cu lar dys tro phy
(GRMD) [Coo per 1988; Val entine 1992].
GRMD dogs show prom inent necrosis and 
regen er a tion in mus cle biop sies, with
marked fiber size vari ation and fibro sis,
and in dogs over 1 year of age fibro sis was
more prom inent than fat infil tration [Val -
entine 1990]. As our mus cle specimens
were obtained post mor tem, it was pos si-
ble to examine complete muscle cross-sec -
tional areas to avoid sampling error.
Meth ods
Ultrasound mea surements of 14 mus cles
were made in two GRMD dogs with
end-stage cardiomyopathy aged 27 (dog 1) 
and 20 months (dog 2) . The study was
approved by our insti tutional ani mal care
and use com mittee. The fol lowing mus cles
were mea sured: rectus femoris, adductor
magnus, sar torius, tibialis ante rior,
deltoid (each of the 3 parts sep arately),
supraspinatus and trap ezoid mus cle.
Ultra sound mea sure ments
We used a phased array real-time scan ner
(Sonos 2000 Phased Array Imag ing
System; Hewlett-Packard Company,
Andover, Mas sachusetts, USA) with a 7.5
MHz transducer for dog 1 and a broad band
linear 5-17 MHz transducer (Philips IU22, 
The Netherlands) for dog 2.
Despite the differences in sys tem hard-
ware and type of trans ducer, phan tom
measurements of both devices had shown
that a linear cor relation existed for echo
intensities between 15 and 70 on a scale
from 0 (black) to 255 (white), when mea -
sured at a depth between 0.5 and 3.5 cm
(see chap ter 6). Pilot stud ies had shown
that these mus cles of GRMD dogs are
located up to 2.5 cm deep and mus cle echo
intensities of GRMD dogs are within this
range. Therefore muscle echo intensities
obtained with device 2 were com parable
to device 1 after appli cation of a cor rection
factor [Pillen 2009b].
Two ultra sound images were made in the
transverse plane at the loca tion of the mus -
cle belly (max i mum mus cle diam e ter) and
at 1 cm prox imal and dis tal of the mus cle
belly. Echo intensity was determined
quan ti ta tively using com puter-assisted
grey scale analysis, as described pre viously
[Scholten 2003]. Briefly, the grey scale
analysis was applied after selecting a region
of interest which comprised the entire
mus cle with out the sur round ing fas cia
(figure 3.1). The mean echo intensity of
this region was next calculated with a stan -
dard his togram func tion (Adobe Photo-
shop (Adobe sys tems Inc., San Jose, Cali-
fornia, USA) and expressed as a value
between 0 (black) and 255 (white) as the
ultrasound was created with 8 bit grey
scale. The echo intensity was measured in
the six images taken of each muscle group,
and the mean was taken to reduce mea -
sure ment vari a tion.
Mus cle his tol ogy
Prior to the ultra sound exam ination the
locations of the ultra sound mea surements
had been marked with a water proof sty lus.
After mus cle ultrasound the dogs were
euthanized with a pentobarbital over dose.
Cross-sec tional mus cle spec i mens were
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collected at the exact site of the ultra sound
exam i na tion. Mus cle spec i mens were
fixed in 4% for malin and embed ded in
paraffin. The largest cross-sectional area of 
each sample was selected and cut in 4 m
thick sec tions that were stained with
Masson trichrome. The per centage peri-
mysial and endomysial tissue (for the
larger part con tain ing con nec tive tis sue,
but also blood ves sels and nerve bun dles)
were measured for each muscle using digi-
tal image analysis as previously described
[van der Steen 1994]. The per centage
inter sti tial fat was deter mined man u ally in
20-25 ran domly sam pled fields of vision
using a 10x enlargement with a specimen
level field size of 3.2 mm2.
Sta tis ti cal anal y sis
Statistical analysis was done using the SPSS
package for Win dows 12.0.1 (SPSS Inc.,
Chicago, Illi nois, USA). We performed
Pearson's cor re la tions and par tial cor re la -
tions to determine the influ ence of the
amount of fibrous tissue and fat on mus cle
echo intensity.
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Figure 3.1 Ultrasound images and mus cle his tology of the tibialis anterior mus cle (A and C) and rectus
femoris muscle (B and D). The cir cles in the ultrasound images represent the com plete cross-sectional area
of the mus cle under inves tigation. Of this region mean mus cle echo inten sity was cal culated. Mus cle his -
tology was exam ined in the same region (panel C and D). A trichrome stain ing was applied to the mus cle
specimen. With this stain ing perimysial tissue becomes green (grey in this black-and-white picture),
whereas mus cle tis sue is pink (dark gray in this pic ture). Note the increased amount of fibrous tis sue in
the rectus femoris mus cle which cor responds well with the increased echo inten sity (whiter muscle). The
bar in the right lower cor ner of each image rep resents 1 mm. T= tibia, F = fib ula, V = vastus
intermedius.
Results
Histological exam ination of the mus cles
revealed only small amounts of fat (median 
1.5%; range 0 to 11%). The per centage
fibrous tissue var ied from 5 to 38%
(median 13%). The sec ond dog showed
less fibrosis than the first dog, which can be 
explained by his youn ger age. Echo inten -
sity ranged from 13 to 55 (median 23).
The high est echo inten sities were found in
the sartorius and rectus femoris mus cle,
the low est echo inten sities in the deltoid
and adductor magnus mus cles. Exam ples
of the ultrasound and biopsy mea sure-
ments are shown in fig ure 3.1.
Mus cle echo inten sity was sig nif i cantly
correlated to the amount of fibrous tis sue
(r=0.87; p<0.001), and this correlation
remained after cor rection for fat content
(r=0.88; p < 0.001) (figure 3.2). No sig-
nif i cant cor re la tion between fat con tent
and echo intensity was found before
(r=-0.05; p = 0.82) or after correction for 
fibrous tissue (r=- 0.33; p = 0.14), but as
only lit tle variation in the amount of fat
was pres ent a sig nif i cant cor re la tion was
not expected either.
Dis cus sion 
Previous studies have already shown a
strong cor re la tion between mus cle biopsy
findings and mus cle echo intensity
[Heckmatt 1982; Reimers 1993a and
1993b]. Especially the infil tration of fat
was held respon sible for an increase of
reflective inter faces resulting in higher
echo inten sities [Reimers 1993b]. The
present study shows that fibrous tissue too
leads to increased mus cle echo intensity.
Both find ings combined again indicate that
muscle ultrasound is a reliable method to
investigate changes in muscle struc ture.
The overall fibrous tissue and fat content
were correlated to echo intensity, but the
exact loca tion and organi sation of these
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Fig ure 3.2 This fig ure shows the cor relation of mus cle echo inten sity and per centage of fibrous tis sue.
structures was not taken into account. It is
hypothesized that when these struc tures
are smaller than the wave length no
increase of echo inten sity will be found
because scattering instead of reflection of
the sound beam occurs. Fur ther studies
are nec essary to determine the influence of 
the organisation and loca tion of fat and
fibrosis on the mus cle ultrasound appea-
rance.
We found a higher cor relation between
muscle structure and mus cle echo inten-
sity com pared to previous stud ies
[Reimers 1993a and 1993b]. This can be
explained by the fact that the muscle speci-
mens used in this study comprised the
mus cles' com plete cross-sec tional area,
whereas pre vi ous stud ies were sus cep ti ble
to sam pling error because of the use of
smaller biopsy sam ples. Other vari ables
such as over lying skin and super ficial fas cia
as well as mea surement vari ations induced
by alterations in probe posi tion could also
have influenced muscle echo intensity, but
their influ ence appeared to be rel atively
small in this study because most of the vari -
ance in echo intensity was explained by the
fibrous tissue con tent.
As muscle echo intensity can be caused by
both fibro sis and fatty infil tration it is
impossible to know in an indi vidual patient
whether an abnor mal mus cle ultrasound
has resulted from fibro sis, fatty infil tration
or both, based on calculation of mean mus -
cle echo intensity alone. To determine the
exact kind of mus cle pathology other
investigations such as a muscle biopsy are
currently nec essary. Future types of quan -
ti ta tive ultra sound image anal y sis, such as
texture analysis, might become helpful for
fur ther dif fer en ti a tion. Tex ture anal y sis
was shown to be capable of dif ferentiating
between spe cific groups of neuromuscular
disorders [Pohle 2000], but this is still
under inves ti ga tion.
We con clude that increased echo intensity
is both caused by the infil tration of fat and
fibrous tis sue. As muscle echo intensity is
strongly correlated with these struc tural
changes, quan ti ta tive mus cle ultra sound is
a reli able method to detect structural mus -
cle changes and determine the severity of
muscle pathology. Muscle echo intensity
can be used in the diag nosis of patients
with suspected neuromuscular dis orders,
guiding mus cle biopsy or as a fol low-up
tool in intervention studies.
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Quan ti ta tive skel e tal mus cle
ultra sound

Introduction
Muscle ultrasound can aid in detecting
mus cle atro phy by mea sur ing mus cle
thickness. Struc tural muscle changes such
as fibro sis and fatty infil tration give rise to
increased mus cle echo intensity. Pre vious
studies used a visual evaluation of the
ultrasound images [Heckmatt 1988;
Zuberi 1999]. How ever, this is subjective
and depend ent on the experience of the
observer. Quan ti fi ca tion of mus cle thick-
ness and echo intensity is more objec tive
and possibly more sen sitive in detect ing
muscle changes caused by neuromuscular
disorders [Reimers 1993b and Heckmatt
1989]. Before quan ti ta tive mus cle ultra-
sound can be applied in clinical prac tice,
ref er ence val ues for mus cle thick ness and
echo inten sity need to be available. These
reference val ues have been estab lished in
adults [Reimers 1996b], while in children
only nor mal val ues for mus cle and subcu-
taneous tissue thickness of the quandriceps
muscle have been described [Heckmatt
1988a; Schmidt 1992]. 
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muscle ultrasound in children4
Abstract
The pur pose of this study was to establish nor mal val ues of mus cle thickness, ratio of mus cle
thickness to sub cutaneous fat thickness, and mus cle echo intensity in chil dren between 11
weeks and 16 years old. Transverse scans of 4 mus cles were made by standardized ultra -
sound exam ination. The scans were digitized and mean echo intensity was mea sured using
grey scale analysis. A multiple-regression equation was used to study which independent
variable (age, height, weight, or sex) influences parameters for each muscle. Mus cle thick -
ness depended on the child’s weight. After cor rection for weight the other parameters did
not significantly influ ence muscle thickness . The ratio of mus cle thickness to sub cutaneous
fat thickness depended on age. Echo intensity showed no cor relation with either of the vari -
ables. As a result all nor mal val ues including the equa tions to cal culate them are described.
Adapted from: Scholten RR, Pillen S, Verrips A, Zwarts MJ. Quantitative ultrasonography of skeletal
muscles in children: nor mal val ues. Mus cle Nerve 2003; 27:693-698
The pur pose of this study was to establish
normal val ues of mus cle thickness, ratios
of mus cle thick ness to sub cu ta ne ous fat
thickness, and echo intensity in healthy
children up to 16 years of age.
Subjects and meth ods
Sub jects
We exam ined 59 healthy children. They
were recruited from out side the hospital
and were healthy and phys ically active.
Anthropometric data are given in table
4.1. The children were exam ined after
obtaining informed con sent from their
parents. The study was approved by the
local eth ics com mit tee.
Equipment and sys tem set tings
The ultrasound mea surements were per -
formed using a phased array real-time
scanner (Sonos 2000 Phased Array Imag -
ing sys tem; Hewlett-Packard Company,
Andover, Mas sachusetts, USA) with a 7.5
MHz transducer. The sys tem-setting
parameters were set at: gain 86dB, com -
pression 70, three focal points at 1.5, 2.0
and 2.5 cm and the bars of the TGC in neu -
tral position. These set tings were kept
constant throughout the stud ies. The only
per mit ted adjust ment dur ing exam i na tion
was alteration of the depth settings in
order to display the entire mus cle for mea -
surement of mus cle thick ness. The raw
(analog) video signal was fed directly into a 
computer using a video grab ber card
(Meteor/RGB 571-0201, Matrox Elec-
tronic Sys tems Ltd., Dorval, Quebec,
Canada). The resulting bitmaps had a res o-
lution of 800 x 600 pix els with 256
grey-levels and were stored as ‘tagged
image file format’ (TIFF) files for fur ther
off-line anal y sis.
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125.0  (95.5 - 151.5)24.3  (14.3 - 40.4)6.5  (3.1 - 12.2)25Female
119.0  (88.0 - 136.3)22.4  (13.6 - 37.8)6.2  (1.8 - 10.9)34Male
Height (cm)Weight (kg)Age  (yrs)nSex
Anthropometric data of subjects
median (interquartile range)
Table 4.1 Anthropometric data of sub jects (n=59).
Figure 4.1 Mus cle ultra sound mea surement in a
9-month old child.
Mea sure ment pro to col
A short pro tocol was chosen that could be
performed within 15 min utes and com-
prised four mus cles: the left biceps brachii,
right fore arm flexors, right quadriceps and 
left tibialis anterior mus cle. In this way
both prox imal and dis tal mus cles of arm
and leg were measured. The children were
examined in a supine posi tion with their
arms and legs extended and mus cles com -
pletely relaxed (figure 4.1). The hands
were placed in a supine position and the
feet in a neutral posi tion with respect to
endo- and exorotation. The mus cles were
measured in a transverse plane at ana tomi-
cally defined posi tions, cor re spond ing to
the larg est mus cle diam e ter (fig ure 4.2).
The biceps brachii muscle was measured at
two-thirds of dis tance from the acromion
to the antecubital crease of the left arm.
The flexors of the fore arm were mea sured
in the right arm at two-fifths of the dis-
tance from the antecubital crease to the
distal head of the radius. The quadriceps
femoris muscle was measured on the right
leg half way along the line from the ante-
rior supe rior iliac spine to the supe rior
aspect of the patella. The left tibialis ante-
rior mus cle was mea sured at one quar ter
of the distance from the infe rior aspect of
the patella to the mid dle of the lat eral
malleolus.
The trans ducer was placed per pen dic u lar
to the imaged mus cles. Oblique scan ning
was avoided by adjusting the angle of the
transducer so the best bone echo was
achieved. The pressure of the trans ducer
exerted on the skin was kept to a min imum
by using a gen erous amount of con tact gel
and by decreas ing pressure, if nec essary,
while observing the out line of the skin
surface on the screen, which should be
slightly convex.
Mea sure ment of tis sue thick ness
Mus cle and sub cu ta ne ous fat thick ness of
the biceps brachii, fore arm flexors,
quadriceps and tibialis ante rior mus cle
were mea sured with electronic callipers
dur ing the exam i na tion (fig ure 4.3). The
thickness of the biceps brachii muscle was
defined as the distance between the
humerus and the ventral fas cia of the
biceps, and of the fore arm flexors as the
distance between the interosseous mem-
brane (next to the radius) and the ven tral
fascia of the most ventral flexors. Thick-
ness of the quadriceps femoris mus cle was
defined as the distance between the femo-
ral bone and the ven tral fas cia of the rectus
femoris, and of the tibialis anterior mus cle
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Figure 4.2 Loca tions of the mea surements of the
screening pro tocol used in this the sis.
between the interosseous mem brane (next
to the tibia) and the ventral fas cia of the
tibialis ante rior mus cle. The sub cu ta ne ous
tissue was measured in the same images
and was defined as the distance from the
ventral fas cia to the line separating the
dermis from fat. If the fas cia sur rounding
the mus cle was thick or com prised sev eral
layers, the edge clos est to the mus cle was
chosen for the mea surement of mus cle
thickness, while the edge clos est to the
sub cu ta ne ous tis sue was cho sen for mea-
sure ment of sub cu ta ne ous tis sue.
Mea sure ment of mus cle echo
inten sity
Quan ti fi ca tion of mus cle echo inten sity
was done by cal culating the mean mus cle
echo intensity by com puter-assisted grey
scale analysis. A region of interest was
selected in each image (figure 4.4). The
criteria for select ing this region were
inclusion of as much of the mus cle as pos si-
ble without sur rounding fas cia. Mean echo 
intensity of this region was then calculated
with a standard his togram func tion (Adobe
Photoshop; Adobe systems Inc., San Jose,
California, USA) and expressed as a value
between 0 (black) and 255 (white) as the
ultrasound was created with 8 bit grey
scale. For each muscle, three images were
made to mea sure the echo intensity.
Between each measurement the subject
was allowed to move and the transducer
was repo sitioned afresh. The mean of
these three images was taken to keep the
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Fig ure 4.3 Measurements of mus cle thick ness of the mus cles of our screen ing pro tocol (“x”). In every mus-
cle care was taken to mea sure at the same loca tion to be able to com pare dif ferent indi viduals. A: biceps
brachii mus cle (BI = biceps brachii, H = humerus), B: flexors of the fore arm ( R = radius, U = ulna),
C: quadriceps femoris mus cle (FE = femur, R = rectus femoris), D: tibialis ante rior mus cle ( T = tibia, F 
= fib ula, TA = tibialis ante rior mus cle).
variation to a min imum. In the quadriceps
femoris, the rectus femoris mus cle was
chosen for anal ysis of echo intensity, as in
severe neuromuscular disorders the out-
lines of the vastus intermedius muscle can
be difficult to detect [Heckmatt 1980].
The mean coefficient of vari ation of the 3
measurements was 7.3% (n = 10 compa-
risons).
Anal y sis of find ings
A mul ti ple regres sion equa tion was
employed to study which independent
variables (age, height, weight, or sex)
influenced muscle thickness, ratio of mus -
cle thick ness to sub cu ta ne ous fat thick ness,
and echo intensity. Apply ing the test of
normality by Kolmogorov – Smirnov, the
values obtained for mus cle thickness, the
thickness ratio, and echo inten sity for
every mus cle group were found to fol low a 
Gaussian dis tri bu tion. There af ter the
mean plus or minus 2 standard devi ations
for each mus cle group was determined on
the basis of a nor mal dis tribution. In this
study the sta tistical sig nificance was set at a 
level of p < 0.05. 
Results
Mus cle thick ness
The mul ti ple regres sion anal y sis dem on-
strated that the muscle thick ness sig nifi-
cantly depended on the child’s weight (p < 
0.05) in all muscles up to the age of 16
years. Age, height, and sex did not sig nifi-
cantly influence mus cle thick ness after
correction for weight. Regression coeffi-
cients (x1) for weight (W) were calculated
for every mus cle group. Using this regres-
sion coefficient, nor mal val ues of mus cle
thick ness (Mn in cm, and M0 as the origin
on the y-axis of muscle thick ness) accord-
ing to weight can be described by the fol-
low ing equa tion:
Mn(cm) = M0 + x1 W (kg) (1)
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Fig ure 4.4 Example of a grey scale anal ysis of the rectus femoris mus cle. A region of inter est is drawn
within the bor ders of the mus cle. In the right lower cor ner the cor responding his togram is shown, which is 
the result of the com puter-assisted grey scale analysis. The horizontal axis shows the grey scale (black =
0, white is 255), the ver tical axis shows the amount of pix els. The mean echo inten sity of this mus cle
(calculated from the his togram) is 30. VM = vastus medialis; VI = vastus intermedius;  VL = Vastus
lateralis; F = femur
The equations, with the standard devi a-
tions (SD) for each muscle are:
Biceps brachii:
Mn (cm)= 0.77 + 0.028 W (0.16)
Fore arm flexors:
Mn (cm)= 1.18 + 0.018 W (0.23)
Quadriceps femoris:
Mn (cm)= 1.63 + 0.042 W (0.34)
Tibialis ante rior:
Mn (cm)= 0.81 + 0.019 W (0.19)
The results of the muscle thick ness mea-
surements are shown in Figure 4.5.
Thick ness ratio
With mul ti ple regression anal y sis the ratio
of mus cle thick ness to sub cu ta ne ous fat
thickness appeared to be sig nificantly
dependent on age (p < 0.05) until the age
of 12 years. Above the age of 12 years, the
ratio depended on both age and sex. Too
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Figure 4.5 Ultra sound mea surements of mus cle thick ness in biceps brachii mus cle, fore arm flexors,
quadriceps femoris mus cle and the tibialis anterior mus cle. In all 4 mus cles the mus cle thick ness depended
on weight. Each value rep resents one mea surement. Solid lines indi cate the mean of the mus cle thick ness.
The dashed lines rep resent the 2.5 and 97.5 per centiles (2 standard devi ations below or above the mean).
few children above the age of 12 years
were included in this study  (n=12) to sep -
a rately estab lish reli able nor mal val ues of
the ratio for boys and girls aged 12 - 16
years. Analysis of the thickness ratios was
therefore based on chil dren up to 12 years
old (n= 47).  Weight and height did not
significantly influ ence this ratio after cor -
rection for age. For every muscle group a
regres sion coef fi cient (x2) for age (A) was
calculated. Using this regres sion coeffi-
cient nor mal val ues (Rn) of the thick ness
ratio according to age, with R0 as the ori-
gin on the y-axis of the ratio of mus cle to
fat, can be described by the equa tion:
Rn = R0 + x2 A (years) (2)
For each muscle the equa tions, with the
stan dard devi a tions, are:
Biceps brachii:
Rn = 3.3 + 0.69 A (2.20)
Fore arm flexors:
Rn = 5.1 + 0.37 A (2.98)
Quadriceps femoris:
Rn = 3.7 + 0.27 A (2.01)
Tibialis ante rior:
Rn = 3.1 + 0.20 A (1.57)
Echo inten sity
The mul ti ple regres sion anal y sis dem on-
strated that the echo intensity was inde -
pendent of any of the investigated vari ables
(age, weight, height, and sex). No
regres sion coef fi cients were there fore
used to calculate the nor mal val ues for
echo intensity. The nor mal val ues for  echo
intensity can be described by a sin gle value
(EIn) and a stan dard devi ation (SD) for
each muscle group. These val ues were
39.7 ± 7.94 for biceps brachii, 43.9 ±
6.16 for the fore arm flexors, 35.3 ± 7.12
for quadriceps femoris, and 41.5 ± 9.07
for the tibialis anterior mus cle.
Dis cus sion
In this study we ana lyzed echo inten sity,
muscle thickness, and the ratio of mus cle
thick ness to sub cu ta ne ous fat thick ness,
because previous studies have shown that
they can describe the changes caused by
neuromuscular dis or ders [Heckmatt
1988b; Zuberi 1999]. Echo intensities are
increased in neuromuscular dis orders such
as Duchenne mus cu lar dys tro phy, spi nal
mus cle atro phy and con gen i tal myopa-
thies, because muscular architecture is dis-
rupted by mus cle cell replacement by fat
and fibrous tissue [Heckmatt 1982;
Reimers 1993a; Pillen 2009a]. Neuro-
pathies are often associated with atro phy,
which can be detected by measuring the
muscle thick ness [Bargfrede 1999]. The
ratio of mus cle thick ness to sub cu ta ne ous
fat thickness could be helpful in detecting
spe cific neuromuscular dis or ders. For
example, previous studies have shown that
one of the dis tinguishing fea tures of spi nal
muscle atrophy is muscle atrophy and an
increase of sub cu ta ne ous fat thick ness,
which results in a decreased ratio
[Heckmatt 1988b; Schmidt 1992].
Reimers and co work ers [1996b] found
that muscle thickness in adults depended
on age, height, and weight, whereas in
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children we found that mus cle thickness
depended on weight only. After cor rec-
tion for weight, mus cle thickness in chil -
dren was not sig nificantly depend ent on
either age or height. Echo intensity in
adults was found to increased with age
[Reimers 1996b]. In chil dren, the echo
intensity is not age dependent. This is a
remarkable find ing, as the muscle volume
changes con siderably in the course of
development of the musculoskeletal sys -
tem. The diameters of muscle fibers grad-
ually enlarge from 6 to 7 m in the
20-week fetus to 38 to 42 m at the age of
10 years [Engel 1986]. As a result of
enlargement of mus cle fibers, the dis tance
between reflecting sur faces increases, so
that the num ber of reflections per square
cen ti me ter decreases, caus ing a dimin-
ished echo intensity. How ever large mus-
cle fibers can also cause an increase in echo
intensity, as large interfaces result in
reflection instead of scattering of the ultra -
sound beam. Scattering occurs when inter -
faces are smaller than the wavelength of
the ultrasound beam (approx imately 200
m in the ultrasound device used in this
study), which is apparently the case in
muscles of young children. Over all, we
found that mus cle echo intensity does not
change sig nif i cantly dur ing nor mal devel-
opment of mus cles. There fore an
increased mus cle echo intensity in children
is most likely due to patho logical changes,
such as the infil tration of fat and con nec-
tive tis sue.
The nor mal val ues for mus cle thickness
and thickness ratio pre sented in this study
can be applied to ultra sound imag ing in
other cen tres if the same measurement
protocol is used.  Unfor tunately, the nor -
mal val ues for the echo inten sity found in
this study cannot auto matically be used by
others, because the sys tem set tings differ
between ultra sound devices and this
affects the echo intensity.  In chap ter 6 of
this the sis this sub ject is further addressed
[pillen 2009b].
In con clusion, mus cle thickness, ratio of
mus cle thick ness to sub cu ta ne ous fat
thickness, and mus cle echo intensity can
easily be assessed in chil dren. The pre-
sented nor mal val ues can next be applied
to pae diatric patients with sus pected
neuromuscular dis orders to determine the
diag nos tic value of quan ti ta tive mus cle
ultra sound.
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This textbox pro vides prac ti cal infor ma tion about the quan ti fi ca tion of mus cle thick ness
and mus cle echo intensity, and pro vides available ref erence values.
Measuring muscle thickness
Muscle thickness is usu ally determined online, with a calliper func tion that is generally
incorporated in the ultrasound device. In most cir cumstances assessment of mus cle thick-
ness will be suf ficient to deter mine whether muscle atro phy or hypertrophy is present. It is
also possible to measure muscle cross sec tional area. This type of mea surement has recently 
become a standard fea ture in new ultra sound devices. Measurement of mus cle cross sec-
tional area can have addi tional value in for exam ple the estimation of total mus cle mass
[Sanada 2006] or to relate the force gen erating capacity of mus cle to its cross sectional area
[Clague 1995]. The assessment of the cross sectional area can quite easily be done in small
muscles, when the whole mus cle width is vis ible on the screen. How ever, larger mus cles
such as the rectus femoris or biceps brachii mus cle often do not fit the size of the transducers
(normally 4 to 5 cm) and can therefore not be visu alized in one image except when they are
severely atrophic or in neonates (figure B 2.1). Addi tional image pro cessing such as the
so-called panoramic view are then nec essary to visualize the entire muscle (figure B 2.1)
[Chi-Fishman 2004]. 
It is advisable to measure muscle thick ness from a highly reflective struc ture such a an
underlying bone, as other structures such as the surrounding fas cia can be dif ficult to rec og-
nize in severe neuromuscular disorders. This might imply that the measured muscle thick -
ness comprises more than one mus cle, for exam ple the rectus femoris and vastus
intermedius when mea suring the quadriceps. The under lying bone remains detectable in
most cir cumstances, although it might be nec essary to adjust the sys tem set tings to visualize
the bone, for exam ple by increasing TGC, adjusting the focus or using a trans ducer with a
lower frequency (figure B 2.2).
Ref er ence val ues of mus cle thick ness 
Muscle thickness is dif ferent for each mus cle and increases dur ing the nor mal devel opment
of chil dren. In order to describe the amount of atrophy (or hypertrophy) it is necessary to
compare the measured muscle thick ness to references val ues. In chapter 4 ref er ence val ues
of 4 limb muscles have been established (biceps brachii, forearm flexors, quadriceps and
tibialis ante rior muscle). These ref erence val ues and the equa tions to calculate them are
summarized in table B 2.1. The presented nor mal val ues can only be reliably applied in clin-
ical prac tice when site of mea surement and posi tion of the child is the same as in the study
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Figure B 2.1 Because the calf mus cles are to big to be imaged in one pic ture addi tional meth ods have to
be applied to visu alize the entire medial and lat eral gas trocnemius mus cle. The bot tom pic tures shows an
example of a mea surement apply ing pan oramic view, which is incor porated in some newer ultrasound
devices. This makes it pos sible to visualize the entire mus cle in one image. How ever, care has to be taken
to measure dis tances and intensities in these pic tures as they can be sub ject to artefacts. GM = medial
gastrocnemius mus cle; GL = lat eral gas trocnemius mus cle; PL = peroneus longus mus cle.
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Fig ure B2.2 Ultrasound image of the quadriceps mus cles of a 10-year-old patient with Duchenne mus cu-
lar dys trophy. In severe neuromuscular disorders visu alization of struc tures beneath mus cle tis sue can be
difficult because of atten uation of the ultrasound beam (left). Mea suring with a lower fre quency, adjust -
ing the time gain com pensation (TGC) and the focal zone (right) enables visu alization of the femur,
which is necessary to mea sure mus cle thickness.
Normal values of muscle thickness in children
0.190.81 + 0.019* weight (kg)1/4 of line inferior aspect of patella
to middle of lateral malleolus
Tibialis anterior
0.341.63 + 0.042* weight (kg)1/2 of line anterior superior iliac
spine to superior aspect of patella
Quadriceps
0.231.18 + 0.018* weight (kg)2/5 of line antecubital crease to 
distal head of radius
Forearm flexors
0.160.77 + 0.028 * weight (kg)2/3 of line acromion to
antecubital crease
Biceps brachii
Standard
deviation
Equation to calculate
normal value
Site of measurementMuscle
Table B 2.1 Ref erence val ues of 4 mus cles for chil dren up to 16 years of age. Nor mal val ues can be cal -
culated if the weight of the child is known.
protocol (table B 2.1). These reference values are independent of the ultra sound device
used as transducer and sys tem set ting do not influence mus cle thick ness mea surements.
Quan ti fi ca tion of mus cle echo inten sity using grey
scale anal y sis
It is preferable to make at least 3 images of each mus cle to reduce mea surement variation, as
slight changes of the probe posi tion already induce variation in mus cle echo intensity.
Between each measurement the subject is allowed to move and the transducer has to be
repositioned afresh. The images have to be stored for off-line calculation of mean mus cle
echo intensity.
Computer software is necessary to select a region of interest of which the mean grey value
can be calculated. In the first studies we used the area selection and his togram func tion of
Adobe Photoshop (Adobe systems Inc., San Jose, Cal ifornia, USA) to cal culate mean mus-
cle echo intensity, but any other histogram func tion can be applied as they all result in the
same values.
The region of interest preferably con sists of a large area within the mus cle to avoid sam pling
errors. Sam pling error can especially occur in neuromuscular disorders with a patchy ultra-
sound appear ance such as spi nal mus cular atro phy (figure B 2.3), see also chapter 11). The
surrounding fas cia should be avoided as this can falsely ele vate muscle echo intensity.
From the region of interest a histogram can be con structed of which the mean grey value
can be calculated, resulting in a value between 0 (black) and 255 (white) as most ultrasound
devices produce images with an 8 bit grey scale.
Reference val ues of mus cle echo intensity
Unfortunately mus cle echo intensity is highly depend ent on the ultrasound device and the
system set tings used. It is there fore not pos sible to present nor mal values that can automati-
cally be used by other centres if another device is used. Once nor mal values are established
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Figure B 2.3 Ultrasound image
of a patient with spi nal
muscular atro phy. The mus cle
echo inten sity of the rectus
femoris mus cle (cir cle) is
inhomogeneously increased with
a moth-eaten pat tern. In this
patient a small region of inter est
could have lead to sampling
error. VI = vastus intermedius
muscle; F = femur; dou ble
arrow = sub cu ta ne ous tis sue.
it is possible to convert nor mal val ues to be used on other ultrasound devices based on phan -
tom mea surements, which are described in chapter 6 and box 3.
When using ref erence val ues of echo inten sity it is very important to keep all set tings that
influence the grey value, such as the gain, com pression, focus, and TGC, constant through-
out all mea surements. It is also advisable to perform qual ity checks of the ultra sound device
once every while to ensure that pre viously established normal values can still reliably be
used [Thijssen 2007].
Cal cu la tion of z-scores fur ther stan dard izes mus cle
ultra sound mea sure ments
To be able to com pare dif ferent mus cles or dif ferent patients, mea sured values of mus cle
thickness and echo intensity can be expressed as z-scores. A z-score describes the amount of
standard devi ations that a mea sured value deviates from nor mal. Z-scores can be calculated
using the fol lowing equa tion:
measured value - nor mal value
    z-score of mea sured value   =       -------------------------------------
 stan dard devi ation of nor mal value
The nor mal value and corresponding standard devi ation are specific for each mus cle and
depend on specific patient variables (such as weight in mus cle thickness in children or age
and sex in mus cle echo intensity in adults [Arts 2007]). 
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Intro duc tion
To describe the amount of alterations on
ultrasound, Heckmatt and co-workers
[1982] devel oped a visual grad ing scale, in
which grade I rep resented nor mal mus cle
and grade IV increased muscle echo inten-
sity with total loss of bone echo. Other
clas si fi ca tions to describe the ultra sound
image, such as homo ge ne ity and vis i bil ity
of structures within and surrounding the
muscle, have also been used [Aydinli
2003; Bargfrede 1999; Fischer 1988].
With these meth ods it was pos sible to
detect neuromuscular dis orders in chil-
dren with a sen sitivity of 67 to 78% and a
specificity of 84 to 92% [Heckmatt 1988c;
Zuberi 1999]. 
However, visual detection of alterations
can be dif ficult. Mus cles have an
inhomogeneous, speckled appear ance on
ultrasound images [Lamminen 1988]. Fas -
cicles can give a strong or weak reflection,
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Muscle echo intensity: visual
versus quantitative evaluation5
Abstract
In this study we com pared the value of visual ver sus quan titative eval uation of skeletal mus -
cle ultrasound in children sus pected of hav ing a neuromuscular dis order. Ultrasound scans
of 4 mus cles were made in 76 chil dren. All images were visually evaluated using the
Heckmatt criteria and quan titatively evaluated with com puter assisted grey scale anal ysis of
muscle echo intensity.
Visual evaluation achieved a sensitivity up to 71% and a specificity of 92%. Quantification
resulted in a sen sitivity of 87% which makes it more suitable for use as a screen ing tool. The
accompanying spec ificity was lower (67%), but the spec ificity can be increased if nec essary
by adjusting the cut-off point. Quan tification resulted in an excellent interobserver agree-
ment (kappa 0.86), whereas the agreement of the visual eval uation was only mod erate
(kappa 0.53).
We con clude that quan tification of echo inten sity is a more objective and accu rate method.
Because it can achieve higher sen sitivities, it is better suited for the screen ing task in the
diagnostic phase of children with a neuromuscular dis order.
Adapted from: Pillen S, van Keimpema M, Nievelstein RA, Verrips A, van Kruijsbergen-Raijmann W, Zwarts
MJ. Skel e tal mus cle ultrasonography: Visual ver sus quan ti ta tive eval u a tion. Ultra sound Med Biol.
2006;32:1315-21.
depending on size and direc tion, which
can make it dif ficult to detect a small, but
patho log i cal increase in reflec tions. More-
over, changes in sys tem-settings, espe -
cially increased gain, can give mus cles a
whiter appear ance, and this can be mis -
taken for pathology. Dif ferent degrees of
experience and the fact that visual judg -
ment is not sys tematic are also known to
contribute to the rel atively high rates of
inter- and intra-observer vari ation of
visual image anal ysis [Krupinski 2004;
Mello-Thoms 2001; Nodine 1999]. For
this reason, computer-aided techniques
have been intro duced for image inter pre-
tation. The most used appli cations so far
are the detection of masses in mam mo-
grams or chest images [Doi 2005;
Krupinski 2004]. Quan ti fi ca tion of mus cle 
echo inten sity has been previously
reported [Bargfrede 1999; Heckmatt
1989; Maurits 2003; Maurits 2004; Pillen
2003; Pohle 2000; Reimers 1993a]. Since
it is more objective and allows for statisti-
cal analysis it seems very suit able for
research pur poses. How ever, quan ti fi ca -
tion is thought to be more time con suming
and is influ enced by the char acteristics of
the ultra sound device used. It might there -
fore be more difficult to apply in everyday
clinical prac tice than a visual grad ing sys-
tem. In chil dren higher sen si tiv i ties with
quan ti fi ca tion of echo inten sity have been
reported com pared to visual evaluation,
both in boys with Duchenne mus cular dys -
trophy [Heckmatt 1989] as in chil dren
with various NMDs [Pillen 2003]. This
would sug gest quan ti ta tive mus cle ultra-
sound to be more suitable than visual anal -
ysis for a screen ing task, i.e. the initial
assessment of chil dren with sus pected
neuromuscular dis or ders. How ever, the
two methods have never been com pared in 
one study.
The purpose of this study was there fore to
compare the diag nostic value and
interobserver agree ment of visual and
quan ti ta tive eval u a tion of skel e tal mus cle
ultrasound in children sus pected of hav ing
a neuromuscular dis order.
Meth ods
Patients
The study was approved by the local eth ics
committee and informed con sent was
obtained from all par ents, and patients
when older than 12 years of age. Between
June 2001 and March 2003 all patients
referred to our tertiary neuromuscular
centre because of a suspected neuromus-
cular dis order, and in whom fur ther inves-
tigations were indi cated based on history
and phys i cal exam i na tion, were pro spec-
tively included in the study. Patients over
18 years or with a known diag nosis at time
of the measurement were excluded.
The final diag nosis was made by the cli ni-
cian based on med ical history and clinical
inves ti ga tion, electromyography, bio-
chem i cal eval u a tion, exten sive genetic
evaluation when avail able, and a mus cle
biopsy. The choice of diagnostic instru-
ments was depend ent on the clinical pre -
sentation. Cli nicians were not blinded for
the ultrasound results. The gold stan dard
was the clin ical diag nosis, based on all per-
formed investigations and a 2 to 4 year fol -
low-up period. Patients were excluded
from assess ment of sen si tiv ity and spec i fic-
ity if no final diagnosis had been estab-
lished or if the ultrasound mea surements
had been the only investigation
per formed. 
70
P a r t  II
Ultra sound mea sure ments 
The method of ultra sound scan ning is
described pre viously in chapter 4
[Scholten 2003]. The equip ment, system
set ting param e ters, and study pro to col,
were in concordance with this study, to be
able to use the estab lished normal values.
The standard four mus cles were examined
in the transverse plane: the biceps brachii,
forearm flexors, quadriceps, and tibialis
ante rior mus cles.
Visual assess ment of echo inten sity
The mea sure ments were eval u ated twice
by the same investigator (S.P.) to assess
intraobserver agreement and once by a
pedi at ric radi ol o gist work ing in a dif fer ent
centre (R.A.J.N.) and an inexperienced
inves ti ga tor (med i cal stu dent with one
month experience, M.K.) to assess
interobserver agree ment. All inves ti ga tors
were blinded for the clin ical pre sentation,
final diag nosis, and eval uations of the other
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Grade I
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V
Grade III Grade IV
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F
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Grade II
Fig ure 5.1 Visual assessment of ultrasound scan of the quadriceps femoris mus cle using Heckmatt’s scale:
grade I: nor mal
grade II: sig nificant increase of mus cle echo inten sity, bone echo still distinct
grade III: marked increase in mus cle echo inten sity and a reduced bone echo 
grade IV: very high mus cle echo inten sity and complete loss of bone echo
Arrow: subcutaneous tis sue; R = rectus femoris; V = vastus intermedius; F = femur.
inves ti ga tors. Before start ing the eval u a-
tion all investigators practiced with a sepa-
rate set of mus cle ultrasound exam inations
(60 healthy children and 33 patients with
and with out neuromuscular dis orders),
with direct feed back on the pres ence or
absence of a neuromuscular dis order, in
order to get famil iar with the spe cific set-
tings of the ultrasound device.
The dig itized images were visu ally evalu-
ated using Heckmatt's scale [Heckmatt
1982]. Grade I was nor mal, grade II signi-
fied an increase in mus cle echo intensity
while bone echo was still dis tinct, grade III
indicated a marked increase in mus cle
echo intensity and a reduced bone echo,
and grade IV showed a very high mus cle
echo intensity and com plete loss of bone
echo (fig ure 5.1). Three images of each
muscle were evaluated and one grade was
assigned. The eval u a tion of the pae di at ric
radi ol o gist was used for com par i son with
the quan ti ta tive eval u a tion as this inves ti-
gator was most famil iar with a visual evalu-
ation and most objec tive as he was
working in a dif ferent centre.
Quan ti ta tive assess ment of echo
inten sity
Echo intensity was determined using com-
puter-assisted grey scale analysis as
described in chapter 4. In each image the
entire muscle area was selected just within
the bor ders of the mus cle. In the
quadriceps femoris mus cle the rectus
femoris muscle was cho sen for analysis of
echo intensity.
The mean echo intensity of this region was
then calculated by using the standard his to-
gram func tion of Adobe Photoshop
(Adobe sys tems Inc., San Jose, California,
USA) and expressed as a value between 0
(= black) and 255 (= white) (fig ure 5.2).
The echo intensity was measured in three
images taken of each mus cle group, and
the mean was taken to reduce the
vari a tion.
Quan ti ta tive eval u a tion was done directly
after the ultra sound investigation by the
electrodiagnostic technicians and one
month after visual evaluation and after
randomly rear ranging of the imagesby one
investigator (M.K.). All were blinded for
the final diag no sis. The ini tial eval u a tion
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Fig ure 5.2 Quantitative assessment of echo intensity of the quadriceps femoris muscle. A region of interest is
selected within the bor ders of the rectus femoris muscle (white line). Of this region the mean echo intensity is
determined using a histogram as shown in the right pic ture. Black = 0 (left), white = 255 (right).
was used for com parison with the visual
assess ment by the pedi at ric radi ol o gist. 
To be able to com pare dif ferent mus cles,
the echo intensities were compared with
normal val ues of each mus cle [Scholten
2003] and trans formed into z-scores, i.e.
the amount of stan dard devi ations above
or below nor mal (see also box 2).
Sta tis ti cal anal y sis 
Statistical analysis was done using the SPSS
package for Win dows 12.0.1 (SPSS Inc.,
Chi cago, Illi nois, USA). Sta tis ti cal sig nif i -
cance was defined as p < 0.05. Reciever
oper a tor char ac ter is tic (ROC) curves
based on the most abnor mal mus cle were
drawn for both the visual and the quan tita-
tive analysis. The area under the curve was
cal cu lated for the quan ti ta tive eval u a tion,
but could not be determined for the visual
method because of the ordi nal scale and
too few cut-off points. For the same rea-
son no sta tistical test could be applied to
compare the ROC curves. To pro vide an
impres sion of achiev able sen si tiv i ties and
specificities of each method a cut-off point
was cho sen based on previous investiga-
tions: the visual evaluation was called
abnormal if one mus cle was grade 2 or
higher, in accordance with the cut-off
point of Zuberi and co-workers [1999];
the cut-off point for the quan titative
method was set at 3 or more mus cles with
an echo intensity of at least 0.9 SD above
normal in con cordance with the estab-
lished cut-off point by Pillen et al. [2003].
The ultrasound results for each group of
disorders are reported. The cases in which
the two meth ods did not match are
described in detail, to report the advan tage
or dis advantage of each method in spe cific
neuromuscular dis or ders.
Intra- and interobserver agree ment was
determined with Cohen's Kappa [Fleiss
1981]. There are no uni versally accepted
standards for reli ability, but the fol lowing
criteria have been pro posed by Landis and
Koch [1977] for inter preting agreement of 
Cohen's Kappa statistics: <.00, poor;
.00-.20, slight; .21-.40, fair; .41-.60,
mod er ate; .61-.80, sub stan tial; .81-1.00
almost per fect. Because of the expected
high cor relation of the interobserver
agree ment of the quan ti ta tive eval u a tion,
the intra-observer agree ment (which
would be equal of higher) was not inves ti-
gated. The Heckmatt scores were com-
pared to the z-scores of each mus cle to
investigate which alterations in echo inten-
sity can be visually detected. The visual
grading of mus cles was com pared using a
Chi-square test (for com paring percent-
ages) or an inde pendent sam ples Mann-
Whitney U test (for com paring means).
Results
Seventy-six patients fulfilled the inclusion
criteria for this study (45 boys, median age
5.4 years, range 1 month to 15.5 years; 31
girls, median age 3.0 years, range 3 weeks
to 17.5 years). Thirty-eight patients had a
neuromuscular dis order (table 5.1 for
diagnosis), 24 patients did not have a
neuromuscular dis order, in 13 patients no
diagnosis could be established at the time
of anal ysis and in 1 patient the par ents
refused fur ther inves ti ga tions.
The ROC curves for both meth ods are
shown in fig ure 5.3. The high est achiev -
able sensitivity of the visual method was
71%, whereas the quantitative method
could result in higher sensitivities, but this
was accompanied by lower specificities.
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The results of both methods after applying
the chosen cut-off points are pre sented in
table 1. Visual evaluation resulted in 11
false neg a tive patients (sen si tiv ity 71%),
while the quan titative method was unable
to detect 5 patients with a neuromuscular
dis or der (sen si tiv ity 87%). Two patients
who were nor mal accord ing to the quan ti-
tative cut-off point were detected with
visual evaluation, because they had only
one clearly abnor mal mus cle. Quan ti ta tive
evaluation detected 8 patients with a
neuromuscular dis order, who were nor -
mal on visual inspection. Three of them
were diagnosed with mito chondrial myo-
pathies, 2 with an inflam matory myopa-
thy, 2 with spinal mus cular atro phy, and 1
with a hereditary motor sen sory neuropa-
thy (HMSN) type 2. The cut-off point of
the quantitative method resulted in 8 false
pos i tive results (spec i fic ity 67%), com-
pared to 2 false pos itive results with the
visual method (spec ificity 92%). Both
these patients whose ultrasound result was 
visually judged to be abnormal were also
abnor mal with quan ti ta tive eval u a tion.
The quan ti ta tive eval u a tion of the ultra-
sound images showed a higher inter-
observer agreement than the visual eval ua-
tion (kappa respectively 0.86 (excellent)
and 0.53 (mod erate); p = 0.001). The
cor re la tions of the visual eval u a tion dete ri-
orated when the images where analyzed by
an inex perienced observer (kappa 0.37).
The intra-observer agreement of the visual 
method was 0.74 for the most experi-
enced observer.
Ninety-three percent of the visually
graded images were grade I or II. Grade IV
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Number
abnormal
visual
Number
abnormal
quantitative
Number
of
patients
Diagnosis
2614No final diagnosis
2 (8%)8 (33%)24No neuromuscular cause of symptoms
27 (71%)33 (87%)38Total neuromuscular disorders
111Amyoplasia
Other
779Peripheral neuropathies
577Anterior horn cell disorders
Lower motor neuron disorders
136Metabolic/mitochondrial myopathies
466Inflammatory myopathies
333Congenital myopathies
666Muscular dystrophies
Myopathies
Diagnosis of patients and corresponding ultrasound results
Table 5.1 Diagnosis and ultrasound results.
was only scored in one mus cle. Grade II
images had sig nificantly higher echo inten-
sity (quan ti ta tively deter mined) than
grade I, but there was a broad range of
echo intensity with both scores (figure
5.4). Grade I was scored in muscles that
had a quan ti ta tively deter mined echo
intensity up to + 6 SD. The relation
between stan dard ized quan ti ta tively
determined echo inten sity and visual grad-
ing was dif ferent for each muscle (fig ure
5.4). For exam ple, of all tibialis anterior
muscles with an echo intensity above + 2
SD (n=33) 33% were graded as nor mal
(n=11), whereas 61% of all quadriceps
muscles with an echo intensity above + 2
SD (n=41) were graded as nor mal (n=25)
(difference 28%; p=0.025). In 3 patients
the tibialis anterior mus cle was graded as
abnor mal, although the quan ti ta tively
determined echo intensity was below +2
SD. One of them had clearly vis ible focal
changes in the mus cle caused by
dermatomyositis, which did not result in
an over all increase in echo inten sity.
Dis cus sion
This study shows that the visual evaluation
of mus cle ultrasound has a sensitivity of
only 71 per cent for the detection of
neuromuscular dis orders. To achieve this
sen si tiv ity, the most sen si tive cut-off point
for abnor mality was used, i.e. one or more 
muscles with Heckmatt grade 2 or higher.
Com puter-aided quan ti ta tive assess ment
of muscle echo intensity was able to
achieve higher sen si tiv i ties, depend ing on
the cut-off point chosen. The cut-off point
used in this study was based on a pre vious
investigation [Pillen 2003], and resulted in 
a sen sitivity of 87 %, but was accompanied
by a lower spec ificity (67%). One of the
main advan tages of quan ti fi ca tion is that,
depend ing on the clin i cal sit u a tion (detect-
ing or excluding a neuromuscular dis or-
der) and the type of neuromuscular
dis or der (sin gle mus cle involve ment or
generalized) other cut-off points can be
chosen [Feinstein 1985]. In this study both
meth ods had dif fi cul ties detect ing patients
with a mitochondrial myopathy and to a
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Fig ure 5.3 ROC curves of the quantitative and visual eval uation based on the most abnormal muscle. The dots 
of the visual eval uation represent grade I to IV. The area under the curve of the quantitative method is 0.88.
lesser degree patients with a polyneuro-
pathy, but visual eval uation was also inca -
pable of detecting 30% of the patients with
an inflam matory myopathy or anterior
horn cell dis order, which is unde sirable if
the test is used for screen ing purposes.
Dif fer ent mus cles have dif fer ent echo
intensity val ues. Of the muscles inves ti-
gated in this study for exam ple, the tibialis
anterior mus cle is relatively white com-
pared to the nor mal range of mus cle echo
intensities vary ing from 20 to 55: it has a
normal mean echo intensity of 41,
whereas the rectus femoris is relatively
black, with a nor mal mean echo intensity
of 35 [Scholten 2003]. As can be seen from 
the results of this study, visual evaluation
with the Heckmatt criteria does not cor-
rect for this fact. The tibialis anterior
muscle was more often graded abnor mal
than the quadriceps mus cle, which could
be judged as nor mal visu ally with echo
intensities up to + 6 SD (figure 5.4). We
therefore con clude that because of the dif -
ferences in nor mal appear ances of dif fer-
ent mus cles, and the inabil ity to make
mental cor rections for this, visual assess -
ment is an inap propriate method to
describe the dis tribution of affected mus -
cles throughout the body.
One patient had focal changes in a mus cle
that were detect able visually, but had a
normal over all mus cle echo intensity. In
such patients visual evaluation has addi -
tional value when applied in com bination
with quan ti fi ca tion. More over, visual
eval u a tion can give infor ma tion about the
dis tri bu tion of echo inten sity through out a
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Fig ure 5.4 This figure shows the visual eval u a tion with cor re spond ing echo inten si ties for each mus cle. The
quantitatively deter mined echo inten sities (expressed in z-scores) for each muscle are shown and each grade
according to the Heckmatt scale. Dot ted line represents 2 SD above nor mal. Note the broad range of echo
intensities for each visual score. Grade 1 (visu ally nor mal) of the quadriceps cor responds to echo inten sities up
to 6 SD above nor mal, with 40 per cent above 2 SD. The biceps brachii, fore arm flexors and quadriceps
required an echo intensity of at least 1.5 SD to be visu ally graded abnor mal. Two patients with an echo
intensity of 0.5 SD in their tibialis ante rior mus cle were graded abnor mal visu ally.
muscle, i.e. whether it is homogeneous or
inhomogeneous. New developments in
quan ti fi ca tion of mus cle ultra sound, such
as tex ture anal ysis will also hopefully be
able to detect such properties, as they have 
been able to detect focal changes in other
image modal i ties with high sen si tiv ity and
specificity (like breast- and prostate
sonograms) [Chen 2003; Loch 1999].
Tex ture anal y sis has been inves ti gated in
skeletal mus cle ultrasound of patients with
neuromuscular dis orders [Pohle 2000] and 
has been suc cessful in adults in discrimi-
nating between neurogenic dis orders and
myopathies [Maurits 2003], but fur ther
inves ti ga tions to eval u ate the diag nos tic
value in children with var ious neuromus-
cular disorders have yet to be done (see
also chap ter 14).
Because ultra sound of mus cles was already
proven to be use ful in the diagnosis of
neuromuscular dis orders, the child neu -
rologists could not be blinded from the
ultrasound results for ethical rea sons. It is
possible that the ultra sound result influ -
enced the decision of the cli nician to per-
form sub se quent inves ti ga tions. How ever
since in most patients exten sive inves tiga-
tions had been done combined with a 2 to
4 year fol low-up period, we think that this
has not substantially influ enced our cur -
rent results.
The interobserver agreement of quantita-
tive eval uation of mus cle echo intensity
was excellent (kappa 0.86) and much
better than visual evaluation with only a
moderate kappa of 0.53. Although all
investigators had prac ticed with the same
images, the image interpretations differed
con sid er ably. When clin i cal deci sions are
based on indi vidual test scores, reli ability
has to be good. This means that visual
eval u a tion of skel e tal mus cle ultra sound
images alone has an unac ceptable low
interobserver agree ment [Landis and Koch 
1977], especially when an inex perienced
observer is inter preting the images (kappa
0.37). Quan ti ta tive mea sure ment of echo
intensity has good reproducibility both in
our as in other studies [Bargfrede 1999]. In 
the pres ent study the sec ond performer of
the quan ti ta tive mea sure ment was an inex-
perienced observer, which shows that
even inex pe ri enced inves ti ga tors can reli-
ably per form a quan ti ta tive anal y sis. How-
ever, this study did not include the
variation that occurs when the ultrasound
measurement is also repeated. How much
this will influence the agree ment of both
methods will have to be evaluated
sep a rately.
In sum mary, we com pared the diag nostic
value and interobserver agree ment of
visual and quan ti ta tive eval u a tion of skel e-
tal mus cle ultrasound in children sus -
pected of hav ing a neuromuscular
disorder. Based on the results of this study
we con clude that quan ti fi ca tion of mus cle
ultrasound is necessary to obtain objective
and accu rate mea surements on which
decisions in indi viduals can be made. Only
with quan tification of echo inten sity it is
pos si ble to reli ably com pare dif fer ent
muscles, in order to describe the distribu-
tion of affected mus cles throughout the
body, which can be help ful in mak ing the
diag no sis and direct ing mus cle biopsy.
Visual eval u a tion of mus cle ultra sound
showed a sensitivity of only 71 %, which in 
our opin ion is not high enough when this
tool is used for screening pur poses dur ing
the diagnostic phase of children sus pected
of hav ing a neuromuscular dis order. With
quan ti fi ca tion higher sen si tiv i ties can be
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achieved, and by vary ing the cut-off point
this method can be adjusted to the
require ments of a spe cific clin i cal sit u a tion
to increase spec i fic ity.
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Introduction
Quan ti fi ca tion of mus cle echo inten sity
using computer assisted grey scale analysis
has been shown to be more reliable and
more sensitive in detect ing neuromuscular
dis or ders, and is there fore pref er a ble in
daily clin ical prac tice [Pillen 2006a]. How -
ever, mus cle echo intensity is influenced
by ultra sound system hard ware and soft-
ware, and will therefore be dif ferent for
each ultrasound device used. This implies
79
Quantitative grey scale analysis:
two ultrasound devices compared6
Abstract
Quan ti fi ca tion of mus cle echo inten sity using com puter-assisted grey scale analysis is more
reliable and more sensitive than visual eval uation of the ultra sound images. How ever, quan -
tified mus cle echo intensity is dependent on the ultrasound device and transducer character-
istics as they vary from machine to machine. This implies that a new set of nor mal val ues will 
have to be established for each new ultra sound device used.
In this study we tested a method to reli ably use nor mal val ues established with one ultra -
sound device to be used on another device. Based on measurements of a ded icated phan tom
and in 7 healthy sub jects a con version equa tion was calculated to con vert the mean echo
intensity. A Bland-Altman plot revealed that more vari ation between the two devices was
present at high echo inten sity lev els. As these values only occur in severely affected patients
this find ing will not affect sensitivity or specificity of mus cle ultrasound for the detection of
neuromuscular dis orders. The reliability of the con version equa tion was evaluated in a fol -
low-up study of 22 healthy children. These measurements showed that after appli cation of
the conversion equa tion no residual dif ference in echo intensity was present between the
two ultrasound devices. This indi cates that mean mus cle echo intensity is a solid param eter
and allows for nor mal val ues obtained with one device to be used on another device. This is
an impor tant step for ward towards the use of quan titative mus cle ultrasound in daily clinical
care.
Adapted from: Pillen S, van Dijk JP, Weijers G, Raymann W, de Korte CL, Zwarts MJ. Quan ti ta tive
grey scale anal ysis in skel etal muscle ultra sound: comparison study of two ultra sound devices. Mus cle
Nerve. 2009 In press
that new nor mal val ues need to be deter-
mined for each device. As this is a time
con sum ing pro ce dure, it might ham per
the use of quan titative mus cle ultrasound
in a clin ical setting.
Pre vi ous stud ies have attempted quan ti fi -
cation methods that are nearly inde pend-
ent of the char acteristics of ultra sound
devices, using raw frequency (rf-)signals
or back scat ter anal y sis [Hughes 2007;
Knipp 1997]. Raw fre quency (rf-)signals
derived from the transducer are inde pend-
ent of the post-processing incor porated in
ultrasound devices and would therefore be 
pref er a ble for quan ti fi ca tion of mus cle
echo intensity. But even rf-signals are not
com pletely device-inde pend ent. The
intensity of the rf-signal is depth depend-
ent due to attenuation and beam pro file
char ac ter is tics. More over, rf-data require
a large amount of addi tional dig ital pro -
cessing before muscle echo intensity can
be cal culated, which in turn requires tech-
nical sup port that is not widely available.
Also, rf-data are also often not retrievable
from ultra sound devices because of com -
pany related restrictions. Therefore the
use of raw frequency sig nals in daily prac-
tice is cur rently lim ited. Another quan tifi-
ca tion tech nique called back scat ter
analysis con verts grey scale values to deci -
bels based on phan tom mea surements, to
approximate the amount of backscatter.
This tech nique has been investigated pri-
marily in car diac mus cles and has shown to
be rel atively inde pendent of the ultra -
sound device used [Knipp 1997; Perez
1994], but fur ther research is needed to
determine whether this tech nique is also of
value in skeletal mus cle ultrasound. Until
these new tech niques have been further
devel oped, quan ti ta tive grey scale anal y sis
is the only quan titative mus cle ultrasound
technique with proven clin ical util ity that
is cur rently avail able.
A com pletely dif ferent approach to the use 
of the same set of nor mal val ues on dif fer-
ent ultrasound devices is to search for the
relation in echo intensities between differ-
ent ultrasound devices, and then to calcu-
late a conversion equa tion to transpose
normal val ues obtained with one ultra-
sound device to another device. Of course
it will not be possible to create iden tical
images due to dif ferences in trans ducer
fre quen cies and post-pro cess ing tech-
niques. How ever, mean mus cle echo
intensity is calculated from a rel atively
large area and although ultra sound devices
create images that are dif ferent on a pixel
level they are com parable on a macro
level. This suggests that echo inten sity
might be com parable between ultrasound
devices, which would make it possible to
use the same nor mal val ues on dif ferent
ultrasound devices, after the appli cation of 
a cor rec tion fac tor.
 In this study we used a clinically applicable
approach and ana lyzed the same muscle
samples with two com pletely different
ultrasound devices to evaluate their influ -
ence on mean echo intensity. We showed
that it is possible to convert nor mal mus cle
echo intensity val ues obtained with one
device so that they can be reliably used on
another even without the use of rf- or
other raw data.
Meth ods
Outline of the study
Two ultra sound devices with dif ferent
trans ducer and post-pro cess ing char ac ter -
istics were selected. First we cal culated a
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conversion equa tion based on mea sure-
ments made with both devices on a ded i-
cated phan tom and in 7 sub jects. With this
equation echo inten sities obtained with
device 2 could be con verted to be com pa-
rable to device 1.
In the second part of the study the reli abil-
ity of this conversion equa tion was tested
in 22 healthy children. The study was
approved by the local eth ics committee
and informed con sent was obtained of all
parents and sub jects them selves when
older than 12 years of age.
Equip ment
Device 1 was a phased array real-time
scanner with a 7.5 MHz transducer (Sonos
2000 Phased Array Imag ing system;
Hewlett-Packard Com pany, Andover,
Massachusetts, USA). With this ultra-
sound device nor mal val ues of mus cle echo
intensity in chil dren had pre viously been
established [Scholten 2003]. We applied
the same sys tem-setting parameters as in
that study (gain 86dB, compression 70,
time gain compensation in neu tral posi -
tion, and three focal points at 1.5, 2.0 and
2.5 cm). Device 2 was a Philips IU22 with
a 5-17 MHz lin ear broad band trans ducer
(Philips Healthcare, Eindhoven, The
Neth er lands). Sys tem set tings were
adjusted to achieve muscle ultrasound
images visually comparable to device 1
regarding brightness and contrast (gain 70,
com pres sion 55, time gain com pen sa tion
in neu tral posi tion and focal zone 1.0 to
2.5 cm). Addi tional image enhancement
settings (Sono-CT and Xres) were not
applied. All settings were kept constant
throughout the study.
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Fig ure 6.1 Ultrasound image of the phan tom using device 1 (left panel) and device 2 (right panel). Note 
the nee dle tip and the poly ester strand (indicated with cir cles) that were manually iden tified. Based on
these points a rectangle was automatically selected (dot ted line), com prising an area at a depth of 0.5 to 
2.75 cm and at 0.5 cm distance from the nee dle tip. Within this rect angle 10 regions of 1 x 0.5 cm
(dotted line) with partial over lap were selected of which the mean echo inten sity was cal culated.
Part 1: estab lishment of the
con ver sion equa tion
To establish the equa tion to convert echo
inten si ties, stan dard ized mea sure ments of
the same samples were made with both
devices. For clin ical rel evance, the mea-
surements had to result in echo inten sities
within the range of nor mal and dis eased
muscle tis sue as determined in previous
studies using device 1, i.e. between 20 and
80 out of 256 pos sible grey lev els [Pillen
2003; Scholten 2003]. The regions under
examination had to be at a depth between
0.5 and 3.0 cm, as this is the depth at
which mus cle ultrasound imag ing is usu -
ally fea sible [Arts 2008; Scholten 2003].
Unfortunately we could not find a com -
mercially available phan tom that resulted
in the nec essary range of grey values. We
therefore con structed our own phantom,
using three lay ers of pig mus cle with dif-
ferent echo intensities (fig ure 6.1). Poly -
ester strands at the bottom and a nee dle at
the top of the phantom ensured the exact
same measurement site for both ultra-
sound devices. Images were made at 14
locations. In each image, 10 rectangular
regions of inter est were automatically
selected after man ually indi cating the tip
of the needle and the poly ester strand at
the bot tom of the image (figure 6.1). At
each location 5 images were made and the
mean was taken to compensate for mea-
surement vari ation. As the echo intensity
values obtained with the pig phan tom
were mostly in the lower range of clin i-
cally relevant echo intensities (between 15
and 45 out of 256 grey lev els), we next
added in vivo mea surements with
expected higher mus cle echo inten sities.
Four mus cles (biceps brachii mus cle, fore -
arm flexors, rectus femoris mus cle and 
tibialis ante rior mus cle) were mea sured in
3 patients with Duchenne mus cular dys -
trophy (aged 8, 9 and 12 years) and 4
healthy sub jects (aged 22, 35, 81, and 82
years). The measurements with both
devices were made according to a previ-
ously pub lished protocol [Scholten 2003],
with the excep tion that the mean echo
intensity was cal culated based on seven
measurements of each muscle instead of
three to min i mize mea sure ment vari abil -
ity. In each image a region of interest was
selected that com prised as much of the
muscle as pos sible but avoided the sur -
round ing fas cia. All mea sure ments were
performed by the same inves tigator
(W.R.).
Because device 1 had a non lin ear look-up
table (LUT) we matched the LUTs of both
machines using a non-linear transforma-
tion. The cor re la tion of echo inten si ties
between both ultra sound devices was
expressed in an equa tion with cor respond-
ing con fidence intervals and r2. To assess
the exis tence of a pos sible residual correla-
tion a Bland-Altman plot was applied.
Part 2: Eval uation of the reliability
of the conversion equa tion
The reli ability of the conversion was eval u-
ated in a clinical setting. Mus cle ultra-
sound mea surements were evaluated of 22 
healthy con trols (age 0.5 to 14 years) mea -
sured 4 times in a period of two years with
6-month inter vals. The first two measure-
ments were made with device 1 (t = 1 and
2), the last two with device 2 (t = 3 and 4). 
These sequen tial measurements could be
used to evaluate the con version equa tion
because muscle echo inten sity does not
change until the age of 16 [Scholten 2003].
Four mus cles were mea sured according to
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a pre vi ously described pro to col (biceps
brachii mus cle, fore arm flexors, rectus
femoris mus cle and tibialis ante rior mus -
cle) [Scholten 2003]. The con version
equation derived from the first experi-
ment was applied to the mea surements of
device 2. The mean of both measurements
of each device was cal culated and a paired
t-test was applied to determine whether a
constant error existed between echo
intensities of device 1 and device 2. The
coef fi cient of vari a tion was cal cu lated to
assess if a difference in measurement varia-
tion existed between both devices. Addi-
tionally, a Bland-Altman plot was created
to inves ti gate if a resid ual cor re la tion was
present after appli cation of the con version
equa tion.
Results
Part 1: Establishing the con version
equa tion
The com bined mea surements of the pig
phantom and the 7 sub jects resulted in
echo intensities rang ing from 5 to 90 in
device 1, which covers the clin ically rel e-
vant range (i.e. 20 – 80). Within this range
of echo intensities (EI) the ultrasound
devices were found to have a lin ear cor re-
lation (fig ure 6.2), which could be
described by the fol lowing equa tion:
EI device 1 =  A* EI device 2 + B
with A being 1.38 (95% con fidence inter-
val 1.28 – 1.49) and B being 9.14 (95%
confidence interval  6.8 - 11.5). The r2 was
0.81.
The Bland-Altman plot revealed that
higher muscle echo intensities (above 70
with device 1) showed more vari ation and
possibly higher values when obtained with
device 1 com pared to device 2 (fig ure
6.3).
Part 2: Reliability of conversion
equa tion
Echo inten sities deter mined with device 1
ranged between 24 and 56. After applying
the con ver sion equa tion no sig nif i cant dif-
ference in muscle echo intensity between
the two ultra sound devices was pres ent
(mean echo intensity device 1 = 39.8
(standard devi ation 5.9); mean echo inten -
sity device 2 = 40.2 (5.9); dif ference 0.4;
p = 0.46). The coefficient of vari ation was
exactly the same in both devices (14.7%).
The Bland-Altman plot showed no resid-
ual cor re la tion, indi cat ing that the con ver-
sion equa tion had resulted in a reli able
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Fig ure 6.2 Correlation between mean echo inten -
sity determined with device 1 and device 2. The
line rep re sents the lin ear cor re la tion between the
echo inten sities of both devices.
conversion within this range of echo inten -
si ties (fig ure 6.4).
Dis cus sion
This study shows that val ues of muscle
echo intensity in the normal and patho logi-
cal range established with one ultrasound
device can be reli ably applied to mea sure-
ments made by another device. After
apply ing a cor rec tion fac tor, val ues
obtained with one device became sim ilar
to those of another device, even though
the ultrasound machines were quite dif fer-
ent, both in post-processing and trans-
ducer characteristics (a phased array 7.5
MHz transducer versus a broad band lin ear
17-5 MHz transducer). This is an impor -
tant find ing as it will improve the clin ical
appli ca bil ity of quan ti ta tive mus cle ultra-
sound. The con version was made only for
the clinically relevant range of echo inten -
sities (i.e. grey val ues between 16 and 80
on an 8 bit scale). Eval uation of this con -
version was performed in a healthy con trol
group showing echo inten sities in the
lower part of the clin ically rel evant range,
i.e. between a grey value of 24 and 56. The
reliability of values above this range was
therefore not deter mined. The first exper -
iment showed that especially values above
70 were more variable between device 1
and 2 and pos sibly higher in device 1 com-
pared to device 2. A pos sible expla nation
could be that the higher transducer fre-
quency of device 2 resulted in more atten-
uation of the ultra sound beam, which
becomes more prominent in tissues with
higher echo inten sities [Pillen 2008]. In
daily clin ical prac tice this will not pose a
large problem, as even with this deviation
all val ues remain very abnor mal on both
devices, i.e. above 3 to 4 stan dard devi a-
tions above nor mal. As such echo inten si-
ties are found only in patients with severe
neuromuscular dis orders, this will not
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Fig ure 6.3 Bland-Altman plot of mean echo inten sities of device 1 and 2 of the first exper iment (phan-
tom mea surements and 7 sub jects). The con version equa tion has been applied to the echo inten sities of
device 2. Higher echo inten sities show more vari ation and pos sibly higher val ues in device 1 com pared to 
device 2. EI = echo intensity; dot ted line rep resents 2 standard devi ations above and below the mean
dif fer ence.
affect sen si tiv ity or spec i fic ity to detect a
neuromuscular dis order with mus cle
ultrasound [Pillen 2007; Scholten 2003]. 
The conversion was confined to superficial
muscles (between 0.5 and 3.5 cm depth),
which is in accordance with the mus cle
ultrasound pro tocol most often used in
daily clinical care [Arts 2008; Heckmatt
1988a; Maurits 2003; Scholten 2003].
Con ver sion of mea sure ments at a dif fer ent 
(especially deeper) depth might not be as
reliable, as echo inten sities of deeper lay-
ers will be influenced by a higher atten ua-
tion of devices with higher trans ducer
fre quen cies [Fish 1990].
Pre vi ous devel op ments in clin i cal ultra-
sound have mainly focused on the
enhancement of the image resolution to
iden tify and dis crim i nate indi vid ual struc-
tures. These developments are accom pa-
nied by a growing dif ficulty to com pare
quan ti ta tive mea sure ments between dif-
ferent ultrasound devices. New develop-
ments in ultrasound technology are
necessary that focus on eas ily acces sible
device-inde pend ent ultra sound out put
that can be used for quantitative mea sure-
ments. Until then, image-derived meth -
ods such as quan titative grey scale anal ysis
will be predominantly used in clin ical
prac tice. When per form ing quan ti ta tive
mus cle ultra sound one should pref er a bly
refrain from addi tional post-processing
such as com pound imag ing or other reso-
lu tion enhance ment set tings, to min i mize
the dif ference between ultrasound
devices, as this will improve the quality of
the conversion. To perform a con version,
the use of a stan dard com mercially avail-
able and pre servable phan tom would be
preferable, as this will give the oppor tu-
nity to per form many mea surements in a
short time frame. It will have to be a ded i-
cated phan tom con taining grey scale tar -
gets with grey val ues cov ering the clinical
relevant range of muscle echo inten sities at 
a rel evant depth to ensure a reli able con -
version. Unfor tunately such a phantom is
not yet avail able for the ultra sound devices
used in this study. It would be advisable to
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Fig ure 6.4 Bland-Altman plot of the eval uation of the con version equa tion (sec ond exper iment, mus cle
ultrasound mea surements in 22 healthy con trols). After appli cation of the con version equa tion no resid -
ual cor relation or dif ferences in vari ation  at different echo inten sity lev els were pres ent. EI = echo
intensity dot ted line rep resents 2 stan dard devi ations above and below the mean dif ference.
assemble ref erence val ues as soon as possi-
ble after nor mal values are established, in
case the ultrasound device should break
down or is replaced for other rea sons.
These ref erence val ues can also be used to
perform qual ity checks once in a while to
ensure that the ear lier established normal
values are still valid [Thijssen 2007].
We con clude that nor mal val ues of quan ti-
fied muscle echo intensity can be used reli -
ably on dif ferent ultrasound devices,
which is an impor tant step for ward in the
use of this technique in daily clin ical
prac tice. 
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Quantification of mus cle echo intensity by grey scale anal ysis is depend ent on the ultra-
sound device used. Hard ware and transducer characteristics dif fer between ultrasound
devices, which influences the mean grey value. This implies that normal values obtained
with one device can not auto matically be applied to another. Fortunately, the mean mus cle
echo intensity is a solid variable, probably because it is cal culated from a rather large area
and mainly influ enced by the macro texture of an image that remains approx imately the
same with dif ferent ultrasound devices. This makes it possible to achieve a reli able conver-
sion of nor mal val ues after appli cation of a con version equa tion as outlined in chapter 6.
Before a conversion can be suc cessfully used in clinical prac tice cer tain aspects need to be
taken into account. These will be out lined in this box.
choice of system settings to facil itate a future
con ver sion
Recent devel opments in ultrasound have resulted in all kinds of post-pro cessing techniques
that improve image res olution, such as compound imag ing or Xres®. These image-enhanc-
ing tech niques have a pos si ble neg a tive influ ence on the com pa ra bil ity of dif fer ent ultra-
sound devices. In quan titative mus cle ultrasound a better resolution is not really necessary
as long as the muscle of interest can be iden tified. We would therefore advise to refrain
from such addi tional post-processing as much as pos sible for quan titative mea surements to
minimize the dif ference between ultrasound devices, as this will improve the quality of the
con ver sion. 
For the same rea son it would be advis able to avoid large dif ferences in trans ducer fre-
quency. Other system settings such as gain, compression and focal points can best be
adjusted to result in approx imately the same image on the ultra sound screen. In addi tion to
a better con version, this will also improve the visual eval uation that is for exam ple needed
when mus cles are mea sured of which no nor mal val ues are avail able.
Phan tom mea sure ments
To per form a con version the use of a standard com mercially available and pre servable
phantom would be preferable, as this will pro vide the oppor tunity to per form many mea -
surements in a short time frame. It will have to be a ded icated phan tom con taining grey
scale tar gets with grey val ues cov ering the clinically relevant range of mus cle echo
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intensities at a rel evant depth to ensure a reli able conversion. This means that the grey scale
targets have to be located at a depth between 0.5 and 3.5 cm, as this is the depth at which
most muscles eval uated with muscle ultrasound are located. The grey values of the tar gets
will have to com prise the full grey scale range of pre viously established normal values (-2 to
+2 SD). In addi tion, the range of patho logically increased echo intensities up to +3 to +4
SD will have to be included in the conversion to ensure that all clinical rel evant mus cle echo
intensities can reli ably be converted. A reliable con version above +4 SD would be attrac-
tive, but is not nec essary when mus cle ultrasound is used as a screen ing tool. These echo
intensities are only found in patients with severe structural mus cle changes and never in
healthy subjects. A less reliable conversion in this range will there fore not influence the sen -
sitivity or specificity of mus cle ultrasound for the detection of neuromuscular dis orders.
It is advisable to assemble ref erence val ues as soon as possible after nor mal values are estab-
lished, in case the ultrasound device should break down or is replaced for other reasons.
Unfortunately a ded icated phan tom is not always available. In that case standardized mea -
surements in healthy sub jects and patients or a non-preservable phan tom can be used
instead. How ever, these mea surements can only be made when both the new and the old
device are available at the same time, which can be a prob lem if the ultra sound device sud -
denly breaks down.
Limitations of using nor mal values on another
ultra sound device.
If a con version equa tion is applied to a mea sured mus cle echo intensity the resulting value
can be compared to previous established normal val ues and expressed as a z-score. How -
ever, when interpreting the z-score the fol lowing lim itations have to be taken into account.
Differences in trans ducer frequencies result in a dif ferent attenuation of the ultra sound
beam. This means that con version of mea surements at depths below approx imately 3 cm
are less reliable when the trans ducers have a large frequency difference. Dif ferences in
beam char acteristics can result in dif ferences in the depth pro file of echo inten sities. This
means that at a certain depth higher or lower echo intensities can be found with dif ferent
transducers. Most muscle echo intensities are calculated from a rel atively large region of
interest, which reduces this influence, but when the region of interest is small the mean
echo intensity can be falsely higher or lower. Phantom measurements can reveal the depth
profile of a cer tain transducer and indi cate how large this influ ence is in a certain ultra sound
device and region of inter est. This can help in interpreting ultra sound results of small
region of interests after a conversion.
A con version equation is only reliable for the grey scale lev els that were used in the phan-
tom measurements (preferably -2 SD to +4SD). Although a less reli able conversion outside
this range will not influ ence sensitivity or specificity, it can influ ence the inter pretation of
follow-up mea surements in individual patients when the ini tial mea surements were out side
this range.
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Intro duc tion
The diagnosis of neuromuscular dis eases is
gen er ally based on clin i cal eval u a tion, and
is usu ally sub stan ti ated by lab o ra tory
inves ti ga tions, electromyography (EMG),
muscle biopsy or genetic evaluation (see
also chap ter 1). Especially EMG and mus -
cle biopsy are invasive inves tigations that
are ide ally only applied when they are
expected to aid in the final diagnosis.
Previous studies have shown that muscle
ultrasound, a non-invasive and eas ily
applicable method, can aid in the diagnosis
of neuromuscular disorders as it can detect
muscle atrophy and structural mus cle
changes. The latter gives rise to increased
muscle echo intensity, which can be
detected visually, but appli cation of quan -
ti fi ca tion meth ods, i.e. grey scale anal y sis,
has shown to increase reliability and
sensitivity [Pillen 2006a]. 
In this prospective pilot study we inves ti-
gated the diagnostic value of mus cle ultra-
sound.  The pur pose of this study was to
deter mine the sen si tiv ity, spec i fic ity, and
predictive value of muscle echo inten sity
in dis crim i nat ing between chil dren with
and with out neuromuscular dis order. A
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neuromuscular disease: a pilot
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Abstract
In this study the diag nostic value of quan titative ultra sound for detecting neuromuscular
disorders in children was pro spectively determined.  Ultrasonographic scans of 4 mus cles
were made in 36 chil dren with symp toms or signs sug gestive of neuromuscular dis ease,
such as mus cle weakness and hypotonia. The mus cle thickness, ratio of mus cle thickness to
subcutaneous fat thickness and echo intensity were determined quantitatively in each mus -
cle.  Thir teen of the 36 patients had a neuromuscular disorder (6 a myopathy and 7 a neu -
rop a thy). Dif fer en ti a tion between neuromuscular dis eases and non-neuromuscular dis eases
could be made on the basis of echo inten sities with a sensitivity of 92%, a spec ificity of 90%,
a pos itive pre dictive value of 86% and a negative pre dictive value of 95%. We con clude that
computer-assisted quan titative anal ysis of mus cle echo intensity is a reli able method to dis -
criminate between neuromuscular and non-neuro-mu scular diseases in chil dren.
Adapted from: Pillen S, Scholten RR, Zwarts MJ, Verrips A. Quan titative skeletal mus cle
ultrasonography in chil dren with sus pected neuromuscular dis ease. Mus cle Nerve 2003; 27:699-705
second goal was to exam ine whether it is
pos si ble to dis tin guish between spe cific
neuromuscular dis orders within the group
of chil dren with proven neuromuscular
disease, using mus cle thick ness or the ratio
of muscle to subcutaneous fat thickness.
Patients and meth ods
Patients
We pro spectively studied 36 patients (23
boys: median age 5.3 years, interquartile
age range 2.0 – 7.8 years; 13 girls: median
age 6.2 years, interquartile age range 2.2 – 
8.5 years) who were referred to our ter-
tiary referral cen ter in 2000 and 2001 with
a sus pected neuromuscular dis order. At
the time of mea surement the diagnosis was 
not yet estab lished. Symptoms such as
muscle weak ness, fatigue, mus cle pain,
delay in motor devel opment, and
hypotonia were the basis for sus pecting a
neuromuscular dis ease. The children were
diag nos ti cally eval u ated using elec tro-
myography (EMG; n=33), biochemical
and genetic evaluation, and in 19 cases a
mus cle biopsy. Bio chem i cal eval u a tion
included determination of serum glucose,
creatine kinase, transaminases, lac tate
dehydrogenase, lac tate lev els, and
lysosomal enzyme activities in all patients.
The mus cle biopsies were obtained from
the quadriceps mus cle in 15 patients with a 
Bergström nee dle and in 4 patients by a
sur gi cal pro ce dure. The spec i mens were
processed for light microscopic investiga-
tions and stained with hematoxylin/
phloxine and for ATP-ase, succinate
dehydrogenase, cytochrome oxidase
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Age at studyNumber with abnormal EI*
(total number)
Diagnosis
12 (13): 92 %Total
6 y
9 m, 2 y
4 y
6 y, 9 y
5 (6)
1 (1) 1, 3, 5
2 (2) 1, 3, 4, 5
0 (1) 1, 3, 4, 5
2 (2) 1, 3, 4, 5
Myopathic disorders
Duchenne dystrophy
Mitochondrial encephalomyopathy 
Type I predominance
Unclassified
6 m
2 y, 5 y
12 y
4 y
13 y
2 y
7 (7)
1 (1) 2, 3, 5
2 (2) 2, 3, 5
1 (1) 2
1 (1) 2, 5
1 (1) 2, 5
1 (1) 2
Neurogenic disorders
SMA type I 
SMA type II
CIDP
SMA with polyneuropathy
Friedreich's ataxia with axonal polyneuropathy
Myelocele with lumbosacral polyradiculopathy
Ultrasound results of patients with a neuromuscular disorder
Table 7.1 Diag noses and ultrasonographic find ings of 13 chil dren with neuromuscular dis orders
CIDP: chronic inflam matory demyelinating polyneuropathy; SMA: spi nal mus cular atro phy
* abnor mal echo inten sity defined as 3 mus cles have an echo inten sity above 0.9 SD
Studies con firming the diag nosis: 1= serum anal ysis; 2= electromyography; 3 = mus cle biopsy; 4 = bio -
chem i cal inves ti ga tion of mus cle (respi ra tory chain enzyme activ i ties); 5 = genetic anal y sis.
(COX), and acid phosphatase. In 4
patients the muscle spec imen was inves ti-
gated ultrastructurally. In 3 patients the
respi ra tory chain enzyme activ i ties were
measured in mus cle tissue according to
estab lished, pre vi ously pub lished pro ce -
dures [Fischer 1986]. Genetic anal ysis was
done for the patients with sus pected
Friedreich’s ataxia, Duchenne muscular
dystrophy, and spinal muscular atrophy.
Table 1 and 2 show the diagnostic
evaluation of all patients.
Ultra sound mea sure ments 
Ultrasound scan ning was performed and
ana lyzed blinded for clin i cal pre sen ta tion
of the patients or results of other investiga-
tions. The method of ultra sound scan ning
is described in chapter 4 [Scholten 2003].
The equipment, sys tem set ting para-
meters, and study pro tocol were in con -
cordance with this study, to be able to use
the estab lished normal values. The stan -
dard four mus cles were examined in the
transverse plane: the biceps brachii, fore -
arm flexors, quadriceps, and tibialis
anterior muscles.
Mus cle and sub cu ta ne ous fat thick ness
were measured on-line with elec tronic
calipers. The echo intensities were deter -
mined quan titatively using a com -
puter-assisted grey scale analysis (see also
chapter 4 and box 2) [Scholten 2003]. In
the quadriceps femoris, the rectus femoris
muscle was cho sen for anal ysis of echo
intensity.
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Ultrasound results of patient without a neuromuscular disorder
2 (20): 10 %Total
0 (1)                                           11 yIdiopathic pain
0 (1) 6 yDelay in motor development
0 (2) 2 y, 5 yHyperlaxicity
0 (3)                                           10 m, 1 y, 7 yCerebral palsy
0 (1) 6 yFatigue and muscle pains
0 (2) 2 y, 3 y Hypotonia and  (psycho)motor delay
1 (1)                                           12 yHypotonia or fatigue of unknown origin
EMG, genetic and biochemical evaluation normal
9 y0 (1)Idiopathic toe-walking
4 y0 (1)Cerebral palsy
7 y1 (1)Fatigue and muscle pains
1 y, 1 y0 (2)Hypotonia and motor delay
6 y, 6 y, 7 y, 14 y0 (4)Hypotonia or fatigue of unknown origin
Biopsy, EMG, genetic and biochemical evaluation normal
Age at studyNumber with abnormal EI* 
(total number)
Diagnosis
Table 7.2 Diag noses and ultrasonographic find ings of 20 chil dren with non-neuromuscular dis orders
* abnormal echo intensity definied as 3 mus cles have an echo intensity above 0.9 SD.
Anal y sis of find ings
The mus cle thick ness was compared to
normal val ues according to weight
[Scholten 2003]. The ratio of mus cle thick-
ness to sub cutaneous fat thickness was only 
assessed in children youn ger than 12 years,
because no nor mal val ues are available for
children above that age. The ratio was
compared with nor mal val ues according to 
age [Scholten 2003]. Echo intensities were
compared with nor mal val ues. These val -
ues are independent of age, sex, height or
weight [Scholten 2003]. The mea sured
values were next trans formed into a
z-score (i.e. the amount of standard devi a-
tions above or below nor mal, also see box
2).
Z-scores of mus cle thick ness, ratio of mus-
cle thick ness to sub cu ta ne ous tis sue thick-
ness, and echo intensity were compared
between patients with and without a
neuromuscular dis ease, using a Students
t-test. Sta tis ti cal sig nif i cance was defined
as p<0.05. Only echo intensity appeared
to be sig nif i cantly dif fer ent between both
groups in all muscles (p<0.01). A cut-off
point of the echo intensities had to be
deter mined for dis crim i nat ing neuromus-
cular dis eases from non-neuromuscular
diseases. To deter mine this, we inves ti-
gated whether 1, 2, 3, or 4 mus cles had to
be abnor mal to con sider the test pos itive
with the high est sen si tiv ity and spec i fic ity.
Therefore, we con structed 4 receiving
oper a tor char ac ter is tic (ROC) curves.
Then the cut-off point that gave the best
sen si tiv ity and spec i fic ity was deter mined.
Sen si tiv ity, spec i fic ity, pos i tive pre dic tive
value, and negative predictive value were
calculated with a 95 % confidence
interval.
Z-scores of mus cle thick ness, ratio of mus-
cle thick ness to sub cu ta ne ous tis sue thick-
ness, and echo inten sity were also
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Ultrasound results NMD versus non-NMD
0.27-1.4 - 0.41-0.500.13  (0.98)-0.37 (1.6)Tibialis anterior
0.01*-2.8 - -0.39-1.60-0.35 (1.3)-1.95 (2.0)Quadriceps femoris
0.54-0.86 - 0.46-0.20-0.41 (0.78)-0.61 (1.1)Forearm flexors 
0.09-1.7 - 0.13-0.800.096 (1.4)-0.71 (1.1)Biceps brachii
Muscle thickness
< 0.001*5.1 - 1.93.50.12 (1.3)3.6 (3.0)Tibialis anterior
< 0.001*5.4 - 2.23.81.00 (1.1)4.8 (3.2)Quadriceps femoris
< 0.001*4.8 - 1.63.20.35 (1.4)3.5 (3.0)Forearm flexors
< 0.001*3.5 - 1.22.40.26 (1.2)2.6 (2.1)Biceps brachii
Echo intensity
Mean (SD)Mean (SD)
p-value95% CIDifferenceNon-NMD
(n = 20)
NMD
(n = 13)
Muscle
Table 7.3 Dif ferences in stan dardized mus cle thick ness and echo inten sity between neuromuscular and
non-neuromuscular dis ease.
* Ssignificant dif ference. NMD = neuromuscular dis ease; CI = con fidence inter val.
compared between patients with a myo-
pathy and patients with a neuropathy using
a Stu dent’s t-test.
Results
After diag nos tic eval u a tion of the 36
patients, 13 were found to have a neuro-
muscular dis order: 6 had a myopathy and 7 
had a neu ropathy (see table 7.1 for diagno-
ses). Twenty patients who presented with
muscle symptoms and signs did not show
any evidence of a pri mary neuromuscular
disorder on mus cle biopsy or other investi-
gations (see table 7.2 for diagnoses). Three 
patients were not diag nosed at the time of
analysis. The results of the measurements
of these patients were not included in this
study.
The echo intensity was sig nificantly differ-
ent between patients with and with out a
neuromuscular dis order in all investigated
muscles (table 7.3). The ROC curve (fig-
ure 7.1) shows that the best cut-off point is 
0.9 standard devi ations (SD) above nor mal
in 3 or more mus cles. This cut-off point
gives a sen sitivity of 92% (95% confidence
inter val: 78 – 100%), a specificity of 90%
(77 – 100%), a pos itive pre dictive value of
86% (68 – 100%), and a neg ative pre dic-
tive value of 95% (85 – 100%). 
Using this cut-off point, 92% of the chil-
dren with a neuromuscular dis order had
an abnor mal ultra sound (fig ure 7.2). Only
one child with a myopathy had nor mal
echo intensities. This child showed only
minimal changes on mus cle biopsy (type 1
predominance) had a nor mal EMG and an
exact diag nosis could not be made despite
all of the diagnostic studies used.
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Fig ure 7.1 Receiver oper a tor char ac ter is tic (ROC) curves con structed using sen si tiv ity and false pos i tive
rate, when 1, 2, 3, or 4 abnormal echo intensities are con sidered to be a pos itive test result. The optimal
cut-off point is 0.9 SD above nor mal in 3 or more mus cles. This gives a sen sitivity of 92 % (95 % con fi-
dence inter val, 78 – 100%) , a spec ificity of 90 % (77 – 100%), a pos itive pre dictive value of 86 %
(68 – 100 %), and a neg ative pre dictive value of 95 % (85 – 100 %).
Of the chil dren without a neuromuscular
disorder, 90 % had nor mal echo intensi-
ties. Two children without a neuromus-
cular dis order had abnor mal echo intensi-
ties, 1 with hypotonia and fatigue without
a neu ro log i cal expla na tion, and 1 patient
with fatigue and idio pathic pains, in whom
EMG and mus cle biopsy did not show any
abnormalities.
When this cut-off point of 0.9 SD above
normal in 3 or more mus cles would be
applied to the nor mal sub ject group (from
our pre vious study) [Scholten 2003], 6 of
59 healthy children (10%) would have an
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figure 7.2 Mus cle ultra sound of a patient without a neuromuscular dis order (left panel) and a boy with
Duchenne mus cular dys trophy (right panel). The echo inten sity of the rectus femoris mus cle (cir cle) is
severely increased in the patient with Duchenne. The out line of this mus cle and the under lying vastus
intermedius mus cle (V) and femur is not vis ible any more. Dou ble arrow = sub cutaneous tis sue.
Ultrasound results myopathies versus neuropathies
0.54-3.1 - 1.7-0.68-0.06 (2.3)-0.74 (0.77)Tibialis anterior
0.30-1.7 - 0.59-0.56-0.82 (1.0)-1.38 (0.53)Quadriceps femoris
0.72-1.2 - 0.86-0.17-0.73 (0.83)-0.90 (0.63)Forearm flexors
0.16-0.2 - 1.10.45-1.44 (0.56)-0.99 (0.37)Biceps brachii
(n = 20)(n = 20)Thickness ratio*
0.99-2.1 - 2.0-0.015-0.36 (1.9)-0.38 (1.5)Tibialis anterior
0.19-3.9 - 0.85-1.51-1.13 (1.8)-2.64 (2.0)Quadriceps femoris
0.60-1.7 - 1.0-0.33-0.43 (1.3)-0.76 (0.92)Forearm flexors
0.68-1.7 - 1.1-0.27-0.56 (0.70)-0.83 (1.4)Biceps brachii
(n = 20)(n = 13)Muscle thickness
Mean (SD)Mean (SD)
p-value95% CIDifferenceMyopathyNeuropathyMuscle
Table 7.4 Dif ferences in mus cle thick ness and thick ness ratio in neuropathies and myopathies.
* Thick ness ratio, ratio of mus cle thick ness to sub cutaneous fat thick ness; CI = con fidence inter val.
abnor mal ultra sound, resulting in a speci-
ficity of 90%.
In most mus cles the mus cle thick ness and
ratio of mus cle thick ness to sub cu ta ne ous
fat thick ness were not sig nificantly differ-
ent between patients with and with out a
neuromuscular dis ease (p > 0.1). Only the
quadriceps muscle thick ness was smaller in
children with a neuromuscular dis ease (p
< 0.05) than in chil dren without such dis -
ease (table 7.3). Neuropathies had slightly
smaller val ues for mus cle thick ness and
thickness ratio com pared to children with
a myopathy, but this dif ference was not
significant (p > 0.1) (Table 7.4).
Dis cus sion
This study shows that quan titative ultra -
sound of 4 mus cles is a highly sen sitive and
specific method in detecting neuromus-
cular dis or ders in chil dren. Quan ti ta tive
analysis of muscle echo inten sity using
computer-assisted grey scale analysis can
dif fer en ti ate between neuromuscular and
non-neuromuscular dis eases with a sensi-
tivity of 92%, a spec ificity of 90%, a pos i-
tive pre dictive value of 86%, and a
negative pre dictive value of 95%. With
these val ues quan ti ta tive mus cle ultra-
sound can be help ful in prioritizing sub se-
quent invasive inves tigations such as EMG
and mus cle biopsy. For example, when
mus cle ultra sound exam i na tion reveals a
normal echo intensity, structural changes
are unlikely to be found on mus cle biopsy.
Addi tion ally, echo inten sity mea sure -
ments in 4 different mus cles gives infor-
mation of the dis tribution of the dis ease,
which can help in the diagnosis and can be
used to guide biopsy and EMG. This is
especially helpful for neuromuscular
disorders with selective muscle
involvement [Heckmatt 1985 and 1987].
Since myopathies differ widely in the dis-
tribution of affected mus cles, the likeli-
hood of find ing abnor mal i ties with
ultrasound depends on the choice of the
muscles imaged. We chose to measure 4
muscles; 2 prox imal and 2 dis tal limb mus -
cles. Despite the limited number of mus -
cles inves tigated, ultra sound still proved
very sen si tive for iden ti fy ing pathol ogy. In
this study the cut-off point for abnor mal
echo intensity was set at 0.9 SD above nor -
mal in 3 or more mus cles, as this pro vided
the high est sen si tiv ity and spec i fic ity.
However, it is pos sible that patients with
selective mus cle involvement will not be
detected using this cut-off point, when
only 1 or 2 mus cles show an abnor mal
echo intensity. For these patients, either
another cut-off point, based on an abnor -
mal echo intensity in 1 mus cle, must be
established or additional muscles have to
be examined.
All patients in this study were referred to a
tertiary center for neuromuscular disor-
ders. The diagnostic value may be differ-
ent when neurologists in cen ters less
spe cial ized in the eval u a tion of chil dren
with neuromuscular disorders apply this
test. Fur thermore, our study does not
cover the entire spectrum of neuromus-
cular diseases. Cer tain diseases, for exam-
ple inflam matory myopathies, were not
diagnosed in any of the children in our
study. How ever other studies indicate that 
a vari ety of neuromuscular diseases show
abnormalities in echo intensity on mus cle
ultrasound [Heckmatt 1982; Reimers
1993a]. Fur ther inves ti ga tions are nec es-
sary to determine the exact diag nostic
value of dis crim i nat ing between spe cific
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neuromuscular disorders using ultra-
sound.
Myopathies and neuropathies tend to have
a dif fer ent mus cle ultra sound appear ance.
Neuropathies are often associated with
atrophy, whereas in myopathies mus cle
thickness is usually preserved [Heckmatt
1988b; Schmidt 1992]. One of the dis tin-
guish ing fea tures of spi nal mus cu lar atro-
phy is a change in the thick ness ratio,
which is lower in affected than nor mal
children or in chil dren with Duchenne
mus cu lar dys tro phy [Heckmatt 1988b;
Schmidt 1992]. In our study, 2 of 3 chil -
dren with spi nal mus cular atro phy (with
normal weight) had an abnormal ratio
(<P5), but abnor mal ratios were also
found in other patients. One of the reasons
for a low ratio, besides atro phy, is obe sity.
The mea sured ratios can therefore have
more than one meaning in obese children.
Quan ti ta tive grey scale anal y sis has already
proven to be more sen sitive than visual
evaluation of the ultra sound images [Pillen 
2006a]. In this study too the sensitivity of
muscle ultrasound for detecting neuro-
mus cu lar dis or ders was higher com pared
to ear lier studies that used visual evalua-
tion [Heckmatt 1982 and 1988c; Zuberi
1999]. We found that an echo inten sity of
0.9 SD above nor mal in 3 or more mus cles
was the opti mal cut-off point to dif ferenti-
ate between neuromuscular and non-
neuromuscular dis or ders. A dif fer ence in
grey level of 0.9 SD can only be detected
by com puter-assisted grey scale analysis,
since it is too small for visual detection.
This indi cates that quan ti ta tive ultra sound
can detect sub tle changes on the ultra-
sound image which would not have been
detected by visual assess ment alone. This
is especially impor tant in detecting minor
alterations in patients who are in an early
phase of their illness. There fore we con -
clude that mus cle ultrasound, in par ticular
the quan ti ta tive eval u a tion of mus cle echo
intensity, is of addi tional value in the initial
assessment in children with suspected
neuromus cu lar disease.
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Intro duc tion
The pilot study reported in the previous
chap ter showed that quan ti ta tive mus cle
ultrasound is capable of detecting
neuromuscular dis orders with high predic-
tive val ues [Pillen 2003]. Patients with a
neuromuscular dis orders had a signifi-
cantly increased mus cle echo intensity
compared to patients with out a neuromus-
cular dis order. The opti mal cut-off point
to dif fer en ti ate between both groups
appeared to be 3 out of 4 mus cles with an
echo intensity above 0.9 SD. How ever,
this cut-off point and corresponding
diag nos tic accu racy were inves ti gated in a
small group of patients in which not all
groups of neuromuscular dis orders were
present. For exam ple, neuromuscular dis-
orders with selective mus cle involvement
were absent. To detect these patients,
another cut-off point based on an abnor -
mal echo intensity of only one muscle
might be needed.
In this prospective study we investigated
the diagnostic value of mus cle ultrasound
in a large group of chil dren with var ious
neuromuscular dis orders. We aimed to
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Abstract
In this study we inves tigated the diag nostic value of quan titative skel etal mus cle ultrasound
in 150 con secutively referred children with symp toms suspect for a neuromuscular dis or-
der. Muscle thickness and quan titatively determined echo inten sity of 4 mus cles and the dis-
tribution of these variables throughout the body were examined.
Patients with and without a neuromuscular dis order could be dis criminated with a pos itive
predictive value of 91% and a negative pre dictive value of 86%. Below the age of 3 a higher
false negative rate of 25% was found, whereas the pos itive pre dictive value in this group
approaches 100%. Above the age of 3, only 1 patient had a false negative ultra sound investi-
gation, resulting in a negative pre dictive value of 95% above the age of 3.  We conclude that
skeletal mus cle ultrasound is a good, prac tical and non-invasive aid in the diagnosis of
neuromuscular dis orders in children, that is able to discriminate between chil dren with and
without a neuromuscular disorder with high predictive values.
Adapted from: Pillen S, Verrips A, van Alfen N, Arts I, Sie L, Zwarts M. Quantitative skeletal muscle
ultrasonography: diag nostic value in child hood neuromuscular dis ease. Neuromuscular Dis orders
2007;17:509-516
establish new cut-off points for an optimal
dis crim i na tion between patients with and
without a neuromuscular disorder.
Patients and Meth ods:
Patients
Between Feb ruary 2000 and December
2004 we pro spectively included 150 chil -
dren consecutively referred to our ter tiary
neuromuscular cen tre because of a sus-
pected neuromuscular dis order, in whom
the diag nosis had not yet been estab lished.
Symptoms such as mus cle weak ness,
fatigue, myalgia, delay in motor develop-
ment, and hypotonia had been the basis for 
sus pect ing a neuromuscular dis or der. In
addition to ultrasound the chil dren were
diag nos ti cally eval u ated using EMG, bio-
chem i cal and genetic eval u a tion, and mus-
cle biopsy when nec essary. Histological
eval u a tion and mea sure ments of mito-
chondrial respiratory chain enzyme activi-
ties were done according to established,
pre vi ously pub lished pro ce dures [Janssen
2003; Vermeer 2004]. The choice of diag -
nostic instrument depended on the clin ical
presentation. The gold standard was the
final diag nosis, established by the pae diat-
ric neu rol o gist. Because mus cle ultra-
sound has proven to be use ful in the
diag no sis of neuromuscular dis or ders, the
pae di at ric neu rol o gists could not be
blinded from the ultra sound results for
ethical rea sons. It is pos sible that the ultra-
sound result influ enced the decision of the
cli ni cian to per form sub se quent inves ti ga -
tions. How ever, since in most patients
exten sive inves ti ga tions had been done
combined with a 1 to 5 year fol low-up
period we think that this has not sub stan-
tially influenced our results. The study was 
approved by the local eth ics committee
and per formed in accordance with the eth -
ical standards laid down in the 1964 Decla-
ration of Hel sinki. Informed con sent was
obtained of all par ents and patients them -
selves when older than 12 years of age. We 
adhered to the Standards for Reporting of
Diagnostic Accuracy (STARD) criteria for
design and presentation of diagnostic
studies [Bossuyt 2003].
Ultra sound mea sure ments 
Four mus cle were exam ined (biceps
brachii, fore arm flexors, quadriceps and
tibialis ante rior mus cle). The method of
ultra sound scan ning, mea sure ment of
muscle thick ness and mus cle echo inten-
sity was according to our previous study in
healthy children as described in chap ter 4
[Scholten 2003]. 
Sta tis ti cal anal y sis 
Statistical analysis was done with the SPSS
package for Win dows 12.0.1 (SPSS Inc.,
Chicago, Illinois, USA). The mus cle thick -
ness was cor rected for weight and com -
pared to nor mal val ues for children
established in a previous study; mus cle
echo intensity is inde pendent of age,
weight and sex and required therefore no
correction [Scholten 2003]. All val ues
were expressed as z-scores, which in effect 
reflects the num ber of standard devi ations
a mea sure deviates from nor mal. The
z-scores of muscle thick ness and echo
intensity were com pared between sub jects
with and without a neuromuscular dis or-
der, using a two-independent-samples test
(Mann-Whit ney U). Sta tis ti cal signifi-
cance was defined as p-value < 0.05. 
Using receiver oper a tor char ac ter is tic
(ROC) curve analysis, we estab lished a
cut-off point for nor mal (to exclude a
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neuromuscular dis order with high neg a-
tive pre dictive value) and for abnormal (to
confirm a neuromuscular disorder, with a
high pos i tive pre dic tive value) [Feinstein
1985]. Sen si tiv ity, spec i fic ity and pre dic -
tive val ues (with 95% con fidence inter-
vals) were calculated for the entire group
and sep arately for chil dren below and
above 3 years of age. False pos itive and
false-negative results are described in
detail to pro vide infor mation about the
diagnostic value of ultra sound in specific
situations.
Results
Patients
After diag nos tic eval u a tion of the 150
patients (90 boys, median age 6.6 years,
range 3 weeks - 16.7 years; 60 girls,
median age 4.4 years, range 1 week - 17.5
years), 65 patients were diagnosed with a
neuromuscular dis order: 36 had a
myopathy, 28 had a neurogenic disorder,
and 1 amyoplasia congenita (for details see
table 8.1 and fig ure 8.1). As all patients
were inves tigated in the diagnostic phase
they were all only mildly to mod erately
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Diagnosis and ultrasound results
3 / 6 / 94.3 y    (0.05 – 15.3)18No final diagnosis 
4 / 3 / 67.1 y    (0.9 – 12.9)13Inconclusive
Excluded from further analysis:
2 / 11 /145.0 y    (0.02 – 15.3)37No muscle biopsy performed a
3 / 2 / 126.2 y    (0.6 – 15.2)17Muscle biopsy negative
No NMD after diagnostic work-up (non-NMD)
1 / 0 / 011 m1Amyoplasia
Other
4 / 1 / 06.6 y    (2.1 – 12.1)5Other
9 / 2 / 08.7 y    (3.5 – 15.3)11Polyneuropathy
10 / 1 / 11.1 y    (0.2 – 6.4)12Anterior horn cell disorder
Neurogenic disorder
2 / 0 / 14.0 y; 6.2 y; 16.7 y3Other
3 / 4 / 31.8 y    (0.6 – 9.2)10Metabolic/ mitochondrial myopathy
3 / 0 / 01.3 y; 10.9 y; 12.9 y3Congenital myopathy
6 / 1 / 05.1 y    (2.9 – 17.5)7Inflammatory myopathy
0 / 1 / 13.5 w; 7 m2Presymptomatic
10 / 1 / 06.4 y    (3.3 – 9.7)11SymptomaticMuscular dystrophy
Myopathy
US result 
A/B/N
Age
Median (range 
(y))
Number of
patients
Diagnosis
Table 8.1: diagnosis, age and ultrasound results of all patients.
a NMD excluded based on EMG, lab oratory find ings, clin ical fea tures. NMD = neuromuscular dis order; y
= year; m = month; w = week; US = ultra sound; A = abnor mal; B = borderline abnormal; N = normal.
affected, except for the spi nal mus cular
atrophy (SMA) I patients. The mea sure-
ments could be per formed with out move -
ment artefacts in all patients. All diagnoses
were estab lished with mus cle biopsy,
genetic evaluation or EMG stud ies as
appropriate. Fifty-four patients who pre -
sented with muscle symp toms and signs
did not show any evi dence of a neuromus-
cular dis order on mus cle biopsy (n=17) or 
other investigations (n=37), during a 1 to
5 year fol low-up period.  In 18 patients the 
diagnosis had not yet been established by
the time of anal ysis and in 13 patients the
inves ti ga tions were not con clu sive: a
neuromuscular dis order could neither be
established nor excluded. The results of
these 31 patients were excluded from
further analysis of diagnostic accuracy.
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Normal (n = 57)
Clinical diagnosis:
NMD or non-NMD
Clinical diagnosis:
NMD or non-NMD
Abnormal (n = 60)
Clinical diagnosis:
NMD or non-NMD
Referred to child neurologist 
for possible NMD (n=150)
Muscle US (n=150)
Inconclusive 6
No diagnosis 9
Inconclusive  3
No diagnosis 6
Inconclusive 4
No diagnosis 3
Non
NMD
n = 36
Non
NMD
n = 13
Non
NMD
n = 5
NMD
n = 6
NMD
n = 48
NMD
n = 11
Borderline (n = 33)
Figure 8.1: Standards for Reporting of Diag nostic Accu racy flow dia gram. NMD = neuromuscular dis or-
der; US = ultrasound.
Dis crim i na tion between neuro-
muscular and non-neuromuscular
dis or ders
The echo intensity of all muscles was sig -
nificantly higher in neuromuscular dis or-
ders than in non-neuromuscular dis orders
(p < 0.001). Muscle thickness in neuro-
mus cu lar dis or ders was only sig nif i cantly
decreased in the quadriceps muscle (p =
0.001) (table 8.2).
ROC-curve analysis revealed that the opti -
mal cut-off points were defined as:
Abnor mal: echo intensity above 3.5 SD
in 1 mus cle or 2.5 SD in 2 muscles or 1.5
SD in 3 mus cles. This cut-off point gave a
sen si tiv ity of 71% (95% con fi dence inter-
val: 60 – 82%) and a spec ificity of 91% (83
– 99%). Val ues above this cut-off point
had a pos itive pre dictive value of 91% (82
– 98%).
Nor mal: echo intensity of all mus cles
below 2.0 SD and 3 mus cles below 1.5 SD
and 2 mus cles below 1.0 SD. This cut-off
point gave a sen sitivity of 91% (95% con fi-
dence interval: 84 - 98%) and a specificity
of 67% (54 - 80%). Val ues below this
cut-off point had a neg ative pre dictive
value of 86% (76 - 96%).
If the found val ues fell between these
cut-off points, the ultrasound was called
'bor der line abnor mal'. Of the 33 chil dren in
this group, 11 had a neuromuscular disor-
der, 13 had no evidence of a neuromus-
cular dis order. That makes the positive
and neg ative pre dictive val ues equal to the
prior prob a bil ity, i.e. approx i mately 50%.
Table 8.1 reports the ultrasound results
for each diagnosis; fig ure 8.2 shows exam -
ples of ultrasound images.
The sensitivity of ultrasound was lower in
the 43 patients below 3 years of age, with a 
higher false neg ative rate (25%). No false
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Ultrasound results NMD versus non-NMD
< 0.001* 0.52 (1,3)2.7 (2,1)Tibialis anterior
< 0.001*0.89 (1,1)3.8 (2,7)Quadriceps femoris
< 0.001*0.50 (1,3)2.7 (2,4)Forearm flexors
< 0.001*0.31 (1,1)2.0 (2,1)Biceps brachii
Echo intensity
0.44- 0.31 (1.3)- 0.50 (1,4)Tibialis anterior
0.001*- 0.95 (1.4)- 1.91 (1,5)Quadriceps femoris
0.57- 0.55 (1.1)- 0.67 (1,2)Forearm flexors
0.09- 0.81 (1.5)- 1.25 (1,3)Biceps brachii
Muscle thickness
Significance
NMD - non-NMD
p-value
Non-NMD
Mean z-score (SD) 
(n=54)
NMD
Mean z-score (SD) 
(n=65)
Table 8.2: Mus cle thick ness and echo inten sities of patients with and with out a NMD.
* = dif fer ence is sta tis ti cally sig nif i cant. NMD = neuromuscular dis or der; SD = stan dard devi ation.
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1
2
3
4
1
2
3
4
1
2
3
4
Fig ure 8.2: Transverse scan of the quadriceps mus cle of a patient without a neuromuscular dis order (top),
a patient with spi nal mus cular atro phy (SMA) type II (middle) and a patient with Duchenne mus cular
dystrophy (DMD, bot tom).  The patient with out a neuromuscular dis order showed a nor mal mus cle ultra -
sound. In both the SMA and the DMD patient an increased echo inten sity of the rectus femoris mus cle is
visible with a dimin ished bone echo. The SMA patient has severe atro phy, espe cially of the vastus
intermedius mus cle, whereas the DMD patient has a nor mal mus cle thick ness. The scale is in centimeters.
Arrow = femur; dou ble arrow = sub cutaneous tis sue; R = rectus femoris mus cle; V = vastus intermedius
muscle. Dot ted black line rep resents the bor ders of the rectus femoris in the SMA and DMD patient.
Within this area the mean mus cle echo inten sity was cal culated.
positive patients were found below the age 
of 3, which makes the pos itive pre dictive
value of an abnor mal ultra sound scan
100% in this group. Only one patient
older than 3 years, with a con genital fibre
type dis pro por tion, had a neg a tive ultra-
sound inves ti ga tion, giv ing a neg a tive pre-
dictive value of 95% above the age of 3. 
Details of false pos itive and false
neg a tive patients
Six children with a neuromuscular dis or-
der (2 with a mito chondrial myopathy, 1
M. Pompe, 1 myopathy (undetermined), a 
presymptomatic Duchenne mus cular dys -
trophy (DMD), and a neonate with SMA
type 1) had a nor mal ultra sound scan.
Conversely there were 2 chil dren with a
very abnormal ultra sound scan (echo
intensity between +2 and +6 SD), but
without fur ther evidence of a neuromus-
cular dis order on both EMG and mus cle
biopsy. One was diag nosed with a cen tral
ner vous sys tem dis or der (periven tric u lar
leucomalacia with central hypotonia), the
other had mus cle cramps on exer tion
without an iden tifiable cause. Three other
patients without a neuromuscular dis order
had only a mild increase of echo intensity
(z-score +1.5 to +2.0 SD).
Dis cus sion
In this study we showed that muscle ultra-
sound is capa ble of dis crim i nat ing between
children with and with out a neuromus-
cular dis order with high pre dictive val ues
of 86 to 91%. To achieve these val ues we
established new cut-off points for mus cle
echo intensity. With these cut-off points
both neuromuscular disorders with selec-
tive mus cle involvement as well as
neuromuscular dis orders with systemic
muscle involvement will be detected,
because it requires either one very abnor-
mal muscle or more mus cles with a small
increase of echo intensity.
Currently mus cle ultrasound is used pre -
dominantly in the ini tial - or screening -
phase of the diag nostic pro cess in sus -
pected neuromuscular dis orders. Espe -
cially in chil dren a short, easily appli cable
pro to col is desir able. The pres ent pro to col 
pro vided high diag nos tic accu ra cies in only
15 min utes and could be per formed with -
out dif ficulties or seda tion in all children.
Since only 4 muscles of arms and legs were 
measured we could, of course, have
missed neuromuscular disorders with only 
very prox i mal or pre dom i nant facial mus-
cle involvement. But such disorders are
relatively rare in children [Jones 2002] and 
since a sensitivity up to 91% was achieved,
our pro tocol seems to be able to detect
most neuromuscular dis orders well. We
did not encounter children with severe or
acute weak ness, apart from SMA I. There-
fore, the sensitivity and specificity in these
children is not yet known.
Muscle ultrasound showed a lower sensi-
tivity in children below the age of 3 and in
chil dren with mito chon drial myopathies,
both in our as in other stud ies [Heckmatt
1988c; Pillen 2006b; Zuberi 1999]. This
can be explained by the fact that structural
changes within the mus cle can still be
minor in the early stages of a neuromus-
cular dis order and coarse structural
changes are usu ally absent in mito chon-
drial myopathies. How ever, since the pos -
itive pre dictive value of mus cle ultrasound
is high in these children, an abnormal
ultrasound can still direct fur ther - invasive
- investigations.
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A new diag nostic instrument can statisti-
cally never be better than the gold stan -
dard to which it is compared [Feinstein
1985]. Unfor tunately, the per fect gold
standard to exclude a neuromuscular dis -
order does not exist. Mus cle biopsy can be
negative because of sam pling error and
EMG is quite often nor mal in chil dren
with myopathies [David 1994; Hellmann
2005; Rus sell 1992]. This means that
within our group of 'non-neuromuscular
disorder' patients, although the mean fol -
low-up period was 3 years and exten sive
investigations had been done, it is still pos -
sible that some children had a not yet
detected neuromuscular disorder. Some
investigators choose a healthy control
group for com parison [Maurits 2004;
Reimers 1993a]. How ever, larger dif fer-
ences in ultra sound param eters are
expected when patients with a neuromus-
cular dis order are compared with a healthy
control group, than when  patients with a
neuromuscular dis order are compared
with oth ers with similar symp toms but no
neuromuscular dis order [Feinstein 1985],
lead ing to falsely higher sen si tiv i ties and
specificities [Shapiro 1983]. This is illus-
trated by the decreased muscle thick ness in 
our non-neuromuscular dis order group,
which was prob ably caused by mus cle dis-
use. There fore we chose to per form this
study with a pro spective design in a clin ical
setting, com paring children who had the
same rea son for refer ral, thus mim icking
the clin i cal sit u a tion in which mus cle ultra-
sound will be applied, i.e. in case of a
suspected neuromuscular disorder
[Bossuyt 2003; Feinstein 1985].
We con clude that skeletal mus cle ultra-
sound can be a valu able non-invasive aid in
the diagnosis of neuromuscular dis orders
in chil dren, because it makes it pos sible to
dis crim i nate between chil dren with and
without a neuromuscular dis order with
high pre dictive val ues, in a short time and
with minimal discomfort. 
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Intro duc tion
Oxidative phosphorylation (OXPHOS) is
the major source of energy pro duction of
the cell, and takes place in the mito chon-
dria. Mitochondrial dis orders are the most
common inborn errors of metabolism
with an estimated fre quency of 1:10 000
live births [Schaefer 2004]. Due to the
central role of mitochondria in energy
metab o lism mito chon drial dis eases are
often multi-organ dis orders with pre dom-
inant involvement of brain and mus cles
[Smeitink 2001]. To diag nose defects in
OXPHOS, mus cle is the tis sue of choice
for exam ination. As the collection of a
muscle spec imen requires an invasive pro-
cedure it would be desirable to have a
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Diagnostic value in children with
a mitochondrial disorder9
Abstract
Muscle ultrasound has proven to be use ful in the diagnostic evaluation of children sus -
pected of hav ing a neuromuscular dis order. Mitochondrial myopathies, however, are often 
not accompanied by structural mus cle changes and might therefore be missed by this diag -
nostic instrument. In this pro spective study we investigated the diag nostic value of quan ti-
tative skel etal mus cle ultrasound in 53 children suspected of hav ing a mito chondrial
disorder. Muscle thickness and echo intensity of 4 muscles were quantitatively
determined.
Twenty-eight children were con firmed to have a mito chondrial dis order. A sensitivity of
25 to 46% was found, depend ing on the cho sen cut-off point (abnor mal or bor derline
abnormal), with a specificity of 85 to 100%. Except for 1, all abnor mal ultra sound scans
were found in children over 5 years of age. Within the group of patients with a mito chon-
drial dis order, a significant correlation was found between mus cle echo intensity and age (r
= 0.38; p = 0.047). We con clude that skeletal mus cle ultrasound can be of addi tional
value in the diag nosis of children with sus pected mito chondrial dis orders, espe cially in chil-
dren above the age of 5 years. With its low sen sitivity for detecting this disorder, it is not
suitable for screening pur poses. How ever, since all abnor mal ultra sound scans were found
in chil dren with a mito chondrial dis order, mus cle ultrasound can be used in addi tion to
other diag nostic instruments to facil itate the decision-making in pursuing further invasive
diagnostics.
Adapted from: Pillen S, Morava E, Van Keimpema M, Ter Laak HJ, De Vries MC,  Rodenburg RJ,
Zwarts MJ. Skel etal mus cle ultra sonography in chil dren with a dys function in the oxi dative
phosphorylation system. Neuropediatrics. 2006;37:142-7
diagnostic instrument to determine if such
an invasive investigation is required.
Pre vi ous inves ti ga tions have dem on strated 
that some patients with mito chondrial
myopathies showed marked atro phy and
fatty infiltration on CT or MRI, which was
correlated with an increased fatty infiltra-
tion in the mus cle biopsy [Fleckenstein
1992; Karppa 2004; Olsen 2003;
Wortmann 2002]. How ever, these inves-
tigations have mainly been limited to
adults with specific mitochondrial DNA
mutations.
In chil dren ultrasonound is an attractive
tool because of its non-inva sive nature and
the avoidance of sedation. Neuromuscular
dis or ders gen er ally cause increased mus cle 
echo inten sity, which pos i tively cor re lates
with the infil tration of fat and fibrous tis-
sue [Heckmatt 1982; Reimers 1993b;
Pillen 2009a]. Although this technique has
proven to be a very sensitive method to
detect structural changes in muscles
caused by neuromuscular dis orders in gen-
eral [Heckmatt 1988c; Pillen 2007;
Zuberi 1999], lower sensitivities can be
expected in the sub group of mito chondrial
myopathies, since children with mito -
chondrial myopathies rarely show struc-
tural changes in their mus cle biopsy.
However, up to 70 per cent of chil dren
with a mitochondrial myopathy did show
an abnor mal ultra sound scan, sug gesting
that muscle ultrasound could also be help -
ful in the diagnosis of these patients
[Fischer 1988; Heckmatt 1988c; Pillen
2007]. One could hypothesize that in these
patients the short age of energy pro duction
of the mus cle could lead to metabolic
stress, result ing in mus cle damage that
would be visible on mus cle ultrasound, as
it is in adults withother image modal ities.
But until now the diag nostic value of
skel e tal mus cle ultra sound in chil dren
with sus pected mito chon drial dis or ders
has never been systematically studied in a
large group of patients.
The pur pose of this pro spective study was
there fore to inves ti gate the diag nos tic
value of skeletal mus cle ultrasound in chil-
dren with sus pected mito chondrial dis or-
ders. We hypothesized that its sen sitivity is 
correlated to the age of the child and the
type and severity of the mito chondrial dis -
order: Older age and more severe bio -
chem i cal abnor mal i ties might be
correlated with a higher num ber of struc -
tural changes in the mus cle [Kang 2005;
Mitsui 1996]. We therefore cor related our 
findings to the age of the patient, type of
mito chon drial dis or der, sever ity of
symptoms and biochemical abnormalities.
Meth ods
Patients
Between May 2004 and Sep tember 2005,
we pro spectively included 53 chil dren
referred to our ter tiary cen tre for met a-
bolic dis orders because of a suspected
mito chon drial dis or der. The study was
approved by the local eth ics committee,
and informed con sent was obtained of all
parents and patients when older than 12
years of age. As part of the regular
work-up in children with a sus pected dis -
order of the oxi dative phosphorylation
system we analysed the blood lactate (mul -
tiple measurements) and pyruvate lev els,
blood gas ses, serum acylcarnitine, serum
and urine amino acid pro file, and urine
organic acid pro files. Cere bral spi nal fluid
inves ti ga tions were per formed depend ing
on the presence of central nervous sys tem
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involve ment. Fur ther more, patients
under went a diag nos tic pro to col of mul ti -
ple inves ti ga tions includ ing ECG, chest
X-ray, EEG, visual evoked poten tials,
acoustic evoked potentials, sen sory
evoked poten tials and a cerebral MRI.
Muscle ultrasound was performed in the
initial evaluation phase of the diagnostics.
Based on a pre vi ous pro spec tive clin i cal
and bio chem i cal study a con sen sus mito-
chon drial dis ease cri te ria (MDC) scor ing
system has been estab lished to facilitate the 
diagnosis in patients with a suspected
mitochondrial dis order. The MDC score is 
pos i tively cor re lated to the like li hood of a
mito chon drial dis or der, con firmed by the
bio chem i cal abnor mal i ties mea sured in a
fresh mus cle biopsy [Wolf 2002b]. The
MDC sys tem uses a combined scor ing of
mus cle symp toms (max i mal score: 2
points), CNS abnor mal i ties (max i mal
score: 2 points) and multisystem involve-
ment (max imal score: 3 points) with a
maximal total clinical score of 4 points,
and the addition of met abolic abnor mali-
ties and the results of the neuroimaging
(maximal addi tional score: 4 points). Spe-
cific histologic anom alies found at the time
of the biopsy might increase the final MDC 
score fur ther with 4 points, leading to a
total max imal score of 12 points [Wolf
2002]. The scoring system was orig inally
established as a method to reach the final
clinical diag nosis. In case of a high clin i-
cal/metabolic subscore of the MDC scale,
the appli ca tion of the cri te ria facil i tates the
decision mak ing in the fur ther diagnostic
steps already prior to the muscle biopsy.
Conversely, a low MDC score (lower than 
3) makes the presence of mito chondrial
dysfunction highly unlikely. In the pres ent
study we used the MDC score to clin ically
eval u ate mito chon drial dys func tion. If a
patient had a MDC score lower than 3 or
improving clin ical signs, a mus cle biopsy
was not performed. If a patient had a MDC 
score of 3 points or higher we performed a
muscle biopsy to confirm the diagnosis on
the biochemical level.
Mus cle biopsy and bio chem i cal
anal y sis
After the ini tial evaluation, the patient's
clinician decided whether an open mus cle
biopsy was indi cated, based on the MDC
score (3 or higher), the pres ence of persis-
tent and/or pro gressive symptoms and the
possible famil ial occur rence of the symp-
toms. Muscle biopsy was performed under 
general anaesthesia within 3 months of the
mus cle ultra sound exam i na tion. In chil-
dren with a spon taneously improv ing clin -
ical pic ture and decreasing MDC scores
the biopsy was post poned and fur ther fol -
low-up was initiated. Due to the pro spec-
tive nature of the study, both groups of
patients (with or without a mus cle biopsy)
were included for further analysis.
A part of each mus cle biopsy was used for
histopathological exam i na tion. Frozen
muscle sections were stained according to
standard histological and enzyme
histochemical methods and were eval u-
ated for evidence of mitochondrial dis or-
ders (COX neg ative or COX deficient
fibres and ragged-red fibres) and other
neuromuscular dis orders. Since structural
abnor mal i ties like fatty infil tra tion and
fibro sis cor re late with abnor mal mus cle
ultrasound, the per centage of fat cells and
perimysial tis sue (for the larger part con-
taining con nective tis sue, but also blood
vessels and nerve bundles) were measured
for each mus cle biopsy. Pic tures from
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Sudan Black B stained sec tions served to
determine the fat cell area. Trichrome
stained sec tions were used for perimysial
tissue measurements. For both measure-
ments a systematic ran dom point sam pling
design was used. The results were
obtained by sum ming the points covering
the fat cell area or con nective tis sue area in
relation to the respective total area of the
biopsy section.
Detailed bio chem i cal inves ti ga tions
includ ing sub strate oxi da tion rates
(pyruvate, malate, succinate), ATP pro -
duction rate from pyruvate oxi dation and
the activity of the mitochondrial com-
plexes I, II, III, IV, V and PDHc were mea-
sured in a fresh mus cle sample according
to pre viously described methods [Janssen
2003; Janssen 2006; Wijnhoven 2006]. 
Molec u lar genetic anal y sis
Mutation anal ysis of the MELAS
3243A>G, MERRF 8344A>G and
Leigh/NARP 8993T>C, sequence anal y-
sis of the mtDNA for muta tions in the
genes ND1, ND2, ND3, ND4, tRNA Leu
(uur) and tRNA Lys, long tem plate PCR
anal y sis for mito chon drial dele tions and
sequence anal ysis of the nuclear encoded
PDHA1, SURF1, NDUSF1, NDUSF2,
NDUSF4, NDUSF7 and NDUVF1 genes
were performed in the patients diag nosed
with a def i nite mito chon drial dis or der,
appro pri ate to the clin i cal pre sen ta tion
and the detected biochemical alterations.
Gold standard
Since the underlying muta tion is only dis -
covered in a minor ity of pae diatric patients
with mito chon drial dis or ders [Schaefer
2004; Thorburn 2004], we applied a func -
tional-bio chem i cal def i ni tion to val i date
mus cle ultra sound. Based on bio chem i cal
evaluation and mus cle biopsy, the children
were assigned to the following groups:
1. Mito chon drial dis or der:
a. def i nite: decreased pyruvate oxi dation
rate, ATP pro duction rate, and at least
one enzyme com plex activity below
the control range
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Patient characteristics and ultrasound results
0.9; 3.3ND3.2   (1.1 – 14)1.0  (0 – 6.5)2.6 (0.4 – 6.7)biopsy % fibrous tissue
0.0; 0.4ND1.9   ( 0 – 4.2)0.4  (0 – 7.0)0.6  (0 – 10)biopsy % fat
27; 34ND48    (43 – 70)32   (21 – 40)25   (6 – 43)ATP production
2; 2; 6
2
4.5 (2 – 6)
0
4      ( 1 – 6)
7
6     ( 3 – 8)
15
6     (3 – 11)
13
MDC score
Patients with biopsy (n)
2.7 (0.2 – 3.0)1.5 (0.01 – 10)8.0  (3.6 – 15)4.2 (0.7 – 11)3.6 (0.9 – 12)Age (y)
0 / 00 / 20 / 14 / 43 / 2
US results (abnormal / 
borderline abnormal (n))
31071513Number of patients
no biopsy 
requested
confirmed on 
biochemical level
possibledefinite
Other
diagnosis*
No mitochondrial disorderMitochondrial disorder
Table 9.1: diagnosis, age, MDC score, ATP pro duction and ultrasound results of all patients
Values rep resent median and range. * Prader Willi syndrome, chromosomal disorder with secondary mito -
chon drial dys func tion (n=2).
b. pos si ble: decreased pyruvate oxi dation
rate, ATP pro duction rate below the
control range but nor mal enzyme com-
plex activ i ties
2. No mito chon drial dys func tion:
a. excluded on the bio chemical level
(with muscle biopsy)
b. no mito chon drial dys func tion sus-
pected / no biopsy requested: low MDC
score, improve ment of clin ical signs.
3. Other diagnosis
Skel e tal mus cle ultra sound
mea sure ment
In all patients an ultra sound mea surement
was obtained before the diag nosis had been
established and before a mus cle biopsy had
been per formed. The inves ti ga tor was
blinded for the clin i cal pre sen ta tion and
the results of other inves tigations. The
method of ultrasound scanning was
according to the pre viously described pro-
tocol (see chapter 4) [Scholten 2003]. Our
stan dard screen ing pro to col was applied
comprising 4 mus cles: biceps brachii,
forearm flexors, quadriceps femoris, and
tibialis ante rior mus cle. All val ues were
compared to nor mal val ues and trans-
formed into z-scores, i.e. the amount of
standard devi ations above or below nor -
mal (see also box 2).
Sta tis ti cal anal y sis
Data were ana lyzed with the SPSS package
for Win dows 12.0.1 (SPSS Inc., Chi cago,
Illi nois, USA) and sta tis ti cal sig nif i cance
was defined as p-value < 0.05. The stan -
dardized echo inten sity and mus cle thick-
ness were compared to nor mal using a
one-sample t-test, and com pared between
patients with a mito chondrial dis order
(def i nite and pos si ble) and patients
with out a mito chon drial dis or der using an
independent samples Mann-Whitney U
test.
Sen si tiv ity and spec i fic ity were deter-
mined after applying the pre viously estab-
lished cut-off points [Pillen 2007] (see also
Chap ter 8):
- An abnor mal ultra sound mea sure ment
was defined as 1 very abnormal mus cle
(z-score > 3.5 SD) or 2 abnor mal mus -
cles (>2.5 SD) or 3 slightly abnormal
muscles (> 1.5 SD).
- A nor mal ultra sound mea sure ment was
defined as all muscles below 2.0 SD and
3 mus cles below 1.5 SD and 2 mus cles
below 1.0 SD. 
- Between these cut-off points, the ultra-
sound mea surement was called bor der line
abnor mal.
With these cut-off points both patients
with selec tive mus cle involvement and
patients with gen er al ized mus cle involve-
ment would be detected with the high est
pre dic tive val ues [Pillen 2007].
To deter mine the cause of increased echo
intensity in patients with mito chondrial
disorders, the echo intensity sum score
was cor related to age, initial MDC-score,
ATP pro duction, and percentage fat and
fibrous tis sue in the muscle biopsy. Two
combined terms were added because of
the hypoth esis that both age and sever ity of 
the disorder would determine the amount
of mus cle dam age: MDC x age and
ATP/age. The cor relations were deter -
mined with a Pearson's correlation
coefficient.
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Results
Forty-eight chil dren were assigned to the
diagnostic groups as fol lows: 28 children
had a def i nite or pos si ble mito chon drial
disorder; 17 children did not show any
evi dence of a mito chon drial dis or der. In
the group of the children with a def inite
mitochondrial dis order 1 patient was diag-
nosed with a com mon ATPase 6 mtDNA
mutation, and another 1 with a nuclear-
encoded homozygous SURF1 muta tion.
The 3 remaining patients were diag nosed
with Prader Willi syn drome (n=1) or a
chro mo some dis or der with sec ond ary
mito chon drial dys func tion (n=2). Table
9.1 sum marizes the results of the diag nos-
tic eval u a tion. Five chil dren were
excluded from fur ther anal ysis: 1 child was
lost to fol low-up; muscle biopsy was indi -
cated but postponed in 4 children due to a
significant spontaneous improvement or
social problems.
Muscle thick ness of all muscles except for
the forearm flexors was significantly
decreased in all patients with or without a
mitochondrial dis order, but was not sig-
nif i cantly dif fer ent between patients with
and with out a mito chon drial dis or der.
Mus cle echo inten sity was sig nif i cantly
higher in all muscles, except for the fore-
arm flexors, in patients with a mitochon-
drial dis order com pared to patients
with out a mito chon drial dis or der (table
9.2). Fig ure 9.1 shows an exam ple of 2
ultrasound scans of the quadriceps.
Seven out of 28 chil dren with a def inite or
pos si ble mito chon drial dis or der had an
abnormal ultra sound scan. With the
exception of 1 child, all these children
were over 5 years of age. Six patients had a
bor der line abnor mal ultra sound scan. This
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Ultrasound results of patients with and without a mitochondrial disorder
0.0010.131.10 †Tibialis anterior
0.0100.50 †1.46 †Quadriceps femoris
n.s.- 0.160.30Forearm flexors
0.001- 0.630.39 †Biceps brachii
Echo
intensity
n.s.- 0.63 *- 0.44 *Tibialis anterior
n.s.- 1.33 *- 1.36 *Quadriceps femoris
n.s.0.06- 0.10Forearm flexors 
n.s.- 1.1 *- 0.95 *Biceps brachii
Muscle thickness
Significance of 
difference
(p-value)
No mitochondrial
disorder
(z-score)
Mitochondrial
disorder
(z-score)
Table 2: Dif ferences in mus cle thick ness and echo inten sity between patients with and with out a mito -
chon drial dis or der. * Sig nif i cantly decreased com pared to nor mal. † Sig nif i cantly increased com pared to
nor mal.
gives a sen sitivity of 25 to 46% depend ing
on the cut-off point chosen (abnormal or
borderline abnor mal). No child without a
mito chon drial dis or der or other diag no sis
had an abnor mal ultra sound scan; 3 had a
bor der line abnor mal ultra sound scan. This
gives a specificity of  85 to 100%. 
Within the group of patients with a possi-
ble or def i nite mito chon drial dis or der, a
sig nif i cant cor re la tion was found between
the sum of muscle echo intensity of all
muscles and age (r = 0.38; p = 0.047; fig -
ure 9.2). The MDC-score, ATP pro duc-
tion the com bination of these param eters
with age did not correlate significantly
with muscle echo inten sity. Mus cle biopsy
specimens con tained only lit tle fibrous tis -
sue (median 2.2%; range 0 - 13.7%) and
even less fat (median 0.5%; range 0 -
10%). This prob ably explains why no sig-
nif i cant cor re la tion between mus cle echo
intensity and either param eter was found
(fat: r = 0.34; p = 0.079 and connective
tissue: r = -0.038; p = 0.85).
Dis cus sion
In this prospective study, we investigated
the value of mus cle ultrasound in the diag -
nostic workup in children with a sus pected
dysfunction in the OXPHOS. We found a
sensitivity of up to 46%, which was lower
than the sensitivity reported in chil dren
with other neuromuscular dis orders
[Heckmatt 1988c; Pillen 2003; Zuberi
1999]. With this sensitivity mus cle ultra-
sound is not suit able for screening pur -
poses since a negative ultra sound result
will not exclude a mitochondrial myo-
pathy. How ever, mus cle ultrasound did
show a very high pos itive pre dictive value:
all abnor mal ultra sound results were
found in chil dren with a "def inite" or
"pos si ble" mito chon drial dis or der. The
ultrasound technique can therefore be
used to com ple ment the clin i cal diag nos tic
scor ing sys tem and other inves ti ga tions. In
children with a clin ically uncertain diag -
nostic score, a pos itive ultra sound would
support the decision to perform further,
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Figure 9.1: Trans verse ultra sound scan of the quadriceps mus cle. Left: nor mal mus cle appear ance of a
6-year-old patient with out a mito chondrial dis order. Right: abnor mal ultrasound scan with increased
echo inten sity of the rectus femoris mus cle. This patient, who was also 6 years old, suf fered from a com -
plex I, III and V defi ciency. R = rectus femoris muscle; VL = vastus lateralis muscle; VI = vastus
intermedius mus cle; F = femur; dou ble arrow = sub cutaneous tis sue.
more invasive investigations such as a
muscle biopsy.
In our study group, almost all abnor mal
ultrasound results were found in children
over 5 years old, indi cating that the diag-
nostic value is higher in older chil dren.
Conversely, as the sensitivity is very low in 
youn ger chil dren skel e tal mus cle ultra-
sound is not very likely to con tribute to the 
diagnosis in young children with mito -
chon drial dis or ders. More over, based on
these results one could state that if an
abnormal ultra sound result is found in a
child younger than 5 years of age, the pres-
ence of another neuromuscular dis order
might be more likely [Heckmatt 1988c;
Pillen 2007]. 
Although not inves ti gated pro spec tively,
muscle MRI has also been used in children
with var i ous neuromuscular dis or ders
includ ing mito chon drial myopathies.
These reports indi cated that mito chondrial
myopathies show only lim ited abnorma-
lities on this imaging modal ity too, com pa-
rable to the ultrasound results found in this
study [Chan 2002; Fleckenstein 2000].
A sig nif i cant cor re la tion between age and
echo intensity was found in the group of
chil dren with mito chon drial dys func tion,
where older chil dren showed higher mus-
cle echo intensities. This is in con cordance
with pre vi ous inves ti ga tions in which
higher sen sitivities in adults and increased
abnormalities with age were reported
[Fleckenstein 1992; Karppa 2004; Olsen
2003; Reichmann 1993]. The defect in
OXPHOS results in metabolic stress dur-
ing exercise which can cause dam age to
DNA and apoptosis [Mitsui 1996], even tu-
ally lead ing to structural changes like
fibro sis and fatty infil tra tion accu mu lat ing
over years. This phenomenon may explain
the increase in sever ity of the disease with
age [Kang 2005]. However, the pro spec-
tive nature of the present study resulted in
an inclu sion of youn ger children with
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Fig ure 9.2: Correlation between age and mus cle echo inten sity in patients with a mito chondrial dis order
(n = 28).
relatively severe and older chil dren with a
rel a tively mild pre sen ta tion of a mito chon -
drial dis order. This prob ably explains the
limited correlation with age found in this
study. Another study including children
with various dura tions of their ill ness or a
longitudinal study design would be more
appropriate to investigate if an increase in
echo intensity occurs when children with
mitochondrial disorders grow older.
The absence of a sig nif i cant cor re la tion
between the MDC score and the mus cle
echo intensity indicates that the pres ence
of clin ical symptoms and mus cle involve-
ment does not directly lead to increased
echo intensity, and that mus cle ultrasound
can therefore be used to com plement this
diag nos tic scor ing sys tem. Pre vi ous stud-
ies have shown that muscle echo inten sity
is strongly correlated with structural
changes in the mus cle biopsy [Reimers
1993b; Pillen 2009a]. How ever, in the
pres ent study the cor re la tion between
muscle biopsy find ings and echo inten sity
was not very strong, prob ably because
only a few patients showed a pathologi-
cally increased percentage of fat or fibrous
tissue. Moreover, the location and size of
fat and fibrous tissue collections also
effects echo intensity. Struc tures smaller
than the wavelength of the ultrasound
beam do not cause a reflection and do
therefore not increase echo inten sity
[Fischer 1988; Heckmatt 1982; Heckmatt
1988c]. This fact was not taken into
account in the cal cu lated cor re la tion.
In this study the diag nosis of most patients
was based on the clinical evaluation and
con firmed with bio chem i cal mea sure -
ments in a fresh mus cle biopsy, which
gives sen si tive, func tional infor ma tion
about mito chondrial func tion. Since an
underlying gene muta tion is only dis cov-
ered in the minor ity of pae diatric patients
with mito chon drial dis or ders, we applied
this func tional-bio chem i cal def i ni tion to
validate mus cle ultrasound. In many adult
patients, especially in the familial cases,
mtDNA-defects could be confirmed early
on in the diagnostic phase. In children
however, most OXPHOS dis orders are
caused by de novo nuclear gene defects,
most of which still await iden tification
[Schaefer 2004; Thorburn 2004; Uusimaa
2000]. How ever, mito chon drial func tion
can be temporarily or secondarily
impaired due to extreme inac tivity, mal -
nutrition or other neuromuscular dis or-
ders [Jongpiputvanich 2005; Morava
2005; Ushmorov 1999]. Con versely, bio -
chemical results can be normal, even in
patients with a def inite disorder in
OXPHOS and a known mito chondrial
DNA muta tion, for example if the per -
centage of heteroplasmy in the muscle tis -
sue under examination is below the
threshold level that gives rise to a detect -
able OXPHOS defect. This has to be taken
into account when inter preting the results
of our study, but could not be avoided
because of its prospective design.
We con clude that skeletal mus cle ultra-
sound can be of addi tional value in the
diagnosis of children between 5 and 18
years of age with sus pected mito chondrial
disorders. With its low sensitivity it is not
suitable for screen ing purposes. However,
since a high pos itive pre dictive value was
found, it can be used to com plement this
scoring sys tem to facilitate the deci -
sion-making in request ing further invasive
diag nos tics.
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Muscle ULTRASOUND in specific
neuromuscular disorders

Intro duc tion
Previous studies have described the muscle
ultrasound appear ance of neurogenic dis-
orders and myopathies. Myopathies gener-
ally cause a homo geneous increase of echo
intensity, whereas neurogenic dis orders
show an inhomogeneously increased echo
intensity [Maurits 2003; Fischer 1988;
Heckmatt 1988c]. Neurogenic disorders
are gen erally more associated with muscle
atrophy. Based on these differences in
mus cle ultra sound appear ance, attempts
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differentiation of myopathies and
neurogenic disorders in children10
Abstract
In this study we inves tigated the diag nostic value of quan titative skel etal mus cle ultrasound
for the dif ferentiation of neurogenic disorders from myopathies based on the dis tribution of
ultrasound abnor malities throughout the body. One hun dred and fifty consecutively
referred chil dren with symp toms suspect for a neuromuscular dis order were pro spectively
included. Mus cle thickness and quan titatively determined echo inten sity of 4 mus cles and
the distribution of these variables throughout the body were exam ined. Only patients with
an increased muscle echo inten sity were selected for further analysis.
Seventy-seven patients had an abnor mal or bor derline abnor mal increased mus cle echo
intensity (31 a myopathy, 27 a neurogenic dis order, 1 amyoplasia, 18 a non-neuromuscular
disorder). Patients with neurogenic dis orders appeared to have more atrophy in the legs
compared to patients with myopathies (p < 0.05). The echo intensity of the biceps brachii
muscle was sig nificantly higher in myopathies (p = 0.008), while in the tibialis ante rior
muscle the echo inten sity tended to be higher in neurogenic disorders (p=0.06). Patients
with a neurogenic dis order could be dis tinguished from myopathies and non-neuromus-
cular dis orders with a pos itive pre dictive value of 86% and a negative pre dictive of 84%,
using the pat tern of dis tribution of pathol ogy throughout the body. 
We con clude that skeletal mus cle ultrasound is a good, prac tical and non-invasive aid in the
diagnosis of neuromuscular dis orders in children, and is able to discriminate between
neurogenic dis orders and myopathies with high pre dictive values.
Adapted from: Pillen S, Verrips A, van Alfen N, Arts I, Sie L, Zwarts M. Quantitative skeletal muscle
ultrasonography: diag nostic value in child hood neuromuscular dis ease. Neuromuscular Dis orders
2007;17:509-516
have been made to discriminate between
neurogenic dis orders and myopathies with
mus cle ultra sound. The dis crim i na tion
between myopathies and neurogenic dis -
orders has so far only been successful in
floppy infants [Aydinli 2003] and in adults
[Maurits 2003], but not in children with
various neuromuscular disorders [Maurits
2004].
The pur pose of this pro spective study was
to inves ti gate the diag nos tic accu racy of
quan ti ta tive skel e tal mus cle ultra sound in
dis crim i nat ing between neurogenic dis or -
ders and myopathies in a large group of
children with var ious neuromuscular dis -
orders, using echo inten sity and mus cle
thickness, and the distribution of these
variables within the body.
Patients and Meth ods:
Patients and ultrasound
measurements
For this study we used the ultrasound
results of the same 150 patients with a sus -
pected neuromuscular dis order that were
prospectively included in the study
described in chapter 8.  For detailed infor -
mation on the method of ultra sound mea -
sure ments and fur ther diag nos tic
evaluation of the patients we refer to chap-
ter 4 and 8. Mus cle thickness and muscle
echo inten sity were quan ti ta tively deter-
mined of 4 mus cles (biceps brachii, fore -
arm flexors, quadriceps femoris, and
tibialis ante rior mus cle). The mus cle
thickness was corrected for weight and
compared to nor mal val ues for children
established previously; muscle EI is inde-
pendent of age, weight and sex and there-
fore requires no cor rection [Scholten
2003]. All val ues were transformed into
z-scores (i.e. the num ber of standard devi -
ations from nor mal) to be able to compare
different muscles (see also box 2).
The study was approved by the local eth ics
committee and performed in accordance
with the ethical standards laid down in the
1964 Dec la ra tion of Hel sinki. Informed
consent was obtained of all par ents and
patients them selves when older than 12
years of age. We adhered to the Standards
for Report ing of Diag nostic Accuracy
(STARD) cri teria for design and pre senta-
tion of diag nostic studies [Bossuyt 2003].
Anal y sis 
Statistical analysis was done with the SPSS
package for Win dows 12.0.1 (SPSS Inc.,
Chicago, Illi nois, USA). Patients with an
abnor mal ultra sound mea sure ment
(defined as 1 very abnormal mus cle
(z-score > 3.5 SD) or 2 abnor mal mus cles
(>2.5 SD) or 3 slightly abnormal mus cles
(> 1.5 SD)) or with a bor derline abnor mal
ultrasound mea surement (defined as 1
muscle with a z-score > 2.0 SD or 2 mus -
cles above 1.5 SD or 3 mus cles above 1.0
SD) were included in this study. These
cut-off points were pre viously established
and are either highly specific (abnormal
cut-off point) or highly sen sitive (bor der-
line abnor mal cut-off point) for the detec-
tion of neuromuscular disorders.
Next we investigated if it was possible to
dis crim i nate between neurogenic dis or -
ders and myopathies, using echo inten sity
and mus cle thickness and the dis tribution
of these vari ables throughout the body
(i.e. arms / legs, prox imal / dis tal). We
used a ROC curve analysis to investigate
the spe cific features for either myopathies
or neurogenic dis orders in order to select
2 cut-off points: 1 to detect neurogenic
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dis or ders (and dis crim i nate them from
myopathies and patients without a
neuromuscular dis order) and 1 to detect
myopathies.
Results
Patients
Ninety-three patients had an abnormal
(n=60) or borderline abnor mal (n= 33)
muscle echo inten sity. After diagnostic
evaluation 59 patients were diag nosed
with a neuromuscular disorder: 31 had a
myopathy, 27 had a neurogenic disorder,
1 amyoplasia congenita (for details see
table 10.1 and fig ure 10.1).  In 9 patients
the diag nosis had not yet been established
by the time of anal ysis and in 7 patients the
inves ti ga tions were not con clu sive: a
neuromuscular dis order could neither be
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Muscle US
neurogenic (n=21)
Muscle US not
neurogenic (n= 56)
myopathy
n = 1
neurogenic
n = 9
Normal (n = 57)
Referred to child neurologist
for possible NMD (n=150)
Muscle US (n=150)
Inconclusive 7
No diagnosis 9
neurogenic
n = 18
Borderline (n = 33)
Abnormal (n = 60)
Non-NMD
n = 2
Non-NMD
n = 16
Myopathy
n = 31*
Fig ure 10.1 Standards for Reporting of Diag nostic Accu racy flow dia gram. NMD = neuromuscular dis -
order; US = ultrasound. * This group includes the amyoplasia patient.
established nor excluded. The results of
these 16 patients and the remain ing 57
patients with a nor mal ultra sound investi-
gations (6 with a neuromuscular disorder,
42 with a non-neuromuscular dis order, 9
inconclusive) were excluded from further
analysis.
Neurogenic dis or ders ver sus
myopathies
Patients with neurogenic dis orders
appeared to have more atro phy in the legs
compared to patients with myopathies (p
< 0.05). The echo intensity of the biceps
brachii mus cle was significantly higher in
myopathies (p = 0.008), while in the
tibialis ante rior mus cle the EI tended to be
higher in neurogenic dis orders (p = 0.06)
(table 10.2). Although mus cle thickness
was sig nif i cantly dif fer ent, dis crim i na tion
between neurogenic dis orders and
myopathies based on the mus cle thick ness
alone had low diagnostic accuracy (area
under ROC-curve < 0.72). For this rea -
son we searched for a com bination of
cut-off points that would rep resent the
dis tri bu tion of pathol ogy throughout the
body. In fig ure 10.2 the dif ferences in echo 
intensity and mus cle thick ness between
arms and legs are plot ted for neurogenic
disorders, myopathies and non-neuromus-
cular dis orders. This dif ference was cal cu-
lated by sub tracting the summated
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Diagnosis and ultrasound results
2 / 115.3 y    (0.6 – 12.3)13No muscle biopsy performed a
3 / 28.6 y    (4.3 – 14.9)5Muscle biopsy negative
No NMD after diagnostic work-up (non-NMD)
1 / 011 m1Amyoplasia
Other
4 / 16.6 y    (2.1 – 12.1)5Other
9 / 28.7 y    (3.5 – 15.3)11Polyneuropathy
10 / 11.5 y    (0.3 – 6.4)11Anterior horn cell disorder
Neurogenic disorder
2 / 06.2 y; 16.7 y2Other
3 / 42.1 y    (0.8 – 9.2)7Metabolic/ mitochondrial myopathy
3 / 01.3 y; 10.9 y; 12.9 y3Congenital myopathy
6 / 15.1 y    (2.9 – 17.5)7Inflammatory myopathy 
0 / 13.5 w1Presymptomatic
10 / 1 6.4 y    (3.3 – 9.7)11SymptomaticMuscular dystrophy
Myopathy
US result A/B
Age
Median (range (y))
Number of
patients
Diagnosis
Table 10.1: diagnosis, age and ultrasound results of the patients with an abnor mal or bor derline abnor -
mal ultrasound scan.a NMD excluded based on EMG, lab oratory find ings, clin ical fea tures. NMD =
neuromuscular dis order; y = year; m = month; w = week; US=ultrasound; A=abnor mal; B=bor derline
abnor mal.
z-scores of the biceps brachii and the fore -
arm flexors from the tibialis ante rior and
the quadriceps mus cle. Patients with a
neurogenic dis order showed a higher echo
intensity and more atro phy in the legs than
the arms com pared to myopathies and
non-neuromuscular dis orders (left upper
quadrant in fig ure 10.2). A com bined
cut-off point (echo inten sity legs 1 SD
more than arms and mus cle thickness of
the legs less than the arms: represented by
the lines in fig ure 10.2) can be used to
detect neurogenic dis orders with a sen si-
tivity of 67% (95% con fidence interval 49
- 85%) and a specificity of 94% (87 -
100%). This will lead to a pos itive pre dic-
tive value of 86% (71 - 100%) and a nega-
tive pre dictive value of 84% (74 - 94%).
Both peripheral neuropathies and anterior
horn cell dis orders could be dis tinguished
from myopathies and non-neuromuscular
disorders with the same accuracy. If the
same com bined cut-off point that was used
to detect neurogenic dis orders was applied 
to myopathies, a low pos itive pre dictive
value was found (54%) because this cut-off
point did not discriminate myopathies
from non-neuromuscular dis orders (fig-
ure 10.2). How ever the neg ative pre dic-
tive value for excluding a myopathy was
95%. Because of the het er o ge ne ity within
the group of myopathies and the sim ilarity
of dis tribution with the non-neuromus-
cular disorder group, we did not find
another cut-off point with an acceptable
positive predictive value for detecting
myopathies.
Dis cus sion
This study showed that muscle ultrasound
is capa ble of dis criminating patients with a
neurogenic dis order from patients with
myopathies or non-neuromuscular
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Ultrasound results myopathies versus neuropathies
0.063.5 (2.2)2.5 (1.9)Tibialis anterior
0.564.2 (2.6)3.8 (2.7)Quadriceps femoris
0.803.0 (2.6)2.9 (1.9)Forearm flexors
0.008*1.6 (1.7)2.9 (2.3)Biceps brachii
Echo
intensity
0.016- 0.80 (1.3)0.07 (1.3)Tibialis anterior
0.007*- 2.4  (1.3)- 1.3  (1.4)Quadriceps femoris
0.66- 0.62 (1.2)- 0.48 (1.1)Forearm flexors 
0.45- 1.1  (1.2)- 1.4  (1.4)Biceps brachii
Muscle thickness
Significance of 
difference
(p-value)
neurogenic
mean z-score (SD)
(n=28)
myopathy
mean z-score (SD)
(n=36)
Table 10.2: Mus cle thick ness and echo inten sities of patients with a myopathy and a neurogenic dis order.
* = Dif fer ence is sta tis ti cally sig nif i cant.
dis or ders with a pos i tive pre dic tive value
of 86% and a neg ative pre dictive value of
84%. As expected, neurogenic dis orders
showed more changes (atrophy and
increased echo inten sity) in the legs, while
myopathies and non-neuromuscular dis or-
ders showed a more equal dis tribution of
muscle thickness and echo intensity
throughout the body. Both anterior horn
cell disorders and neuropathies could be
distinguished from myopathies and
non-neuromuscular dis orders with the
same diag nos tic accu racy. The pos si bil ity
to dif fer en ti ate between ante rior horn cell
disorders and myopathies might be
espe cially help ful in clin i cal prac tice, as
this distinction can be a diag nostic chal-
lenge in some children. The group of
myopathies in this study con sisted of a het-
erogeneous group of dis orders, with a sim-
i lar dis tri bu tion pat tern of changes as
non-neuromuscular dis orders. It was
there fore not pos si ble to dis crim i nate
myopathies from non-neuromuscular
disorders and neurogenic disorders with
satisfactory positive predictive values. 
Pre vi ous stud ies have used dif fer ent meth-
ods to discriminate between myopathies
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Fig ure 10.2 Differences in dis tribution of echo inten sity and mus cle thick ness of arms and legs between
neurogenic dis orders and myopathies. Neurogenic dis orders showed more atro phy and a higher echo inten -
sity of the leg mus cles (left-upper-quad rant) than myopathies and non-neuromuscular dis orders. Most
myopathies showed equal dis tribution of mus cle thick ness and echo inten sity through out the mus cles.
and neurogenic dis orders. Aydinli and
co-workers [2003] used a visual evaluation
of ultra sound pic tures of the quadriceps in
floppy infants. "Neurogenic" was
described as an inhomogeneous increase of 
echo intensity with atrophy and an
increased sub cu ta ne ous tis sue thick ness,
"myopathic" as a homo geneous increase of 
muscle echo intensity with a preserved
mus cle to sub cu ta ne ous fat ratio and
decreased bone echo. In their study of 40
floppy infants, ultra sound showed a con -
cordance of 92% with electromyography
findings. In adults, Maurits and co-work-
ers [2003] also successfully dis tinguished
between myopathies and neurogenic dis -
or ders using dig i tal image anal y sis. They
used mus cle inhomogeneity and white
area index (which measures the presence
of patches of high echo intensity) as well as
muscle echo intensity of 2 prox imal mus -
cles. In chil dren with var ious neuromus-
cular disorders how ever, the same analysis
was not effective [Maurits 2004]. Fur ther
investigations on the use of digital image
analysis in this field are necessary (see
chapter 14).
We con clude that quan ti ta tive skel e tal
mus cle ultra sound can dis tin guish neuro-
genic dis orders from myopathies and
non-neuromuscular dis orders based on the
descrip tion of dis tri bu tion of pathol ogy
throughout the body. This fea ture will fur -
ther increase the appli cation of mus cle
ultra sound in the diag nos tic eval u a tion of
patients with sus pected neuromus cular
disorders.
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Intro duc tion
The value of ultra sound for detecting spe -
cific types of neuromuscular disorders and
their dif fer en ti a tion has not been inves ti-
gated prospectively. Most studies have
been confined to a description of ultra -
sound appear ances without men tion of its
sen si tiv ity and spec i fic ity. This chap ter
reviews the main ultra sound find ings in
several types of neuromuscular dis orders.
The results are sum marized in Table 11.1,
which also pro vides an impression of the
pos si ble sen si tiv ity of mus cle ultrasound to
detect these disorders.
Mus cu lar dys tro phies
Muscle ultrasound changes in
neuromuscular dis orders were first
described in patients with Duchenne mus -
cular dys trophy (DMD) [Heckmatt 1980].
In pre clin i cal cases mus cle ultra sound is
often nor mal [Heckmatt 1982 and 1988c;
Pillen 2007]. But when the first clin ical
signs become appar ent mus cle ultrasound
is abnor mal in almost every patient, show -
ing nor mal mus cle thickness with
increased mus cle echo intensity [Fischer
1988; Pillen 2007]. Rarely mus cle ultra-
sound is nor mal at the time of diag nosis,
but when the disease progresses all
patients will eventually show an abnor mal
ultrasound. Throughout the mus cle the
echo intensity has an homo geneous (fine
129
specific neuromuscular disorders11
Abstract
Muscle ultrasound is mainly used as a screening tool to detect neuromuscular dis orders in
general. Apart from an increased over all echo inten sity, dif ferent neuromuscular disorders
tend to show specific mus cle ultrasound changes such as dif ferences in dis tribution of mus -
cle echo inten sities through out the muscle or differences in muscle involvement (proximal
or dis tal etc.). These fea tures might be help ful in the dif ferential diag nosis. For exam ple
Duchenne mus cular dystrophy results in a severe homogeneous increase of muscle echo
intensity with nor mal mus cle thickness, whereas spi nal mus cular atro phy shows an
inhomogeneous increase of echo intensity with severe atrophy. This chapter reviews the
value of mus cle ultrasound as a diag nostic tool in several types of neuromuscular disorders.
Partially adapted from: Pillen S, Arts IMP, Zwarts MJ. Mus cle ultra sound in neuromuscular dis orders.
Muscle and Nerve 2008;37:679-93
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gran u lar) dis tri bu tion [Fischer 1988;
Heckmatt 1982]. Prox imal mus cles have
the high est i.e. most abnormal echo inten -
sities. With advancing disease echo inten-
sity further increases. This is accompanied
by increased attenuation of the ultra sound
beam, resulting in a dimin ished or absent
bone echo (Figure 11.1) [Heckmatt 1982
and 1988c]. 
Similar find ings were reported in chil dren
with Becker mus cular dys trophy in whom
the severity of the ultrasound find ings was
also found to progress with age and clin ical
severity [Heckmatt 1988c]. The find ings
in dystrophinopathies contrast with ultra-
sound find ings in children with con genital
mus cu lar dys tro phies, in whom mus cle
echo intensity is already severely increased
at young age without a clear cor relation to
dis ease sever ity or pro gres sion [Heckmatt
1982]. This may be explained by the fact
that the extent of histopathological mus cle
changes found in con gen i tal mus cu lar dys-
trophies is often not correlated either to
clinical severity [Dubowitz 1995]. In some 
patients with a form of con genital mus cu-
lar dys tro phy, ultra sound imag ing may
show strik ing dif fer en tial involve ment of
the quadriceps mus cle with spar ing of the
rectus femoris and a markedly increased
echo intensity in the vasti, cor relating with 
needle biopsy and MRI findings [Heckmatt
1987; Mercuri 2005]. 
With regard to mus cle texture limb gir dle
mus cu lar dys tro phies also show strik ing
increased mus cle echo intensity with a
homogeneous spread throughout the mus -
cle just like dystrophinopathies. In
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Figure 11.1 Trans verse ultra sound image of a nor mal left quadriceps mus cle (A) and of a patient with
Duchenne muscular dystrophy (DMD) (B); both are 3.5 years old. The rectus femoris mus cle is encir cled.
The mean echo inten sity of this region is mea sured, as shown in the his tograms below (scale black = 0;
white = 255). The rectus femoris of the DMD patient has an increased mus cle echo inten sity, with the
corresponding his togram dis placed to the right. Note the fine gran ular pattern of echo inten sities homo -
geneously spread among the muscle and also the attenuation of the ultrasound beam, with a decreased
echo inten sity in deeper areas of the mus cle. Intramuscular fas cia, for exam ple the cen tral fas cia in the
anterior part of the rectus femoris (sin gle arrow), are more dif ficult to rec ognize in the DMD patient. VM 
= vastus medialis; VL = vastus lateralis; VI = vastus intermedius; F = femur; double arrow = sub cuta-
ne ous tis sue.
Bethlem myopathy mus cle ultrasound
revealed a pecu liar echo den sity in the
anterior mid dle of the rectus femoris mus -
cle, the "cen tral shadow sign", cen tered
around the cen tral fas cia that is nor mally
seen in this mus cle [Bonnemann 2003].
This corresponds to the myopathic pro cess
in this dis order which pro ceeds in an
unusual fash ion from the fascia inwards.
Con gen i tal myopathies
Con gen i tal myopathies are a het er o ge -
neous group of inher ited myopathies with
ultrastructural abnor malities. Only a few
reports of ultra sound find ings in these
patients are available. In most the ultra-
sound exam i na tion was abnor mal, but
with highly het er o ge neous find ings and
selec tive mus cle involve ment cor re spond-
ing to the wide range of clinical phe no-
types [Heckmatt 1988c; Pillen 2007].
Patients with nemaline myopathy can
show marked selec tive mus cle involve-
ment (figure 11.2), although the ultra -
sound scan can also still be nor mal at
clin i cal pre sen ta tion [Heckmatt 1982 and
1988c]. Three patients with a central core
or minicore myopathy have been
described, all showing increased mus cle
echo intensity [Heckmatt 1982]. No other
mus cle ultra sound find ings in con gen i tal
myopathies are yet reported.
Inflam ma tory myopathies
Inflammatory myopathies show spe cific
changes on mus cle ultrasound [Heckmatt
1988c; Reimers 1993a]. Muscle echo
intensity is increased with focal alterations
within the muscle (see chap ter 12) (Figure
11.3a). This makes it possible to dif feren-
tiate them from other myopathies if one
has some expe rience. In the acute phase of
an inflam matory myopathy only mild to
moderately increased echo intensity is
present, often accompanied by a slightly
increased mus cle thick ness caused by
oedema. Oedema itself is not vis ible, but is 
important to take into con sideration
because it may cause falsely lower echo
intensities. This explains why we saw sev -
eral times that the start of prednisone
treatment, which decreases the oedema,
paradoxically resulted in an increase of
muscle echo intensity. If the disease pro-
gresses mus cle echo intensity will further
increase and atrophy will develop
[Reimers 1993a].
In polymyositis mus cle atrophy and
increased mus cle echo inten sities are usu-
ally more pro nounced in the lower
extremities, whereas in dermatomyositis
the upper and lower extremities are
equally involved [Reimers 1993a]. Sub cu-
ta ne ous and intra mus cu lar calcifications,
which are more often seen in children with
dermatomyositis, are eas ily vis ible as
highly echogenic struc tures with a shadow
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Figure 11.2 Trans verse ultra sound scan of the
arm of a one-year-old child with nemaline
myopathy. Mus cle echo inten sity is slightly
increased in the biceps brachii mus cle (Bi). The
underlying brachialis mus cle shows a very high
echo inten sity (arrow). H = humerus; dou ble
arrow = sub cu ta ne ous tis sue.
underneath (Figure 11.4). Inclu sion body
myositis shows more atro phy and higher
echo inten si ties at diag no sis com pared to
other inflammatory myopathies (Figure
11.3b). These find ings can be focal, and
are often asymmetrical and most pro-
nounced in the dis tal muscles [Reimers
1993a and 1997].
mito chon drial and
Met a bolic myopathies
Met a bolic and mito chon drial dis or ders
usually have nor mal or only slightly ele-
vated muscle echo intensity [Fischer 1988; 
Heckmatt 1988c; Pillen 2006b and 2007]
and decreased muscle thick ness [Pillen
2006b]. In the ini tial diag nostic phase only
25% to 45% of the children with mito -
chondrial dis orders showed an increased
muscle echo intensity, and this per centage
was even lower in children below the age
of 5 years (see chapter 9) [Pillen 2006b].
Con se quently, nor mal mus cle ultra sound
does not exclude the presence of a mito-
chondrial myopathy in this group. Higher
mus cle ultra sound sen si tiv i ties for the
detec tion of mito chon drial myopathies
can prob ably be found in older chil dren
and adults, as more structural mus cle
abnormalities are seen with increasing age
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Figure 11.3 Ultrasound image of the biceps brachii and brachialis mus cle of a 55-year-old man with
acute, untreated dermatomyositis (A) and a 65-year-old man with inclu sion-body myositis (IBM) (B). In
the dermatomyositis patient (A) a moderately increased echo inten sity is vis ible with an inhomogeneous,
patchy appearance. Muscle thick ness is nor mal. Con versely, the IBM patient (B) has severe atrophy and
selective mus cle involve ment. The biceps brachii mus cle shows a very high echo inten sity with atrophy,
whereas the brachialis mus cle appears nor mal. The dif ference between both mus cles can not fully be
explained by attenuation of the ultrasound beam, as fas cia within the brachialis mus cle as well as the
bone under neath can still be eas ily rec ognized. The dif ference in res olution of both pic tures is caused by a 
difference in trans ducers: the left image is made with a broad band 5-17 MHz trans ducer, while in the
right image a phased array 7.5 MHz transducer was used. Bi = biceps brachii mus cle; Br = brachialis
muscle; H = humerus; dou ble arrow = sub cutaneous tis sue.
[Pillen 2006b; Fleckenstein 1992]. The
sen si tiv ity of mus cle ultra sound to detect
mito chon drial myopathies is com pa ra ble
to that of other imag ing techniques such as
MRI [Chan 2002; Fleckenstein 1992 and
2000; Karppa 2004].
Motor neu ron dis or ders
Spi nal mus cu lar atro phy (SMA) causes
severe mus cle atro phy which is easily vis i-
ble on ultrasound. This is accompanied by
increased echo intensity, although early in
the course of any of the four forms of SMA
the ultrasound image can still be nor mal
[Fischer 1988; Heckmatt 1982, 1988b and 
1988c; Pillen 2007]. The distribution of
ultra sound abnor mal i ties is dis tinct in
SMA. The lower limbs and espe cially the
quadriceps mus cle show most abnormali-
ties, whereas the biceps brachii and
sternocleidomastoid mus cles are relatively
spared [Heckmatt 1988c; Pillen 2007]. In
more advanced cases the lat ter mus cles
also grad ually become more abnor mal.
Muscle echo inten sity shows an
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Fig ure 11.4 Muscle ultra sound of the quadriceps
muscle of a 15-year-old girl who had suf fered
from juve nile dermatomyositis with a monocyclic
course when she was 2 years old. One year after
the diag no sis she devel oped severe sub cu ta ne ous
and intramuscular calcifications, espe cially in the 
right leg caus ing a flexion contracture of her
right knee. Mus cle ultra sound of the quadriceps
muscle in a trans verse plane revealed mul tiple
subfascial cal cified plaques, vis ible as echogenic
struc tures cast ing a con spic u ous shadow (closed
arrow). R = rectus femoris; V = vastus
intermedius; dou ble arrow = sub cu ta ne ous tis sue.
Fig ure 11.5 Left quadriceps mus cle of a 2-year-old boy with spi nal mus cular atro phy type 2. The echo
intensities are very inhomogenously spread through out the mus cle, with a moth-eaten pat tern prob ably
representing atro phic and hyper trophic mus cle fibres. Nor mal struc tures within and sur rounding the mus -
cle are dif ficult to dis tinguish. Mus cle thick ness is dimin ished. The right panel depicts the dif ferent
structures sche matically. RF = rectus femoris muscle.
inhomogeneous, moth-eaten pat tern (fig-
ure 11.5), cor responding to areas with
atrophic fibres (bright areas) and groups of
hypertrophic fibres (black areas) that are
also seen on mus cle biopsy [Fischer 1988;
Van Baalen 2005]. The fas cia nor mally
seen within the mus cle are often not vis i-
ble. Mus cle out lines are well visible in
patients with a low to mod erate elevation
of the echo intensity, but fade and dis ap-
pear in severely affected patients with an
accompanying decrease in bone echo.
In patients with amyotrophic lat eral scle-
rosis (ALS) mus cle ultrasound can aid in
the diag nosis as it shows increased echo
intensity, decreased muscle thick ness, and
extensive fasciculations (video 11.1*),
even in early stages of the dis ease [Arts
2008]. A higher degree of diag nostic cer-
tainty can be reached when more body
regions are affected [Brooks 2000]. Ultra-
sound exam ination can therefore help to
strengthen the diagnostic cer tainty in
patients with a limited dis ease pre senta-
tion, although fur ther prospective stud ies
are nec essary to validate this hypothesis.
Periph eral nerve
dis or ders
Although EMG is the investigation of
choice for detect ing and char ac ter iz ing
peripheral neuropathies, and has a high
diagnostic accuracy even in young chil dren
(88% - 100%) [David 1994; Hellmann
2005], ultra sound can also detect neuro-
pathies by showing atro phy and increased
echo intensity in muscles innervated by the 
affected nerve [Bargfrede 1999; Gunreben 
1991]. Polyneuropathies clearly show a
more severe distal than prox imal involve -
ment [Heckmatt 1988c; Pillen 2007]. 
Compression neuropathies can be
detected by nerve ultrasound, showing
thickened nerves prox imal to the com -
pression [Beekman 2004].  Mus cle ultra-
sound in these and other focal
neuropathies shows increased echo inten -
sity in the major ity of patients, while atro -
phy was present in only one third of the
patients. Com pared to EMG mus cle ultra-
sound was equally or slightly less capa ble
of detecting var ious focal neuropathies
with sen si tiv i ties esti mated at 70%
[Bargfrede 1999; Gunreben 1991;
Schwennicke 1998]. Mus cle echo intensity
was cor related to the presence of spon ta-
neous activ ity on EMG. The ear liest ultra -
sound abnor mal i ties became appar ent at
10 to 14 days after nerve injury, which in
these stud ies was also the time when spon -
ta ne ous activ ity became notice able on
EMG [Bargfrede 1999; Gunreben 1991;
Schwennicke 1998].
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* The video is pro vided on the CD accom panying this thesis.
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inflammatory myopathies and
connective tissue disorders:
3 case reports
12.1 Juve nile dermatomyositis
12.2 Eosinophilic fasciitis
12.3 Morphea profunda 
12
Abstract
So far mus cle ultrasound has mainly been used as a screening tool. An abnor mal ultra sound
indicates structural mus cle changes which war rants fur ther diag nostic evaluation to make a
diagnosis. How ever, in indi vidual cases mus cle ultrasound can fur ther aid in the diagnostic
process. In this chap ter we report the use of mus cle ultrasound in 3 indi vidual cases. A
patient with juvenile dermatomyositis showed a focally increased mus cle echo intensity, a
typical ultra sound find ing,that was espe cially visible with angulation of the transducer. As
this feature is typ ical for juvenile dermatomyositis it can help in the dif ferential diag nosis of
patients in which the disorder is suspected. The sec ond case report describes a patient with
eosinophilic fasciitis. Mus cle ultrasound in this patient showed mark edly thickened fas cia
within and surrounding the mus cle, which cor responded to muscle biopsy and MRI find -
ings. Finally, muscle ultrasound in a patient with morphea profunda showed severe mus cle
involvement at locations where skin lesions were hardly pres ent or even absent.
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Intro duc tion
Juvenile dermatomyositis is a multisystem
dis ease char ac ter ized by vasculitis and
inflam ma tion of the skel e tal mus cles and
skin. The diag nostic criteria of Bohan and
Peter [1975] con sist of the presence of
cutaneous changes and 3 of the fol lowing 4 
cri te ria: sym met ric prox i mal mus cle
weakness, raised serum mus cle enzyme
levels and abnor mal find ings on
electromyography or muscle biopsy.
When skin changes are absent or develop
later in the course of the dis ease, which
occurs in 25% of the patients [Pachman
1998], the diag nosis can be dif ficult, espe -
cially since mus cle biopsy can be negative
because of sam pling error. Mag netic res o-
nance imag ing (MRI) has proven to be a
useful test for assess ing disease activ ity,
aiding in the selection for a mus cle biopsy
site and guid ing ther a peu tic deci sions.
Therefore, MRI was pro posed to be
included in the sup porting diag nostic cri-
teria of JDM [Hernandez 1993; Maillard
2004]. How ever, the availability and cost
of MRI as well as the need for seda tion in
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12.1 juvenile dermatomyositis
Abstract
In this case report we describe the contribution of skeletal mus cle ultrasound to the diag no-
sis of juvenile dermatomyositis in a 3-year-old girl. An inhomogeneous increase of mus cle
echo intensity was found in several mus cles. Angulation of the transducer revealed focal
parts within the muscles with increased echo intensity, espe cially of the tibialis anterior
muscle. This fea ture is nor mally not seen in healthy chil dren or in chil dren with other,
non-inflam ma tory neuromuscular dis or ders. Ultrasound exam i na tion fur ther showed
increased mus cle thickness that indi cated mus cle oedema, which dimin ished rapidly after
start of treat ment. This case reports shows that muscle ultrasound can be help ful in the
diagnosis of juvenile dermatomyositis and that the sensitivity of this technique can be
improved with angulation of the transducer dur ing exam ination, especially when an
inflammatory myopathy is suspected.
Adapted from: Pillen S, Cuppen I, Hoppenreijs EPAH, Ter Laak HJ, Zwarts MJ, Fiselier TJW. Spe cific
muscle ultra sound find ing in juve nile dermatomyositis. Sub mitted
young children limit its use. Ultra sound is
an easy accessible and non-invasive tool to
visu al ize mus cles. Pre vi ous stud ies have
shown that skeletal mus cle ultrasound can
detect changes caused by neuromuscular
dis or ders includ ing juve nile dermatomyo-
sitis [Heckmatt 1988c; Pillen 2007]. In this
case report we describe specific muscle
ultrasound changes in a patient with juve -
nile dermatomyositis that can aid in mak -
ing the diag nosis of this dis order.
Case report
A pre viously healthy 3-year-old girl was
hos pi tal ized because of pro gres sive mus cle 
weakness. Six weeks before she had suf -
fered from a Varicella Zoster virus infec -
tion. A week after the Varicella Zoster
virus infection she com plained about pain
in her legs and was unable to climb the
stairs. She had raised muscle enzymes that
were first inter preted as postviral
myositis. How ever, mus cle weak ness pro-
gressed and she became tired and irritable
and developed dysarthria. She was unable
to walk or dress herself and com plained of
pain all over her body. Phys ical exam ina-
tion revealed prom inent axial and prox i-
mal muscle weak ness, with a Gowers'
sign, inabil ity to hold the head upright, and 
oedema of the extremities, most promi-
nent in the arms and upper legs. Pal pation
of the extremities was painful. Reflexes
and sen sibility were nor mal. She had no
fever and no skin changes or nail fold capil-
lary abnor mal i ties. 
Lab o ra tory inves ti ga tions showed raised
muscle enzymes (CK 6081 U/l, ASAT
285 U/l, ALAT 77 U/l and LD 1647 U/l)
with a nor mal gamma-GT. Quan titative
skel e tal mus cle ultra sound revealed an
increased echo intensity of the biceps
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Fig ure 12.1.1 Transverse scan of the ante rior tib ial mus cle at ¼ between the patella and the lateral
malleolus, per pendicular (above) and with an angulation of 20 degrees (below). The white line depicts
the bor ders of the ante rior tib ial mus cle. The echo inten sity of the ante rior tib ial mus cle is increased with
a patchy appearance. Angulation of the trans ducer reveals a hyperechoic part of the ante rior tib ial mus -
cle (arrow), which was not visible in the per pendicular plane. Dou ble arrow = sub cutaneous tis sue; T =
tibia; F = fib ula.
brachii mus cle, fore arm flexors and tibialis 
ante rior mus cle, indi cat ing struc tural
changes in these mus cles [Pillen 2003;
Reimers 1993]. The quadriceps femoris
muscle showed a nor mal echo intensity.
The most prom inent mus cle ultrasound
finding was a focal increase of echo inten -
sity on angulation of the transducer, which
was also vis ible in areas of the mus cle that
were hypoechoic in the per pendicular
plane. This fea ture was most pro nounced
in the tibialis anterior mus cle (fig ure
12.1.1). Despite muscle dis use of sev eral
weeks mus cle thick ness was found to be
normal or even slightly increased in
several muscles, which sug gested mus cle
oedema.
A nee dle mus cle biopsy of the quadriceps
femoris muscle was performed. No clear
pathologic changes were present on rou -
tine histological and histochemical stain-
ing. How ever, immune his to chem is try
revealed mem brane attack com plexes
(MAC) in endomysial cap illaries as well as
expression of HLA-ABC on all mus cle
fibres. This con firmed the diagnosis of a
dermatomyositis. Addi tional electron
microscopy showed swol len and necrotic
cap il lar ies with fre quent pres ence of
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Figure 12.1.2 Muscle fibres reveal increased sarcolemmal expression of HLA-ABC (A). Mus cle cap il lar ies
visible as black dots between mus cle fibres in fig ure B are strongly pos itive for anti bodies against MAC
(membrane attack com plex). Elec tron micros copy in C shows part of a cap illary with swol len endo thelial
cells. The encir cled endo thelial cell con tains both nor mal endoplasmatic retic ulum as well as the char ac-
teristic abnor mal tubuloreticular struc tures also known as undu lating tubules (D). Bars rep resent 50 m
(A and B), 1 m (C), and 0,5 m (D).
undulating tubules in endo thelial cells (fig -
ure 12.1.2).
The patient was treated with pulsed intra-
venous methylprednisolone (30 mg/kg/
day) for 3 days, fol lowed by an oral dose of 
2 mg/kg/day. Skeletal mus cle ultrasound
one week after the start of treat ment
showed a significant decrease of mus cle
thickness, which cor related well with the
clinically decreased oedema. Dur ing the
next weeks muscle strength slowly
improved. How ever, since muscle
strength and CK-levels were not nor mal-
ized after 2 months of prednisolone ther-
apy, methotrexate was added. Mus cle
ultrasound still showed severely increased
muscle echo intensity too. A few months
after start of treatment she developed the
typ i cal skin con di tions of juve nile derma-
tomyositis with periungual erythema and
Gottron's papules.
Dis cus sion
This case report shows that skel etal muscle
ultrasound can aid in the diag nosis of juve-
nile dermatomyositis. Typ ical changes
include an inhomogeneous (patchy)
increase of echo inten sity with nor mal or
increased mus cle thick ness in the acute
phase of the dis ease. If the dis ease follows a 
chronic active course, atrophy and a fur -
ther increase of echo intensities are pres-
ent on ultra sound exam i na tion [Reimers
1993a and 1997]. This fur ther echo inten-
sity increase can be explained by the fact
that increased echo inten sity is
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Figure 12.1.3 Lon gitudinal ultra sound image of this healthy tibialis ante rior mus cles shows that this
muscle has a bipennate struc ture, which results in a dif ferent pennation angle of the super ficial and deep
part of the muscle. When the trans ducer is placed per pendicular to the fas cicle direc tion of the super ficial
part (left panel), only the reflec tions from the super ficial part return to the transducer, whereas the deep
part is hit obliquely and gets deflected (dot ted line). Con versely the trans ducer can also be placed per pen-
dicular to the fas cicle direc tion of the deep part, ensur ing opti mal reflec tion from this part of the mus cle
(right panel).
pre dom i nantly caused by intra mus cu lar
infiltration of fat and fibro sis [Reimers
1993b and Pillen 2009a], which is more
pronounced in the chronic than in the
acute phase of dermatomyositis.
In the patient presented, a typical focal
increase of echo inten sity with angulation
of the transducer was seen in all mus cles,
especially in the tibialis ante rior mus cle. In 
our expe rience this is nor mally not seen in
healthy children or in chil dren with other,
non-inflam ma tory neuromuscular dis or -
ders. Heckmatt and co-workers [1988c]
described the same feature in the vastus
intermedius mus cle as typ ical for juvenile
dermatomyositis. It prob ably arises from
focal mus cle involvement occurring in a
muscle with a pennate structure. For
example in the tibialis ante rior mus cle the
pennation angle of mus cle fas cicles is dif -
ferent in the deep and the superficial part
(figure 12.1.3). This influ ences the
amount of reflection of the ultra sound
beam, because when an ultrasound beam
hits muscle fas cicles at too large an angle
the sound will not return to the transducer
and the echo inten sity decreases (figure
12.1.3). When the mus cle is mea sured at
several angles, all parts of the muscle will
at least once be imaged perpendicular.
This ensures that focal mus cle changes in
all parts of the mus cle are detected, which
is especially impor tant in case of a sus -
pected inflam ma tory myopathy.
Not all mus cles are equally affected in
dermatomyositis, as can be seen from the
ultrasound results in our patient. Although
the prox imal leg mus cles were clin ically
affected, the ultra sound scan showed an
overall nor mal echo intensity in the
quadriceps mus cle in the per pen dic u lar
plane. This was consistent with the mus cle
biopsy find ings: no clear histological
changes were present. How ever, immune
his to chem is try did show clear changes
with elevated expression of HLA and
MAC. This emphasizes the fact that in
early cases histological changes can be
minor, and that immune stain ing can be
helpful to establish the diag nosis [De
Visser 1989; Li 2004]. 
Eval u a tion of ther apy in dermatomyositis
is mainly based on clin ical param eters,
espe cially after nor mal iza tion of mus cle
enzymes [Wedder burn 2004; Huber
2004]. MRI has been pro posed to mon itor
treat ment, but delayed nor mal iza tion has
been reported [Huppertz 1994]. In our
case ultrasound was able to detect the
decrease of oedema, but fur ther studies
are nec essary to evaluate the value of skel-
etal mus cle ultrasound in the fol low up of
treated dermatomyositis.
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Intro duc tion
In 1974 Shulman first described a new
clinical syn drome of dif fuse fasciitis with
hypergammaglobulinemia and eosinophi-
lia [Shulman 1974]. This syn drome, later
termed eosinophilic fasciitis, is a rare dis -
order of unknown aetiology. In the revised
clas si fi ca tion sys tem of morphea (local ized
scleroderma) proposed by Peter son et al.
[Peterson 1995], eosinophilic fasciitis
belongs to the sub type of deep morphea.
The fas cia are the pre dominant level of
involve ment. Char ac ter is tics of eosinophi-
lic fasciitis include pain ful induration of
the skin and soft tissues with peau d'orange
appearance, and inflamed and later on
scle rotic super fi cial fas cia under ly ing cuta-
neous lesions. These changes can appear in
any part of the body, but are mainly con -
fined to the extrem i ties. Char ac ter is tic
lab o ra tory find ings include an ele vated
eryth ro cyte sed i men ta tion rate (ESR),
peripheral eosinophilia and hypergamma-
globulinemia. Full thickness biopsy of
skin, fascia and mus cle shows thickening of 
the fascia and fasciitis with infil tration of
lymphocytes, plasma cells, histiocytes and
eosinophils in a variable degree.
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12.2 Eosinophilic fasciitis
Abstract
A 14-year-old boy was suspected of hav ing a myopathy with joint contractures. He pre -
sented with progressive painless joint contractures of his right wrist and fingers, and
reduced mus cle strength of his right arm, without obvi ous skin changes. Lab oratory investi-
gation showed a nor mal CK, hypergammaglobulinemia and eosinophilia. ultrasound
revealed thickened fasciae in the fore arm. A com bined skin, fas cia and mus cle biopsy con -
firmed the diag nosis of eosinophilic fasciitis. The contractures disappeared quickly with
prednisolone and methotrexate treatment. An ultrasound scan two years after diag nosis
showed improvement, although some thickening of the fasciae was still pres ent indi cating
residual changes. In conclusion, eosinophilic fasciitis has to be regarded as a dif ferential
diagnosis of pain less joint contractures in children. ultrasound can be help ful to establish the
diag no sis.
Adapted from: Pillen S, van Engelen B, van den Hoogen F, Fiselier T, van der Vossen P, Drost G.
Eosinophilic fasciitis in a child mim icking a myopathy. Neuromuscul Disord. 2006;16:144-148.
In chil dren eosinophilic fasciitis usu ally has 
the same pre sentation as in adults. How -
ever it pre dominantly occurs in girls, and
arthri tis or haema to logi cal dis or ders (like
aplastic anae mia or thrombocytopenic
purpura) are less com mon [Farrington
1993; Grisanti 1989]. Two thirds of the 21 
paediatric patients described by Farrington
and co-workers [1993] with biopsy proven
eosinophilic fasciitis had pro gressive cuta-
neous fibro sis resulting in flexion
contractures. Fur ther more, spe cific clin i -
cal pre sentations not seen in adults have
been reported. For exam ple the devel op-
ment of pain less contractures without
involvement of the skin might be a pheno-
type of eosinophilic fasciitis specific to
childhood [Huppke 2002]. 
In this paper we dis cuss a 14-year-old boy
in whom a myopathy was suspected
because of pain less joint contractures and
muscle weak ness in the absence of skin
changes. In such a case, eosinophilic
fasciitis has to be con sidered as a differen-
tial diag nosis of a neuromuscular dis ease in 
childhood.
Case report
A right-handed 14-year-old boy was
referred to our neuromuscular centre
because of a sus pected neuromuscular dis -
order with joint contractures. Since 8
months he had noticed a pain less limitation
of movements of his right forefinger with
progressive stiffness of the other fingers,
right wrist and elbow. He had not suf fered
from fever, skin changes, joint swelling or
pain, or decreased muscular strength, nor
signs of Raynaud's phe nomenon. He could
play hand ball with out any dif fi cul ties up
till a few weeks before referral when he
noticed prob lems in catching the ball
because of stiff ness of his right wrist.
Except for hay fever for which he used
loratadine (Claritin®) his pre vious his tory
was unre markable. He had known a
normal growth and development.
Phys i cal exam i na tion showed lim ited
mobility of his right elbow and severe limi-
tations of motion in his right wrist and
small joints of this hand (fig ure 12.2.1a),
with an inability to make a fist. The mobil -
ity of his left hand was also slightly lim ited.
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Fig ure 12.2.1 Flexor contractures of the fin gers
of the right hand at pre sentation (A) and after
two years of treatment (B).
He could not walk on his heels due to lim -
ited motion of his ankles. There was no
swelling or dis coloration of the joints or
skin. Sub cu ta ne ous thick en ing was
observed on pal pation of the skin of his
right fore arm, but the skin was not
attached to subdermal tissue. Muscle tone
as well as all ten don reflexes were nor mal.
Muscle force of the right finger flexors was 
slightly reduced.
Lab o ra tory blood test ing revealed nor mal
white blood cell counts but 18%
eosinophils, CK level, erythrocyte sed i-
mentation rate and C-reac tive pro tein
level were normal. Quantitative test ing
for immunoglobulins showed raised IgG
levels (23.9 g/l, nor mal: 7 - 16 g/l) ,
slightly decreased IgA (0.41 g/l, normal
0.7-4.0 g/l) and nor mal IgM lev els. Com -
plement levels of C3 and C4 were nor mal.
Rheumatoid fac tor and antinuclear anti -
bod ies were neg a tive. Pul mo nary func tion 
tests were within nor mal lim its. Electro-
myography showed normal nerve conduc-
tion studies and needle EMG showed small
and polyphasic motor unit action poten-
tials in the right extensor digitorum
communis and biceps brachii mus cle.
Ultrasound of the dor sal side of the fore -
arm revealed thickened fas cia, more pro -
nounced on the right than left, with
increased echo inten sity of the extensor
muscles (fig ure 12.2.2). The echo inten-
sity of other mus cles (biceps brachii mus-
cle, flexors of the forearm, rectus femoris
muscle and tibialis anterior mus cle) was
nor mal. Mag netic res o nance imag ing of
the right forearm showed a slight thick en-
ing of the fas cia between both the flexors
and extensors of the fore arm, with
enhancement of the inten sity of these fas-
cia after admin istration of an i.v. con trast
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Fig ure 12.2.2 Ultra sound of the dor sal side of
the right fore arm in the transverse plane at 2/5
between the elbow and the wrist. At ini tial pre -
sentation (above), at the same location two years
later (middle) and a healthy con trol (below).
Arrows show reflec tions of the fasciae. In the
patient, both the super ficial (short arrow) and the
deeper fas cia (long arrow) appeared to be thick-
ened at pre sentation. After two years of treatment
the thick ness of the fas cia has dimin ished, but is
still slightly increased com pared to the healthy
control sub ject. R = radius, U = ulna.
agent (fig ure 12.2.3). Histological exam i-
nation of a nee dle biopsy taken from the
right quadriceps mus cle showed no abnor -
malities. Full thick ness biopsy of the skin,
fascia and mus cle of the right fore arm
revealed active fasciitis with infil trates of
lymphocytes, plasma cells, histiocytes and
a few eosinophilic granu locytes. The
inflam ma tion was mainly con cen trated in
the fascia but spread partially to the septa
between the muscle fascicles (figure
12.2.4).
The diagnosis of an eosinophilic fasciitis
was made based on the clin ical pre senta-
tion, peripheral blood eosinophilia, ele -
vated IgG levels and the imag ing findings,
and was finally confirmed by the results of
the histological exam inations of the full
thick ness biopsy.
Treatment with prednisolone 15 mg once
a day and methotrexate 15 mg per week
was ini ti ated together with phys io ther apy.
Within 2 months joint mobil ity improved
and mus cle strength returned to nor mal.
After 3 months, the dos age of pred-
nisolone could be tapered down and
stopped within 2 months without wors en-
ing of the symp toms. After 1 year
methotrexate had to be discontinued
because of gas tro in tes ti nal side effects.
Two years after start of therapy the patient
had only a mild lim itation of flexion and
extension of the right wrist. More over,
the right prox imal interphalangeal joints of 
the 2nd to 5th fin ger could not be com-
pletely extended (figure 12.2.1b). The
ultrasound scan of the dor sal side of his
right fore arm showed improvement com -
pared to the ini tial ultrasound scan, but the
fasciae were still slightly thick ened com-
pared to healthy subjects (figure 12.2.2).
Dis cus sion
The clin i cal pre sen ta tion of eosinophilic
fasciitis is diverse. Usually it presents with
painful thickening of the skin that eventu-
ally pro gresses to cutaneous fibro sis and
joint contractures. Swelling and stiffness
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Fig ure 12.2.3 T1-weighted MRI of the right fore arm at the same loca tion as the ultrasound scan, with -
out (A) and with contrast agent (B) (repetition time msec/echo time msec, 645/15; 4 mm slices). After
administration of a con trast agent, enhance ment of the fasciae at both the dor sal (short arrow) and ven -
tral side (long arrow) is vis ible. With cour tesy of Dr. T. M. van der Vliet, MD.
of the extremities may mimic muscle
weakness. How ever, mus cle strength is
hardly impaired and mus cle enzymes are
normal. Although the inflam mation pre -
dominantly involves the fas cia it may also
involve the deep dermis, sub cutaneous tis -
sue and super ficial muscles [Peterson
1995]. Clin ically and histologically
eosinophilic fasciitis dif fers from the
inflammatory myopathies. Our patient
differs from the usual pre sentation of
eosinophilic fasciitis because of the absence
of char ac ter is tic cuta ne ous symp toms and
pain. A pre sen ta tion with pro gres sive,
painless contractures was first reported by
Huppke et al. in an 11-year-old girl
[Huppke 2002]. These authors men tioned
also one earlier report of the same type of
pre sen ta tion by a Jap a nese group. Our
patient is therefore the third reported case
of eosinophilic fasciitis with pain less
contractures with out obvi ous skin
involvement or arthri tis. This clin ical pre -
sen ta tion, espe cially when accom pa nied
by mus cle weak ness, can mimic myo-
pathies. In our patient a myopathy was
considered, although it was deemed less
likely because of the far more pro nounced
contractures com pared to the degree of
muscle weak ness. Bethlem myopathy,
Emery-Dreifuss mus cu lar dys tro phy and
limb gir dle mus cu lar dys tro phy type 2A
are neuromuscular dis orders in which
contractures can be the first pre sentation.
A Bethlem myopathy was espe cially sus-
pected in our case because of the
contractures of the fin ger flexors. The
absence of a fam ily history, car diac
involvement and a history of hyperlaxicity
made the diag nosis less likely, although
Bethlem myopathies are known for their
broad phenotypic range [Bonnemann
2004]. Systemic sclerosis and mixed con-
nective tis sue dis ease were considered
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C h a p t e r  12.2
Fig ure 12.2.4 Full thick ness biopsy from the skin to the extensor carpi radialis brevis, approximately at
the loca tion of the ultra sound scan. The black and white pic ture (enlarge ment 200x, HE) shows inflam -
mation of the fas cia (asterix) with pre dominantly lymphocytic infil tration. The infil tration spreads to the
superficial part of the adja cent mus cle, through the sep tum between the mus cle fas cicles (between black
closed arrows). The col oured pic ture (enlarge ment 400x, HE) shows that a few eosinophilic granulocytes
were also pres ent, both in the fas cia (short open arrows) and intravascular (long open arrow). With cour -
tesy of Dr. M. M. Y. Lammens MD PhD.
unlikely because of the absence of
sclerodactyly, Raynaud's phenomenon and 
antinuclear antibodies.
On MRI the thin fibrous structure of the
fascia is nor mally of a lower signal inten -
sity than mus cle and fat on all sequences.
Significant changes in MRI with thickening
and hyperintensity of the fas cia, more pro -
nounced after i.v. con trast admin istration,
have been reported in eosinophilic fasciitis
[Chan 2004; Imai 2003; Moulton 2005].
However, the changes can also be subtle
especially in the sub acute phase of the dis -
ease [Moulton 2005], as was the case in our 
patient. Ultrasound is capable of detecting
thickened fas cia too [Chan 2004; Huppke
2002] and has the advan tage of its wide
availability and low costs. In our patient
the ultrasound scan of the right extensors
of the forearm clearly revealed thick
hyperechoic structures between the mus-
cles. The results of the full thick ness
biopsy indi cates that in this patient the
thickened, inflamed fas cia may have
caused the changes seen on ultrasound.
But the inflam mation of the adja cent mus -
cle could also have been responsible for
additional reflections of the ultra sound
beam. These reflec tions taken together
with the reflections of the fascia itself can
create the impression of a thickened "fas -
cia", while in fact the inflamed mus cle is
visible. The echo intensity of other inves ti-
gated muscles was normal. The pres ence
of a neuromuscular disorder, including a
Bethlem myopathy which is known for its
typical echo density in the rectus femoris
muscle, was therefore less likely
[Bonnemann 2003; Pillen 2003]. 
The diagnosis of eosinophilic fasciitis was
confirmed by histopathological find ings of
a full-thickness biopsy from epi dermis to
mus cle. The char ac ter is tic appear ance is
that of a thickened and oedematous deep
fascia with the pres ence of a variable mix -
ture of lym phocytes, plasma cells,
histiocytes and some times eosinophils
[Grisanti 1989; Peter son 1995].
Corticosteroids and other immunosup-
pressive ther apies are most widely used to
arrest the progression of this disease. Our
patient improved after a com bined treat-
ment of low dose prednisolone and
methotrexate. The ultra sound scan 2 years
after diag nosis showed a dimin ished thick-
ness of the fascia, although they were still
slightly thickened, indi cating that resid ual
changes and prob ably fibro sis were still
present, which explains the lim ited
mobility of his wrist and fingers.
In con clusion, eosinophilic fasciitis should
be con sidered in young patients with pain -
less joint contractures. This is especially
important because eosinophilic fasciitis is a 
treatable con dition, in which early diag no-
sis and treatment are desirable. Diagnosis
is based on eosinophilia in periph eral
blood and histological find ings of a
full-thickness biopsy from epi dermis to
mus cle. Ultrasonographic eval u a tion of
the muscles and fas cia can be help ful to
establish the diag nosis and to monitor
treat ment.
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P a r t  IV
Intro duc tion
Localized scleroderma (morphea) com -
prises a group of dis tinct con ditions char-
acterized by idio pathic fibro sis of the skin
and adja cent structures. They range from
very small plaques involving only the skin
to dis eases that may cause a significant loss
of func tional abil ity and cosmetic defor-
mity. These various distinct types of
localized scleroderma are: plaque
morphea, bullous (vesicular) morphea,
deep mor- phea, and lin ear scleroderma,
the latter of which includes the 'en coupe
de sabre' type and pro gressive hemifacial
atrophy (´Parry Romberg` syn drome)
[Chung 2006; Laxer 2006; Sehgal 2002].
The pathogenesis of localized scleroderma
has not been fully elu cidated. Cur rently,
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12.3 Morphea profunda
Abstract
Localized scleroderma is characterized by idiopathic fibrosis of the skin and adjacent
structures, and muscle involvement occurs predominantly in deep morphea. We report a
patient with linear scleroderma who presented with slowly progressive atrophy, muscle
weakness, and loss of function of her right arm, mimicking a neuromuscular disorder.
Muscle biopsy eventually revealed zones of myositis, compatible with morphea profunda.
Morphea profunda may thus present as a neuromuscular mimic, even in case of non-pro -
gressive skin sclerosis.
Myositis in morphea profunda is gen erally lim ited to one region, whereas inflam matory
myopathies gen er ally cause dif fuse prox i mal mus cle weak ness and atro phy. Fur ther more,
skin changes in morphea profunda dif fer from those seen in dermatomyositis, and
histological fea tures of mus cle biopsy can fur ther distinguish between morphea profunda
and inflam matory myopathies. Mus cle biopsy in morphea profunda implies the risk of sam -
pling error, whereas results of electromyography and muscle imaging might better rep re-
sent the extent of muscle inflammation.
Adapted from: Voermans NC, Pillen S, De Jong E.M, Creemers MCW, Lammens M, Van Alfen N.
Morphea profunda pre senting as a neuromuscular mimic. Jour nal of Clin ical Neuromuscular Dis ease.
2008;9:407-414.
sclerosis of the skin is thought to involve 3
major, closely connected com ponents:
vascular changes, acti vated T-cells, and
altered con nec tive tis sue pro duc tion by
fibroblasts [Röcken 2003]. Environmental
factors such as accidental trauma, med ica-
tions, chem i cals, malig nan cies, and radi a -
tion ther apy may trig ger dis ease onset
[Chung 2006; Takehara 2005]. Treatment
options include pred nisone, metho-
trexate, vitamin D3, and phototherapy
with ultraviolet light [Laxer 2006; Röcken 
2003].
Mus cle involve ment occurs pre dom i -
nantly in deep morphea, and may involve
fascia or superficial mus cle [Olsen 1996;
Peterson 1995]. It may be seen in sub cuta-
neous morphea, eosinophilic fasciitis,
morphea profunda, disabling pansclerotic
morphea of children, and to a lesser extent
in lin ear scleroderma. The pri mary dif fer-
ence in muscle involvement in these types
is the depth of the inflam matory changes
[Bielsa 2007; Röcken 2003]. If pres ent in
deep morphea, mus cle inflam mation is
gen er ally lim ited to super fi cial mus cle and
reports on marked myositis are rare
[Dunne 1996]. Addi tionally, localized
scleroderma may pre cip i tate mus cle
cramps, possibly caused by local nerve
injury [Zivkovic 2006].
We here report a patient who had been
diagnosed with lin ear scleroderma of her
right arm 3 years previously. She pre-
sented with slowly progressive atro phy,
muscle weakness, and loss of func tion of
her right arm, mim icking a neuromuscular 
dis or der. The ini tial mus cle biopsy
showed no signs of a con comitant neuro-
muscular dis order or deep morphea. The
skin scle rosis went in remis sion after treat -
ment, but the atro phy and mus cle
weakness recurred. A new biopsy 3 years
later revealed zones of myositis, com pati-
ble with morphea profunda.
Morphea profunda may pres ent as a
neuromuscular mimic, especially if skin
scle ro sis is in remis sion. Fur ther more,
muscle biopsy implies the risk of sam pling
error, whereas results of electromyo-
graphy and muscle imaging might better
represent the extent of mus cle inflamma-
tion in morphea profunda.
Case report
A now 26-year old woman pre sented at
the age of 20 with linear scleroderma of
her right arm and abdo men. Dermatolo-
gical inves ti ga tion showed local ized
hyperpigmented, mildly sclerotic lesions
on the extensor side of the right arm, with-
out any lilac ring or erythema. A skin
biopsy at the age of 20 showed increased
hyalinisation of col lagen, thickened colla-
gen, and par al lel organi sa tion of col la gen
fibres in superficial and deep dermis,
extend ing into sub cu ta ne ous fat. A
perivascular inflam ma tory infil trate was
pres ent with lym pho cytes, eosinophils,
and some plasma cells. This confirmed the
clin i cal diag no sis of lin ear scleroderma.
Since skin sclerosis was clin ically not pro -
gressive, no treatment was ini tiated. Since
then, she had expe rienced a grad ually
increasing atro phy of her right lower arm
and hand without changes of skin sclerosis.
At the age of 23 (in 2004), the patient
experienced sud den increase of stiff ness,
coldness, and weak ness of her right lower
arm and hand. She lost the ability of fin ger
flexion and thumb adduction. In the same
period she expe rienced an episode of sub -
acute shoul der pain, which was fol lowed
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within weeks by atro phy and mus cle weak-
ness of the right shoulder muscles and
gradually increasing pain. The skin lesions
of her right arm became slightly more scle -
rotic compared to 3 years before. She had
to give up work ing in a child day care cen -
tre and playing tennis, and although
right-handed she increasingly used her left
arm because of these symp toms. Physical
exam i na tion revealed scle ro sis of the skin
of her right arm and shoul der, mod erate
weakness (MRC grade 4) and severe atro -
phy of her right arm and shoul der, winged
scapula on the right side, nor mal
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Maximal shoulder exorotation (both sides)
and elbow flexion (right arm). Atrophy of
the right shoulder and upper arm mus cles
(deltoid and tri ceps mus cle) is vis ible, as
well as skin sclerosis of the dorsal upper
arm (arrow).
Maximal shoulder exorotation (both sides)
and elbow flexion (right arm), and max i-
mal fist clench ing (both sides). Atrophy of
the shoulder and upper arm mus cles
(deltoid, biceps brachi, brachioradialis
muscle) can be seen.
Max i mum fin ger exten sion; both actively
(left panel) and passively (right panel).
Atrophy of the forearm flexors (left panel)
and fore arm extensors (right panel) can be
seen.
Fig ure 12.3.1 Muscle atro phy and contractures of right arm mus cles.
sensation, and decreased deep tendon
reflexes on the right arm (figure 12.3.1).
There was no Raynaud phenomenon,
sclerodac- tylia, or visceral involvement,
and skin temperature of both arms and
hands was equal. Exam ination of the left
arm, legs, and cranial nerves revealed no
abnor mal i ties.
The dif fer en tial diag no sis included neu ral -
gic amyotrophy, focal myositis, dermato-
myositis, Lyme's dis ease, reflex sym pa-
thetic dystrophy (complex regional pain
syndrome type I), and deep morphea, in
par tic u lar morphea profunda or
eosinophilic fasciitis. Neu ralgic amyotro-
phy and focal myopathies or myositis were
deemed less probable since they are gen er-
ally not associated with skin changes.
Hirayama's disease was considered
unlikely since it has a benign evolution
with clin i cal sta bi li za tion in around one
year and is not asso ciated with skin sclero-
sis. Addi tionally, electromyography in this 
patient  did not reveal any neurogenic
changes.
Exten sive lab o ra tory stud ies showed a
normal serum creatine kinase, nor mal
acute phase reactants, and nor mal total
blood eosinophil count, neg ative ANA and 
ENA, nor mal immunoglobulines, nega-
tive Borrelia serol ogy, nor mal ACE,
aspecific increase of rheumatoid fac tor,
and no other abnormalities. X-ray studies
of the right humerus, radius, ulnar bone,
wrist, and hand were unre markable.
Nerve con duction studies of the arms and
legs were within nor mal lim its, although
the CMAP amplitudes were lower in the
right arm com pared to the left. Needle
electromyography revealed spon ta ne ous
muscle fibre activity and small polyphasic
motor units with complex repetitive
discharges in all exam ined mus cles of the
right arm (biceps brachii, flexor digitorum 
profundus, extensor digitorum commu-
nis, and first dor sal interosseus mus cle).
Additionally small and mildly polyphasic
units were encountered in the left
infraspinatus and left biceps brachii mus -
cle. These results excluded peripheral
nerve involvement from Lyme's disease
and neu ralgic amyotrophy as a cause of the
symp toms. Mus cle ultra sound showed
atrophy and increased muscle echo inten-
sity of the right biceps brachii, brachio-
radialis, extensors and flexors the fore arm
and tri ceps (figure 12.3.2). MRI of the
right shoul der, arm, and fore arm revealed
no signs of fasciitis, but did show mild
atrophy of right upper arm and forearm
muscles (fig ure 12.3.3). A biopsy of skin,
fascia and mus cle of the right brachio-
radialis mus cle at the age of 23 did not
show any signs of der mal inflam mation.
Unexpectedly, histological signs of myosi-
tis, vasculitis or fasciitis were absent, and
staining with HLA-ABC and mem brane
attack com plex (MAC) antibodies was
negative. There was only a mildly
increased mus cle fibre diameter vari ance
and some atro phic fibres. Reflex sym pa-
thetic dystrophy was considered as differ-
en tial diag no sis; how ever, no sympathic
skin changes were pres ent dur ing progres-
sion of atro phy and mus cle weakness.
Focal myositis was again deemed unlikely
as the exclusive diagnosis due to pres ence
of scleroderma.
The patient was referred to a reha bilitation
centre where she was given phys ical and
occu pa tional ther apy through out the
course of her dis ease. Treat ment with oral
prednisone (1 mg/kg: 70 mg daily) was
started, with sub stantial improvement of
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skin sclerosis but no effect on mus cle
strength, arm func tion or pain. She suf -
fered from severe ste roid-induced acne,
for which minocycline was pre scribed,
prednisone was tapered, and oral metho-
trexate 15 mg weekly with folic acid was
started. The skin scle rosis further abated
within 6 months, spontaneous activity dis-
appeared in the needle EMG  and progres-
sion halted. How ever, because of the side
effects includ ing nau sea, recurrent pneu-
monia, and hair loss, the treatment was
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Fig ure 12.3.2 Mus cle ultra sound abnor mal i ties: 
Upper pan els: Mus cle ultra sound of the brachioradialis mus cle in 2004. The affected right side shows
increased mus cle echo inten sity, whereas the left side is nor mal. The echo inten sity has an inhomogeneous 
spread, with focal parts of nor mal mus cle (asterix). This could explain the (false neg ative) mus cle biopsy
result. Because of the increased mus cle echo inten sity the bone echo of the radius is hardly vis ible on the
right side. 
Lower pan els: Mus cle ultra sound of the biceps brachii mus cle in 2007: the affected right side shows
increased mus cle echo inten sity, with a homogeneous spread in most of the mus cle. Mus cle biopsy revealed 
that only fibrous tis sue is left in this mus cle. In the super ficial part of the mus cle some areas with a low
echo inten sity are vis ible (asterix), prob ably con taining (not yet affected) mus cle tis sue.
R = radius; H = humerus; dou ble arrow = sub cutaneous tis sue.
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Fig ure 12.3.3 T1-weighted MRI images of the right upper (in sagittal plane) and fore arm (in coro nal
plane) in 2004 (left panel) and 2007 (right panel). The MRI of 2007 shows mus cle atro phy (i.e.
decrease in trans verse diam eter of mus cle in com parison with unaf fected left side (not depicted here)) and
fibrosis (i.e. increase in MRI sig nal inten sity in com parison with nor mal val ues and unaf fected left side
(not depicted here)) in the fol lowing mus cles: right deltoid, tri ceps, brachioradialis, fore arm flexors and
forearm extensors. Overall, these abnormalities had increased com pared to those in 2004.
stopped after one year. In the fol lowing
months pain, func tional impair ment and
the contracture again increased, and spon -
taneous activity on the electromyography
recurred. Methotrexate was restarted in a
lower dose (7.5 mg weekly), unfortu-
nately with sim ilar side effects, after which 
it was stopped again. Since then, she has
expe ri enced a grad ual wors en ing of the
contractures of her right shoul der and of
the functional impair ments, whereas the
skin scle ro sis remained clin i cally inac tive.
One-year follow-up by electromyo-
graphy, mus cle ultrasound, and MRI
showed an increase of the ini tial abnor mal-
ities described above (fig ure 12.2.2 and
12.2.3). A new mus cle biopsy, of the
clearly abnor mal biceps brachii mus cle to
avoid a sam pling error that was sus pected
for the first biopsy, unfor tunately con -
tained only fibrous tissue. However, a
third biopsy of the right deltoid mus cle
revealed an irreg ular pat tern with micro -
scopically zones of perivascular and
endomysial lymphocytic infil trates of
T-and B-lym pho cytes. Fur ther more,
some plasmocytes with a few con comitant
necrotic fibres, non-necrotic fibres with
mononuclear infil trate, zones of mus cle
cell atro phy with interstitial fibro sis, and
zones with out sig nif i cant abnor mal i ties
were observed. Stain ing of myocyte mem-
branes with HLA-ABC was also uneven
(figure 12.3.4)  There was no positive
stain ing of cap il lar ies with anti bod ies
against C5b-9 (MAC). These findings con -
firmed the diag nosis of morphea profunda. 
After care ful con sid er ation, metho-
threxate was reinitiated sub cu ta ne ously
(25 mg weekly) in addi tion to UVA1
phototherapy. This resulted in marked
recovery of the skin scle rosis, mild
reduction of the flexion contracture of her
right elbow, and sta bilization of the mus -
cle weakness and atrophy.
Dis cus sion
We have reported a patient with morphea
profunda of her right arm, who pre sented
with a slowly progressive atro phy, mus cle
weakness, flexion contractures of the fin -
gers and loss of func tion of her right arm,
thus mim icking a neuromuscular dis order.
The dif fer en tial diag no sis included var i ous
neuromuscular and rheu matic disorders,
which were excluded by ancillary investi-
gations. A third mus cle biopsy eventually
con firmed the diag no sis morphea
profunda, which indi cates pres ence of
more extensive mus cle involvement than
in lin ear scleroderma.
This case con tains some valu able teaching
points. First, pro gression of mus cle weak-
ness, atro phy, and elbow contracture
occurred in absence of progressive skin
sclerosis. As such, morphea profunda can
present as a mimic of var ious neuromus-
cular disorders. Since the weakness and
atro phy was local ized pre dom i nantly in
one limb, a find ing that was con firmed
with electromyography, mus cle ultra-
sound and mus cle MRI, myositis in
morphea profunda may be des ignated as
'segmental myositis' and may occur in
absence of pro gressive skin scle rosis.
Second, only a third repeated mus cle
biopsy revealed signs of myositis, thus
con firm ing the diag no sis morphea
profunda. Because of the patchy changes,
in hind sight, the first biopsy prob ably
showed no abnormalities due to sam pling
error. This would also be much more
compatible with the results of elec tro-
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The left side of this muscle biopsy con tains
almost nor mal mus cle. In the mid dle part of
the pic ture interstitial lymphocytic infil-
trate with one eosinophilic necrotic fibre
(arrow) is vis ible. Unfor tunately this fibre is
not rec ognizable as such because of black
and white image, for colour display see orig -
inal article. The upper right part con tains
severely atro phic mus cle fibres with fibrosis
(asterisk). HE stain ing, bar represents 100
m.
Detail with variation of fibre diam eters,
and lymphoplasmocytic infil trate, lym pho-
cytes infil trating non-necrotic fibres
(arrow). HE staining, bar rep resents 50
m.
HLA-ABC immunohistochemical staining is
not upregulated at the muscle mem brane
and nor mal in the cap illaries. Bar rep resents
50 m.
Fig ure 12.3.4 Muscle biopsy of the right deltoid mus cle (2007).
myography, mus cle MRI, and mus cle
ultrasound [Baumann 2005; Olsen 1996;
Pillen 2007].
Third, myositis in morphea profunda is
generally restricted to the super ficial lay -
ers of mus cle [Peterson 1995], and exten-
sive mus cle involvement as in this case
seems rare [Dunne 1996]. Myositis in
morphea profunda can generally be distin-
guished from dermatomyositis by the
histological pattern of inflam mation (no
perifascicular atro phy) and the absence of
MAC-immunohistochemical staining of
capillaries, although the lat ter may be
absent and is partly depend ent on the
phase of the pro cess in dermatomyositis.
The histochemical dis tinction from
polymyositis is more dif ficult, although
HLA-ABC immunohistochemical stain ing
of muscle fibre mem branes was more
patchy in the pres ent case than gen erally
seen in inflammatory myopathies [van der
Pas 2004]. The segmental, monomelic
involvement which per sisted over years is
highly uncom mon in both dermatomyo-
sitis and polymyositis.
Treatment with oral pred nisone and
methotrexate had not resulted in improve-
ment of the skin scle rosis, contractures or
muscle weak ness. How ever, higher dose
sub cu ta ne ous methotrexate in addi tion to
UVA1 phototherapy was well-tolerated
and resulted in con siderable improvement
of skin sclerosis and reduction of
contractures. Mus cle strength and mass
has not improved yet; this may indi cate
that the deep morphea has already resulted
in end-stage myopathy in this patient.
How ever, the pres ence of spon ta ne ous
muscle fibre activ ity on electromyography
points to an ongo ing pro cess of inflam ma-
tion, which might imply that par tial mus -
cle recovery might still occur with fur ther
treat ment.
Finally, spon ta ne ous mus cle fibre activ ity
on electromyography dis appeared with
immunosuppressive therapy and recurred
after this treatment was stopped; it there -
fore seemed to be indicative of disease
activity in this patient. Electromyography
can be used to mon itor spon taneous activ-
ity to eval uate the effect of treat ment,
whilst ultra sound and / or MRI can be
used to mon i tor dis ease pro gres sion and
help select opti mal site for diagnostic
biopsy.
Neu rol o gists should con sider this diag no -
sis in patients with seg mental muscle
weakness and atrophy, especially in case of 
skin scle rosis and even if skin lesions are
min i mal and not pro gres sive. Der ma tol o -
gists and rheumatologists should realize
that extensive morphea profunda can be
present underneath localized and non-pro -
gressive skin scle rosis. This may result in
serious dis ability if left untreated and
requires immunosuppressive treat ment.
Muscle biopsy car ries the risk of sampling
error, whereas results of electro-
myography and mus cle imag ing might
better rep resent the extent of mus cle
inflam ma tion.
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Intro duc tion
Fibril la tions are spon ta ne ous depolariza-
tions of indi vidual mus cle fibers that indi -
cate the loss of con tact with their
innervating axon, and result in contraction
of the fiber [Midrio 2006]. For this rea son
fibril la tions are a prom i nent symp tom in
acute or severe peripheral nerve dis orders,
but can also occur in myopathies when
muscle fibers are split or inflam mation is
present. As fibril lations are invis ible on the 
outside they can cur rently only be
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Muscles alive: ultrasound
detects fibrillations13
Abstract
Muscle ultrasound is a dynamic technique that can easily visualize mus cle movements.
Recent improve ments of resolution and frame rate have raised the ques tion whether it is
also pos sible to detect small-scale spontaneous mus cle fibre activity such as denervation. In
this study we inves tigated the abil ity of dynamic mus cle ultrasound to detect fibril lations,
and assessed the observer agreement and temperature dependency of our find ings.
Eight patients with fibril lations were mea sured simultaneously by ultra sound and EMG to
ver ify which move ments on ultra sound exam i na tion cor re sponded to fibril la tion poten tials
on EMG. Sub sequently, the tem perature dependency of ultrasound detected fibril lations
and the interobserver and intraobserver agree ment was assessed in 5 healthy subjects with
focal denervation induced by bot ulinum toxin.
Muscle ultrasound was found to be capa ble of visualizing fibril lations. They appeared as
small, irreg ularly oscil lating move ments within the mus cle while the over all shape of the
muscle remained undis turbed. Vis ibility of fibril lations with ultrasound decreased rap idly
with lower temperatures, with a 32% decrease already at 30 °C com pared to 39 °C. The
interobserver agree ment was substantial with a kappa of 0.40 for inex perienced observers
and 0.65 for more experienced observers.
We con clude that visualization of fibril lations by mus cle ultrasound opens the way for a
new diag nostic appli cation of this technique. Con sistent results can be obtained from
trained observers. Care has to be taken to ensure an opti mal mus cle temperature to avoid
false negative results, espe cially in dis tal muscles.
Adapted from: Pillen S, Nienhuis KH, van Dijk JP, Arts IMP, van Alfen N, Zwarts MJ. Mus cles alive:
muscle ultra sound detects fibril lations. Clin ical Neurophysiology. 2009 In press
detected by nee dle electromyography
(EMG), which is an invasive and some -
times uncomfortable technique.
Previous studies have shown that muscle
ultrasound is useful in the diagnostic evalu-
ation of neuromuscular dis orders, as it can
show mus cle atrophy and structural
changes due to fibro sis or infil tration of fat
[Pillen 2008; Walker 2004]. In con trast to
other imag ing techniques ultrasound can
be used to visualize muscles move ments
such as vol un tary con trac tion and
fasciculations [Chi-Fishman 2004;
Reimers 1996c; Walker 1990]. Ultra-
sound appeared to be even more sensitive
than needle EMG for detecting fascicula-
tions, prob ably because of its larger sam-
pling area [Reimers 1996c; Walker 1990;
Wenzel 1998]. Res olution and frame rate
of ultra sound have improved over the
years. This has raised the question if it is
possible to detect smaller scale spon tane-
ous mus cle activity such as fibril lations. A
previous report stated that this is not yet
possible because with the cur rent res olu-
tion indi vidual mus cle fibres can not be
visualized [Scheel 2004]. The axial resolu-
tion of mus cle ultrasound with a 17 MHz
probe is 100 m at best [Cosgrove 1992],
which is larger than the diam eter of a nor -
mal mus cle fibre (40 to 80 m) [Engel
1986]. How ever, in a sub sequent report
ultrasound seemed capa ble of detecting
fibrillations in patients with spinal mus cu-
lar atro phy, with fibril lating mus cle fibres
appear ing as "con tin u ous, cha otic-like
movements" [van Baalen 2007]. 
In this study we aimed to confirm the abil-
ity of ultrasound to detect fibril lations.
Intra- and interobserver agree ment for the 
visual detection of fibril lations with ultra -
sound were assessed. As nee dle EMG
studies have shown fibrillations to be tem-
per a ture depend ent, espe cially below
22°C [Denys 1991; Lee 1997], we also
studied this variable.
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P a r t  V
Patient characteristics
Left brachioradialis muscle
Left supinator muscle
Right quadriceps muscle
Neuralgic amyotrophy338
Right biceps brachii muscleDermatomyositis747
Right gastrocnemius muscleS1 radiculopathy746
Right biceps femoris muscle
Right tibialis anterior muscle
Partial lesion of sciatic nerve735
Left extensor hallucis longus muscleL5 radiculopathy754
Right first dorsal interosseus muscleCompression neuropathy of ulnar nerve703
Left extensor indicis muscleLesion of radial nerve 422
Left deltoid muscleLesion of axillary nerve721
Muscle(s) examinedDiagnosisAge
(years)
Subject
Table 13.1 Description of patients and selected mus cles.
Meth ods
Simul ta neous ultra sound and EMG
mea sure ments
Eight patients with EMG-proven fibril la-
tions were included after written
informed con sent had been obtained. The
study was approved by our local eth ics
committee. Table 13.1 outlines the
patient char ac ter is tics and selected mus-
cles. Eleven muscles in total were mea-
sured simultaneously with EMG (Medelec
Mystro MS20, Surrey, United Kingdom;
con cen tric nee dle elec trode) and ultra-
sound (Phillips IU-22, Eindhoven, the
Netherlands, 5-17 MHz lin ear trans-
ducer). The EMG nee dle was inserted par-
allel to the transducer surface so it
appeared as a trans verse bright white line
on the ultrasound image (figure 13.1).
Measurements were made both with out
and with zoom applied, the lat ter to
increase the frame rate from 20 to 30 to
above 60 Hz (figure 13.1). Sub jects were
instructed to keep their mus cles relaxed
during the measurements. After the
recording the ultra sound and EMG data
were syn chro nized with elec tri cal pulses
that were added to both the EMG signal
and the ECG input of the ultra sound
device dur ing the mea surement, and con-
verted to videos in a avi-file format with a
resolution of  640 x 480 pixels.
Anal y sis of find ings
Analysis was per formed off-line. Ultra -
sound vid eos were visually screened for
move ments sus pect for fibril la tions.
Ultrasound recordings and the cor re-
sponding EMG signal were compared to
assess which spe cific movements on ultra -
sound cor re sponded to fibril la tion poten-
tials on EMG and vice versa. Attention was 
paid to the least amount of fibril lation
potentials on EMG that were still vis ible
with ultrasound, to ascertain the sen sitiv-
ity. A descriptive analysis was made of
other move ments that mimicked fibrilla-
tions.
Tem per a ture depend ency
The tem per a ture depend ency of fibril la -
tions detected by ultra sound was evaluated
in 5 healthy sub jects who had participated
in another study involving the injec tion of
botulinum toxin in their extensor
digitorum brevis mus cle (EDB). This had
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Figure 13.1: Example of ultra sound mea surement
of the tibialis anterior mus cle with out zoom
(above) and zoomed in (below) on the area
around the tip of the nee dle (represented by the
white square in the upper pic ture). When zoom -
ing in, the frame rate increased from 23 to 69
Hz. Notice the nee dle (arrow) and its banded
reverberation arti fact on the mid-left espe cially
visible in the lower frame. TA = tibialis anterior;
T = tibia.
caused a decrease in max imal com pound
muscle action potential (CMAP) ampli -
tude (median decrease 77%, range 8 to
95%), indicating that denervation had
occurred [Hamjian 1994]. In 2 sub jects
permission was obtained to verify the
cause of the move ments seen on ultra-
sound by per form ing simul ta neous EMG
and ultra sound before start of the
temperature dependency measurements.
The foot was sub merged in a water bath to
main tain a con stant tem per a ture dur ing
each measurement. The ultrasound trans-
ducer was fixed to the EDB with use of a
stand and flex ible arm. In each sub ject 5
measurements of 15 seconds each were
made at dif fer ent tem per a ture lev els: 39°,
30°, 23°, 17° and 14°C, resulting in a
total of 25 mea surements per sub ject.
After each set of 5 measurements the
water temperature was low ered with at
least 5 minutes between each tem perature
level to allow the muscle to reach the
desired tem per a ture. Two mea sure ments
were made without zoom (giving an over-
view of the mus cle with a depth set ting of
2 cm and a frame rate of 28 Hz) and
another 3 with zoom, creating an area of
approx i mately 1 cm2  and a frame rate of
87 Hz. We chose to zoom in on the area
that showed most fibril lations in the mea -
surement at 39°C.
Anal y sis of find ings
The ultrasound vid eos were ana lyzed
off-line. The presence of fibril lations in
each video was deter mined by 2 observers,
blinded and in a ran dom order. In case of
disagreement the final score was based on
con sen sus. The per cent age of mea sure-
ments with detectable fibril lations was
deter mined for each tem per a ture level.
When present, the amount of fibril lations
was scored on an ordi nal grad ing scale: 1 = 
intermittent fibril lations; 2 = focal contin-
u ous fibril la tions; 3 = dif fuse con tin u ous
fibril la tions. No vis i ble fibril la tions was
graded 0. The scores were related to the
percentage decrease of CMAP ampli tude
at 39°C using the Spearman rank correla-
tion coefficient. The amount of fibril la-
tions at each temperature level was
described.
Intraobserver and interobserver
agree ment
Twenty-five mea surements derived from
the tem per a ture depend ency study were
evaluated by 7 observers to assess inter-
observer agreement. From each sub ject
and tem perature level a zoomed and a
non-zoomed video were ran domly
selected and the presence of fibrillations
was determined based on both mea sure-
ments. After 2 weeks the same vid eos but
in a dif ferent order were reevaluated by 1
observer to deter mine the intraobserver
agree ment. Before start ing the eval u a tion
all 7 observers were trained with the same
train ing set con tain ing 16 mea sure ments
with various amounts of fibril lations and
several artefacts such as arterial pul sations,
vol un tary con trac tions and fasciculations.
The mea surements were scored in 3 cat e-
go ries: 1) fibril la tions def i nitely absent, 2)
uncertain whether present or absent, and
3) definitely present. The agree ment was
calculated using weighted kappa with a
quadratic weighting scheme because of
mul ti ple cat e go ries [Sim 2005]. There are
no uni versally accepted stan dards for reli -
abil ity, but the fol low ing cri te ria have
been pro posed by Landis et al. [1977] for
inter pret ing agree ment of Kappa sta tis tics:
<.00, poor; .00-.20, slight; .21-.40, fair;
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.41-.60, mod er ate; .61-.80, sub stan tial;
.81-1.00 almost per fect. The interobser-
ver agree ment was also calculated sepa-
rately for "experienced" observers
(approximately 4 months, n=3) and
observers without prior experience
(n=2).
Results
Simul ta neous ultra sound and EMG
mea sure ments (n=11)
True positives (n=4): Four out of 11 mus cles
showed fibrillations on ultrasound exam i-
nation that were con firmed by EMG.
Fibrillations were visible on the ultra sound
video as small, irregularly oscil lating
movements of mus cle tis sue in all direc-
tions, while the over all shape of the mus cle
was pre served (video 13.1*). In these 4
muscles EMG showed fibril lation poten-
tials with an overall fre quency of at least 5
Hz. In 1 of these mus cles the fibrillations
were clearly elic ited by the EMG needle,
as the char ac ter is tic move ments were not
present before the EMG nee dle reached
the area and started imme diately after
positioning of the nee dle. In 3 mus cles the
fibrillations were pres ent in both the
zoomed as well as the nor mal ultra sound
video, whereas in 1 mus cle the fibril lation
became apparent only after zoom ing in.
True neg a tives (n=2): In 2 out of 11 mus cles
both ultrasound and EMG showed no
fibrillations (video 13.2*). In 1 of these
muscles, EMG showed intermittent pos i-
tive spike waves (less than 1 per sec ond),
with out ultra sound cor re late.
False neg a tives (n=3): In 3 out of 11 mus cles
EMG recordings showed fibril lation
potentials but the ultrasound video did not 
show any move ments. In these mus cles the 
fibrillation poten tials on EMG were inter -
mittent and had an over all fre quency of
less than 5 Hz.
False positives (n=2): In 2 out of 11 mus cles
(both of the same patient with neuralgic
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Fig ure 13.2: Per cent age of mea sure ments with vis i ble fibril la tions for each tem per a ture level.
* The vid eos referred to in this chap ter are stored on the CD that is attached to this book.
amyotrophy) move ments sus pi cious for
fibrillations were seen with ultra sound.
However, the EMG recording did not
show spon ta ne ous activ ity, but neurogenic
motor unit potentials that were of long
duration and large ampli tude, indi cating
col lat eral reinnervation. The phe nom e non 
seen on ultrasound was therefore inter-
preted as a so-called "con traction pseudo-
tremor" or "contraction fasciculations"
[Moosa 1973; Riggs 1983]. The move -
ments on ultrasound dis appeared when the
patient was instructed to fully relax the
mus cle. Reeval u a tion of the ultra sound
video showed that these movements dif-
fered from the movements caused by
fibrillations, with larger ampli tudes and
having a more rhythmic appear ance (video
13.3*).
Other pit falls: In sev eral videos other move-
ments within or surrounding the mus cle
were seen. Arterial pul sations could be
dis tin guished from fibril la tions because of
their local ized, rhythmic appear ance. Vol -
un tary mus cle con trac tion involved larger
areas of the muscle simultaneously. Move -
ment of the trans ducer or of the patient
resulted in dis placement of structures both 
within and surrounding the mus cle in 1
direc tion, whereas fibril la tions caused
movements in all direc tions without
move ment of sur round ing struc tures.
Muscle tis sue at the edge of the ultra sound
image as well as in close prox imity to bone
often showed increased background noise
which resembled the movements caused
by fibril lations but with a smaller ampli -
tude. EMG recordings of those areas con -
firmed that the movements were artifacts
as no fibril lation potentials or other activ-
ity were observed.
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Figure 13.3: Amount of fibril lations at each temperature level (in degrees Cel sius)
* The vid eos referred to in this chap ter are stored on the CD that is attached to this book.
Tem per a ture depend ency
Before starting this experiment simulta-
neous EMG and ultra sound mea surements
in 2 sub jects had con firmed that the move-
ments seen with ultra sound were indeed
fibril la tions. 
At 39°C 22 out of 25 mea surements
(88%) in 5 subjects showed fibril lations.
The amount of fibrillations seen on ultra-
sound was sig nif i cantly cor re lated to the
CMAP ampli tude reduction of the EDB (r
= 1.0; p < 0.001). The subject with only
8% CMAP ampli tude reduction showed
the least amount fibrillations: only 2 out of 
his 5 mea surements at 39% showed inter -
mit tent focal fibril la tions. Con versely the
subject with 90% CMAP reduc tion
showed con tin u ous dif fuse fibril la tions at
all measurement above 17 degrees. At
30°C the num ber of mea surements show-
ing fibril lations had decreased to 56%.
Below this tem per a ture the per cent age
visible fibril lations was even lower, being
24% at 14°C (figure 13.2). The amount of
fibril la tions also grad u ally decreased at
lower temperatures. At 39°C 10 out of 25
mea sure ments showed con tin u ous dif fuse
fibrillations whereas at lower tem pera-
tures fibril lations were mostly focally or
intermittently present (figure 13.3).
Interobserver and intraobserver
agree ment
The kappa of the interobserver agree ment
was mod erate (0.48; range 0.22 - 0.77)
for all observ ers. With increas ing expe ri-
ence rat ings became more consistent,
reflected by a substantial kappa of 0.65
(range 0.63 - 0.67) for the 3 most expe ri-
enced observers. Conversely the 2 least
experienced observers showed less agree -
ment with a kappa of 0.40 (range 0.22 -
0.55). The intraobserver agreement
showed a kappa of 0.64. 
Dis cus sion
This study shows that even with the cur -
rent res o lu tion mus cle ultra sound is capa-
ble of visu al iz ing fibril la tions. Detec tion of
fibril la tions with ultra sound was pos si ble
with a substantial interobserver agree ment
and the amount of fibril lations could reli -
ably be assessed too, indicated by the sig -
nif i cant cor re la tion between this amount
and decrease of the CMAP ampli tude in
subjects with denervation caused by
botulinum toxin.
Even though the resolution of ultra sound
is still not that of a sin gle mus cle fibre,
movements caused by contractions of sin -
gle mus cle fibres are vis ible. Apparently
fibrillating mus cle fibres cause enough dis -
placement of the mus cle tis sue to be seen
with ultrasound.
The sensitivity of ultrasound for detecting
fibrillations might be lower than EMG, as
the overall fre quency of fibril lation poten -
tials had to exceed 5 Hz to become vis ible
with ultrasound. It was clear from 1 mea -
surement that the fibrillations were caused 
by insertion or repo sitioning of the nee dle.
These fibril la tions would prob a bly have
not been vis ible if the ultra sound record-
ing was made without EMG. More over, in 
this study mainly super ficial muscles were
examined. One could hypothesize that the
sensitivity of ultrasound to detect fibril la-
tions in deeper muscles will be lower as
deeper structures are visualized with a
lower resolution and frame rate.
The vis i bil ity of fibril la tions with ultra-
sound was highly dependent on tempera-
ture. This is in con cordance with EMG
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studies showing that the amount of fibril la-
tion potentials decreases rap idly with
lower temperatures [Denys 1991; Lee
1997]. With ultrasound not only the
amount of fibril lations but also the char ac-
ter is tics of the cor re spond ing mus cle
twitch will influ ence its detectability.
Lower temperatures are known to cause a
longer dura tion of con traction and relax -
ation of mus cle fibres and a lower twitch
force [Bennett 1985]. This means that
tem per a ture will both influ ence the
amount of fibril lation potentials and the
amount of tis sue dis placement, and this
might make detection of fibril lations with
ultrasound even more sus ceptible to tem-
perature than EMG. While this may not
pose a prob lem in prox imal mus cles,
which usu ally have a tem perature above
34°C, warm ing of dis tal mus cles will be
essential to ensure an optimal sensitivity of
ultrasound for fibrillation detection.
We identified sev eral pitfalls such as arte-
rial pul sa tions, vol un tary mus cle con trac-
tion and move ment of the trans ducer or
the patient that have to be taken into con -
sideration when mus cle ultrasound is used
to detect fibril lations. Care has to be taken
when zoom is applied and structures sur -
rounding the mus cle are not visible any -
more, because this makes it more difficult
to interpret such movements. Fur ther
studies should also refrain from anal ysis of
areas in close prox imity to bone as they are
sus cep ti ble to false pos i tive results. Con-
traction pseudotremor caused by volun-
tary contraction of large neurogenic motor 
units [Moosa 1973; Riggs 1983] also mim -
icked fibril lations. It could be dis tin-
guished from fibril lations by its larger
amplitude, a more rhythmic appear ance
and ces sation upon full relax ation of the
muscle. We did not encounter
fasciculations, but pre vious studies have
shown that fasciculations result in short
jerky movements, comprising a larger area
of the mus cle and an irregular appear ance
in dif ferent parts of the mus cle [Walker
1990]. Therefore they will be easily
distinguishable from fibrillations.
The abil ity to detect fibril lations by mus cle
ultrasound opens the way for new diag nos-
tic appli cations of this technique. The big -
gest chal lenge will be the dif fer en ti a tion
between small irregular movements
caused by fibril lations and nor mal back -
ground noise and artefacts caused by other
move ments. Fur ther inves ti ga tions are
nec es sary to deter mine the diag nos tic
accuracy and clinical value of this
technique.
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Video leg ends:
Video 13.1 
Fibrillations potentials on EMG and cor responding movements on ultra sound of
the extensor hallucis longus muscle of a patient with a L5 radiculopathy.
Muscle tis sue around the tip of the EMG nee dle shows inter mittent irreg ularly oscil lating move -
ments. The cor responding EMG sig nal shows inter mittent fibril lation poten tials. The rest of the
tissue is not mov ing, apart from a pul sating ves sel on the lower right side of the screen.
Video 13.2 
No fibril lations in the extensor indicis mus cle of a patient with a radial nerve
lesion on both EMG and ultra sound.
The EMG record ing shows no fibril lation poten tials only inser tion activ ity half way the video
fragment. At the same time, no move ments sus pect for fibril lations are seen in close prox imity of
the nee dle tip.
Video 13.3 
Move ments mim ick ing fibril la tions caused by con trac tion pseudotremor.
Muscle ultra sound imag ing of the rectus femoris mus cle of a patient with neu ralgic amyotrophy
showed rel atively large, rhyth mic, move ments caused by vol untary con traction of a large
reinnervated motor unit as can be seen on the EMG sig nal. At the end of the video record ing the
patients slowly relaxes his mus cle result ing in grad ually dis appearance of the motor unit poten -
tials and move ments on the ultra sound video.
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After per forming a mus cle ultrasound exam ination the results have to be inter preted and
reported to the refer ring cli nician. This box pro vides practical infor mation about the evalu-
a tion of ultra sound mea sure ments, cut-off points and cor re spond ing diag nos tic accu racy,
and clues lead ing to a specific diagnosis.
Evaluating the qual ity of a muscle ultra sound
exam i na tion
Before the z-scores can be interpreted, the qual ity of the ultra sound mea surement has to be
evaluated for pos sible measurement errors (see also box 1). All images have to be reviewed
according to the checklist presented in table B 4.1. 
Inter pre ta tion of
muscle echo intensity
When mus cle ultrasound is used as a
screening tool for the detection of
neuromuscular dis orders, a short pro-
tocol is generally chosen that com prises
four limb mus cles. In chap ter 8 two
cut-off points for the detection of
neuromuscular dis orders in children
have been established: one for detect ing
neuromuscular dis orders with the high -
est positive pre dictive value and one to
exclude a neuromuscular dis order with
the high est neg a tive pre dic tive value.
Figure B 4.1 pres ents a flow chart to
determine whether an ultrasound
examination should be regarded as nor -
mal, bor derline abnor mal or abnor mal.
The chance of having a neuromuscular
disorder not only depends on the ultra-
sound result but also on the age of the
child and the type of dis order sus -
pected. For example mus cle ultrasound
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How to interpret muscle
ultrasound results4XOB
Screening protocol:
Ultrasound measurement
of 4 muscles
1 muscle above + 3.5 SD
2 muscles above + 2.5 SD
3 muscles above + 1.0 SD
2 muscles above + 1.5 SD
1 muscle above + 2.0 SD
3 muscles above + 1.5 SD
No
No
No
No
No
No
Abnormal
Borderline
abnormal
Normal
Yes
Yes
Yes
Yes
Yes
Yes
Figure B 4.1 Flowchart to deter mine whether an ultra -
sound exam i na tion is nor mal, bor der line abnor mal or
abnor mal.
above the age of 3 years has a sen sitivity of almost 100% in mus cular dystrophies , whereas
nearly all children with a mito chondrial myopathy below the age of 5 years have nor mal
muscle echo intensities. Table B 4.2 and B 4.3 show the diagnostic value of mus cle ultra-
sound in case of a sus pected neuromuscular dis order and in case of a sus pected mito chon-
drial dis or der respec tively. Age-spe cific pro spec tive val ues are given.
False negative ultra sound results are mainly found in chil dren below the age of 3 years and
in patients with neuromuscular dis orders that cause only few structural mus cle changes or
only intracellular abnor mal i ties, such as mito chon drial, met a bolic and cer tain con gen i tal
myopathies. False pos itive ultra sound results are hardly found below the age of 3 years.
Above this age false pos itive results can be pres ent. Most of these ultra sound results appear
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Check and make sure that:Measurement error
Reflective structures such as calcifications are visible as bright
spots with a black line underneath. They will falsely lower the
mean echo intensity.
Reflective structures
superficial or in the muscle
Strong attenuation of the ultrasound beam occurs in severe
neuromuscular disorders and can be identified by a very bright
superficial part of the muscle which gradually decreases in
deeper parts. This feature should be noticed as it will falsely
lower the mean echo intensity.
Increased attenuation
decreasing mean muscle echo 
intensity
Identify the right muscle. The region of interest has to contain
almost the entire muscle area but surrounding fascia have to be
excluded.
Wrong position of region of
interest for measuring muscle
echo intensity
Identify the right muscle and check for the accurate calliper
position. Recalculate if necessary.
Wrong calliper position for
measuring muscle thickness
The resolution of the image has to be approximately the same in
all images. If the muscles have a “fuzzy” appearance the patient
probably was not fully relaxed when the image was captured.
Such a measurement should be excluded from further analysis.
Movement artefacts
The entire image has to be of the same quality without vertical
black lines indicating air artefacts.
Air artefacts
The bone echo and fascia have to be clearly visible unless a 
strongly increased echo intensity is present.
Not perpendicular to the
underlying bone
The outline of the skin has to be slightly convex.Too much pressure exerted
Check if the correct transducer and preset are selected and if the
correct (standard) values for gain, compression and focal points
are visible in the image.
Wrong system settings
Checklist for evaluation of measurement quality
Table B 4.1 Check list for eval uating the qual ity of mus cle ultra sound mea surement.
to be just above the abnormal cut-off point. In other words, the higher the z-score, the
higher thelikelihood of presence of a neuromuscular disorder.
Inter pre ta tion of mus cle thick ness 
Decreased muscle thick ness is indicative of muscle atro phy, but this is not nec essary cor re-
lated with the pres ence of a neuromuscular disorder. Also, patients without a
neuromuscular dis order but with symptoms such as hypotonia and delay in motor develop-
ment often show mus cle atrophy, which can largely explained by dis use. Exercise pat tern
and body com position also influ ence muscle thickness, and should be taken into account
when interpreting the results. For example, atrophy of the quadriceps mus cle in wheel-
chair-bound patients is not very surprising and will therefore not aid in determining
whether a neuromuscular dis order is present. True hypertrophy can also be found in both
healthy sub ject (as a training effect) and patient with neuromuscular disorders, such as
myotonia congenita. Increased mus cle thickness can also be caused by pseudohypertrophy,
which for exam ple is present in Duchenne mus cular dys trophy. Muscle thickness will
therefore have to be evaluated in combination with the result of the echo intensity mea sure-
ment. If atrophy is present, an increased mus cle echo intensity indi cates that the atrophy is
probably caused by a neuromuscular disorder, whereas a normal echo intensity is sug ges-
tive of disuse atro phy (table B 4.4).
175
B
O
X
4
5%44%87%Above 3 years of age
25%60%100%Below 3 years of age
14%50%91%All children
NormalBorderline abnormalAbnormalUltrasound result
Probability of the presence of a neuromuscular disorder
Table B 4.2 Chance of the presence of a neuromuscular dis order when mus cle ultra sound is used as a
screen ing tool, depending on age and ultrasound result.
56%67%
36%Not available100%Above 5 years of age
100%Below 5 years of age
50%67%100%All children
NormalBorderline abnormalAbnormalUltrasound result
Probability of the presence of a mitochondrial disorder
Table B4.3 Chance of the pres ence of a mito chondrial dis order when mus cle ultra sound is used as a
screening tool depending on age and ultrasound result.
Inter pre ta tion of the
dis tri bu tion of mus cle
ultra sound find ings
When both prox imal and dis tal mus cles
are mea sured, the distribution of ultra -
sound find ings throughout the body can be
described. This can help in the dif ferential
diagnosis, for exam ple by showing a
proximal - dis tal gra dient or limb-gir dle
dis tri bu tion of abnor mal i ties. A visual
representation in the ultra sound report
(figure B 4.2) can be helpful for this
purpose.
In chap ter 10 the dif fer en ti a tion between
myopathies and neurogenic dis orders
based on the dis tribution of mus cle ultra-
sound find ings was inves tigated. A cut-off
point for the dis crim i na tion between
neurogenic dis orders and myopathies in
children was estab lished. This cut-off
point is shown in fig ure B 4.3 together
with the accompanying diagnostic accura-
cy.
Patterns of selec tive mus cle involvement,
for exam ple spar ing of the rectus femoris
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1. Pseudohypertrophy
a. Dystrophinopathies
2. True hypertrophy with structural
muscle changes:
a. Myotonic syndromes
b. Neurogenic hypertrophy
1. Atrophy caused by a 
neuromuscular disorder (echo
intensity often more increased
than atrophy)
2. Severe disuse atrophy (atrophy
far more pronounced than echo
intensity)
Increased echo
intensity
1. “True hypertrophy”
a. Normal / Training effect
b. Myotonia syndromes
c. Other: Satoyoshi Syndrome, Myostatin
deficiency, Gigantism
1. Disuse atrophy
2. Atrophy caused by a 
neuromuscular disorder without
structural muscle changes
Normal echo
intensity
HypertrophyAtrophy
Table B 4.4 Interpretation of mus cle thick ness in cor relation with mus cle echo inten sity find ings.
Figure B 4.2 Sche matic over view of the dis tribution
of mus cle echo inten sity of a 49-year-old patient
with dermatomyositis and a 35-year-old patient
with a polyneuropathy. The grey val ues cor respond
to the amount of stan dard devi ations above nor-
mal, after cor rection for age and sex. Pre senting
ultrasound inves tigations in this man ner will help
in the dif ferential diagnosis and in select ing mus cle
biopsy loca tion.
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Screening protocol:
Ultrasound measurement
of biceps brachii, forearm
flexors, quadriceps and
tibialis anterior
Echo intensity
(quadriceps + tibialis
anterior) – (biceps brachii
+ forearm flexors ) > 1 SD
Muscle thickness
(quadriceps + tibialis
anterior) – (biceps brachii
+ forearm flexors) > 0 SD
No
No
Myopathy
(or false positive US result)
Predictive value for the
presence of myopathy:
Positive predictive value: 54%
Negative predictive value: 95%
Yes
Yes
Neurogenic disorder
Predictive value for the presence
of neurogenic disorder:
Positive predictive value: 86%
Negative predictive value: 84%
Abnormal or borderline
abnormal ultrasound
result (see flowchart
B4.1)
Yes
Flowchart to differentiate between myopathies and neuropathies
Figure B 4.2 Flowchart to deter mine whether the mus cle ultrasound results points to a neurogenic
disorder or to a myopathy. This flowchart can be applied when the ultra sound exam ination has been
applied as a screen ing tool in patients with sus pected neuromuscular dis orders and when the men -
tioned 4 mus cles have been mea sured.
when the vasti are clearly involved, should also be reported as they can help in the dif feren-
tial diag no sis of for exam ple spe cific con gen i tal myopathies and mus cu lar dys tro phies.
Visual assess ment of the ultrasound images
As described in chapter 11 and 12, mus cle ultrasound images can con tain addi tional clues to 
a spe cific (group of) neuromuscular dis orders. These fea tures can not be quan tified (yet)
and are therefore derived from visual inspection of the ultra sound images. This requires a
certain amount of experience before one can interpret these fea tures in clin ical prac tice.
Moreover, one has to keep in mind that the diag nostic accuracy of these fea tures has not yet
been inves ti gated pro spec tively. 
First the dis tribution of echo inten sities throughout the mus cle has to be evaluated: is it
homogeneous or inhomogeneous? If inhomogeneous: does the image con tain focal areas of
increased mus cle echo intensity that become especially appar ent with angulation of the
transducer pointing to an inflam matory myopathy? Or is it a moth-eaten appear ance con-
taining very black areas that can be found in spi nal mus cular atro phy? Table B 4.5 sum ma-
rizes sev eral pat terns of echo inten sity dis tri bu tion and the cor re spond ing pos si ble
diag no sis.
The fas cia sur rounding the mus cle should also be eval uated: are they thin and clearly
demarcated (i.e. nor mal) or thickened with a fuzzy appear ance suggestive of a fasciitis? One 
should fur ther screen the entire mus cle for the presence of sub cutaneous and intra muscular
calcifications, espe cially when a dermatomyositis is suspected.
Dynamic imaging
During the ultra sound mea surement one has to watch for pathological mus cle movements,
that could fur ther indicate a spe cific neuromuscular disorder. Patients can be asked to con -
tract a spe cific mus cle to judge if a nor mal con traction is visible. If pos sible one should com -
pare this to the healthy contralateral side. At rest, the pres ence of pathological spon taneous
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Clues for specific diagnosis
FasciitisThickened fascia with unclear demarcation
Bethlem myopathy, Ullrich muscular
dystrophy
Increased echo intensity in an “outside-in fashion”,
especially surrounding intramuscular fascia
Spinal muscular atrophyMoth-eaten pattern with severe atrophy
Inflammatory myopathiesFocally increased echo intensity especially with angulation
of the transducer
Muscular dystrophyHomogeneous with attenuation of the ultrasound beam
Possible diagnosisEcho intensity distribution throughout and
surrounding the muscle
Table B 4.5 Clues to spe cific neuromuscular dis orders.
muscle activity such as fasciculations and fibril lations should be evaluated. Care has to be
taken to instruct the patient to fully relax his or her mus cles. The posi tion of the patient
should also be taken into account as some posi tions cause mus cle contractions without real -
izing, for exam ple supination of the forearm is accompanied by contraction of the supinator 
muscle.Table B 4.6  describes the ultrasound appear ance of pathological mus cle move-
ments and potential pitfalls.
The detec tion of fibrillations is especially susceptible to sev eral pitfalls. Low muscle tem -
perature will decrease the detectability of fibrillations. Sev eral artefacts caused by exter nal
movements or noise sur rounding bone could also be mistaken for fibrillations. Table B 4.7
summarizes the main pit falls in the detection of fibril lations and methods to avoid them.
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Ultrasound characteristics of pathological muscle movements and pitfalls
Displacement of muscle tissue and surrounding tissue in equal
amounts.
Movement of transducer
Movement comprising the entire muscle with altering of the overall
shape.
Voluntary muscle 
contraction
Rhythmic contraction confined to one area. Application of doppler
imaging reveals blood flow.
Arterial pulsation
Pitfalls
Small to medium sized rhythmic oscillating movements that can 
resemble fibrillations or fasciculations but disappear on relaxation of 
the muscle (video 13.3)
Contraction pseudotremor
Small, irregularly oscillating movements within the muscle while the
overall shape of the muscle remains undisturbed (video 13.1)
Fibrillations
Short jerky movements confined to one area of the muscleMyokymia
Short jerky movement in focal areas of the muscle. Often not 
confined to one area. The overall shape of the muscles can be slightly
disturbed depending on the amount and location of the fasciculations
(video 10.1)
Fasciculation
Pathological muscle movement
Ultrasound appearanceMovement
Table B 4.6 Descrip tion of the ultrasound appear ance of sev eral patho logical mus cle move ments and
potential pit falls. Examples of some of these muscle move ments are pro vided on the supplementary CD. 
rt j r  t i  f al ar as f t  s l . ft  t
c fi e t  e area. e verall s a e f t e scles ca  e slig tly
ist r i   t  a t a  l ati  f t fas i lati s
( i  1. )
s i l ti
And now…
If all above men tioned checklists and flowcharts are fol lowed, a reliable ultrasound mea -
surement will be pro duced and the interpretation will be evi dence-based. This will
improve the appli cation of skeletal mus cle ultrasound in daily clinical practice.
Enjoy mus cle ultrasound!
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Pitfall Method for improvement
Warm distal muscles prior to measurement (> 30 °C)
and ensure sufficiently warm environment .
Low muscle temperature
Pitfall reducing the detectability of fibrillations
Refrain from evaluating areas near bone.Increased background noise in muscle tissue
close to bone
Verify if muscles are completely relaxed when
movements are seen or evaluate the influence of muscle
contraction.
Contraction pseudotremor
Measure in a position that enables the patient to lay still
and fully relax the muscle. Instruct patient to hold breath
while measuring around chest wall.
- Of patient
Use stand to fix probe.- Of transducer
External movement artefacts
Pitfalls resembling fibrillations
Pitfalls in the detection of fibrillations
Table B 4.7 Pit falls in the detec tion of fibril lations and meth ods to avoid them.
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Summary, Discussion
and future directions

Intro duc tion
This thesis has shown that quan tification of 
muscle ultrasound using grey scale anal ysis
improved the reli abil ity and sen si tiv ity of
muscle ultrasound for the detection of
neuromuscular dis orders. This makes
muscle ultrasound a valu able screening
tool in children with a sus pected
neuromuscular dis or der. How ever, fur-
ther dis crim i na tion between spe cific
neuromuscular pathol ogy is currently only 
pos si ble by visual eval u a tion of ultra sound
images. Visual anal ysis is dependent on the
experience of the observer, which can be a
drawback. Dynamic ultrasound still
requires visual assessment too. The ques -
tion arises if new quan tification techniques
could aid these specific mus cle ultrasound
appli ca tions and improve objec tiv ity and
diagnostic accuracy. In this chapter we
report on the results of 3 pre liminary stud-
ies of quan ti ta tive mus cle ultra sound tech-
niques and discuss the possible directions
for future research in this field.
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Future directions in
quantitative techniques:
preliminary results
14
Abstract
Quantification of mus cle ultrasound using grey scale anal ysis has improved the sen sitivity
and reli ability of this technique. The ques tion is if other quan titative techniques can fur ther
enhance the diagnostic utility of ultrasound. We therefore per formed 3 pilot studies to
investigate the use of first and second order texture anal ysis and elastography in mus cle
ultrasound. Dif ferentiation between groups of neuromuscular dis orders based on other
parameters derived from the grey value histogram or the use of a co-occurrence matrix
appeared to be ineffective. This is probably caused by the fact that these meth ods are based
on a sin gle-pixel level anal ysis, which is dis turbed by the speckled appear ance of the ultra -
sound image. Future quan tification methods need to describe the ultra sound image on a
larger scale or use filters that smoothe out this speckled appearance.
Elastography might facil itate anal ysis and reliability of dynamic imag ing. It was able to quan -
tify mus cle contraction and is prob ably also useful in the quan tification of fasciculations.
However, move ments caused by fibrillations are too small to allow for pixel tracking.
Other types of quan tification will have to be developed for such small irregular movements.
Partially adapted from: Pillen S, Van Dijk JP, Tuininga H, Van Alfen N, Zwarts MJ. Quan titative mus -
cle ultra sound: a pre liminary report on the devel opment of new tech niques. (Sub mitted)
Quan ti fi ca tion of static
images
As quan tified mus cle echo intensity
already results in high pre dictive val ues for
the detection of neuromuscular dis orders,
the need for new quan tification methods
for mus cle ultrasound used as a screening
tool is lim ited. Such quantitative meth ods
might be very use ful, however, to differ-
en ti ate between dif fer ent types of
neuromuscular dis orders as these tend to
show a dif ferent distribution of echo inten -
sities throughout the muscle (see Chapter
10).
Sev eral quan ti ta tive meth ods have already
been developed within the field of dig ital
image processing in gen eral. These meth-
ods are often referred to as texture anal y-
sis. The ques tion is whether the exist ing
texture anal ysis methods are also use ful in
muscle ultrasound or if new methods
would have to be developed. In the pre vi-
ous chapters we used a grey value histo-
gram to calculate mean muscle echo
intensity. From the same histogram other
parameters such as the standard devi ation,
skewness, and entropy can also be cal cu-
lated, and they can pro vide addi tional
infor ma tion about the dis tri bu tion of echo
inten si ties. His to gram-based quan ti fi ca -
tion is called first-order sta tistics, indi cat-
ing that the image tex ture is described
based on indi vidual pix els without con sid-
ering the spa tial rela tion between pix els.
To describe and quan tify the rela tions
between neigh bour ing pix els, sec ond
order statistics such as a co-occurrence
matrix can be used, that describe the dis -
tribution of grey val ues within an area, i.e.
whether it is homogeneous, inhomoge-
neous or fol lows a specific pattern
[Thijssen 2000]. In another field of
med i cine, appli ca tion of a co-occur rence
matrix to ultrasound images has been
investigated in oncol ogy patients with
promising results. It appeared to be pos si-
ble to differentiate between benign and
malignant tumours in pros tate and breast
sonograms, even when the tumour had the
same overall grey level as the surrounding
tissue [Alvarenga 2007; Moradi 2007]. 
Both first and second order statistics have
also been applied to muscle ultrasound in a 
pre lim i nary study inves ti gat ing if dif fer -
ences between groups of neuromuscular
disorders could be detected [Pohle 2000].
This study indi cated that myopathies and
neuropathies in general and spi nal mus cu-
lar atro phy and hereditary motor sen sory
neuropathies in specific showed dif fer-
ences in sev eral tex ture analysis parame-
ters, includ ing param eters derived from
the grey value his togram and a co-occur-
rence matrix. Although the exact type of
dif fer ences were not fur ther spec i fied,
their results indi cate that texture anal ysis
might be use ful in mus cle ultrasound. Fur -
ther stud ies are necessary to develop and
validate this technique.
We per formed 2 pilot studies to eval uate
new quan ti fi ca tion meth ods in the dif fer -
en ti a tion between neuromuscular dis or -
ders, 1 using histogram based first order
statistics and 1 using a co-occurrence
matrix. We aimed to iden tify their clin ical
use and also the limitations and pitfalls that
should be taken into account in fur ther
research of this application.
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Quan ti ta tive mus cle ultra sound
and first order sta tistics:
parameters based on the grey value 
his to gram
Aim and Meth ods
In the first pilot study we investigated if
parameters derived from the grey value
his to gram could dif fer en ti ate between 4
groups of neuromuscular dis orders. The
fol low ing param e ters were used: mean
grey value, standard devi ation, smooth-
ness, "third moment", uni formity and
entropy [Bountris 2005]. Table 14.1 out -
lines the math e mat i cal expres sion and
explanation of each parameter.
Ultrasound images in Duchenne mus cular
dys tro phy (DMD) gen er ally show
increased echo inten sity with a homoge-
neous fine gran u lar dis tri bu tion, whereas
spinal mus cular atro phy (SMA) shows a
very inhomogeneous pat tern with a
moth-eaten aspect (figure 14.1). Poly-
neuropathies generally also show a rather
homogeneous pat tern of increased echo
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Table 14.1 The math ematical expres sions and expla nation of 6 tex ture fea tures that can be derived from
the grey value his togram are described in this table. g sym bolizes the pos sible val ues of inten sity and H(g)
the per centage of pix els with inten sity value g.
intensity but with a more coarse structure
com pared to mus cu lar dys tro phies (fig ure
14.1). These features might result in dif -
ferences of grey value histogram parame-
ters. For exam ple, it can be hypothesized
that the homogeneity of DMD results in
higher val ues of uni formity and lower val -
ues of standard devi ation and third
moment, whereas SMA could result in the
opposite. Polyneuropathies might result in 
higher val ues of standard devi ation and
lower val ues of smoothness compared to
DMD. Inflam matory myopathies often
show focally increased echo inten sity (fig -
ure 14.1). This could increase the standard
deviation com pared to DMD but prob ably
not as much as in SMA, as in that dis order
black areas are also present within the
muscle tissue, a feature that is usually
absent in inflammatory myopathies.
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Figure 14.1 Typ ical ultra sound image of the quadriceps mus cle of a patient with duchenne mus cular
dystrophy (DMD) (left upper panel) and a patient with spi nal mus cular atro phy type II (right upper
panel). The rectus femoris muscle (within oval) shows a homo geneous increased echo inten sity in the
DMD patient whereas the patient with spi nal mus cular atro phy has a inhomogeneously increased echo
intensity with a so-called moth-eaten pat tern. In the rectus femoris of the DMD patient atten uation of
the ultra sound beam resulted in high echo inten sities in the super ficial part of this mus cle whereas deep
parts are black.
The lower pan els show ultra sound images of the tibialis ante rior mus cle (encircled) of a patient with a
polyneuropathy (left lower panel) and a patient with dermatomyositis (right lower panel). The patient
with a polyneuropathy showed increased echo inten sity in this dis tal mus cle with a homo geneous coarse
granular spread throughout the mus cle. The tibialis ante rior mus cle of the dermatomyositis patient has
focally increased echo inten sity. Dou ble arrow = sub cutaneous tis sue; F = fib ula; T = tibia; VI =
vastus intermedius; VL = vastus lateralis.
Ultrasound mea surements of 40 healthy
children and 45 patients with a
neuromuscular dis order were used in this
study: mus cu lar dys tro phies (n=11),
inflammatory myopathies (n=11), spi nal
muscular atro phy (n=12), and polyneuro-
pathy (n=11). The ultra sound mea sure-
ments were derived from a database previ-
ously established in the study described in
chapter 4 [Scholten 2003] and chapter 9
[Pillen 2007]. The ultra sound mea sure-
ments were made according to our stan-
dard pro tocol, which includes 4 mus cles
(biceps brachii, fore arm flexors, rectus
femoris and tibialis ante rior). In the
patient groups all ultrasound mea sure-
ments had been made in the ini tial phase of
the diag nos tic eval u a tion, i.e. before the
def i nite diag no sis was estab lished. The
final diag nosis was val idated on fol low-up,
based on the treating cli nician's judgement
and includ ing the results of EMG, muscle
biopsy and / or genetic evaluation.
Results and con clusions
Although the patients with a neuromus-
cular dis or der were eas ily sep a rated from
the healthy con trol group because of large
dif fer ences in many param e ters, only
small dif ferences between the individual
groups of neuromuscular dis orders were
found (fig ure 14.2). These differences are
probably too small to extract (a com bina-
tion of) param eters that predicts the pres-
ence of 1 of these disorders with
suf fi ciently high accu racy. A pos si ble
explanation for these neg ative results is the 
absence of spa tial infor mation in first
order sta tistics. One therefore can not tell
whether the pixels with high inten sity are
clustered together or spread throughout
the muscle. For this rea son we think that
the pos si bil i ties of these his to gram-derived
quan ti fi ca tion meth ods as sole param e ters
to dif fer en ti ate between specific neuro-
muscular disorders are and will be limited.
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Figure 14.2 Results of the his togram-based texture anal ysis. The boxplots show that all groups of
neuromuscular dis orders have higher val ues of smooth ness and stan dard devi ation com pared to healthy
controls, but the dif ferences between the dis orders are too small to dif ferentiate them with suf ficient pre -
dictive val ues. MD = mus cular dys trophies; SMA = spi nal mus cular atro phy; IM = inflam matory
myopathies; PNP = polyneuropathy.
Quan ti ta tive mus cle ultra sound
and sec ond order sta tistics: add ing
spa tial infor ma tion
Aim and Meth ods
In our sec ond pilot study we investigated if
the use of a co-occurrence matrix could
dif fer en ti ate between patients with
Duchenne mus cu lar dys tro phy and
patients with a spi nal mus cular atrophy.
Four param eters can be calculated from a
co-occurence matrix: contrast, correla-
tion, energy, and homo geneity. Table
14.2 shows the equa tions to cal culate these
parameters and explains their use in tex -
ture analysis. Our hypothesis was that
DMD patients would show high val ues on
the param e ters energy and homo ge ne ity,
whereas SMA would result in high val ues
of the param eter contrast and low val ues
of energy and homogeneity.
In a co-occurrence matrix grey lev els of
individual pix els are com pared to each
other. First the total range of grey levels -
which is 256 - has to be brought back to a
predefined num ber of grey val ues. One
then has to specify which pix els have to be
com pared by pre de fin ing the direc tion
(hor i zon tal, ver ti cal or oblique) and the
distances between pixels that are com-
pared. In this study we chose a frequently
used preset: 8 dif ferent grey lev els and
com par ing of neigh bour ing pix els (dis-
tance 1). Pix els were com pared in the hor -
i zon tal plane, as atten u a tion of the
ultrasound beam can distort the results in a 
vertical plane. 
From the database established in Chapter 9 
we selected 3 patients out of both dis or-
ders with a "typ ical" ultra sound appear -
ance, i.e. inhomogeneous increased echo
intensity caus ing a moth eaten pattern in
SMA and a homo geneous increased echo
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Returns a value that measures the closeness of the
distribution of elements in the GLCM to the GLCM
diagonal. Homogeneity is 1 for a diagonal GLCM.
Homogeneity
This is also known as uniformity, uniformity of energy
and angular second moment. The energy is the
monotonic grey-level transition. Higher values indicate
higher homogeneity. Energy is 1 for a constant image.
Energy
Indicates the local grey-level dependency on the texture
image. Higher values can be obtained for similar grey-
level regions. Correlation is 1 or –1 for a perfectly
positively or negatively correlated image.
Correlation
Contrast is also known as variance and inertia. Measures
the local variability of the texture image. Local varia-
tions lead to high contrast values. Contrast is 0 for a 
constant image.
Contrast
Measure of textureExpressionMeasurement
Table 14.2 A grey level co-occurence matrix (GLCM) cal culates how often a pixel with grey-level value i
is pres ent adja cent to a pixel with a value j. From this matrix the above men tioned param eters can be
cal cu lated.
intensity in DMD (figure 14.1) and 3
healthy con trols for com par i son. The
ultrasound mea surements of the quadri-
ceps mus cle were selected for further anal-
ysis, as this muscle usu ally shows most
abnormalities.
Results and con clusions
The analysis showed results that were
exactly oppo site to our hypothesis: DMD
patients had rel atively high values on the
parameter contrast and low val ues on
energy com pared to both SMA and healthy
controls, whereas SMA had lower val ues
of con trast and higher val ues in energy
compared to DMD (table 14.3). In hind -
sight we think that these unex pected
results were prob ably caused by the fact
that the method was performed on a sin gle
pixel level. With other imag ing anal ysis
techniques outside the field of ultrasound
this normally does not pose a prob lem.
Ultrasound, however, has one specific
image char acteristic that has major impli -
cations for this analysis: the speckle. Both
reflections as well as background noise
result in a speckled appear ance, i.e. white
(or grey) and black pix els lie next to each
other. This makes ultrasound always
inhomogeneous on a micro level, while on
a somewhat larger level a homogeneous
appearance may be pres ent (figure 14.3).
This explains why high values of con trast
were found in DMD patients, which made
it impos si ble to dif fer en ti ate them from
SMA at least with parameter settings used
in this pilot study.
Future direc tions in quan ti fi ca tion
of static mus cle ultrasound
These pre liminary studies learned us that
the main challenge in tex ture anal ysis of
muscle ultra sound will lie in the cor rect
anal y sis and inter pre ta tion of ultra sound
images after tak ing their speckled appear-
ance into con sideration. This means that
quan ti fi ca tion meth ods on a sin gle pixel
level, such as a his togram analysis or a
co-occurrence matrix, are prob ably of lit -
tle use for this goal. The speck led ultra-
sound appear ance is prob ably also the
reason that the previously used Sobel fil-
ter, which is a method to mea sure
inhomogeneity and also derived from a
single pixel level, did not have addi tional
value in mus cle ultrasound in children
[Maurits 2004]. In this study children with
mus cu lar dys tro phies showed high val ues
of inhomogeneity too. Only in patients
with myopathies in an advanced stage such
as adults with mus cular dys trophies the
ultrasound image became com pletely
white, resulting in low values of inhomo-
geneity. In this end-stage myopathies
could be dif fer en ti ated from neuropathies
as the lat ter still showed a relatively
inhomogeneous ultra sound image
[Maurits 2003]. But as such extensive
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0.860.830.80Homogeneity
0.280.230.16Energy
0.740.780.74Correlation
0.300.380.45Contrast
HealthySMADMD
Results of co-occurrence matrix
Table 14.3 Results of co-occurence matrix showing the oppo site of our hypoth esis.
muscle ultrasound changes are hardly
found in the diagnostic phase of patients
with neuromuscular disorders, the diag-
nostic value of this feature will probably be 
low.
Future studies will have to use methods
that either describe the ultra sound image
on a larger scale or use a fil ter that
smoothes out the speckled appear ance.
This will make it pos sible to quan tify the
moth-eaten appearance in spinal mus cular
atrophy, the coarse granular increased
muscle echo intensity in neuropathies and
the fine gran ular mus cle appearance in
mus cu lar dys tro phies, which are readily
apparent to the trained human eye.
Another type of second order statistics that 
might be use ful in mus cle ultrasound is
quan ti fi ca tion of the amount of atten u a -
tion of the ultra sound beam, which
appears to be dif ferent in specific neuro-
mus cu lar dis or ders. Strong atten u a tion is a
very prominent fea ture in Duchenne mus -
cu lar dys tro phy, espe cially in more
advanced dis ease (fig ure 14.4). This gives
the ultrasound image a typical appear ance
with bright super ficial mus cle lay ers,
whereas the deeper layers are darker and
the nor mal reflec tions like fas cia or bone
have disappeared because of lack of reflec-
tive sig nal. Previous studies have shown
that atten u a tion can be quan ti fied
[Heckmatt 1989; Thijssen 2008] and is
useful in estimating the amount of hepatic
steatosis [Thijssen 2008]. Fur ther studies
are nec essary to determine if this method
can also be use ful in dis criminating
muscular dystrophies from other neuro-
mus cu lar disorders.
Quan ti fi ca tion of
dynamic images
Recent advan tages in dynamic mus cle
ultrasound (Chap ter 13) have raised the
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Figure 14.3 Typ ical mus cle ultra sound appear ance of a patient with Duchenne mus cular dys trophy
showing homo geneous increased echo inten sity on a macro level. On a pixel level a speck led pat tern is vis -
ible. This explains why quan titative anal ysis with a co-occur rence matrix results in high val ues of
contrast which is a measure of inhomogeneity. Dou ble arrow is sub cutaneous tis sue; R = rectus femoris
muscle; VI = vastus intermedius mus cle; VL = vastus lateralis mus cle.
ques tion whether quan ti ta tive anal y sis of
the ultrasound vid eos could facil itate and
or improve the reliability of dynamic
imag ing. It can be dif fi cult to dif fer en ti ate
patho log i cal mus cle move ments such as
fasciculations and fibrillations by visual
inspection from other move ments such as
vol un tary mus cle con trac tions or move-
ments of the transducer or the patient. The
dis tinc tion can be espe cially dif fi cult after
zooming in because sur rounding struc-
tures then no lon ger pro vide infor mation.
How ever, in the ory patho log i cal mus cle
movements give a dif ferent type of tis sue
displacement com pared to other move-
ments and this might be the basis for telling
them apart with quantification of dynamic
techniques.
Quan ti fi ca tion of dynamic ultra sound has
already been per formed in other ultra -
sound appli cations, espe cially in oncology,
vas cu lar med i cine and hepatology [de
Korte 1998; Garra 2007]. Elastography,
for exam ple, is a method to mea sure stiff-
ness or strain that has been applied to
detect tumours: as some tumours have
other elas tic properties then their sur-
rounding tissue they can be indentified if
their elastic prop erties can be iden tified.
Simply put, elastography tracks pixels to
describe the amount and speed of tis sue
dis place ment. When mechan i cal com pres -
sion or vibration is applied dur ing imag ing
the tumour deforms dif ferently com pared
to the sur rounding tissue, meaning the
strain in the tumour is dif ferent from the
surrounding tissue. Elastography can also
be used to describe other types of tis sue
dis place ment, includ ing mus cle tis sue dur-
ing con traction. This has so far only been
investigated in cardiac muscle [Garra
2007].
We per formed a small pilot study to show
that elastography can also be performed in
skeletal muscle. It was possible to measure
the strain dur ing mus cle contraction. This
allows for quan tification of the amount
and direc tion of dis placement, duration of
con trac tion and relax ation. Fur ther
research is necessary to investigate if this
method can aid in quan tification of 
dynamic mus cle ultrasound. At a macro
level mus cle contraction and relax ation
characteristics could aid in the under stand-
ing of pathophysiological mechanisms such
as the devel opment of structural myo-
pathies in con nec tive tis sue dis or ders and
myo tonic dis or ders, by iden ti fy ing dif fer -
ences in strain and relaxation. Elasto-
graphy will prob ably also be capa ble of
quan ti fy ing smaller patho log i cal mus cle
movements such as fasciculations. To
improve diag nos tic accu racy, the
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Figure 14.4 Ultrasound image of the biceps
brachii mus cle in a 10-year-old patient with
Duchenne muscular dystrophy. The echo inten-
sity is homo geneously increased with a strong
attenuation of the ultrasound beam. The
humerus is there fore not vis ible any more. Dou ble
arrow = sub cutaneous tis sue; B = biceps brachii;
H = humerus.
ultra sound char ac ter is tics of fasciculations
that dis crim i nate them from phys i o log i cal
muscle movements and artefacts could
next be inves tigated. For the quan tifica-
tion of fibril lations elastography will cur -
rently not be help ful, as these move ments
are too small to allow for pixel tracking.
Other types of quan ti fi ca tion meth ods will
have to be developed for these small
irregular movement, for example by
quantifying the amount and frequency of
pixel intensity changes.
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Part I - Mus cle ultrasound: an
overview of its devel opment and
pos si bil i ties
Chapter 1 starts with the description of the
current diagnostic approach to children
with suspected neuromuscular dis orders,
as this is the field in which mus cle ultra -
sound will mainly be used. Until recently
neuromuscular dis orders were diag nosed
based on his tory and phys i cal exam i na tion
and the diag no sis was sub stan ti ated by
ancil lary inves ti ga tions such as elec tro-
myography (EMG), muscle biopsy and
DNA anal ysis if pos sible. EMG and mus cle
biopsy are inva sive inves ti ga tions espe-
cially in chil dren and are there fore pref er-
ably applied selec tively. A new non-
inva sive and eas ily appli ca ble diag nos tic
tool to indicate whether these invasive
inves ti ga tion are necessary would
therefore be desirable.
Muscle ultrasound might be such a tool as
it has shown to be capa ble of visu alizing
muscle thick ness and mus cle struc ture
(Chapter 2). In the early 1980s it became
apparent that mus cle ultrasound was capa-
ble of detect ing muscle changes in
neuromuscular dis or ders. Neuromuscular
disorders often cause muscle atrophy, and
the presence and amount of atro phy can be
objectified by ultrasound. Neuromuscular
disorders also often give rise to struc tural
muscle changes such as fibro sis and fatty
infiltration, which result in an increased
muscle echo intensity, i.e. a whiter
appearance, on ultrasound images.
Previous studies have already shown that
an increased intra muscular fat con tent
causes increased echo intensity, whereas
fibrosis was thought to have no sig nificant
influence on muscle echo intensity. In
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Abstract
This chapter summarizes the main find ings of this thesis. The pos sibilities and diag nostic
value of mus cle ultrasound are described. The dis cussion focuses on the posi tion of mus cle
ultrasound in the field of other imag ing techniques and in the diag nostic evaluation of chil-
dren with a sus pected neuromuscular dis order. Addi tionally the future perspectives mus cle
ultrasound within and out side the field of childhood neuromuscular disease are discussed.
15.1 Sum mary
chapter 3 we show that this assump tion is
not right: fibrous tis sue also causes
increased mus cle echo intensity.
Part II - Quan ti fi ca tion of mus cle 
echo intensity: more sen sitive and
reli able
Up till recently muscle echo intensity was
mainly eval u ated visu ally. How ever, to
judge visually if a muscle echo intensity is
patho log i cally increased can be dif fi cult,
because our visual sys tem is rather sub jec-
tive (fig ure 15.1) and indi vidual mus cles
have different mus cle struc ture and there -
fore a dif ferent mean mus cle echo inten-
sity. Addi tionally it has been shown that in
adults mus cle echo inten sity increases with
age (see also fig ure 16.1) [Reimers 1993a].
Part II describes the clin ical appli cation of
quan ti ta tive mus cle ultra sound. Mus cle
echo intensity is quantified using grey scale
analysis. This makes it possible to correct
for the above-mentioned vari ables. Before
this quantitative technique could be used
in clin ical studies, nor mal val ues for mus -
cle echo inten sity and muscle thick ness had 
to be estab lished (Chapter 4). Sub se-
quently we inves ti gated if quan ti ta tive
grey scale analysis is better than visual
assessment of ultra sound images (Chap ter
5). This study showed that quantification
indeed improved the reliability and sensi-
tivity of mus cle ultrasound for the detec-
tion of neuromuscular dis orders
com pared to visual eval u a tion alone.
Quan ti fi ca tion of mus cle echo inten sity
therefore has added value in daily clin ical
practice, even though it is slightly more
time con suming (5 to 10 minutes for the
examination of 4 muscles) and requires the 
establishment of normal values.
A dis ad van tage of quan ti fi ca tion is that it
depends on the ultrasound device used.
This would imply that new nor mal val ues
need to be established whenever another
ultrasound device is used. As this might
ham per the use of quan ti fi ca tion in clin i cal
practice, we searched for a method that
allowed for the use of nor mal val ues on
dif fer ent ultra sound devices with dif fer ent
trans ducer and hard ware char ac ter is tics
(Chapter 6). Mean mus cle echo intensity
was found to be a solid vari able: despite
quite some dif ferences in ultra sound
images, the clin i cal rel e vant mus cle echo
inten si ties were com pa ra ble after appli ca -
tion of a cor rection fac tor.  This means
that normal val ues established with one
device can be reli ably used on another
after establishing and appli cation of this
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Figure 15.1 The human visual sys tem is very
subjective: The grey bar in the upper pic ture
appears to be darker on the right side compared
to the left side when placed against a back ground
with differt shades of gray, while in fact this bar
has only one shade of grey, as can be seen in the
pic ture below.
correction fac tor. It would be advisable to
have a dedicated and pre servable phan tom
for this pur pose to reli ably transfer
reference values in case the ultrasound
device breaks down. 
Part III - Diag nostic value of
muscle ultrasound as a screen ing
tool in children
Part III describes the diagnostic value of
muscle ultrasound when used as a screen-
ing tool in the diag nostic evaluation of chil-
dren with a sus pected neuromuscular
disorder. A pro spective pilot study of 33
patients with a sus pected neuromuscular
disorder (Chap ter 7) fol lowed by a larger
study of 150 patients (Chap ter 8) showed
that muscle ultrasound is a useful and reli -
able tool in the diag nostic evaluation of
these patients. Mus cle ultrasound was
capable of detecting neuromuscular dis or-
ders with a pos itive pre dictive value of
91% and a neg ative pre dictive value of
86%. Above the age of 3 years muscle
ultrasound was very reliable with a neg a-
tive pre dictive value of 95%. Below the
age of 3 years more false neg ative results
were found (pos i tive pre dic tive value
75%). This was probably caused by the
fact that often only few structural changes
are present in early stages of a neuromus-
cular dis order. This results in no or only a
slightly increased muscle echo intensity.
Other false neg ative ultra sound results
were found in patients with a mitochon-
drial myopathy. This dis order is known for 
its sparse structural muscle changes, and
the effect on mus cle ultrasound was con-
firmed in chap ter 9: only 25% to 46% of
the children with a proven mitochondrial
disorder showed a borderline-abnormal or
abnormal ultrasound exam.
Part IV - Mus cle ultrasound in
spe cific neuromuscular dis or ders
In part IV the appli cation of mus cle ultra-
sound in spe cific neuromuscular disorders
is described. Chapter 10 shows that the
dis tri bu tion of ultra sound abnor mal i ties
throughout the body can aid in the dis -
crim i na tion between neurogenic dis or ders
and myopathies. Neurogenic dis orders
showed higher echo intensities and more
atrophy in the legs than the arms, whereas
myopathies showed an equal dis tribution
of pathol ogy between the arms and legs. It
was pos si ble to dis crim i nate neurogenic
disorders from myopathies with a rela-
tively high positive pre dictive value of
86% and a neg ative pre dictive value of
84%. Because of the prospective design of
this study patients with a false pos itive
ultrasound result, i.e. without a neuro-
muscular dis order, were included in this
study too. Patients with a myopathy
showed a sim i lar dis tri bu tion of pathol ogy
compared to those patients. This made it
difficult to dis criminate myopathies based
on the distribution of pathol ogy through-
out the body with sufficiently high
predictive values.
Chapter 11 describes the ultra sound find -
ings in specific groups of neuromuscular
dis or ders based on the avail able lit er a ture
and our own expe rience. Spe cific neuro-
muscular dis orders dif fer in the type of
muscles that are most affected and in the
ultrasonographic appearance of the mus cle
tissue (figure 15.2). For exam ple mus cular
dys tro phies show a homo ge neously
increased echo inten sity, whereas spinal
mus cu lar atro phy is accom pa nied by a
inhomogeneously, moth-eaten pattern of
relatively white and black areas. How well
these pat terns can aid in the dif ferentiation
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between spe cific types of neuromuscular
disorders has not yet been investigated.
Moreover, these patterns are currently
eval u ated by visual anal y sis, which
depends on the experience of the
observer.
Chapter 12 describes 3 cases to illustrate
the use of mus cle ultrasound in inflam ma-
tory myopathies and connective tis sue dis -
eases. A patient with juvenile dermato-
myositis showed typical ultra sound
changes with focally increased echo inten-
sity that became especially apparent after
angulation of the transducer. A patient
with a eosinophilic fasciitis dem onstrated
clearly thickened fas cia within and sur -
round ing the mus cle, cor re spond ing to
subsequent MRI and biopsy find ings.
Finally mus cle ultra sound exam i na tion of a
patient with morphea profunda revealed
extensive mus cle involvement, also found
at loca tions were skin lesions were hardly
present.
Part V - Dynamic mus cle
ultrasound and the detec tion of
fibril la tions
Muscle ultrasound is not only capa ble of
visualizing muscle struc ture, it is also very
suit able to visu al ize mus cle move ments.
Previous studies have already shown that
muscle ultrasound is even more sen sitive
in detecting fasciculations than EMG
(Walker 1990). Recent developments in
ultra sound res o lu tion and frame rate
raised the ques tion whether mus cle ultra-
sound is capable of detecting even smaller
patho log i cal mus cle move ments such as
fasciculations. The study described in
chapter 13 showed that ultrasound, even
though its resolution is still not that of indi -
vidual mus cle fibres, is indeed capable of
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Figure 15.2 Spe cific neuromuscular dis orders
show dif fer ent pat terns of dis tri bu tion of echo
intensity through out the mus cle. The upper
panel shows homo geneously increased echo
intensity espe cially in the upper part of the
rectus femoris mus cle (within rect angle) which is
typ i cal for (Duchenne) mus cu lar dys tro phies
(DMD). The mid dle panel shows a moth eaten
pat tern, typ i cal for spi nal mus cu lar atro phy
(SMA). The lower panel shows focally increased
echo inten sity (arrow) in the tibialis ante rior
muscle in a patient with juve nile dermato-
myositis (JDM). F = femur; Fi = fib ula; T =
tibia.
detect ing fibril la tions. This find ing has
important clin ical impli cations, as it is the
first tech nique to non-invasively detect
this phe nom e non. More over, dynamic
muscle ultrasound con firms that fibril la-
tions, as electrical phe nomena, lead to the
actual contraction of mus cle fibres.
Box 1 to 4 - Prac ti cal appli ca tion
of mus cle ultrasound
In addi tion to the scientific evidence for
muscle ultrasound this the sis also contains
4 prac tical text boxes that enable the
reader to per form and quan tify mus cle
ultrasound (box 1 and 2, respectively).
Box 1 and 2 also pro vide tips and tricks
with regard to sys tem set tings, position of
the patients, measurement errors, and
other useful infor mation. Box 3 describes
the technique for con verting nor mal val -
ues for use with dif ferent ultrasound
devices. Estab lish ing a con ver sion fac tor
makes it pos si ble for quan ti ta tive mus cle
ultrasound to be used more widely in daily
clin i cal prac tice, but is accom pa nied by
certain lim itations that should be taken
into account when using this technique.
Finally, box 4 con tains several checklists,
flow charts, and cut-off points to interpret
muscle ultrasound find ings in children,
that make it pos sible to send the refer ring
clinician a reliable and evidence-based
ultrasound result.
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15.2 Gen eral dis cus sion 
A. Mus cle ultra sound in
the field of mus cle
imag ing tech niques
Muscle imaging tech niques such as MRI,
CT and ultra sound all have their own tech-
ni cal char ac ter is tics and advan tages. Table
15.1 sum marizes the advan tages and dis ad-
vantages of each technique.
Based on these char ac ter is tics, the clin i cal
application of these 3 techniques for mus -
cle imag ing in our opin ion will be the fol -
low ing:
Ultra sound The main appli cation of
muscle ultrasound lies in the screening for
the presence of a neuromuscular disorder
in gen eral, espe cially in chil dren or other
patients who have dif ficulties lying still. It
can addi tionally be used to select the opti-
mal site for muscle biopsy, if nec essary
under direct ultra sound guid ance when a
muscle is focally affected or when other
structures such as ves sels and nerves need
to be avoided. As the perimysium sur-
rounding muscle fas cicles is highly reflec-
tive, muscle architecture such as
pennation angle or the dis ruption of the
fas ci cle struc ture can eas ily be visu al ized.
Infor ma tion on mus cle archi tec ture can
be used to identify lesions caused by
trauma such as mus cle tears or
haematoma [Fornage 2000]. Cur rently it
is not entirely clear what the exact influ -
ence of mus cle oedema on the ultra sound
image and muscle echo inten sity is.
Oedema might for example decrease the
sensitivity of ultrasound in the early
course of inflam matory myopathies, but
this has not been inves tigated.
MRI Both spuerficial and deeper mus -
cles can equally well be dis played by MRI,
which is helpful in deter mining pat terns
of mus cle involvement.  This can aid in
iden ti fy ing the pres ence of spe cific con-
gen i tal myopathies and mus cular dys tro-
phies [Jungbluth 2004; Mercuri 2005].
However, pro spective stud ies on the spec-
ificity of these find ing are not yet avail able.
Muscle MRI is capa ble of both detecting
and dif fer en ti at ing between fatty infil tra -
tion and oedema. As oedema can be an
early sign in inflam matory myopathies
MRI is of addi tional value in case of sus -
pected inflam matory myopathies, even
when mus cle ultrasound is nor mal [Gar cia
2000; Reimers 1997]. 
CT Fatty infil tration can also be dis -
played by CT in both superficial and deep
muscles. How ever this technique is inca -
pa ble of visu al iz ing fibro sis. More over, CT
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Characteristics and differences of muscle imaging techniques
+++++/-
(difficult, impossible when 
overlying muscles are 
severely affected)
Deep muscles
+++/-+
(determination of extent 
difficult)
Calcifications
-+/-++Muscle architecture
(pennation angle etc)
+
(hypodensity)
+ +
(easily visible on T2 
and STIR-weighted
images)
+/-
(possibly less visibility of 
muscle architecture,
decreased EI)
Oedema
+
(hypodensity)
+
(increased signal on T1 
weighted-images)
+
(increased EI)
Fibrosis and fatty 
infiltration
+++Muscle thickness
Muscle imaging
not possiblein experimental
settings
easily applicableDynamic imaging
widelylimitedwidelyAvailability
--+Portability
sedation often 
necessary
sedation or anaesthesia
often necessary
noSedation or anaesthesia
necessary in children
Imaging technique
CTMRIUltrasound
Table 15.1 Char acteristics of ultra sound, MRI, and CT in mus cle imag ing.
++ = very well pos sible, first choice; + = pos sible; +/- = difficult; - not pos sible.
has the dis ad van tage of ion iz ing radi a tion,
which makes it an unat tractive technique
for repeated measurements such as fol -
low-up studies. Comparative studies
between mus cle ultrasound and CT have
indicated that ultra sound detected early
stage struc tural changes while the CT
images were still within the nor mal range
[Cady 1983]. This is prob ably because CT
can not dis tin guish fibro sis from nor mal
muscle tissue and only becomes abnor mal
in case of fatty infil tration, oedema and
atrophy. MRI also appears to be more sen-
sitive com pared to CT in detecting
changes caused by neuromuscular dis or-
ders, espe cially when oedema is present
[Ozsarlak 2001]. As ultra sound and MRI
are good or probably even better alterna-
tives to detect neuromuscular dis orders,
the clinical appli cation of mus cle CT in our 
opinion is lim ited when ultra sound or MRI 
are avail able. The only appli cation in
which CT is preferable is when the extent
of intra- or perimuscular calcifications
needs to be determined.
Quan ti fi ca tion of mus cle CT and MRI
images is also under investigation. It is pos -
sible to quantify muscle CT by measuring
Houndfield units (HU) [Arai 1995; Cady
1983]. Houndfield units range from -1000
HU (air) to +1000 HU (water). Fat
replacement reduces the aver age den sity
of mus cle because fat has a much lower
density (-106 HU) than nor mal mus cle tis-
sue (+54 HU). In this way the extent of
fatty infiltration can be objectified. Sev eral
parameters of MRI images such as T1 and
T2 sig nal intensities and recov ery times
can also be quan tified. This has been
applied to mus cle MRI studies in patients
with several myopathies and denervation
[Kikuchi 2003; Liu 2006; Maillard 2004].
The so-called three point Dixon MRI
technique is another reliable method to
quantify the amount of fat in mus cle tissue
[Kovanlikaya 2005], which has been
applied to a fol low-up study in patients
with Duchenne mus cu lar dys tro phy
[Wren 2008]. These quan ti fi ca tion meth-
ods will improve objec tivity of MRI and
are con sidered useful in fol low-up studies.
But for specific nor mal val ues for each
muscle and age group are prob ably needed
too, as the fat and fibro sis content of skel e-
tal muscles increases with age and differs
between mus cles [Wehrli 2007]. Normal
values could prob ably fur ther improve the
diagnostic accuracy, but are currently not
avail able. Cur rently quan ti ta tive MRI and
CT are mainly used in research set tings,
whereas in daily clinical practice muscle
images obtained with these techniques are
still evaluated visually.
B. The position of muscle
ultrasound in the
diag nos tic eval u a tion of
child hood neuro-
muscular dis or ders
Position of mus cle ultrasound in
the diag nos tic pro cess
Muscle ultrasound can predict the pres-
ence and absence of a neuromuscular dis-
or der with high sen si tiv ity and spec i fic ity
in chil dren. This makes it an excel lent
screening tool for initial patient assess-
ment. It also obviates the need for nee dle
EMG in the initial assessment of chil dren
with a suspected neuromuscular dis order.
The high neg ative pre dictive value of a
normal ultra sound exam makes the pres-
ence of a neuromuscular disorder highly
unlikely. This also means that in case of a
normal muscle ultrasound study chances
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are very low that subsequent nee dle EMG
or mus cle his tology will be abnor mal.
With a nor mal mus cle ultrasound these
invasive procedures can there fore be
avoided. Only very young patients (i.e.
below the age of 3 years) or patients with
neuromuscular dis orders that cause few
structural or only intracellular abnor mali-
ties, such as met abolic myopathies, can
show false-neg a tive ultra sound results.
This infor mation should be taken into
account when interpreting the muscle
ultrasound studies.
The first attempts have been made to dif-
fer en ti ate spe cific neuromuscular dis or -
ders based on their ultra sound appear ance.
It has been shown that quan titative mus cle
ultrasound is capable of describing the dis -
tri bu tion of mus cle pathol ogy through out
the body (Chap ter 10). This aids in the
selection of an opti mal mus cle biopsy site.
It could also aid in the dif ferential diag no-
sis, as polyneuropathies tend to show
more abnor malities in the dis tal mus cles,
whereas myopathies com monly show
prox i mal involve ment. How ever, these
features are not very specific and often also 
clin i cally vis i ble and will there fore have
only limited appli cation in daily clin ical
prac tice. Visual eval u a tion of the dis tri bu -
tion of pathol ogy within a mus cle can pro -
vide clues about the presence of a spe cific
disorder, but depends on observer expe ri-
ence. Fur ther research will be necessary to 
develop new quan ti fi ca tion techniques
that can discriminate specific neuromus-
cular disorders.
In chap ter 1 the current diagnostic evalua-
tion of children with sus pected neuromus-
cular dis orders was described. The diag -
nostic flow chart before "the era of mus cle
ultrasound" shown in figure 1.9 and 1.10
can now be replaced by new flow charts
that incorporate mus cle ultrasound in the
diag nos tic eval u a tion of floppy infants (fig-
ure 15.3) and in chil dren with sus pected
neuromuscular disorders (figure 15.4).
Muscle ultrasound: a tool for
(pae di at ric) neu rol o gists, clin i cal
neurophysiologists or radi ol o gists?
Imaging techniques are nor mally in the
domain of radi ologists as they are most
experienced and famil iar with the pos sibil-
ities and lim itations of these techniques.
But ultrasound, being dynamic and por ta-
ble, is often practiced by the other cli ni-
cians too: car diologists make their own
cardiac ultra sound scans, neonatologists
examine the neonatal brain, and urol ogists
use it to exam ine the pros tate. In the diag -
nos tic pro cess radi ol o gists have the advan-
tage of the avail ability of dif ferent imag ing
techniques whose results can be compared
if nec essary, whereas other cli nicians often
com pare ultra sound with inves ti ga tions
assess ing func tion and elec tri cal phe nom -
ena, for exam ple electromyography
(EMG) in clinical neurophysiology or 
ECGs in cardiology.
So where and with whom does mus cle
ultrasound belong? At this moment mus cle
ultrasound is mainly performed by (paedi-
at ric) neu rol o gists and clin i cal neuro-
phys i ol o gists spe cial ized in neuromuscular
dis or ders. Neu rol o gists per form ultra-
sound as a part of their physical exam ina-
tion and are able to relate its find ings
directly to their clin i cal eval u a tion. Clin i -
cal neurophysiologists have the oppor tu-
nity to relate mus cle ultrasound find ings to
EMG results. Ultrasound can be used to
direct nee dle EMG and aid in the differen-
tial diag no sis. Espe cially the com bi na tion
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of infor mation on mus cle function pro -
vided by EMG and structural infor mation
provided by ultra sound, which can even be
per formed simul ta neously, adds util ity to
both techniques. But as shown in this the-
sis, quan ti fi ca tion of mus cle ultra sound
results is and remains very impor tant.
Therefore, in our opin ion, if the opti mal
technique is used, combining both visual
and quan ti ta tive anal y sis, any one who is
ded i cated to per form quan ti ta tive ultra-
sound, whether a (pae di at ric) neu rol o gist,
radiologist or clinical neurophysiologist,
should be able to perform muscle
ultrasound.
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15.3 Future per spectives in muscle
ultra sound
This the sis described the basis of quantita-
tive mus cle ultrasound and its appli cation
in the diagnostic evaluation. We are now
at the cross roads fac ing sev eral possible
directions of research in this field. Tech ni-
cians might feel the need for improving
quan ti fi ca tion tech niques of both static and
dynamic mus cle imag ing to fur ther
improve diag nos tic pos si bil i ties. Cli ni cians 
could focus on new diag nostic appli cations
of the current technique within childhood
or adult neuromuscular dis ease, or even
outside the field of neu rology.
A. New appli cations in
child hood
neuromuscular dis ease
Dif fer en ti a tion based on pat terns
of mus cle involvement
Muscle ultrasound is capable of describing
the dis tri bu tion of mus cle involve ment.
MRI studies have shown that sev eral con-
gen i tal myopathies and con gen i tal mus cu -
lar dys trophies show spe cific patterns of
muscle involvement which can help in the
dif fer en tial diag no sis of these dis or ders
[Jungbluth 2004). MRI studies have
mainly been confined to leg mus cles.
Ultrasound is a quick method that could
easily visu alize the arm mus cles too, which 
can be of added value as also in the arms
selective mus cle involvement can be pres -
ent (chapter 11).
New ultra sound devel op ments have
resulted in the pos sibility of mak ing "pan -
oramic"-images, which make it possible to
visualize sev eral muscles in one plane (see
also figure 16.4). Deeper muscles, how -
ever, will remain dif ficult to dis play, espe-
cially when over lying muscles are affected.
For an opti mal description of any mus cle
involve ment quan ti fi ca tion will remain
necessary. This implies that future
research should also focus on establish-
ment of new normal val ues for a broad
range of muscles.
Fol low-up and mon i tor ing
treat ment effect
Muscle ultrasound can also be used for the
follow-up of patients with a neuromus-
cular dis order. Because of its non-
invasiveness, mus cle ultrasound can easily
be repeated, and this makes it an ideal tool
to eval u ate new treat ment strat e gies.
We are currently study ing a cohort of
healthy children, fol lowing them for 4
years to determine the nor mal vari ation in
muscle ultrasound with respect to growth,
development and mus cle force. Addi tion-
ally, sev eral patients with dermato-
myositis, spi nal mus cu lar atro phy and
duchenne mus cu lar dys tro phy are cur-
rently included in fol low-up studies to
determine the value of mus cle ultrasound
as an out come mea sure to eval uate
treat ment.
Pre-clin i cal detec tion of
neuromuscular dis or ders
Excit ing new devel op ments in molec u lar
treatments of neuromuscular disorders
have emerged in recent years. There are
indications that these treatments will be
most effective when started as early as pos -
sible, preferrably in the presymptomatic
stage. This has led to the question if mus cle
ultrasound can aid in pre-clinical detection
of chil dren with neuromuscular dis orders.
Several neuromuscular dis orders such as
spi nal mus cu lar atro phy and mus cu lar dys-
trophies already show severely abnormal
muscle echo intensities by the time the
clin i cal diag no sis becomes appar ent. This
would imply that also in a pre clinical sta-
dium ultra sound abnor mal i ties will be
pres ent. How ever, the sen si tiv ity of ultra-
sound is expected to be lower in the pre -
clinical phase as fewer structural changes
are present in early stages of the dis ease.
The diag nostic and clinical value of this
application of mus cle ultrasound could be
promising but needs to be fur ther
inves ti gated.
Adding nerve ultra sound
Besides visu al iz ing mus cles ultra sound is
also capa ble of visu al iz ing nerves.
Currently the main clinical focus of nerve
ultrasound is the diag nosis of nerve entrap-
ments in adults [Beekman 2004]. It has
already been shown that thickened nerves
in cer tain hereditary motor sen sory neuro-
pathies are also visible on ultrasound
[Martinoli 2002]. A combination of nerve
and mus cle ultrasound in the ini tial assess-
ment of children with sus pected neuro-
muscular dis orders might aid in a fur ther
dif fer en ti a tion and the detec tion of such
neuropathies.
B. New appli ca tions
out side child hood
neuromuscular dis ease
Muscle ultrasound in adults with
neuromuscular dis or ders
The high diag nostic value of mus cle ultra-
sound in children has prompted investiga-
tions of the value of the same technique in
adult neuromuscular dis ease. Sev eral stud-
ies are currently performed to investigate
if mus cle ultrasound can aid in strengthen-
ing the diag nosis of amyotrophic lateral
scle ro sis (ALS) and the dif fer en ti a tion
from ALS-mim ics [Arts 2008]. Also, pro-
spective stud ies on the value of muscle
ultrasound in patients with sus pected
myopathies will soon commence.
Sarcopenia
As peo ple become increas ingly older,
sarcopenia is a hot item in current research
on aging [Doherty 2003; Roubenoff 2000;
Janssen 2002]]. Mus cle ultrasound might
aid in the eval uation of mus cle structure
during aging, as it can visualize changes in
muscle structure and mus cle thickness
[Arts 2007]. This can be cor related to
muscle function, tendency to fall, effects
of treatment etc, to see whether muscle
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ultrasound could be a use ful adjunct in this
area too.
Sports med i cine 
Muscle ultrasound is capable of visualize
mus cle archi tec ture such as fas ci cle length
and pennation angle. These parameters
have already been shown to cor relate with
force generation and have been used in the
evaluation of train ing in several types of
sport [Brancaccio 2008]. A new appli ca-
tion of mus cle ultrasound out side the field
of neurology might there fore lie in the
evaluation of training regimes (force ver-
sus dura tion), effects of over use, strain and 
sports injuries.
C. Future direc tions in
quan ti fi ca tion of mus cle
ultra sound
Quan ti fi ca tion of static images
As described in chapter 11, spe cific
neuromuscular dis orders have a dif ferent
muscle ultrasound appear ance which can
aid in a fur ther dif fer en ti a tion between
groups of neuromuscular disorders. So far
these dif ferences have only been described
visually, which is rather sub jective and
depends on the experience of the
observer. Ideally these intra- and
inter-mus cu lar ultra sound pat terns are
also quan tified. Chap ter 14 presented two
pilot studies on the use of new quan tifica-
tion methods based on the grey value his -
togram and a co-occurrence matrix. In
their cur rent form these methods are not
yet suc cessful. The main rea son lies in the
speckled appear ance of the ultra sound
images which strongly influences quantifi-
cation methods that are derived from a
pixel-level anal y sis. Future quan ti fi ca tion
methods will have to focus on larger scale
quantification methods or the use of filters
that smooth the speckled appearance.
Quan ti fi ca tion of dynamic images
Dynamic mus cle imaging is a very promis-
ing tool for the diag nostic evaluation of
patients with neuromuscular dis orders.
Quan ti fi ca tion might be of addi tional value
in this technique too. Elastography is a
prom is ing quan ti ta tive tech nique for
dynamic mus cle ultra sound anal y sis that
may aid in dif fer en ti a tion of patho log i cal
muscle movements such as fasciculations
from artefacts. How ever, this tech nique
will cur rently not be help ful in the quan ti-
fication of fibril lations, as these move-
ments are too small to allow for sin gle
pixel tracking. Other types of quan tifica-
tion methods will have to be devel oped for 
these small irreg ular movements, for
example by quan tifying the amount and
frequency of pixel intensity changes.
Bridging func tion and struc ture
A very interesting project would be the
com bi na tion of quan ti ta tive dynamic tech-
niques, electrodiagnostic measurements
such as sur face EMG and force mea sure-
ments to investigate the inter actions
between elec tri cal phe nom e non, the
result ing mechan i cal (i.e. struc tural) mus-
cle changes and force generation. This
might aid in a fur ther understanding of
elec tro-mechan i cal cou pling, myofascial
force transmission and pathophysiology of
disorders in which these inter action are
disturbed such as extracellular matrix dis-
orders (for example Ehlers Danlos Syn -
drome) and myo tonic syndromes.
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15.4 Con clu sion
Quantitative mus cle ultrasound is a fast, non-invasive, pain less, reli able, and help ful
technique in the diagnostic evaluation of children with a neuromuscular dis order.
Future devel op ments are expected to fur ther facil i tate its diag nos tic capa bil i ties and
application both within and out side the field of neuromuscular dis orders. As almost
every pae di at ric, neu rol ogy and radi ol ogy depart ment has an ultra sound machine
we heartily recommend mus cle ultrasound as an addi tion to the current diagnostic
tools.
For more infor mation about the con tents of this manu script you can con tact the author by e-mail: 
s.pillen @cukz.umcn.nl
DEEL I – Spierechografie:
plaatsbepaling en mogelijkheden
In hoofdstuk 1 wordt het huidige
diagnostische traject van kinderen met de
verdenking op een neuromusculaire aan-
doening beschreven. Dit is namelijk het
gebied waarin spierechografie mogelijk in
de toekomst toegepast zal gaan worden.
Op dit moment wordt de diagnose
‘spierziekte’ gesteld op grond van de
anamnese en het lichamelijk onderzoek,
aangevuld met aanvullende onderzoeken
zoals elektromyografie (EMG), het
spierbiopt en DNA diagnostiek indien
mogelijk. Vooral het EMG en het
spierbiopt zijn voor kinderen belastende
onderzoeken, en worden het liefst zo
gericht mogelijk toegepast. Een nieuwe,
kindervriendelijk diagnostisch techniek
om vast te stellen of verdere, belastende
onderzoeken nodig zijn is daarom wense-
lijk.
Spierechografie is een eenvoudig toepas-
bare techniek om de spierdikte en spier-
structuur in beeld te brengen (hoofdstuk
2). Al in 1980 werd bekend dat
spierechografie gebruikt kon worden voor
het opsporen van neuromusculaire aan-
doeningen. Deze aandoeningen gaan vaak
gepaard met atrofie. De aanwezigheid en
mate hiervan kan met behulp van
spierechografie geobjectiveerd worden.
Daarnaast gaan neuromusculaire aandoe-
ningen vaak gepaard met structurele
spierafwijkingen zoals fibrose en vervet-
ting. Dit geeft echografisch een verhoogde
echointensiteit, wat wil zeggen dat de
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Samenvatting
In dit hoofdstuk worden de belangrijkste bevindingen van dit proefschrift
samengevat. De mogelijkheden en diagnostische waarde van spierechografie
worden beschreven en uitgezet tegen andere beeldvormende technieken en de
diagnostische evaluatie van kinderen met een neuromusculaire aandoening zoals dat
momenteel in de praktijk gebeurt. Daarnaast wordt de toekomstige waarde van
spierechografie zowel binnen als buiten het gebied van neuromusculaire
aandoeningen bediscussieerd.
16.1 Samenvatting
spier er op het scherm witter uitziet dan
normaal. Uit de literatuur was reeds
bekend dat vervetting van de spier een
verhoogde echointensiteit geeft, terwijl
beweerd werd dat fibrose geen significante
invloed heeft op de echointensiteit. In
hoofdstuk 3 tonen we aan dat deze
bewering onterecht is: ook fibrosering
geeft een toename van de echointensiteit.
DEEL II – Kwantificeren van
echointensiteit: sensitiever en
betrouwbaarder
De gemiddelde echointensiteit van een
spier werd meestal op het oog beoordeeld.
Dit is echter lastig omdat ons visuele
systeem erg subjectief is (zie ook figuur
15.1) en spieren onderling verschillen qua
structuur en daardoor een verschillende
gemiddelde echointensiteit hebben. Daar-
naast is het bij volwassenen zo dat de
echointensiteit toeneemt met de leeftijd
(figuur 16.1) [Reimers 1993a]. Om die
reden hebben wij besloten de gemiddelde
echointensiteit te kwantificeren middels
grijswaarde analyse. Hiermee is het
mogelijk om voor bovenstaande variabe-
len te corrigeren. De klinische toepassing
van de grijswaarde ana lyse wordt
beschreven in deel 2. Voordat met deze
kwantitatieve techniek begonnen kon
worden moesten eerst normaalwaarden
worden vastgesteld voor spierdikte en
echointensiteit. In hoofdstuk 4 wordt de
methode voor het opstellen van normaal-
waarden beschreven, en worden voor 4
spiergroepen normaalwaarden gegeven
voor kinderen van 0 tot 16 jaar. Uit deze
studie is gebleken dat de spierdikte het
sterkst gecorreleerd is met het gewicht van 
het kind. De echointensiteit was in deze
leeftijdsgroep niet afhankelijk van leeftijd,
lengte, gewicht of geslacht.
Vervolgens is in een groep van 76 kinderen
onderzocht of kwantitatieve grijswaarde
bepaling daadwerkelijk beter is dan visuele
beoordeling voor het vaststellen of een
spierecho wel of niet afwijkend is
(hoofdstuk 5). Het bleek dat kwantifice-
ring inderdaad leidt tot meer betrouwbare
waarden. Daarnaast was kwantitatieve
spierechografie ook sensitiever in het
opsporen van neuromusculaire aandoe-
ningen in vergelijking met alleen visuele
beoordeling. Het heeft dus zeker
toegevoegde waarde om kwantitatieve
grijswaarde ana lyse toe te passen, ook al
kost dit iets meer tijd voor de analyse zelf
(5 tot 10 minuten per onderzoek) en voor
het vaststellen van normaalwaarden.
Een nadeel van kwantitatieve grijswaarde
bepaling is dat de gemeten waarden sterk
afhankelijk zijn van de gebruikte appa-
ratuur. Dit zou betekenen dat wanneer
men spierechografie gaat verrichten met
een ander echoapparaat, eerst nieuwe
normaalwaarden verzameld zouden
moeten worden. Aangezien dit een brede
toepassing van kwantitatieve spierecho-
grafie in de weg zou kunnen staan, zijn we
in hoofdstuk 6 op zoek gegaan naar een
methode waarmee normaalwaarden vast-
gesteld op het ene echoapparaat ook
vertaald kunnen worden naar een ander
echoapparaat, ook als dit apparaat totaal
andere eigenschappen heeft qua type
transducer en manier van signaal-
verwerking. Uit deze studie bleek dat de
gemiddelde echointensiteit een robuuste
maat is: ondanks dat de plaatjes van beide
machines er tamelijk verschillend uitza-
gen, was het mogelijk door gebruik van
zogenaamde fantoommetingen om een
correctiefactor te bepalen waarmee de
echointensiteiten binnen het klinisch
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relevante gebied vergelijkbaar werden
tussen beide echoapparaten. Dit bevestigt
dat eenmaal opgestelde normaalwaarden
voor echointensiteit ook op andere echo-
apparaten te gebruiken zijn, mits een
correctiefactor wordt vastgesteld en
toegepast. Het is dan ook verstandig om
een geschikt fantoom beschikbaar te
hebben voor de omzetting. Bij voorkeur is
dit een fantoom dat langere tijd houdbaar
is, en waarmee al bij start van het gebruik
van het apparaat normaalwaarde metingen
zijn vastgelegd, voor het geval het ene
echoapparaat het plotseling begeeft en
direct een andere ingezet moet worden.
DEEL III - Diagnostische waarde
van spierechografie als
screeningsinstrument bij kinderen
In deel 3 wordt de diagnostische waarde
van spierechografie bij kinderen met de
verdenking op een neuromusculaire aan-
doening beschreven. Uit een pilotstudie
bij 33 patiënten (hoofdstuk 7), gevolgd
door studie met een groep van 150
patiënten (hoofdstuk 8) wordt duidelijk
dat spierechografie heel goed als
screeningsinstrument bij deze groep van
patiënten gebruikt kan worden. Het bleek
mogelijk om neuromusculaire aandoe-
ningen op te sporen met een positief
voorspellende waarde van 91%, en uit te
sluiten met een negatief voorspellende
waarde van 86%. Boven een leeftijd van 3
jaar was de spierecho nog betrouwbaarder
met een negatief voorspellende waarde
van 95%. Onder de 3 jaar was de
sensitiviteit wat lager: in 25% van de
patiëntjes met een anderszins bewezen
neuromusculaire aandoening werd een
normale spierecho gevonden. Dit komt
omdat in een vroeg stadium van een
neuromusculaire aandoening de structu-
rele veranderingen in de spier soms nog
gering zijn. Dit geeft dan ook slechts een
geringe of helemaal geen echointensiteits-
verhoging op de spierecho. Daarnaast
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Figuur 16.1 De echointensiteit is sterk afhankelijk van de leeftijd zoals hier zichtbaar wordt op deze
echoplaatjes van de m. tibialis anterior bij 3 generaties Pillen. Ondanks de witte spier van opa, wijzend
op fibrosering en vervetting, is hier zeker geen sprake van een spierziekte gezien het feit dat hij op
88-jarige leeftijd nog altijd zonder problemen zijn rozentuin bijhoudt.
betrof het een aantal fout-negatieve
uitslagen bij patiënten met mitochondriële
myopathieën. Van dit type spierziekten is
bekend dat ze maar weinig structurele
spierafwijkingen geven, zoals ook beves-
tigd werd in hoofdstuk 9: slechts 25 tot
46% van kinderen met een mitochondriële
stoornis had een afwijkend spierecho
onderzoek.
DEEL IV – Spierechografie bij
specifieke neuromusculaire
aandoeningen
In deel 4 wordt ingegaan op echografische
kenmerken van verschillende neuromus-
culaire aandoeningen. In hoofdstuk 10
wordt beschreven hoe de echografisch
vastgestelde distributie van spierafwij-
kingen in het lichaam kan helpen bij het
maken van een onderscheid tussen myo-
pathieën en neurogene aandoeningen.
Neurogene aandoeningen hadden zoals
verwacht meer afwijkingen in de benen
dan in de armen, zowel qua spierdikte als
echointensiteit,  terwijl bij de meeste
myopathieën de afwijkingen gelijk ver-
deeld waren over de arm- en beenspieren,
en atrofie minder prom inent aanwezig
was. Op basis van deze gegevens is het
mogelijk om neurogene aandoeningen te
onderscheiden met een positief voorspel-
lende waarde van 86% en een negatief
voorspellende waarde van 84%. Vanwege
de prospectieve opzet van deze studie
bevonden zich in dit cohort ook kinderen
die uiteindelijk geen neuromusculaire
ziekte bleken te hebben. Aangezien deze
groep qua distributie van de echografische
afwijkingen vrijwel overeen kwam met
myopathieën, was het niet goed mogelijk
om op basis van de distributie van
afwijkingen myopathieën te detecteren en
te onderscheiden van de andere 2 groepen.
Een verder onderscheid tussen specifieke
groepen neuromusculaire aandoeningen is
nog niet prospectief onderzocht. Wel is uit 
de histologie bekend dat neuromusculaire
aandoeningen onderling verschillen, zo-
wel in de verdeling van spieren die het
meest zijn aangedaan als in de verdeling
van afwijkingen binnen een individuele
spier. Hoofdstuk 11 bevat een literatuur
studie aangevuld met onze eigen
ervaringen, waarin de echografische
bevindingen bij verschillende typen
neuromusculaire aandoeningen worden
beschreven. Zo vertonen bijvoorbeeld
spierdystrofieën een homogeen verhoogde
echointensiteit terwijl spinale spieratrofie-
en over het algemeen gepaard gaan met
een “gatenkaas”-patroon gekenmerkt door 
gebieden met een sterk verhoogde
echointensiteit afgewisseld met gebieden
die juist erg zwart zijn (zie ook figuur
15.2). De mogelijkheid om op basis van
deze intramusculaire bevindingen een
verder onderscheid te maken tussen
verschillende spierziekten is ook nog niet
onderzocht. Bovendien werden deze
beelden tot nu toe alleen visueel
beoordeeld, en was de beoordeling dus
sterk afhankelijk van de ervaring van de
beoordelaar.
In hoofdstuk 12 worden 3 casus op het
grensvlak tussen neurologie en reuma-
tologie beschreven waarin spierechografie
bijdroeg in het diagnostisch traject. Een
patiënt met een juveniele dermatomyositis
had typische echografische afwijkingen
passend bij deze aandoening: focaal
verhoogde echointensiteit, die beter zicht-
baar worden bij kantelen van de trans-
ducer. Een patiënt met een eosinofiele
fasciitis liet echografisch een duidelijk
verdikte fascie binnen en rond de spier
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zien, corresponderend met de biopt- en
MRI bevindingen. Tot slot toonde de
spierecho bij een patiënt met een morphea
profunda uitgebreide spierbetrokkenheid
opvallend genoeg ook in delen van het
lichaam waar de huidlaesies niet of nauwe-
lijks aanwezig waren.
DEEL V - Dynamische
spierechografie en het detecteren
van fibrillaties
Spierechografie is behalve voor het maken
van mooie plaatjes ook zeer geschikt om
naar de dynamische aspecten van spieren
te kijken. Spierechografie bleek bijvoor-
beeld zelfs sensitiever te zijn in het
opsporen van fasciculaties dan het
traditionele EMG [Walker 1990]. Aange-
zien de resolutie en framerate de laatste
tijd steeds verder verbeteren, ontstond de
vraag of ook nog kleinere pathologische
spierbewegingen zoals fibrillaties zichtbaar 
zijn met echo. In hoofdstuk 13 wordt
beschreven dat het inderdaad mogelijk is
om fibrillaties betrouwbaar waar te nemen 
met echo, ondanks het feit dat de diam eter
van de individuele spiervezels nog altijd
kleiner is dan de resolutie van het
gebruikte echoapparaat. Dit is een belang-
rijke bevinding, aangezien dynamische
spierechografie hiermee de eerste techniek 
is die deze activiteit op een niet-invasieve
manier kan aantonen. Daarnaast bevestigt
deze bevinding dat het elektrische feno-
meen fibrillaties daadwerkelijk leidt tot
contractie van de spiervezel.
Box 1 tot 4 – Praktische toepassing
van spierechografie
Naast het wetenschappelijke bewijs over
spierechografie bevat dit proefschrift ook
4 praktische teksten die de geïnteresseerde
lezer kunnen helpen in het zelf opzetten,
uitvoeren en kwantificeren van spierecho-
grafie. Box 1 en 2 bevatten tips over de
instellingen van het echoapparaat, posi-
tionering van de patiënt, valkuilen die
kunnen optreden bij het meten en andere
praktische informatie. In box 3 wordt het
omzetten van normaalwaarden voor ge-
bruik met een ander echoapparaat
beschreven. Dit maakt het mogelijk om
kwantatieve spierechografie breder in te
zetten in de klinische praktijk. Tot slot
bevat box 4 checklists, flowdiagrammen
en afkappunten die gebruikt kunnen
worden om de uitslag van een spierecho bij
kinderen te interpreteren, zodat het
mogelijk wordt de verwijzer een betrouw- 
bare en evidence-based uitslag te sturen.
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A. Spierechografie ver sus
andere beelvormende
technieken van
spierweefsel
Behalve echografie zijn ook MRI en CT in
staat om spierweefsel af te beelden. Elk
van deze 3 technieken heeft zijn eigen
voor- en nadelen, zoals samengevat in
tabel 16.1. Op basis van de eigenschappen
van de drie technieken kan de klinische
toepassing voor beeldvorming van spieren
als volgt worden samengevat:
Echografie De voornaamste toepassing
van spierechografie ligt in de screening op
de aanwezigheid van een neuromusculaire
aandoening in het algemeen, met name bij
kinderen en andere patiënten die moeilijk
stil kunnen blijven liggen. Daarnaast is
echografie een zeer geschikte techniek om
de beste plaats voor een spierbiopt te
bepalen. Zonodig kan een spierbiopt zelfs
onder directe echogeleide plaatsvinden,
bijvoorbeeld als een spier dieper gelegen
is, dichtbij vaten of zenuwen ligt die men
wil vermijden, of als de spier slechts
pleksgewijs is aangedaan. Spierechografie
is goed in staat om diverse aspecten van de
spierarchitectuur zoals de pennatiehoek of
onderbrekingen in de fascikelorganisatie
in beeld te brengen, omdat het perimysi-
um dat de spierfascikels omringt geluids-
golven sterk reflecteert. Dit kan bijvoor-
beeld gebruikt worden om laesies door
traumata, zoals hematomen of rupturen,
op te sporen [Fornage 2000]. Op dit
moment is het niet geheel duidelijk wat de
invloed van oedeem op een spier-
echobeeld is. Mogelijk verlaagt oedeem de
echointensiteit, waardoor deze vals-
normaal zou kunnen lijken. Hiermee zou
oedeem de sensitiviteit van spierechogra-
fie t.a.v. de detectie van inflammatoire
myopathieën wel eens kunnen ver min-
deren, met name in een vroeg sta dium van
deze ziekten. Dit is echter nog niet
onderzocht.
MRI Goed in beeld brengen van zowel 
diepe als oppervlakkige spieren is een
belangrijk voordeel van MRI. De betrok-
kenheid van verschillende spieren bij een
ziekteproces kan op deze manier goed
beoordeeld worden. Dit kan helpen bij het
identificeren van specifieke typen conge-
nitale myopathieën en spierdystrofieën
[Jungbluth 2004; Mercuri 2005]. Helaas
ontbreken momenteel prospectieve
studies naar de specificiteit van zulke
bevindingen. MRI kan intramusculaire
vervetting en oedeem zowel detecteren als
onderscheiden. Omdat oedeem vaak een
vroeg teken van inflammatoire myopathie-
en is en echografie dit moeilijk kan
detecteren, kan MRI toegevoegde waarde
hebben wanneer de spierecho normaal is
[Reimers 1997]. 
CT Net als MRI is CT ook in staat om 
vervetting aan te tonen in zowel
oppervlakkige als diepe spieren, maar niet
om fibrose in spieren af te beelden. Het
belangrijkste nadeel van CT is het gebruik
van ioniserende straling, waardoor de
techniek minder geschikt is om herhaal-
delijk te worden toegepast zoals voor fol -
low-up studies. Daarnaast is uit een
vergelijkende studie gebleken dat bij
neuromusculaire aandoeningen in een
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16.2 dis cus sie
vroeg sta dium reeds afwijkingen zichtbaar
waren op de spierecho, terwijl de CT scan
nog normaal was [Cady 1983]. Dit wordt
waarschijnlijk veroorzaakt doordat CT
niet in staat is om fibrose van normaal
spierweefsel te onderscheiden, en pas
afwijkend wordt als er ook vervetting,
oedeem of atrofie is opgetreden. MRI is
ook sensitiever gebleken dan CT in het
detecteren van afwijkingen veroorzaakt
door neuromusculaire aandoeningen,
vooral als er oedeem aanwezig is [Ozsarlak 
2001]. Dit maakt dat de klinische toepas-
sing van CT bij de detectie van neuromus-
culaire aandoeningen gering is, wanneer
echografie of MRI beschikbaar zijn. De
enige toepassing waarin CT beter geschikt
is dan MRI of echografie is bepaling van de
uitgebreidheid van eventuele calcificaties
in en rondom spieren.
Ook voor CT en MRI worden momenteel
methodes voor kwantificering van de
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+++++/-Diepe spiergroepen
+++/-+
(uitgebreidheid lastig
vast te stellen)
Calcificaties
-+/-++Spierarchitectuur
(pennatiehoek etc.)
+
(hypodensiteit)
+ +
(eenvoudig in beeld te 
brengen op T2- en
STIR plaatjes
+/-
(spierarchitectuur is
mogelijk slechter
zichtbaar, EI neemt af)
Oedeem
+
(hypodensiteit)
+
(verhoogd signaal op
T1-gewogen beelden)
+
(verhoogde EI)
Fibrosering en vervetting
+++Spierdikte
Afbeeldingsmogelijk
heden
niet mogelijkin experimentele
toepassingen
eenvoudigDynamische beeldvorming
wijdverspreidbeperktwijdverspreidBeschikbaarheid
--+Mobiliteit apparaat
sedatie vaak
nodig
Sedatie of anaesthesie
vaak nodig
neeSedatie of anesthesie nodig
bij kinderen
Technische aspecten
CTMRIEchografie
Tabel 16.1 Karakteristieken van echografie, MRI en CT met betrekking tot de beeldvorming van spieren.
++ = zeer goed mogelijk, eerste keus; + = goed mogelijk; +/- = lastig; - = niet mogelijk.
afbeeldingsresultaten onderzocht. Het is
mogelijk om de densiteit van de spier op
CT-beelden te kwantificeren door het
gebruik van Houndsfield Units (HU) [Arai
1995; Cady 1983]. HU geven de grijs-
waarde aan van -1000 (lucht) tot +1000
(water). Vervanging van spierweefsel
door vet vermindert de gemiddelde
densiteit van de spier doordat vet een veel
lagere densiteit heeft (-106 HU) dan water
(+54 HU). Op deze manier kan de mate
van vervetting geobjectiveerd worden.
Ook met MRI kunnen diverse afbeeldings-
parameters gekwantificeerd worden, zoals 
de T1 en T2 signaalintensiteiten en de
zogenaamde recov ery times. Dit is reeds
toegepast in diverse studies met patiënten
met myopathieën en neurogene denerva-
tie [Kikuchi 2003; Liu 2006; Maillard
2004]. The zogenaamde “driepunts-Dixon
MRI techniek” is een andere betrouwbare
maat om het vetgehalte in spieren te
bepalen [Kovanlikaya 2005]. Deze is
bijvoorbeeld toegepast in een beloopstu-
die bij jongens met de Duchenne spierdys-
trofie [Wren 2008]. Kwantificatieme-
thodes verbeteren de objectiviteit van MRI
en zijn met name zeer geschikt in
beloopstudies. Maar net als bij echografie
zijn er ook bij MRI normaalwaarden nodig
per spier en voor verschillende leeftijds-
groepen, aangezien het bekend is dat het
vet- en fibrosegehalte van skeletspieren
toeneemt bij het ouder worden en
verschilt per spier [Wehrli 2007]. Deze
normaalwaarden zijn momenteel nog niet
beschikbaar. Kwantitatieve MRI en CT
wordt momenteel alleen gebruikt in
onderzoekssetting, terwijl beelden voor
de klinische praktijk vooral visueel beoor-
deeld worden.
B. De positie van spier-
echografie binnen het
diagnostische traject van 
neuromusculaire
aandoeningen bij
kinderen
Positie van spierechografie in het
diagnostisch proces
Spierechografie kan de aanwezigheid van
een neuromusculaire aandoening bij
kinderen nauwkeurig voorspellen, wat het
een geschikte techniek maakt om als
screeningsinstrument te worden ingezet.
Gezien de hoge negatief voorspellende
waarde van een normale spierecho uitslag,
vooral boven een leeftijd van 3 jaar, is de
kans op een neuromusculaire aandoening
bij een normale echo zeer klein. Hierdoor
kunnen verdere invasieve pro cedures zoals
het EMG en het spierbiopt achterwege
gelaten worden. Alleen erg jonge patiën-
ten, en patiënten met neuromusculaire
aandoeningen die slechts weinig structure-
le afwijkingen in de spier geven, zoals
metabole myopathieën of stoornissen in de 
neuromusculaire overgang, hebben een
grotere kans op een foutnegatieve uitslag.
Deze gegevens moeten meegenomen
worden in de beoordeling en interpretatie
van een spierecho uitslag.
Er zijn reeds pogingen gedaan om specifie-
ke neuromusculaire aandoeningen van
elkaar te onderscheiden op basis van hun
spierechobeeld. Kwantitatieve spierecho-
grafie maakt het mogelijk om de distri-
butie van afwijkingen in het lichaam te
beschrijven. Dit kan helpen bij de
differentiaaldiagnose en in het bepalen van
de optimale plaats voor een spierbiopt.
Differentiaaldiagnostisch laten polyneuro-
pathieën bijvoorbeeld meer afwijkingen in
de distale spieren zien vergeleken met de
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proximale laten zien, terwijl veel
myopathieën met name proximale
spierbetrokkenheid geven. Echter, deze
distributie is waarschijnlijk weinig speci-
fiek en klinisch ook zichtbaar, en zal dus in
de klinische praktijk slechts een geringe
bijdrage leveren behalve bij patiënten die
klinisch lastig beoordeelbaar zijn (zoals
hele jonge kinderen).
De verdeling van echointensiteiten binnen
een spier kan aanwijzingen geven voor de
aanwezigheid van een specifieke neuro-
musculaire aandoening zoals een dystrofie
(homogene afwijkingen) of voorhoorn-
lijden (gatenkaas-aspect). Aangezien dit
vooralsnog een visuele beoordeling be-
treft, is de interpretatie vooralsnog erg
afhankelijk van de ervaring van de beoor-
delaar. Verder onderzoek is nodig om ook
voor deze toepassing van spierechografie
kwantitatieve methodes te ontwikkelen,
zodat spierecho beter in staat is om ook
onderscheid te maken tussen verschillende
neuromusculaire aandoeningen.
In hoofdstuk 1 werd de huidige diagnos-
tische evaluatie beschreven van kinderen
met de verdenking op een neuro-
musculaire aandoening. Dit diagnostische
stroomdiagram “vóór het spierechotijd-
perk” kan nu vervangen worden door een
nieuw stroomdiagram, zowel voor de
diagnostische evaluatie van de hypotone
zuigeling (figuur 16.2) als voor het oudere
kind met de verdenking op een neuromus-
culaire aandoening (figuur 16.3).
Spierechografie: een techniek voor
(kinder)neurologen, klinisch
neurofysiologen of radiologen?
Beeldvormende technieken zijn normaal
gesproken het terrein van de radioloog.
Echografie wordt echter in de dagelijkse
praktijk ook vaak beoefend door niet-
radiologen: cardiologen maken hun eigen
echocardiografieën, neonatologen bekij-
ken het neonatale brein en urologen
gebruiken echografie om de prostaat in
beeld te brengen. Om de diagnostiek te
helpen heeft de radioloog de beschikking
over meerdere soorten beeldvormende
technieken waaronder echo, die zo nodig
met elkaar vergeleken kunnen worden,
terwijl andere clinici echografische
bevindingen juist vaak correleren aan
functieonderzoek en electrofysiologische
bevindingen, zoals het EMG bij klinisch
neurofysiologen of ECG’s bij cardiologen.
De vraag is dus waar of bij wie spier-
echografie thuis hoort. Op dit moment
wordt spierechografie met name verricht
door (kinder-) neurologen en klinisch
neurofysiologen gespecialiseerd in neuro-
musculaire ziekten. Neurologen maken de 
spierecho vaak aansluitend op hun
lichamelijk onderzoek om de resultaten
hier direct aan te kunnen correleren.
Klinisch neurofysiologen kunnen de spier-
echobevindingen vergelijken met het
EMG, en beide onderzoeken kunnen
elkaar beïnvloeden in bijvoorbeeld de keus 
van de te onderzoeken spieren. Vooral de
combinatie van EMG en echo-onderzoek
geeft informatie over zowel functionele als 
structurele aspecten van de spier, zeker als 
ze simultaan worden toegepast. Zoals
aangetoond in dit proefschrift is voor de
praktische toepasbaarheid van spierecho-
grafie ook vooral het kwantificeren van de
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bevindingen het belangrijkste. Ons inziens
zijn zowel radiologen, (kinder-)neuro-
logen als klinisch neurofysiologen prima
geschikt om spierechografie te beoefenen,
zolang de optimale techniek wordt
gebruikt waarin zowel visuele als kwanti-
tatieve analyse wordt toegepast.
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16.3 De toekomst van spierechografie
In dit proefschrift wordt de basis gelegd
voor kwantitatieve spierechografie en de
toepassing ervan in de klinische praktijk.
Vanuit deze basis kunnen nu meerdere
wegen ingeslagen worden om deze
techniek en de toepassing ervan verder te
ontwikkelen. De technische aspecten en
kwantificeringsmethodes, zowel van
statische als van dynamische echobeelden,
kunnen zeker nog verder verbeterd
worden om de uiteindelijk de diagnos-
tische mogelijkheden te maximaliseren.
Vanuit klinisch oogpunt kan onderzocht
worden of de diagnostische toepassingen
van deze techniek verder uitgebreid
kunnen worden, zowel binnen gebied van
de neuromusculaire zieketen als ook
buiten de neurologie.
A. Nieuwe toepassingen bij
KINDERneuromusculaire
aandoeningen
Differentiatie op basis van patronen
in spierbetrokkenheid 
Spierechografie is geschikt om de
distributie van aangedane spieren in het
lichaam betrouwbaar te beschrijven. MRI
studies hebben aangetoond dat verschil-
lende congenitale myopathieën en
congenitale spierdystrofieën specifieke
patronen van spierbetrokkenheid laten
zien, wat kan helpen bij de differentiaal
diagnose van deze aandoeningen [Jung-
bluth 2004]. Tot nu toe hebben deze MRI
studies zich echter om technische redenen
beperkt tot de beenmusculatuur. Aan-
gezien spierechografie een eenvoudig
toepasbare en relatief snelle techniek is
waarmee in dezelfde sessie eenvoudig
zowel arm- als beenspieren in beeld
gebracht kunnen worden, kan spierecho
additionele waarde hebben nu gebleken is
dat sommige neuromusculaire aandoe-
ningen selectieve spierbetrokkenheid in
de armen vertonen (hoofdstuk 11).
Nieuwe ontwikkelingen in echoappara-
tuur en software hebben geresulteerd in
de mogelijkheid om zogenaamde pa-
norama-opnames te maken, waarmee
meerdere spieren in hetzelfde vlak beke-
ken kunnen worden (figuur 16.4). Dit
neemt niet weg dat het afbeelden van
diepe spieren een probleem zal blijven,
zeker als bovenliggende spierlagen ernstig 
zijn aangedaan. Om de distributie van
spierafwijkingen optimaal te kunnen
vaststellen, blijft het nodig de echo-
intensiteit van de verschillende spieren te
kwantificeren. Dit houdt de noodzaak  in
om voor veel verschillende spieren
normaalwaarden vast te stellen.
Beloopstudies en evaluatie van
nieuwe behandelingen
Gezien het makkelijk toepasbare en
kindervriendelijke karakter van spier-
echografie is het goed mogelijk om het
onderzoek meerdere malen te herhalen,
waardoor het een uitermate geschikte
techniek is voor de fol low up van nieuwe
behandelmethodes. Op dit moment wordt
een cohort van gezonde kinderen geduren-
de 4 jaar gevolgd om de normale variatie in 
spierechografie in relatie tot groei en
ontwikkeling van kracht te evalueren.
Daarnaast worden patiënten met dermato- 
myositis, spinale spieratrofie en Duchenne
spierdystrofie momenteel geïncludeerd in
beloopstudies om te bepalen of spierecho-
grafie geschikt is als uitkomstmaat om
nieuwe therapieën te evalueren. De
resultaten hiervan worden in 2010
verwacht.
Preklinische detectie van
neuromusculaire aandoeningen
De laatste jaren heeft de ontwikkeling van
nieuwe behandelingen voor neuromuscu-
laire aandoeningen grote stappen ge-
maakt. Er zijn sterke aanwijzingen dat veel 
van deze behandelingen met name
effectief zullen zijn als ze zo vroeg
mogelijk gestart worden, bij voorkeur al
in een presymptomatisch stadium van de
ziekte. Dit leidt tot de vraag of spier-
echografie ook in deze situatie van dienst
kan zijn. Meerdere neuromusculaire aan-
doeningen zoals spinale spieratrofie en
spierdystrofieën vertonen al sterke echo-
grafische afwijkingen op het moment van
diagnose. Dit impliceert dat ook in een
preklinisch sta dium reeds afwijkingen
zichtbaar zouden moeten zijn. Aan de
andere kant valt te verwachten dat de
sensitiviteit lager is dan bij diagnose,
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Figuur 16.4 Nieuwe ontwikkelingen op het gebied van echografie hebben het mogelijk gemaakt om
zogenaamde panorma opnames te maken zodat meerdere spieren in 1 plaatje bekeken kunnen worden. Op
dit plaatje is een pan orama opname van de kuitspieren te zien. GM = mediale gatrocnemius; GL =
laterale gastrocnemius; PL = peroneus longus. 
omdat in de preklinische en vroege fase
van een neuromusculaire aandoening vaak
minder structurele afwijkingen zichtbaar
zijn. De diagnostische en klinische waarde
van deze toepassing van spierechografie is
dus zeker interessant, maar behoeft verder
onderzoek.
Combinatie met zenuwecho 
Naast het in beeld brengen van
spierweefsel is echografie ook goed in staat 
om zenuwen in beeld te brengen. Op dit
moment wordt zenuwecho met name
gebruikt om drukneuropathieën zoals het
carpale tunnel syndroom of drukneuro-
pathie van de n. ulnaris ter hoogte van de
elleboog af te beelden [Beekman 2004].
Ook kunnen verdikte zenuwen, zoals
bijvoorbeeld bij vormen van hereditaire
sensomotore neuropathie, zichtbaar ge-
maakt worden met echo [Martinoli 2002].
Een combinatie van spier- en zenuwecho-
grafie bij de initiële beoordeling van een
kind met een mogelijke neuromusculaire
aandoening zou bij kunnen dragen aan
vergroting van de diagnostische sensitivi-
teit in de detectie en verdere differentiatie
van deze neuropathieën.
B. Nieuwe toepassingen bij
volwassenen en buiten de
neurologie
Spierechografie bij volwassenen
met neuromusculaire
aandoeningen
Aangezien er bij kinderen met neuromus-
culaire aandoeningen hoge diagnostische
waardes van spierechografie zijn vast-
gesteld, is de verwachting dat deze
techniek ook bij volwassenen met neuro-
musculaire aandoeningen een belangrijke
bijdrage kan leveren in het diagnostische
traject. Op dit moment worden er een
aantal onderzoeken uitgevoerd om het
bepalen of de toevoeging van spier-
echografie aan het diagnostische traject bij
amyotrofe lateraal sclerose (ALS) leidt tot
een meer zekere diagnose of helpt in het
onderscheid met aandoeningen die op ALS 
lijken (‘mimics’). Daarnaast zal binnen-
kort in ons centrum een grote pro-
spectieve studie starten naar de waarde
van spierechografie bij de verdenking op
een myopathie bij volwassenen.
Sarcopenie
Sarcopenie, oftewel de effecten van het
ouder worden op spiermassa en
spierkracht, staat sterk in de belangstelling
de laatste tijd, met name doordat mensen
steeds ouder worden. Aangezien spier-
echografie de spierstructuur en spierdikte
kan weergeven, kan deze techniek binnen
het onderzoek naar sarcopenie een bijdra-
ge leveren [Arts 2007]. De echografische
gegevens zouden gecorreleerd kunnen
worden aan spierfunctie, valneiging, inter-
ventie strategieën, etc., als een eenvou-
dige maat voor de toestand van het
spierweefsel en om de effectiviteit van
interventies te bepalen.
Sportgeneeskunde
Spierechografie kan de spierarchitectuur
zoals de lengte en pennatiehoek van
spierfascikels in beeld brengen. Deze
parameters correleren met krachtopbouw
en zijn al gebruikt om bijvoorbeeld het
effect van verschillende sporten op de
spier te evalueren [Brancaccio 2008]. Een
toepassing zou bijvoorbeeld kunnen liggen
in de evaluatie van verschillende trainings-
regimes (kracht- ver sus duurtraining,
etc.), en het effect van overbelasting en
sportblessures op het spierstelsel.
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C. Toekomstige
ontwikkelingen op het
gebied van kwantificering
van spierechografie
Kwantificeren van stilstaande
echobeelden
Zoals beschreven in hoofdstuk 11,
vertonen verschillende neuromusculaire
aandoeningen specifieke eigenschappen op 
hun echobeeld, wat mogelijk kan helpen
bij een verdere differentiatie tussen deze
aandoeningen. Tot nu zijn deze karakteris-
tieken alleen beschreven op basis van een
visuele beoordeling van de echobeelden.
Dit is een tamelijk subjectieve methode,
die tevens erg afhankelijk is van de
ervaring van de beoordelaar. Idealiter
zouden deze patronen, zowel qua spierbe-
trokkenheid als verspreiding van echo-
intensiteiten binnen een spier, ook
gekwantificeerd worden. In hoofdstuk 14
worden 2 pilotstudies beschreven waarin
nieuwe kwantificeringsmethodes, geba-
seerd op het grijswaardehistogram en een
zogenaamde co-occurence matrix, wor-
den beschreven. Deze experimentele
methodes bleken echter nog niet effectief
te zijn. Dit komt met name doordat het
echobeeld van zichzelf een gespikkeld
patroon (‘speckle’) vertoont, wat de
uitkomsten van de onderzochte methodes
te sterk beïnvloedde omdat deze geba-
seerd zijn op anal yses op pixel-niveau.
Toekomstige methodes zullen het echo-
beeld op een wat grotere schaal moeten
benaderen of fil ters moeten gebruiken
waarmee het spikkelpatroon van het
echobeeld wordt weggefilterd of uit-
gevlakt.
Kwantificeren van dynamische
echobeelden
Een belangrijk onderdeel van de toekomst
van spierechografie zal liggen in dyna-
mische beeldvorming van de spier.
Kwantificeren zou ook bij deze toepassing
van toegevoegde waarde kunnen zijn.
Elastografie is een veelbelovende kwanti-
tatieve techniek voor analyse van
dynamische spierechografie, en zou
mogelijk kunnen helpen in de differen-
tiatie tussen pathologische bewegingen
van delen van de spier, zoals fasciculaties,
en bewegingsartefacten. Deze techniek zal
echter niet direct van nut zijn bij de
detectie van fibrillaties, omdat deze bewe-
gingen te klein zijn om met elastografie te
kunnen waarnemen. Elastografie maakt
namelijk gebruik van het volgen van pix els
(‘pixel tracking’) om te beoordelen waar
pixels met een bepaalde intensiteit zich
naar toe verplaatsen. Andere kwantifice-
ringmethodes zullen ontwikkeld moeten
worden om deze hele kleine onregel-
matige bewegingen in kaart te brengen,
bijvoorbeeld door de mate en snelheid van
intensiteitsveranderingen van pixels te
kwantificeren.
Een brug slaan tussen structuur en
functie
Een erg interessant project zou de
combinatie van kwantitatieve dynamische
technieken, electrodiagnostische technie-
ken zoals oppervlakte- of naald EMG, en
krachtmetingen zijn. Hiermee kan de
interactie tussen elektrische fenomenen,
de resulterende mechanische (structurele)
gevolgen en uiteindelijke krachtsontwik-
keling worden geobserveerd. Zo kan men
meer te weten te komen over elektro-
mechanische koppeling, myofasciale
krachtsoverdracht en de pathofysiologie
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van aandoeningen waarbij deze interactie
is verstoord, zoals bij extracellulaire
matrix aandoeningen (bijv. Ehlers Danlos
Syndroom) of myotone syndromen.
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16.4 Con clu sie
Kwantitatieve spierechografie is een snelle, niet invasieve, pijnloze, zeer
betrouwbare en zinvolle techniek in het diagnostische traject bij kinderen met de
verdenking op een neuromusculaire aandoening. Toekomstig onderzoek zal zich
richten op het verder ontwikkelen van de diagnostische mogelijkheden en
toepassingen zowel binnen als buiten dit veld. Aangezien vrijwel elke afdeling
kindergeneeskunde, neurologie of radiologie de beschikking heeft over een
echoapparaat, raden wij spierechografie dan ook graag aan als nuttige en welkome
aanvulling op de huidige diagnostische mogelijkheden.
Voor meer informatie over de inhoud van dit proefschrift kunt u de auteur bereiken via e-mail:
s.pillen@cukz.umcn.nl
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Donderdag 16 december 1999 om 11.30u: twee geneeskunde studenten kloppen aan bij
professor Gabreëls op zoek naar een nieuwe uitdaging...
Zo begon een avontuur dat uiteindelijk uitmondde in dit proefschrift. Een traject van meer
dan 9 jaar waar veel mensen een belangrijke bijdrage aan hebben geleverd en die ik via deze
weg graag wil bedanken.
Ralph Scholten, jij was die andere student. Twee jaar lang hebben we heel intensief
samengewerkt om dit onderzoek van de grond te krijgen. Leren echoën, protocollen
maken, literatuur doorspitten, tot op 29 februari 2000 de echte dag kwam: onze eerste
echte patiënt kwam voor de eerste echte spierecho. Er volgden er nog velen en wat bleek:
de spierecho werkte echt! Behalve de artikelen die het ons opleverde, heeft deze periode
mij vooral geleerd hoe leuk onderzoek doen is, zeker als je dit samen met iemand kan doen
die net zo enthousiast en gedreven is als jezelf. En hoewel jij na twee jaar een andere weg
bent ingeslagen, blijft de spierecho van ons samen, die hebben wij toch maar mooi op de
kaart gezet!
Professor Gabreëls, dank voor de kans die wij hebben gekregen en het vertrouwen dat u ons 
gaf om als derdejaars geneeskundestudenten met dit pro ject te beginnen.
Machiel, bedankt voor de voortreffelijke begeleiding de afgelopen 9 jaar. Jij gaf mij alle
ruimte om mijn eigen weg te zoeken in dit onderzoek, zorgde voor vrijwel ongelimiteerde
ondersteuning van de afdeling en wist mij met je nuchtere opmerkingen te beschermen
tegen mijn soms al te grote enthousiasme.
Aad, jij mocht al na een paar weken de begeleiding van pro fessor Gabreëls overnemen.
Gesprekken met jou zorgde altijd dat ik het liefst de hele nacht wilde doorwerken om alle
nieuwe ideeën tot uitvoer te brengen. Motivatiedips waren hierdoor een zeldzaamheid en
nooit van lange duur! Dank voor je enthousiaste sup port en belangrijke brug naar de
klinische praktijk.
Hans, als paranimf mag jij me komen bijstaan op de dag van de promotie, maar onze
samenwerking stamt al vanaf de eerste dag: 1 februari 2000 om half negen ’s ochtends
maakte we onze eerste proefecho, en natuurlijk waren daar de gebruikelijke computer-
problemen. Sindsdien heb jij een belangrijke bijdrage geleverd aan de technische kant van
dit onderzoek, was je een van de belangrijkste sparringspartners (de beste ideeën ontstaan
in het park!) en hoop ik in de nabije toekomst met jou als businesspartner de spierecho op
de nationale en internationale kaart te krijgen!
Oscar, een praktische dokter in hart en nieren. Jouw gezonde afkeer van onderzoek bracht
mij altijd weer met beide benen op de grond en zorgde er onbewust voor dat het klinische
belang van mijn onderzoek altijd voorop bleef staan in de keuzes die ik maakte. Bedankt
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voor je steun en onvoorwaardelijke vriendschap van de afgelopen jaren. Ik ben blij dat jij als
paranimf naast mij wil komen staan op deze belangrijke dag!
Wilma, met jou hebben Ralph en ik onze eerste stappen gezet in de wereld die spierecho
heet. Hoe raar voelde het om na 2 jaar de rollen omgekeerd te zien en jou en Henny het
nieuwe pro tocol te moeten leren. Daarna hebben jij en Henny, samen met Miriam, de
meeste echo’s gemaakt en gezorgd voor de gigantische databak die er nu is. Bedankt voor de 
fijne samenwerking en jullie tomeloze inzet tot soms laat in de middag: alleen hierdoor is
het mogelijk geweest om zoveel patiënten en proefpersonen gepland en gemeten te
krijgen!
Zonder proefpersonen geen klinisch onderzoek. Inmiddels zijn er ruim 2000 spierecho’s
gemaakt, waarvan de helft bij kinderen en groot deel daarvan in het kader van onderzoek.
De kinderen die direct aan dit onderzoek hebben meegewerkt staan vermeld in de cirkels
op het voorblad. Hoe eng sommigen het in het begin ook vonden, hoe lastig het soms in te
plannen was tussen school, voetbal en vriendjes door, jullie zijn allemaal gekomen,
sommigen 4 jaar lang en wel 8 keer in totaal! Gelukkig is het niemand gelukt mij
daadwerkelijk door de muur te duwen, maar het scheelde niet veel! Door jullie hulp wordt
de spierecho nu dagelijks gebruikt in het Radboud en binnenkort ook in andere
ziekenhuizen. Ook alle vriendjes en vriendinnetjes die meekwamen voor de gezelligheid
(en vaak een geweldige hulp bij de krachttesten waren!) en ouders en grootouders in hun
belangrijke functie als chauf feur wil ik bij deze hartelijk bedanken.
De 7e spierecho van Meike (zelfs een gebroken arm kon haar niet tegenhouden!) en Wouter (nog een paar
keer en dan kan hij zelf de echo maken!).
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May, Yvonne, Netty en Angelique. “Ach, toe, die patient komt helemaal uit Sittard en
moet nog naar Utrecht, die kan er toch wel even tussendoor?” Dat jullie af en toe niet
helemaal gek van mij zijn geworden vind ik nog altijd een raadsel... Super bedankt voor
jullie logistieke ondersteuning!
Eva Morava, Lilian Sie, Michel Willemsen, Gea Drost, Baziel van Engelen, Theo Fiselier,
Esther Hoppenreijs, Henk ter Laak, Mar tin Lammens, Ria Nijhuis-Van der Sanden:
spierecho bevindt zich op het grensvlak van de (kinder)neurologie, reumatologie en KNF
en heeft een duidelijk brug naar de pathologie en fysiotherapie. Bedankt voor de prettige
samenwerking en jullie positie als vraagbaak en brug naar deze disciplines. Ik hoop op een
voortzetting van deze vruchtbare samenwerking.
Mieke, Mark, Xavier, Marjolein en Jacqueline als stagiaires hebben jullie een belangrijke
bijdrage geleverd aan dit onderzoek: Duizenden lasso’s, tientallen statussen en moeilijk
programmeerwerk en dat alles met veel enthousiasme en inzet. Ik heb erg fijn met jullie
samengewerkt en vond het een eer jullie te mogen begeleiden in het worden van echte
onderzoekers!
Ilse, jij hebt de “volwassen tak” van spierechografie overgenomen, met name op het gebied
van ALS. Bedankt voor de fijne samewerking tot nu toe en heel veel succes met je eigen
boekje! Vele handen maken licht werk... Frank, Fleur, Jiske, ook jullie hebben de
afgelopen tijd er voor gezorgd dat de spierecho zich verder binnen de volwassen neurologie
en reumatologie heeft uitgebreid. Bedankt daarvoor.
Nicol en Jeroen, bedankt voor het vertrouwen dat jullie hadden dat spierechografie iets kon 
bijdragen aan jullie promotieonderzoek. Ik vond het erg leuk om met jullie te mogen
nadenken over de pathofysiologie achter de aandoeningen die jullie onderzoeken en met de
spierecho hierin iets te kunnen bijdragen.
Ramon, als iemand mij 10 jaar geleden had gezegd dat ik ooit nog een hond zou echoën en
daarna zelf hele spieren eruit zou halen, dan had ik diegene compleet voor gek verklaard! Ik
vond het een erg bijzondere ervaring, die ook nog heeft geleid tot een van de belangrijkste
artikelen qua fundamentele basis van spierechografie. Bedankt voor deze kans en de fijne
samenwerking (vooral die avondjes met wijn en lekker eten moeten we gauw nog eens over 
doen)!
Merel, bedankt voor je hulp bij het verdere onderzoek naar spierechografie bij Duchenne.
Ik ben blij dat jij de echo meeneemt in je onderzoek naar training bij Duchenne. Ik was er de
komende tijd waarschijnlijk niet aan toe gekomen, en aangezien dit een van de belangrijkste
nieuwe toepassingsgebieden van spierechografie in de toekomst zal zijn, ben ik blij dat het
niet stil is blijven liggen. Bedankt voor je inzet (hoeveel lasso’s waren het ook al weer?) en
fijne samenwerking!
Chris, Gert en Rich ard, van het Klinisch Fysisch Laboratorium kindergeneeskunde, met
jullie uitgebreide basale kennis over kwantitatieve en dynamische echografie waren jullie
zeer geschikte sparringspartners. Het "omzettingsstuk", hoewel misschien niet zo
spectaculair, is een van de belangrijkste fundamentele artikelen van dit proefschrift
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geworden. Alleen hiermee hebben we kunnen aantonen dat kwantitatieve echo niet alleen
beter is, maar ook eenvoudig breed toepasbaar. En met alle plannen ten aanzien van
dynamische spierecho en textuuranalyse hoop ik op een langdurige vruchtbare
samenwerking in de toekomst!
De FTG groep, inmiddels vrijwel volledig van samenstelling veranderd, maar altijd de basis
voor een optimaal onderzoeksklimaat: brain storm sessies, vraagbaak of peptalk, maar
bovenal gezelligheid. Dick, Maartje, Robert, Mireille, Dymphy, Bert, Gijs, Edwin, Hans,
Mark, Jan, Sebastiaan, Paul en alle stagiaires van de afgelopen jaren: mede door jullie ging
ik elke dag fluitend naar de KNF en beschouw ik regelmatige theepauzes en een stevige
wandeling in het park als essentiele voorwaarden voor goed onderzoek!
Alle collega's van de kindergeneeskunde uit het Radboud en het CWZ: van jullie kreeg ik
alle ruimte en medewerking om ook tijdens klinische opleidingsjaren verder aan mijn
onderzoek te werken. Vele van jullie namen mijn pieper even over als ik voor besprekingen
of metingen  naar de KNF moest, en daarnaast hebben jullie direct of indi rect vele proef-
personen aangeleverd en zijn op papa- of mamadagen naar het ziekenhuis gekomen voor
metingen. Super!
De afronding van dit proefschrift valt samen met het begin van mijn zwangerschapsverlof en 
daarmee ook het einde van mijn tijd bij de JA-NVK. Vandaar dat ik van deze plek graag
gebruik maak om alle JA-bestuursleden te bedanken voor de leerzame en erg leuke tijd die
ik heb gehad o.a. als bewaker van de JA-schatkist.Veel succes met jullie belangrijke taak om
ook in deze roerige tijd van opleidingsveranderingen en tekort aan mankracht de belangen
van de AIOS kindergeneeskunde te behartigen.
Pa, Ma, Opa, Oma, Koen, Stef, Moniek, Esther, Evelien, Chris, Anke, Pierre, Kirsten,
Rick, Vanessa, Michiel, Mik, Kevin, Annemiek, Femke, Tim, Judith, Dimitri, Steef,
Beate, Esther, Lot, Floris, Nike, mijn schildersmaatjes Hans, Lex, Pat rick, Selma,
Marjolein, Jeroen, Lianne en Ivo, en alle andere vrienden die ik in de afgelopen jaren om
me heen heb mogen verzamelen: promoveren, opleiding, commissies, creatieve uitspat-
tingen en relaxen met vrienden en familie - waarom zitten er maar 24 uur in 1 dag??
Bedankt voor jullie onvoorwaardelijke vriendschap, gezellige uurtjes en steun als dat nodig
was. Alleen dat heeft het mogelijk gemaakt dat ik energie hield om ook de drukke en
hectische tijden door te komen en dit proefschrift neer te zetten. 
Lieve Nens, volgens mij zijn twee woorden genoeg: 
Optimale belangenverstrengeling. Weet je wel hoe blij ik daarmee ben?


